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Oral evidence
Taken before the Health Committee
on Thursday 19 January 2006
Members present:
Mr Kevin Barron, in the Chair
Mr David Amess Dr Doug Naysmith
Charlotte Atkins Dr Howard Stoate
Mr Ronnie Campbell Dr Richard Taylor
Anne Milton
Witnesses: Dr Felicity Harvey, Head of Medicines, Pharmacy and Industry Group, Mr Mike Brownlee,
Deputy Head of Medicines, Pharmacy and Industry Group, Dr Barry Cockcroft, Acting Chief Dental
OYcer, Mr Ben Dyson, Head of Dental and Ophthalmic Services, and Mr Rob Smith, Director of Estates
and Facilities Management, Department of Health, gave evidence.
Q1 Chairman: Welcome to the first evidence session not know whether my colleagues on the optical and
dental services would like to comment from theirthat we are taking on our inquiry into NHS charges.
particular perspective.I wonder if I could ask you to introduce yourselves.
Dr Cockcroft: From a dental point of view, theDr Harvey: I am Dr Felicity Harvey and I am head
system of charges for patients is based very much onof Medicines, Pharmacy and Industry Group within
the way the clinicians are remunerated for thethe Department of Health. My group looks after
services they provide. It has been a constant sourceprescription charge policy and the NHS Low
of complaint for some time, both the complicatedIncome Scheme.
way we remunerate dentists and the complicatedMr Brownlee: My name is Mike Brownlee and I am
way in which patients therefore are charged. ThatDr Harvey’s deputy.
has been a really diYcult issue for the last few years.Mr Smith: My name is Rob Smith. I am Director of
We have just been through a programme of reformEstates and Facilities Management, which covers
of patients’ charges, with significant patientcar park issues and patient telephones and patient
involvement. A significant message from thetelevisions.
patients was that we needed a much simpler, clearerDr Cockcroft: I am Barry Cockcroft. I am Acting
system, and that fits very neatly into the reform ofChief Dental OYcer for England, responsible for
the way we remunerate dentists which we are goingprofessional advice within the Department of
through at the moment. We are addressing that issueHealth on dental issues.
at the moment in the dental charges.Mr Dyson: I amBenDyson, I am Headof theDental
Mr Dyson: If you look at charges for dental servicesand Ophthalmic Services Division within the
and the system of the NHS sight tests, successiveDepartment of Health.
administrations have taken the view that it is
reasonable to ask those who can aVord to do so to
make a contribution to the cost of those services. I
Q2 Chairman: Thank you very much. I wonder if I think it is also important perhaps to distinguish
could start with the first question, directed to any or between some of the factors that may have led the
all of you. You will have probably heard this governments of the past to introduce such systems.
comment before: Lord Lipsey of the Social Market If you look back, for instance, to 1951, there were
Foundation described the current system of health special circumstances that surrounded dentistry,
charges as “a dog’s dinner, lacking any basis in with, I think it is fair to say, an unexpected level of
fairness or logic”. What are the underlying demand for dentures, so diVerent factors may have
principles of the system that we currently operate? influenced the introduction of those charges in
Dr Harvey: The charges we currently have for the first place. The decision that has faced
prescriptions, dental treatment and ophthalmic administration since then has been more about
services date back to 1951 to 1952. That is the time whether to continuewith these systems orwhether to
that charges were first introduced. Certainly, if you abolish or alter them in some way, and of course
look for prescription charges, they remained until diVerent considerations then come into play.
1965, were abolished, and then reintroduced due to Governments have had to take into account the
concerns, we understand, about the rising drugs bill contribution which the system of charges makes
in 1968. The policy on the individual areas has very towards meeting the overall costs to the health
much related to the clinical services which they service; they have had to take into account the fact
support. Certainly in terms of prescription charges, that there is little evidence to suggest that those
the policy in terms of the broad levels of exemptions, charges produce poorer health outcomes; and they
have had to take into account the fact that thesehas been relatively unchanged really since 1968. I do
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systems are now well established and, broadly, I Welsh Assembly decided to start reducing their
prescription charge there has not been anythink it is fair to say, accepted, in the sense that,
where we receive concerns from patients about, for noticeable change in trend.
instance, dental charges, as Dr Cockcroft says, these
tend to be more about the structure of the system Q7 Chairman: Is there any evidence that charges
than about the principle of charging per se. should be increased, on the basis that if they were
Dr Harvey: I think underlying all of this has been the increased people would seek to take responsibilities
principle, for those areas in which the Government for their own health as opposed to relying on the
decided that charges should be levied, that those that National Health Service?
are able to contribute should do so and those who Dr Harvey: From the prescription charge
are unable to contribute should be protected perspective, certainly the prescription charge has
through either benefits or, indeed, the NHS Low been looked at in recent years annually by
Income Scheme. ministers—I think, in the same way that many of the
benefits are—and there has not been any decision to
Q3 Chairman: My colleagues will be taking one or raise them significantly in recent years. Since about
two of these matters up on a more individual and 1997, the increase has been 10p per year, which
focused based later on. Whilst you cover the areas actually, if you look over the period, that particular
that you have outlined to us, you will not be immune period, is in fact a real terms decrease of 4.5%. I
to the debate that is taking place in diVerent parts of think the Government is very well aware that there
the United Kingdom about the potential to abolish is an issue of aVordability. Certainly, from the work
prescription charges. I wonder if you have any views that was done by Citizens Advice and the MORI
on what the costs of abolishing charges would be in work back in 2001, we are aware that there are some
terms of prescriptions, optical and dental services. low-income groups where a huge rise in prescription
Dr Harvey: In terms of prescription charges, at the charges would be very diYcult. In fact, a lot of the
moment they bring in an income of about £427 work we are doing through the Prescription Pricing
million per year (estimate for 2005–06). Over the last Authority is for the prescription charge that we
year, that has fluctuated slightly: £422 million currently have, trying to get better and better at
(2004–05), £426 million (2003–04), but it is roughly targeting those low income groups, so that they are
in that sort of area. aware not only of the benefits that are available to
Mr Dyson: In terms of dental charges, it is always them through the Department of Work and
slightly diYcult to predict in advance exactly what Pensions but also the NHS Low Income Scheme.
level of dental charges are going to be collected, but
the aim of the new dental charging system, amongst Q8 Chairman: Do you think this is flexible enough at
the benefits it brings for patients, is to make sure that this stage, or do you think there is a level of
we do not raise a greater proportion of charges than inflexibility about it leading from that?
now. That would mean that abolishing that system Dr Harvey: Certainly, in terms of the NHS Low
would mean that the NHS would forego income of Income Scheme and the information we have been
up to around £600 million. For sight tests, we aware of through the Citizens Advice work and
estimate that if you were to extend free sight tests to other work that is being done by academics such as
all those who currently pay privately for sight tests, Professor Peter Noyce, we have tried over that
the costs would be about an additional £92 million, period to make some minor amendments to the
based on the current rate of £18.39 per test. NHS Low Income Scheme so that it is slightly more
flexible in terms of meeting the needs of those people
Q4 Chairman: Are both of those figures, the who have low incomes.
£92 million and £600 million, per annum? Dr Cockcroft: With regard to dentistry, patients’
Mr Dyson: Yes. charges have always been calculated as a percentage
of the fee the dentist receives, so there has always
been a direct link between the percentage increase inQ5 Chairman: Was your figure per annum,
dental fees paid to the dentist and the patient’sDr Harvey.
charge. That has been there since the dental chargesDr Harvey: It is a per annum figure.
were introduced. From April next year, that link is
taken away, but we have been involved withQ6 Chairman: That would be the costs of abolition,
patients’ groups in working out the new system ofeVectively, as far as England is concerned.
patients’ charges, and we have not detected theMr Brownlee: I wonder if I might add, in terms of
intention to make any increase in dental chargesprescription charges—and I do not have a figure for
disproportionate in the new system.you—that we believe there might also be an
influence on the drugs bill, in the sense that, for some
of those people who are currently paying charges Q9 Dr Stoate: Just for the record, could I start by
reminding the Committee of my declaration in theand perhaps go to their community pharmacy and
buy a medicine over the counter, there might be an Members’ interest book that I am still a practising
GP. We have heard from Dr Harvey the reasons whyincentive to go to their GP and get a prescription.
But it is almost impossible for us to forecast we have charges and how it happened, but I have not
yet heard the underlying principles behind it. Are wepotential changes in behaviour, and one has to say
that, if you compare the growth of the drugs bill really saying this is about raising money, reducing
demand on services or reducing the drugs bill?since 2001 between England and Wales, since the
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Dr Harvey: The fundamental principle that we had be worth adding is that certainly with the pre-
back in 1951–52 is historical. I could not tell you payment certificates that are now administered by
exactly why the charges were decided to be made on the Prescription Pricing Authority (PPA), we now
those particular things. We do think that back in have a maximum charge for prescription charges
1968, when prescription charges were reintroduced, annually of £93.20, or, for a four month period, of
there may have been concerns about the NHS drugs £33.90.1 If you look at the number of prescription
bill at that time. items for the exempted groups, they are quite a lot
higher than the average. The average number of
prescription items per person per year is about 14. IfQ10 Dr Stoate: But that does not answer the you look at those people who pay for theirquestion as to why particular conditions were prescriptions and have the pre-payment certificates,singled out. If the Government was simply trying to it is about 46 items per person per year, and, if youreduce the cost of prescriptions, why was there not look at those who are medically exempt, I think it issimply a blanket charge for prescriptions? A about 232 prescription items per year. But I think weprescription costs this much—end of story. I still should also remember that, in terms of prescriptionhave not understood the principles behind it. items, currently 87% of prescription items areDr Harvey: Historically, in terms of why particular
exempt prescription charges. So it is only 13% ofmedical conditions were chosen, it is something that
prescription items where a charge is paid and in facthappened in consultation with the medical
5% of prescription items are paid through pre-profession back in 1968. Those conditions have been
payment certificates.unchanged since that time, even though we have had
representations from a number of diVerent chronic
disease condition groups. But the principle has really Q13 Dr Stoate: When you talk about aVordability,
been around that of: those who can aVord to which I would like to come on to now, figures we
contribute, should do so, and that we protect those have seen from Which?, for example, show that 6%
who have diYculty in aVording charges. That has of those on low incomes fail to take courses of
really been the basis of the changes that have taken prescribed medications because of cost and 24% fail
place in recent years. to consult a dentist for the same reason. Certainly,
as a GP I can recount many occasions when people
have said to me, “I simply cannot aVord threeQ11 Chairman: This sounds suspiciously like: We
prescriptions, which one can I do without?” Myhave always done it and therefore we are carrying on
pharmacist colleagues say exactly the same thing:doing it. You still have not explained to me. The
people will take their prescription to the pharmacistprescription charge principle having been put in
and have quite a diYcult discussion sometimes withplace nearly 40 years ago, no-one seems to have
the pharmacist about which of the medications theychallenged the reasonwhy it was brought in and why
can strike oV, which cannot possibly be good forwe have not changed it.
patient care. You talk about equitable charges andDr Harvey: From what we understand, the issue of
you talk about aVordability and yet there is verythe particular medical conditions that we have at the
good evidence from a number of sources that somemoment, which date back to 1968, has been looked
people simply are not getting the drugs their doctorat on a few occasions but on each of those occasions
says they ought to have because of cost.ministers have made the decision not to add or
Dr Harvey: We are very conscious, particularly, ofchange the list of medical conditions that are exempt
the Citizens Advice work that was done in 2001 and,from prescription charges.
indeed, Professor Peter Noyce’s work around the
same period, and, it is as a result of that, that in 2004
Q12 Dr Stoate: Does that mean that no serious we made the change to the NHS Low Income
consideration has been given in that case to a more Scheme which increased the level by which income
flexible system or an alternative system completely. exceeds requirements for the Low Income Scheme to
For example have we looked in detail at some of the include half the cost of a prescription. Particularly
European alternatives? Have we really considered in for those people on incapacity benefit, who are not
detail what other countries do, in Scandinavia, for passported automatically to free healthcare costs
example, or have we simply said, “We do this, and they would have to apply through the NHSLow
therefore we have to carry on doing it”? Income Scheme, we are aware that from that change
Dr Harvey: On the occasions when ministers have about 44,0003 additional people within income
looked at prescription charges, they have not made benefits, who were only able to have partial help
any decisions to change from the broad principles before that, became able to have full help. We are
that we currently have. I think there is also an issue very much aware of these issues, which is why there
in terms of the medical conditions that we currently have been the changes to the NHS Low Income
have. Clearly there are now very many chronic
medical conditions that we are able to treat and treat 1 Note by witness: Pre-payment certificates (PPCs) have been
very eVectively. I suppose the issue is that, if you available since 1968 and the arrangements have been
administered by the PPA since October 2002.have a large number of medical conditions, where
2 Note by witness: Individualswithmedical exemption have anmight one draw the line? The approach has certainly
average of 33 prescription items per person per year. Seerecently been in terms of aVordability and trying to answer to Q19.
ensure that those who would have diYculty in 3 Note by witness: Estimated froma sample, when rounded the
final figure is near 45,000.paying are protected. The other thing that it would
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Scheme—which include giving people over 65 Dr Harvey: I am sorry, I apologise I made a mistake.
In fact it is 33 items per person per year for thosewhofive-year exemption certificates rather than the 12
months which we have for other people. are medically exempt. My apologies.
Q14 Dr Stoate: People who are 60 do not pay Q20 Dr Taylor: Even that is still quite low. No, it is
prescription charges at all. just more than two items per month. Then you finish
Dr Harvey: But they do pay for dental, optical and up with a figure that something like only 13% of
also health care travel costs. items are charged.
Dr Harvey: They are. In total 13% of prescription
Q15 Dr Stoate: Nevertheless, whichever system you items are charged for. In total 8% are paid for by
bring in, there are going to be people above the people paying at the point of dispensing and 5% in
threshold level. Whatever you do to the threshold total have a prescription pre-payment certificate.
level, there will always be people just above it. Have
you considered a tapering scheme to help such Q21 Dr Taylor: That 13% raises £427 million per
people? year.
Dr Harvey: Again, as a result of the work that has Dr Harvey: That is correct. The issue is that those
been done, the PPA, who took over the people who are medically exempt are medically
administration of the pre-payment certificate in exempt for the condition they have; but they are
October 2002, have been looking at the medically exempt, as a result of which, they are
recommendations that came from Citizens Advice, exempt any prescription charge on any item. That,
which were things such as: Have we considered again, is historical.
monthly payments for the pre-payment certificate?4
and also: “Have we considered doing something Q22 Dr Taylor: Which seems pretty unfair.
through the Low Income Scheme in terms of a Dr Harvey: Although perhaps I could add that the
sliding scale”? These are issues which the PPA has diYculty, where you have people who have a
been looking at. We think they are due to be coming medical exemption, in deciding which of the
to ministers in the not-too-distant future. medications might be either directly related to their
condition or, indeed, partially related to their
Q16 Dr Taylor: Dr Harvey, I think you have lost me condition, would need quite a lot of clinical input to
and I would like to go back over some of this mass make those decisions.
of figures you have given us. First, you have said that
the principle is that: those able to contribute should Q23 Dr Taylor: Meaning that somebody with
and those unable to should be protected. I fear that diabetes you would argue that their treatment for
is going to raise an absolute furore, because there are hypertension was so important for the diabetes that
many who could contribute a great deal more who it was related. I see what you mean.
are exempt and there are many . . . Think of Dr Harvey: I think that is probably one of the
somebody with hypertension, who has to have at reasons why, for those who are exempt, all of the
least a combination of three drugs, all separate, who prescriptions are medically exempt rather than just
is on a low income but not suYciently low for them those specifically tied to the condition. I am not
to be free. Three charges, three times £6.50 a month, exactly sure why, but I would surmise that may
is a vast amount. People are exempt, on average, have been—
23 items per year. Is that what you said?
Dr Harvey: People who have medical exemption I
Q24 Dr Taylor:DrStoate rather touched on this, butthink have about 235 prescription items per person
is there evidence that the prescription charges reduceper year on average.
the take-up of medicines by those who really cannot
aVord to pay?Q17 Dr Taylor: Then, for those who were not Dr Harvey: Certainly, from the Citizens Adviceexempt, you said it was something like 46. research that was done back in 2001, they wereDr Harvey: Those who have a pre-payment flagging that there was a concern that up to 290,000certificate, which is 5% of prescription items, they non exempt patients might suVer as a result of thehave on average 46 prescription items per year. charges. Since that time, we have made further
changes to the NHS Low Income Scheme. The other
Q18 Dr Taylor: Obviously they are people who are thing—and I know this has been flagged—is that
not exempt, who know they are going to have to pay there may well be people who could get help throughan awful lot, pre-paying, so that they pay a bit less the NHS Low Income Scheme but are not aware of
Dr Harvey: They pre-pay, which means that the it, and that is why the Prescription Pricing
maximum they would pay, with a 12 months Authority, since they took over responsibility forcertificate, would be £93.20 per annum. this—and, indeed, they on behalf of the Department
of Health take forward all the publicity—lead with
Q19 Dr Taylor: I find the 23 items per year for those a publication of this particular document. We have
exempt relatively small. provided for the Committee copies of the sort of
information that is published. That is why they are
4 Note by witness: Citizens Advice suggested monthly working very hard with patient groups, Citizenpayments for a PPC not a one month PPC
Advice, and, indeed, the NUS, who are another5 Note by witness: Correct figure is 33 prescription items per
person per year. group, around trying to ensure that we better target
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the information about helpwith health costs to those patient groups around both the targeting of
information about both pre-payment certificates aswho need it. It might be worth adding also that that
information is also on the patient’s part of the well as the NHS Low Income Scheme. So they are
working quite hard with those groups.prescription form—and, again, we have supplied a
copy in the information to the Committee. Mr Brownlee: Chairman, we know also that there
are other reasons why patients either do not go to the
doctor or, having been to the doctor and got aQ25 Dr Taylor: Do you have any feel of the drugs
prescription, decide not to obtain it, and then, eventhat cost less than £6.50 for the number of people
when they have got it, decide not to take it. We knowwho buy those that are available without a
there is something like probably £200 million worthprescription? Was that one of the figures you gave
a year of medicines in people’s medicine cabinetsus?
that are not taken, so there is a whole raft ofDr Harvey: No. The information I have available is
reasons there.that there is an average net ingredient cost for each
of these groupings. If you look at the net ingredient
cost for all of those people who pay for Q29 Chairman: Evidence about pre-payment—the
£93.20, you said.prescriptions, whether it be by pre-payment
certificate or actually at point of collection, the Dr Harvey: £93.20 for a 12 months pre-payment
certificate.average net ingredient cost is £14.32, and obviously
the prescription charge is about 45% of that. But
clearly the prescription items that are prescribed Q30 Chairman: That is money up front, is it?
vary in their cost. Some are much more expensive. Dr Harvey: It is indeed.
Q26 Dr Taylor: Is there any regular information Q31 Chairman: Is there any evidence that that is a
given to a patient, “The prescription charge is £6.50. problem in terms of people accessing that system,
This would only cost you £5 if you bought it without having to find £93.20.
a prescription.” Is there any record of the sorts of Dr Harvey: We certainly know that in terms of the
people who get that information and take it up? take up of pre-payment certificates (PPCs) the take-
Dr Harvey: I do not particularly know of it, up is increasing year on year. We are aware though,
although anecdotally one is aware that sometimes again from the previous research, that there may be
general practitioners might say to patients, “These issues of aVordability for those who are over the
are the things you need. You might want to get that threshold for theNHSLow Income Scheme and that
from your pharmacist.” But I do not have any is why the Prescription Pricing Authority is doing
information on that, I am afraid, no. work around the possibility of monthly payment for
Mr Brownlee: Chairman, anything that is sold to a prescription pre-payment certificates, and also the
patient as an over-the-counter medicine is the other thing which was raised, a sliding scale for the
private business of community pharmacists and we NHS low income scheme. They are looking at that
do not have any remit or record of what takes place. at the moment and will clearly come to ministers. Is
Dr Harvey: But items that are on an FP10, as you it worth adding, Chairman, that in terms of the
know, are the items that are prescribed under the average number of prescription items per script
NHS. (prescription form), the average number is two. If
one were able to move to a monthly payment for a
prescription pre-paid certificate, in fact that is likelyQ27 Dr Taylor: Would chemists have the right, if
something was on an FP10 and they knew it only to be less than the cost of two prescription items.
Also, once you have 15 or more prescription itemscost £4, to cross it oV and suggest the patient bought
it at £4? per year, then in fact that is the pre-payment
certificate paid and that is the level at which it isMr Brownlee: I do not think they have the right. I
think I am right in saying that, if something is capped.7
prescribed by a doctor, then that is what they have
to dispense. What happens in real life, sometimes, Q32 Dr Naysmith: I would like to explore with Dr
might be diVerent. Harvey some things that have already been touched
on. It is this question of the logic behind
exemptions—not just particular diseases beingQ28 Dr Taylor: Again anecdotally we hear stories of
people who have been frightened to go to the doctor exempt, some are and some are not, but, if you are
in hospital, you get your drugs free, but as soon asbecause of the risk of the amount they had to pay
and they could not find it. Is there any evidence to you come out of hospital you are back on to paying
prescription charges again if you are in a certainback that up?
Dr Harvey: The information we have on that dates category. There are one or two other anomalies of
this whole system. For instance, if you are in anback to the research that was done by Citizens
Advice. That is actually why the Prescription Pricing exempt category for a particular disease, then you
get all your prescriptions free, not just the one thatAuthority are working quite hard with Citizens
Advice,6 the National Union of Students and other applies to the exemption. It is riddled with anomalies
6 Note by witness: Citizens Advice are not currently involved 7 Note by witness: The cost of a 12 month PPC is less than the
cost of 15 prescription items. Once a PPC has beenin PPA stakeholder meetings but they do advise on the
development of leaflets and posters. There is regular contact purchased no further charge is due, regardless of the number
of items dispensed.between local CA oYces and the PPA on individual cases.
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and lack of logic, as we have already touched on this Q36 Dr Naysmith: You would accept that for some
disease areas it is a kind of thing that people cannotmorning, but why does the Department not review
this list and get rid of these anomalies now? I have understand, why their particular disease is not
exempt where others are.written to them on a number of occasions, often to
do with cystic fibrosis, as I know a little bit about it, Dr Harvey: We do understand that there are many,
many patient groups which have major concernsand I get two replies back, either that this is being
held under constant review—but you or the about why, indeed, their condition is not exempt.
Department or the particular minister does not say
that anything has ever happened since 1968 to all Q37 Anne Milton: I know this may be slightly trickythese reviews—or they say, “We have recently for you. You did say at the beginning that you werereviewed it and we are not going to review it again responsible for prescription policy. I cannot see thefor a while”. These answers from the Department policy that makes the diseases exempt that areindicate that it is not a priority at least. Why do you exempt, and some, as my colleague mentioned, likenot review this list and get rid of these anomalies? cystic fibrosis, not exempt. What is the policy thatDr Harvey: In response to your comment about lies behind that?whether or not things are being reviewed, it is Dr Harvey: As I said, the exemptions date back tocertainly true to say that when we have issues that when they were brought in in 1968. On the occasionsare raised in correspondence from yourselves, we do that ministers have looked at them, the list has notlook at the issues, particularly in terms of the been extended but we have been looking at theaVordability and the feasibility, and it is on the basis aVordability issues.of those that actually many changes, particularly to
the NHS Low Income Scheme, eg the length of time
Q38 Anne Milton: Nobody is going to change thatwe have certificates for, et cetera, have indeed been
list of diseases, as far as you know.changed. In terms of major reviews of the
Dr Harvey: To date there have been no changes inprescription charge system, this is not something
that list of conditions that are medically exempt.that ministers have asked us to do at the moment.
We are not undertaking a major review of
prescription charges, although, as I say, we do keep Q39 Anne Milton: Are you aware that there is going
under constant review particular issues around to be in the future?
aVordability and making the system work better. Dr Harvey: We have not at the moment been asked
to do a review of medical conditions.
Anne Milton: Thank you.Q33 Dr Naysmith: But not the disease categories and
that kind of thing.
Dr Harvey: These are issues that ministers have Q40 Dr Naysmith: One of my questions was going to
asked oYcials to look at on a few occasions over the be: When are you going to look at the list again? The
years, but on each occasion that they have been other thing you have not answered is whether there
looked, at the ministers’ decisions have been not to is any logic. If someone is on the list and gets the
change them, but more around the aVordability prescription free for that particular condition, if
issues. they develop another condition do they get the
prescription free as well?—even though they may
not be poor.Q34 Dr Naysmith: Sticking with this question of the
Dr Harvey: I think the issue is one of complexity;anomalies—and I think you hinted at it earlier on—
that is, to be able to categorise which prescriptionthere have been such diVerences and medical
items, for example, for somebody who is medicallyimprovements in a number of these conditions, and
exempt, were nothing to do with the underlyingthere is a series of cancers that are very good
condition which gives them medical exemption.examples and also cystic fibrosis as well, that people
That could at times be quite complex and wouldsurvive much longer.
need a great deal of clinical input to do that.Dr Harvey: Yes.
Dr Naysmith: You could almost certainly find a GP
who would back up whichever argument you were
Q35 Dr Naysmith: It is a very diVerent situation, making. I should not have said that, Howard!
looking at these diseases now to looking at them 20
years ago. Why is the logic not extended? You are Q41 Dr Stoate: You talked about aVordability asnot going to say it is the ministers’ fault, are you? being the criterion, if you really are concerned withDr Harvey: Absolutely not. The issue is that clearly aVordability the only logical thing is to abolish allthere are very many very serious chronic conditions prescription charges because then probability goesand these have not been reviewed for a while. The away.issue would always be: where would you draw the Dr Harvey: Prescription charges do bring in aroundline? Therefore the approach has very much been £427 million a year.around aVordability and capping the cost of
prescriptions for those who pay. Again, only 13% of
prescription items are paid for; 87% of items are Q42 Dr Stoate: If aVordability is your criterion then
that is the way of getting round it.exempt prescription charges through age, medical
condition, benefit passporting, NHS Low Income Dr Harvey: I think it comes back to the principle of
those who are able to contribute.Scheme, or, indeed, maternity certificates.
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Dr Stoate: I do notmean to butt in on this, but I have that income versus the loss of that income to the
NHS on other services. If you do something thatone final point, a very quick intervention. If I treat
someone with an overactive thyroid, I give them maintains whatever the level of income is but there
are changes to the exemptions, there will be losers toCarbimazole and they pay for it. The moment I give
them too much Carbimazole and their thyroid pay for those people who are benefiting.
becomes under-active—which very frequently
happens—they do not pay ever again. Where is the Q48 Dr Naysmith: Have the figures been done to
logic in that? look at what the costs would be for extending the list
to include the patients suVering from mental illness
Q43 Dr Naysmith: And can it ever make sense for that I have mentioned and then cancer patients and
wealthy old-age pensioners like me to get their then those with cystic fibrosis? Have the costs been
prescriptions free when some people who are very worked out for individual conditions and the loss of
close to the levels of cut-oV do not get that. revenue that would be involved?
Dr Harvey: In terms of the age that we currently Mr Brownlee: The answer to your question is no,
have for exemption being 60, the age in fact for men and I will explain why. Because of the exemption
was 65, the age for women was reduced from 65 to from all conditions, to say what the cost would be is
60 in 1974, and in fact it was due to a case within the . . . You can do quite a big study through the GPRD
European Court on equality issues that in 1995 the database, but we have not done that. Equally, we do
charges were exempted for men aged 60 as well. not know how many patients suVering from those
conditions or any other conditions are already
exempt through another basis. It is a very diYcultQ44 Dr Naysmith: But that is explaining why they
calculation to do.got rid of the equality diVerences, not why people
Dr Harvey: Could I respond to your earlier point onwho can well aVord to pay for the prescriptions get
mental health patients? The issue around treatmentthem free and some people who cannot really aVord
formental health patients has been looked at aroundto pay for them have to pay for them.
the Mental Health Bill and is under consideration atDr Harvey: And I think again the exemption for
the moment.those—which was age 65 and has now become age
60, as I explained—really goes back to 1968, when
the prescription charges were reintroduced. Q49 Dr Naysmith: As a member of the joint
Commons and Lords Committee that looked into
Q45 Dr Naysmith: Continuing on this line in mental the Mental Health Bill, some of the costs are going
health conditions, changes recently –and there are to be tremendous. Butmaybe that is for another day.
more likely to be more in the future—provide for Finally, sometimes the argument is used—and I do
compulsory treatment in the community under non- not think you have used it yet today—that
residential treatment orders. The liberty of patients exempting people from prescription charges leads
who are involved in this is clearly dependent on their to the frivolous use of medicines and therefore
compliance with a medication regime, and yet they unnecessary charges. Is there any evidence for that?
have to pay for prescriptions. If they are admitted to Mr Brownlee: I am not aware of it. On the basis that
an institution they do not pay, but while they are in you have 87% already exempt, clearly we have other
the community they do pay. Here is another measures in the Department in terms of advising
anomaly. What are we going to do about that? prescribers, in terms of what should be prescribed,
Mr Brownlee: The issue has been that over the years and that is the way of getting at that; not trying to
these anomalies or things similar to them—and do it through prescription charges. If we were trying
obviously they have changed over the years—have to do it through prescription charges, having exempt
been looked at by successive administrations. The 87% to start with, then it would not be eVective.
outcome of this, in the main, apart from the areas we
have already identified to you, has been to retain Q50 Dr Naysmith: If there were any evidence for it,
broadly the same system. then one could get an answer to this question of
whether it exists by comparing the two groups, those
Q46 Dr Naysmith: So it is a series of ministers’ faults. who are exempt and those who are not, and seeing
Mr Brownlee: I am not trying to attribute blame. I whether there was an increase in frivolous use of
do not want to give you the impression that this has medicines in the groups that were getting them free
never been considered by anybody ever in the or exempted.
Department of Health. Mr Brownlee: I think the way this has been looked
at is through advice on prescribing across the piece,
for everybody, not just looking at whether they areQ47 Dr Naysmith: I am sure it has, but I am looking
to see if there is any real rationale behind it. With exempt or not exempt. Those are the measures the
Department has undertaken over a number of years,people suVering from ill health mental conditions,
this is happening because treatment is changing, not generic prescribing rather than brand medicines and
that sort of thing.because anything else is changing.
Mr Brownlee: Every time you are thinking of Dr Harvey: Perhaps I might add that there is
certainly quite a lot of advice to prescribers, bothchanging or abolishing, as was mentioned just now,
it is a matter of the loss of £420 million or £430 that produced by the National Prescribing Centre
but also the Drugs and Therapeutics Committeesmillion, or whatever the figure has been at the time,
and the priorities that administrations have put to and also, indeed, prescribing advisers within
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primary care. So there is quite a lot of advice around Q56 Charlotte Atkins: In April this year, there is a
newdental contract coming into eVect.Do you thinkprescribing and, indeed, the data from prescribing is
data that is received by PCTs so that they are indeed that will have a significant impact on the dental
health of particularly those groups which find dentalaware of the sorts of prescribing habits that are
going on. But I think that is very much a clinical charges hard to aVord?
Dr Cockcroft: I think the contract will have aissue, since prescribing is very much the domain of
the clinical practitioner, primarily doctors, but now significant impact on the way services are delivered.
The service was eVectively designed in 1948, whenalso extended to some other clinical groups as well.
dental disease was rampant, and the focus of that
system was about the so-called drill and fill and itQ51 Chairman: Could I ask a supplementary,
was appropriate at that time because there was aMr Brownlee, about this situation of people with
need for that service. The dental health of thecertain mental illness conditions. By implication,
population is so improved now that that particularnon-residential treatment programmes save quite
treatment modality is inappropriate and we want tosubstantial amounts of money because people are
go to a more preventive phase and build on patients’not living in residency. Has that been taken into
expectations. We are clear that we want to make theaccount when looking round at the issue about
new system of charges consistent with that and notwhether or not these patients should have free
introduce any perverse incentives into the systemprescriptions, or is that still being looked at now?
that take dentists away from adopting a moreMr Brownlee: It still comes under the category of
preventive approach, and we are keen to maintainwhat we said just now: “This area is being looked
that in the new system. We are not changing any ofat”.
the exemption categories. Obviously there are
diVerent areas there about tackling inequalities and
Q52 Chairman: Has it been costed as to the savings addressing the education issues, and we have just
you would make on a non residential treatment published an oral health plan for England which
programme? focuses PCTs’ minds on growing preventive services
Mr Brownlee: Not to my knowledge, but in a sense in their local community and making it part of their
that is not my area. local development plans.
Dr Harvey: We are not aware of it.
Q57 Charlotte Atkins: The new charging system
Q53 Charlotte Atkins: Moving now to the issue of obviously will simplify the whole situation. There
dental charges, could you identify any broad are something like 400 charges at the moment,
changes in dental health since charges were which are obviously very diYcult for patients to
introduced for dental examinations back in 1989? understand. One of the complaints I often get is that
Dr Cockcroft: For dental examinations specifically? a particular procedure that theywant is not available
on theNHS, but obviouslywould be available if they
paid privately for it. What impact will the newQ54 Charlotte Atkins: Yes.
charging systemhave on that?Will there be a re-lookDr Cockcroft: The dental health of the nation has
at what procedures are allowable under privatebeen improving at a steady rate for a considerable
arrangements as opposed to NHS arrangements?period of time now, both in children, adults and
Dr Cockcroft: One of the diYculties is theolder people. I do not think there has been any
complexity of the current system. There is relativelychange in that pattern since 1989. The only area
little that is not available on the NHS that iswhere there has been a flattening out of that
clinically necessary. I cannot think of anything inimprovement is in the very youngest children, where
any particular situation which is clinically necessarythe improvement in health ismore related to diet and
which truly the NHS does not fund, whether youeducation than it is to the provision of treatment. Of
have to pay the charges having done the—course, the introduction of charges for examinations
in 1989 would not have aVected those anyway
because they were obviously exempt from charges, Q58 Charlotte Atkins: When you are dealing with
but I am not aware of a slowdown in the something like teeth, clearly there can be an overlap
improvement in the oral health of adults who are between what is necessary and what is cosmetically
liable for charges since theywere introduced in 1989. desirable.
Dr Cockcroft: Yes, I think that is absolutely right.
One of the things we have said very carefully is thatQ55 Charlotte Atkins: You would put the
improvement in dental health to better diet and we will pay for what is clinically necessary and the
dentist has the freedom to use his clinical judgmenteducation or to issues like fluoridation.
Dr Cockcroft: I think it is a combination of factors. in the new system about what is clinically necessary.
Also we are going to have a programme of patientQuite clearly, fluoridation, both of water in some
areas where that has happened, and its now almost information starting relatively soon, to explain to
them what is available, when it is appropriate for theuniversal availability in toothpaste has been
probably the most significant factor in the NHS not to pay somebody because there is not a
clinical need for that, but also the clarity of theimprovement of oral health across the board.
Obviously patient expectation and increasing charges. The diYculty with the charges at the
moment is two-fold. Because you do not know inawareness of oral health and education have also
played a part as well. advance what the charge is going to be because of the
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way it is calculated, that creates a sort of nervousness Dr Cockcroft: It does. We are well aware of that.
in patients, and the new banding system takes that
away. There is also in some areas a clear diYculty in Q63 Charlotte Atkins: How many children are
people diVerentiating between when they are paying aVected?
for private treatment and when they are paying for Dr Cockcroft: I do not think we would have figures
National Health Service treatment. One of the clear about that.
advantages of the new system is that it is one of the
regulations that the dentist has to put in his surgery, Q64 Charlotte Atkins: It worries me that we are
in the waiting room where it is clearly visible, what having a significant change here in the contract and
these new banded charges are. It would be very you are telling me that you do not know how many
obvious to a patient then, if they are being charged children potentially might be aVected by the new
something which is not one of those bands, if this contract coming in and the possibility that the
treatment includes an item which is not a National dentist will not be treating those children on the
Health Service treatment. NHS from next April.
Dr Cockcroft: Certainly that was a clear issue for
Q59 Charlotte Atkins: If we take a particular case, dentists who were operating an acceptance policy,
say an older person with a fixed income who needs a not that it is conditional but they do treat children.
partial repair to a denture, would that person under If a practice treats adults privately and children on
the new system not be paying more than she is at the the NHS, that is a decision for them to take. It is a
moment? breach of regulations tomake one conditional on the
Dr Cockcroft: The fundamental diVerence between other. I think that is diVerent. We are saying, if you
the new system and the old system is that in the old want to agree a contract with a dentist or a PCT
system you were paying individually for every single wishes to agree a contract with a dentist which
little item of service and in the new system you are allows that practice at the moment to contract and
paying for an overall course of treatment. So it is provide services to children, it can do that, but it
very easy to pick out individual items at the moment does not allow them to make acceptance of those
that are less than the banded charge and make the children conditional on the adults accepting the
comparison. Overall, we considered that when we private policy.
were looking at the system, and patients groups were
very keen on the clarity thing being the most Q65 Charlotte Atkins: You are saying they can treat
important thing. But if you look at an overall course the parents or adults under Denplan and they can
of treatment, it does not only include the particular also, at the same time, treat any children under the
item to which you may be drawing attention; it NHS.
would also include an examination, diagnostic x- Dr Cockcroft: Yes. Absolutely clearly.
rays, and, in the case of a partial denture, any other
treatment that the patient needs on the rest of the Q66 Charlotte Atkins: But it would be incorrect and
mouth. against the regulations for one to be conditional on
the other.
Q60 Charlotte Atkins: But if that was the only item, Dr Cockcroft: Yes.
then she would be paying more.
Dr Cockcroft: There will be instances when that Q67 Charlotte Atkins: The idea that dentists cannot
happens, when you go for a fee per item to a banded treat children on the NHS while still carrying out
system. But we have done an analysis of the case and private practice is incorrect.
obviously the maximum charge comes down very Dr Cockcroft: Yes.
significantly, from nearly £400 to under £200, and Charlotte Atkins: Thank you.
we know that a large number of people in the system, Mr Amess: Witnesses, you must watch yourselves on
if they are doing that, will pay less rather than more. the parliamentary channel. Dr Harvey apart, up
until now you really look as if you are auditioning
Q61 Charlotte Atkins: Of course, the big issue as far for a part on The Glums. Do give the impression you
as dentistry is concerned is the availability of NHS are enjoying things a bit!
dentists to carry out NHS dentistry. That is Charlotte Atkins: They are not.
obviously the big issue. One issue that has been Mr Amess: Clearly they are not.
raised with me very significantly is the situation Charlotte Atkins: We want you to show the teeth.
where parents are possibly bribed to take up a
Denplan arrangement so that their children can Q68 Mr Amess: Smile! Before I get to optical
receiveNHSdentistry. Will you tell me what the new services, Dr Cockcroft, why are you only the Acting
contract will do for that and what impact that will Chief Dental OYcer?
have on NHS dentists who are providing NHS Dr Cockcroft: The previous Chief Dental OYcer,
dentistry for both parents and children? Raman Bedi, went back to his Chair at King’s in
Dr Cockcroft: First of all, to make acceptance of a October. I was previously Deputy Duty Dental
child conditional on signing up for private treatment OYcer and I had been leading on the modernisation
would be a breach of the regulations from April. of primary care. I was asked to carry on the work
that I was already doing in terms of leading on the
modernisation of NHS dentistry, so it did not seemQ62 Charlotte Atkins: But it happens widely now,
does it not? a very sensible time, certainly to me and I hope the
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rest of the Department, to bring in somebody new to of the fee paid to the optometrist or the ophthalmic
do that. I am acting because I have not been medical practitioner, it is true that until about the
substantively appointed as the Chief Dental OYcer early 1990s the approach was to have a so-called
and been through the process to do that. cost-plus approach to setting fees, where the
Department would look with representatives of the
professionals and companies who provided sightQ69 Mr Amess: But you are in the frame to get the
tests at the costs involved. There were two diYcultiesjob.
with that. First of all, it is quite diYcult to pinpointDr Cockcroft: Mr Amess is determined to make me
the true cost of providing a sight test, because yousmile, I can see. I think the job has not been
have to take a number of factors that are commonadvertised. I was substantively appointed as Deputy
Chief Dental OYcer. to running an overall business and then make
judgments about how you apportion those between
the diVerent elements of the business. The secondQ70 Mr Amess: Right. Now we turn to Mr Dyson—
concern was that the cost-plus approach wasand you are not related to the vacuum cleaners
perhaps over mechanistic. It overlooked, and ineither.
some cases maybe even discouraged, eYciencyMr Dyson: No.
improvements, so that the view the Department
took was that rather than a cost-plus approachQ71 Mr Amess: Going back in my parliamentary
we should negotiate with representatives of theannals, when I was Edwina Currie’s private
profession, taking into account recruitment,parliamentary secretary and she was taking the
retention and motivation. On those criteria, thecommittee stage of the Bill, I can remember as if it
current system works very well. We have what Iwere yesterday when we introduced charges, and
think almost everyone would accept is a service thatJerry Hayes, who was then an MP, leaked a very
provides a great degree of choice for patients,embarrassing letter to the Committee. Of course
encourages a wide variety of providers, and, indeed,nowadays it has all changed completely. Perhaps
our minister Rosie Winterton has recently oVeredyou would tell us something about total expenditure
fresh assurances to representatives of the professionon sight tests, because it has obviously changed an
awful lot over the last decade. that that system will continue. Perhaps I could add
Mr Dyson: The current level of expenditure on that it is diYcult to make comparisons but
NHS-funded sight tests is about £184 million. The the Federation of Ophthalmic and Dispensing
most significant step increase over recent years was Opticians, which represents a number of providers,
obviously in 1999–2000, after the Government had recently did a survey amongst their members (so not
reintroduced free sight tests for those aged over 60, entirely representative but it is an interesting
and at that point expenditure grew from what had comparison nonetheless) about the average charge
been just over £100 million in the previous year to that they levied for private sight tests, and that
just under £150 million. Since 1999 expenditure on average sight test fee was on average slightly below
sight tests has grown steadily each year. In 2004–05 the NHS sight test. So, taking 2004–05 as an
there was a 6% increase over the previous year; the example, the NHS fee was just under £18 and the
year before that there had been a 7% increase, and so private sight test fee was an average £17.68, so very,
on and so forth. very similar.
Q72 Mr Amess: You may not have it in your brief
Q74 Mr Amess: I shall not take it any further. Thatthere, because I do not know if our wonderful clerk
is a splendidly crafted argument but it does seem togives you a tip oV, but in real terms what would
me that the principle has been abandoned. I am aroughly be the increase in expenditure from 10
little bit confused as to your justification of that, butyears ago?
c’est la vie. Deregulation of optical services, whichMr Dyson: First of all, I should emphasise that the
has had a huge, huge impact—not even touching onincrease over the last 10 years will have been heavily
laser treatment and all that—has it aVected the entryinfluenced by that one year when we re-introduced
of new providers or waiting times?free sight tests for over 60s. With that caveat, I think
Mr Dyson: I think it is important to be clear whatthe increase—and I would have to check these
one means by regulation or deregulation. It remainsfigures—in cash terms is about 55–60%. I would
the fact that any practitioner who provides opticalneed to check the real terms increase.
services has to register with the General Optical
Council, so they are regulated in that sense. TheyQ73Mr Amess:Perhaps youwould write to us about
have to demonstrate that they are properly qualified,that. The current eye sight test is well below the cost
that they undertake continuing education andof providing the service and until recently, it was
training, that they remain fit to practice. So this is aexpected to cover the cost. Why has this principle,
regulated system in that sense, and of coursewhich we were told was very important, been
practitioners also have to be listed with the primaryabandoned?
care trusts where they provide services and the PCTsMr Dyson: It is perhaps worth making a few
can undertake additional checks. They will takecomments there. First of all, just for the sake of
clinical references, they will inspect premises andclarity, it is important to be clear that the fee that the
equipment and so on and so forth. I assume theNHS pays to those who undertake the sight test has
nothing to do with the cost to the patient. In terms question is more about—
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Q75 Mr Amess: I wondered, first of all, is the are able, when hospital developments take place, to
impose planning constraints on the hospitals thatDepartment happy with deregulation? You can
practically go into a petrol station now and pick up lead them to implement sustainable travel plans, to
try to organise a shift of travel from cars to othera pair of spectacles. Is the Department happy with
the way deregulation has turned out in practice? means of transport, including for patients. That
whole variety of circumstances has led to a situationMr Dyson: I think it is slightly misleading, with
respect, to refer to a completely deregulated system. where it has not been deemed sensible to try to
impose central regulation, which could not deal withWhether you are an optometrist or ophthalmic
medical practitioner who is undertaking a sight test all the circumstances. Indeed, some hospitals that
have undertaken major developments have had toor you are a dispensing optician who is dispensing
spectacles or contact lenses or whatever, you have to make annual contributions to provide bus services
to and from the hospitals. I have worked and been abe registered with the General Optical Council and
you have to show that you are fit to practice, and director of estates in hospitals where, before we
introduced car parking controls and charges to payboth the conduct of the sight test and the dispensing
of appliances is governed by national standards. In for those, we were seen as an unoYcial parking site
for people who worked in oYce blocks locally.terms of the fact that there are no controls, in the
sense that the NHS does not say, “We are going to Rather than draw on NHS funding, which was
directed for patients, certainly the trust that Idictate who provides NHS ophthalmic services in
this area”, we are not going to have a limit on the worked in chose to levy a charge both on visitors and
staV to cover the costs that were incurred in settingnumber of people; we are not going to place
restrictions on patients as to which provider they can that system up and running it—because it required
not just materials and controllers to be bought, butgo to, provided that the people carrying out the
clinical work are registered and appropriately staV to be employed to run that. It was a very
conscious decision not to place that as a chargequalified. The Department takes the view that that
system works very well, in that it promotes patient against the NHS.
choice, and this is an area where we receive very few
complaints about the quality of the service they Q78 Anne Milton: The issue you raise about hospital
receive. car parks being seen as the town centre car park have
been a real problem in the past. I think one of the
problems now is that they are seen and viewed byQ76 Mr Amess: Fine. Fourteen years on, it has been
many patients and visitors as a cash cow, in that thea success, the Department is happy with it and it has
hospital will maximise any income they can from it,made a real contribution to waiting times.
irrespective of the hardship that it causes patients orMr Dyson: As I have said, the minister recently had
visitors. Are there any plans to oVer exemptions tocause to oVer some reassurances to representatives
specific groups of patients or are you going to leaveof the profession who were concerned that the
it simply down to local decision making?current ophthalmic provisions in the Health Bill
Mr Smith: At the moment it is left to local decisionmight lead to a degree of tighter regulation. The
making. Again, in the organisations in which I haveminister was at pains to point out that this was a
worked, consideration has been given not tomisunderstanding of the clauses in the Health Bill.
particular people suVering from particular diseaseWe are satisfied that the current system works well
groups, but more to the concern: Do people have toin terms of quality and choice for patients.
attend for a course of treatment on a regular basis?Mr Amess: Thank you.
and exemptions have been available for part of the
payment. But it is a matter very much for local
Q77 Anne Milton: Mr Smith, it is your moment to discussion. I am not aware that the Department has
cheer up, to smile at the camera! The one subject that contemplated changing that view.
causes a huge amount of grief in people is car Dr Harvey: Could I add that within the NHS Low
parking charges. Maybe you could tell us what the Income Scheme you do get help with travel costs and
principles are underlying the provision of car indeed car parking,8 so those people under the NHS
parking in NHS hospitals. Low Income Scheme who are exempt would get a
Mr Smith: The principles are diVerent from those refund from the local trust for their car parking, I
which have been discussed so far and lie in a number think I am correct in saying.
of roots. One is that trusts are able to generate Mr Smith: Absolutely true.
income from a variety of sources—and I think that Dr Harvey: And indeed, for the travel costs for travel
was put in the note to you from theDepartment. The to the hospital.
other roots are the rise of car ownership and the
desire of people to drive to wherever they want to go Q79 Anne Milton: The burden, if you are attending
to and the burgeoning demand on hospitals, the fact for a frequent course of treatment, is quite
that we deal with a whole spectrum of situations substantial at some hospitals, and actually those
from acute hospitals in very tight urban situations people are probably the people least able to make
that have virtually no car parking, to hospitals in alternative arrangements on public transport
more rural settings that have plenty of land and because they are not well, obviously, by definition.
plenty of availability, and overlaying that—and very What about assistance for travel to non-hospital
importantly, because it is a directive to many trusts
that operate the hospitals—is the fact that Crown 8 Note by witness: Reimbursement for car park charges is
available if the charge was unavoidable.immunity was lifted and local planning authorities
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settings which, of course, is going to become more Dr Harvey: I am not aware of any research
personally, but certainly, of course, some peopleand more relevant with the Government’s drive
trying not to treat people in acute hospitals? will have travel to hospital covered under the
patient transport services—the non-emergencyDr Harvey: Certainly travel to primary care
organisations where a patient is under the care of a ambulances—and those would be on medical
grounds, and that would be that it has beenhospital consultant, an NHS consultant, is indeed
covered within the NHS low income scheme recommended by a doctor that, either due to a
physical condition or particularly a medical(Hospital Travel Costs Scheme); so if you are being
treated under the care of a consultant, wherever that condition that they have, they would need transport
plus or minus an escort, depending on themight be, then, indeed, you are covered.
conditions, and so those people would be covered
under the patient transport services. I am not aware
Q80 Anne Milton: So even if it is not, I mean for of any other issues. I wonder whether it is worth
physiotherapy, speech therapy, something like that. raising that some of these issues have been raised
Dr Harvey: The stipulation is that you are under the during the consultation, Your Health Your Care
care of an NHS consultant. Your Say, around the patient transport services and,
indeed, hospital travel cost schemes and we know
that they are being looked at at the moment.Q81 Anne Milton: If you are having physiotherapy,
are you? Yes, you are.
Dr Harvey: It would depend, I presume, whether Q85 Dr Taylor: The crucial question to me is where
that is a referral through your consultant. do the profits go from car parking: because they are
mostly run by private contractors? Do they get the
profits or does the NHS get the profits?Q82 Anne Milton: Yes, it would be. What about Mr Smith: I think it is diYcult to say that car parkingvisitors? I think it is particularly relevant for elderly situations are normally run by private contractors. Ipeople, particularly the frail elderly, whose contact certainly have no evidence for that, but, equally, Iwith visitors could be said to be part of their find it diYcult to disprove it.treatment—they do much better, they get less
disorientated if they are out of hospital for care. Are
Q86 Dr Taylor: You mean many hospitals run theirthere any exemptions or is there help for car parking
own car parking?for those visitors?
Mr Smith: Absolutely.Dr Harvey: I think if I might add just from the NHS
Low Income Scheme perspective, it does cover
Q87 Dr Taylor: Surely you must have some figurespatients but also, where those patients require
for that, because every hospital I know does not runescorting because of the condition that they have, on
their own car parking system.medical grounds, then those escorts would also be
Mr Smith: I do not have figures for that, but I amexempt from travel costs.
talking from the visits that I have made to hospital.
I was going to go on to say that in many cases,
Q83 Anne Milton: But not the visitors. As I say, it is although the facilities may be operated by a private
particularly relevant, I think, to elderly people? company, they are paid a fee for that and, if there is
Mr Smith: I do not believe that the hospital travel any excess income over and above that fee, it will go
cost scheme does cover visitors unless they are to the hospital trust—those are the circumstances
escorting people, so that would not help. In terms of that I am used to—other than where the trust,
visitors in the majority of acute hospitals—we have because of space constraints or lack of availability of
no collected central information on this, this is just finance, may have worked with a private car park
information that I have observed in places that I operator who will have financed and built a car park
have worked in or have visited—a reduction in cost adjacent to the hospital, and an example of
is usual. If you have a relative in a critical care unit that would be at Queen’s Medical Centre
and there is a recognition that you will be visiting in Nottingham—one exists there—and in that
and staying for long periods of time, the local circumstance it is the operator of the car park who
organisation usually provides relief in those keeps the revenue from people using that car park.
circumstances, but the median of charges in
hospitals is £1 an hour, the median cost across Q88 Dr Taylor: Would it be possible to have a
hospitals in the UK, for the first three hours, so it is breakdown of figures across the country, or would
only after that time that charges generally start to that be a huge work?
escalate significantly, but those charges are levied on Mr Smith: We do not collect that information at the
all visitors. moment. We ask trusts to tell us whether they charge
or not and the level of the charge. We do not ask
them to supply the information about is that carQ84 Anne Milton: Do you have any information
park run, operated orwhere does the finance go. Theabout how people get to hospital: because, I think,
information is not collected.on the small bits of research I have seen, irrespective
of where this problem is, irrespective of how good
public transport is, people will always travel by car? Q89 Dr Taylor: Maybe it is on the telephone side,
because in the information you have given us theThey will get a neighbour, they will get somebody to
take them to hospital by car. cost of incoming telephone calls ranges from 15p to
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49p a minute for somebody who is phoning up the Dr Harvey: I think the issue is that the way in which
patient at their bedside phone. Where do those services have been delivered is changing over time,
profits go to? and I think quite a lot of these issues, as I say, have
Mr Smith: It is a diVerent circumstance. The been raised during the consultation period.
installations have been paid for by private sector
companies, who retain the income from the
Q94 Dr Stoate: If under my new practice-basedtelephone charges, the charges for the television, for
commissioning arrangements I invite the consultantthe provision of those additional services. They
to drop in on a Thursday afternoon, presumably atretain a basket of income from those services to pay
my expense, and the consultant just signs a load offor the capital investment and the running costs of
forms for people to have physio, they can claim theoperating that service. That money does not go to
money back for it, whereas if I do not take thethe NHS.
trouble to invite the rheumatologist over to do that,
the patient cannot get the money back?
Q90 Dr Taylor: Is there any reason why the range of Dr Harvey: We can certainly send you further
costs is so wide—15p to 49p a minute? information on this, but I know this is an issue thatMr Smith: Ofcom have been running an is at the moment being looked at.investigation into that which concluded with the Dr Stoate:Thank you, Chairman. I amgobsmacked!closure notice yesterday, and they have asked the
Chairman: Anne, have you got a supplementary onDepartment of Health to work with the providers of
this?those services and with Ofcom to look into that, but
Anne Milton: No, I just have to back-up whatthey have acknowledged that it is a very complex
Dr Stoate has said. The impression I am left with isarea and complex issue. The Department of Health
that a lot has been attacked, a lot is underhas already agreed to undertake that work, working
consideration but, fundamentally, it is all toowith the private sector providers, working with
diYcult for anybody to ever change anything. YouOfcom, to look at what can be done about those
do not have to comment. It sounds like a veryhigh charges.
diYcult issue.
Chairman: Maybe that is an issue we can have when
Q91 Dr Taylor: If you phone a patient, is there we draw up this report. We are going to the area
automatically a warning of what it is going to cost about information for patients now.
you?
Mr Smith: It is my clear understanding that when
you phone into the hospital you are always given a Q95 Mr Campbell: There have been many
warning message. submissions made that patients were not aware of
what they can claim andwhat they can get in relation
to prescription charges. Even Citizens AdviceQ92 Dr Stoate: This is a fascinating inquiry, because
submitted that a lot of people are now facing courtthe more we look into this the madder the system
action because they have been falsely claimingbecomes. I would like to pick up on something that
prescription charges. The question is: are you failingDr Harvey has just said about the NHS low income
to ensure that patients are made aware that they canscheme about travel to hospital. It appears,
claim? I know you were brandishing a book before,therefore, if I refer a patient for physiotherapy the
and sometimes I get worried when I see thesepatient cannot claim themoney back for travel to the
because some of these are very complicated and youhospital to get the physiotherapy. If, on the other
need a degree to read them. It is like when you get ahand, I waste vast amounts of public money by
toy at Christmas, when you get the instructions youreferring the patient to the rheumatologist, who then
need to be a rocket scientist to put it together.refers the patient for physiotherapy, they can claim
their travel to the hospital. Therefore, I have got to Sometimes these information packs that are
say to my patient, “I can save you a few quid”, produced are very heavy for an ordinary person to
although I am wasting a few hundred quid by read. Are you failing, because if Citizens Advice
referring someone to rheumatology that does not write, and a lot of people are suVering, there is
need to see them. The whole point about general something wrong with the system?
practice is that we avoid referring to hospital where Dr Harvey: I think since the Prescription Pricing
possible, but we do access secondary care services on Authority took over responsibility for the PPCs, and
direct referral because that is very eYcient and very in fact now they cover all the certificates of
quick, but you are now telling me the patient cannot exemption for those that need passporting, like, for
claim the cost. It is daft. example, tax credits, but they have been working
Dr Harvey: These are issues that are being raised quite hard with Citizens Advice,9 with National
during consultation with the National Health Union of Students and with other patient groups
Service and LHAs and they are being looked at at because of a concern that some people are not aware
the moment. that they may well be eligible for help with health
costs. The primary publication that they have, which
Q93 Dr Stoate: The whole system gets madder and is HC11 “Help with Health Costs”. There are also
madder by the minute. I am genuinely amazed. I did quick guides.
not know about this. I am learning a lot this
morning. 9 Note by witness: See footnote 6.
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Q96 Mr Campbell: Is it simple to read? He was always left out of the loop. I have a funny
feeling that sometimes the primary care leaves lot ofDr Harvey: It is very simple to read, but, in fact, we
do also have a number of quick guides. information out of the loop.
Dr Harvey: Certainly, through the PPA, they
actually do send information to all GPs’ surgeries
Q97 Mr Campbell: It is 77 pages? who are not members of the Waiting Room
Dr Harvey: This one is, but there is another one that Information Service Scheme, but the PPA do haveis literally a fold-out. regular discussions with their board and, indeed,
Mr Brownlee: It is a small fold-out. with us looking at the eVectiveness of what they are
Dr Harvey: We have provided the Committee with a doing in terms of getting the information about
pack of the information that is available to patients health costs to patients, but they are always strivingand the public that the Prescription Pricing to make sure that they do it better. We know, forAuthority publish, but I think to start with one needs example, with the incapacity benefit, when weto say that there are advice lines both for the increased theNHSLow Income Scheme level by halfDepartment of Health and for the PPA, through
the prescription charge, we did have an estimatedwhich all of this information can be obtained, there
44,00011 people who went from partial help to fullis information on every prescription form, on the
help group. I do not know if Mr Brownlee has anypatient information side, which also deals with how
additional information.you can get information about helpwith health costs
Mr Brownlee: All I would say is that we are awareand, indeed, pre-payment certificates. There is also
that the position certainly was not as it should havethis information provided through the Waiting
been two or three years ago, which is why we tookRoom Information Services, which many primary
the action we did. We are also aware that one cancare organisations subscribe to, but also
always do more in this sort of area, frankly, in termsinformation available to all primary care
of eVort and money spent, and we are in discussionpractitioners, including pharmacies. However,
fairly frequently with the PPA on this, althoughhaving said that, we are still concerned and the PPA
leaving it to them to do it. We are not just saying,are still concerned with making sure that the way in
“Go away and get on with it”. It is a balance ofwhich they are targeting the information does
looking at the overall position.actually get to those groups—particularly one group
that has been raised with them and with us those on
incapacity benefit who are not passported—so that Q100 Mr Campbell: We have got a situation wherethey are aware of the fact that there is help with evidence suggests that the availability of pre-health costs. The other thing is that all of the payments, PPCs, are not being taken up. In fact theJobcentre Plus bodies also have these leaflets Breast Cancer Care Report said that less than 40%available for people and there is information on the
responded to taking up the PPCs. There has got toDWP websites, and lots of other government
be something wrong there when cancer patients,websites and other bodies that have been working
who obviously need the medical treatment, are notwith the PPA also have information on their
taking this up. Again, it comes down, I think, to thewebsites; so we are working quite hard. I think if you
information.look back to October 200410 before the PPA took
Mr Brownlee: Can I respond by saying that the useover all of this, possibly information was not as
of PPCs—I have not got figures for particularreadily available as it should be, but we are now
conditions, but the use of PPCs has clearly increasedworking and the PPA are working very hard to try
over the last five years since the PPA has takenand ensure that more people are more aware that
responsibility. They have taken measures in terms ofthey may well be able to have exemption, and,
writing to people to remind them when the PPC runsindeed, we know that DWP have done a lot of work
out, campaigns through various organisations toaround the benefits, many of which are passports to
make sure the existence of PPCs are known. The usefree prescriptions and healthcare costs so that people
of PPCs is going against the trend in terms of theare aware that they can claim those.
reduced percentage of items that are in fact paid for.
The use of them over the last five years has gone up
Q98 MrCampbell: How do youmonitor the primary by something like 50% in terms of items, and,
care groups regarding information? whereas the growth of items has gone up by about
Dr Harvey: I am sorry? 30% over the last five years—and I have taken five
years purely because that is the time when you are
trying to do something about it—the use of PPCs hasQ99 MrCampbell: How do youmonitor the primary
gone up per item in terms of items spent by aboutcare groups that have to give this information out? I
40%. I am not trying to say there is not more thatwas sat on the select committee for the ombudsman
should be done, but it is going in the right direction.for many years, and in the hospitals there was never
Dr Harvey: I think certainly the PPA would say thata leaflet about how you can complain to the
this is why they are continuing to work with patientombudsman. There was a leaflet about how you
groups, and if there are ways they can do thingscomplain to the hospital, but never the ombudsman.
better that is what they will be striving to do.
10 Note by witness: The PPA took over the publicity work in
April 2004, although they have been administering the PPC 11 Note by witness: Estimated from a sample, when rounded
is 45,000.purchasing arrangements since October 2002.
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Q101 Mr Campbell: I think we certainly need to see development at the moment and, indeed, those new
devices that are likely to come to the NHS in themore take up. Can I go to the Social Exclusion
Unit Report 2003 Making the Connections. It future, and, indeed, we do look within the funding
envelope generally for the NHS at the sorts ofrecommended that the department develop options
to provide information and advice assessing impacts of those new technologies: because, as you
are very well aware, in terms of quality of patienthealthcare facilities, including transport issues. Is
the Department giving any credence to this sort of care, theDepartment is trying to ensure that patients
have high quality patient care and, in fact, wherething?
Dr Harvey: We understand that this is an issue that innovative medicines should be used for their
conditions that they are indeed used, and that is whyis also under consideration at the moment and is one
of the issues that has been raised around the we have those drugs going through the National
Institute of Health and Clinical Excellence so thatconsultation.12
we can have clinical and cost eVectiveness advice for
the NHS on those drugs. What we have not done isQ102 Mr Campbell: There are lot of things under
specifically looked across at prescription charges inconsideration here. It was 2003 when that report
relation to that, but we do, indeed, look and forecastcame out. It is 2006 now. How long are we going to
the sort of impacts that those new innovationswouldwait for these things to happen?
have on the NHS.Dr Harvey: I think this is an issue that has been
raised again within the consultation and therefore it
is one of the issues that is being considered around Q105 Chairman: Quite clearly, if there is mention of
the White Paper at the moment. one particular drug or one technological innovation,
Mr Campbell: I am afraid we are going to have to if there was a family of drugs coming into the NHS
consider it in our report as well. Thank you, that was going to substantially move, let us say, just
Chairman. the drugs bill up inside the NHS because of this new
family of cancer drugs and things like that, would
you have to look at the issue that currently you getQ103 Chairman: Could I ask you a general question.
somewhere in the region of, I think you said, £426The cost of healthcare, I think most people would
million from prescription charges? Would thatsay, is going to be driven up by technological
inevitably mean an increase in there?innovation and by the introduction of new drugs as
Dr Harvey: I think we have very much looked at itwell. What work has the department done to
in terms of the overall NHS expenditure, what thatestimate the likely costs of such developments and
means in terms of the drug bill growth, and I think Iassess whether they are aVordable without a
am right in saying that the drug bill growth is roundsignificant increase or an extension of charges that
about 8% per annum. At the moment it is relativelywe have talked about this morning in terms of the
flat. We have just made a new agreement on PPRS,prescription charges, et cetera?
the Pharmaceutical Price Regulation Scheme,Mr Brownlee: Clearly, we do work in terms of
where, in fact, we have a 7% price reduction onforecasting costs, so it does not happen—I mean this
medicines, and that is a five-year scheme. We do,is a wider group in terms of our finance colleagues, I
indeed, look at it in terms of growth of the drugs billthink. I do not think that we have been asked to do
and, indeed, the growth of both branded and genericany specific work in terms of if this happens
medicines and, indeed, the take up of generictherefore charges should be at a higher level. What
medicines when branded medicines have come oVwe have said about charges being looked at
patent.annually—I do not want to repeat what we said half
an hour or so ago—but I do not think we look at the
level of the charge in relation to the cost of particular Q106 Chairman: There is no direct correlation
medicines. If the average cost of the medicine was between the drugs bill and the cost of my
going to go up by X%, therefore charges should go prescription then?
up by a similar percentage. Dr Harvey: We have not specifically looked at the
prescription charge in relation to that.
Q104 Chairman: My own PCT is accepting that in
the next financial year, not in this one, it could cost Q107 Dr Naysmith: A chance to ask a couple of
them a million pounds more than they currently pay. tidying up questions really for Mr Dyson and
Has the department looked at that in any sense of Dr Cockcroft relating to things that they mentioned
charges? during their evidence. One is that under optical
Dr Harvey: I think in terms of the costs of new services you said that there has been some
innovations as they are coming forward, clearly the apprehension in the profession about how the new
department determines the work programme for the system was likely to work in the Health Bill, and you
National Institute of Health and Clinical Excellence had met some particularly small practitioners—
and through that we do look—a horizon scan—at particularly it is small practitioners in my area that
both those new pharmaceutical agents that are in I am interested in—and you were able to reassure
them that they misunderstood the qualities in the
12 Note by witness: The White Paper—Our Health, our care, our Bill, and presumably they went away quite happy
say: A new direction for community services, Cm 6737, after you had reassured them. Is there any chance ofJanuary 2006, has been published and makes reference to
getting something in writing about what you used totransport, including patient transport services etc on pages
150–152. reassure them submitted to the Committee?
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Mr Dyson: Of course, yes. The Minister has written Q110 Dr Naysmith: It is the long-term nature of the
contract as well.to a number of stakeholders to make clear that the
purpose in introducing the Bill was to do two things, Dr Cockcroft: Yes, whereas the generalist contract is
open-ended. If they are only providing specialistit was to strengthen controls over redemption of
optical vouchers and, more relevantly in the context services, it has to be under a PDS agreement, which
is necessarily time limited. The legislation does notof sight tests, it was to remove some restrictions on
the range of providers who can provide a sight test. contain any specific time limit, but in the guidance
we have provided to PCTs we have said quite clearlyThe Minister has reassured stakeholders that this is
not about altering the current system whereby sight that the starting point for an orthodontic contract
will be a five-year contract, and we have beentests are paid for.
working very closely with the British Orthodontic
Society, who seem very reassured by that.Q108 Dr Naysmith: It would be nice to see that sort
of evidence. Q111 Dr Naysmith: As I understand it, there areMr Dyson: I am very happy to provide that. some problems to do with appeal procedures about
providing future income.
Dr Cockcroft: I was not aware of that. We have itQ109 Dr Naysmith: Dr Cockcroft, again talking
about dental services this time, there seems to be a very clearly in the primary legislation—and they are
all entitled to a contract if they have a contractbit of apprehension around orthodontics, which I
am sure you are aware of, and now that it is moving now—that, if they are unhappy with the terms of
that contract, they have a right of appeal to thetowards the primary care trust who will be
responsible for commissioning services, as I Litigation Authority, and that is binding on the
PCT, although it is not necessarily binding onunderstand it, which was not the case before, how do
you intend to oversee this and make sure that the clinician. We would hope it would not get to that
situation in most cases, but obviously there is aservices do not just disappear? In particular, there is
supposed to be some sort of appeal procedure, which protection for specific people there; but part
of the process recently has been a much clearerhas not appeared yet but orthodontic practitioners
would like to see soon. I notice this is a very fast process of giving information, a real programme
of concentrated information provision tomoving situation, but I want to raise it today because
I know there is quite a lot of concern. practitioners, and I think there is less degree of
uncertainty and misinformation—like Mrs AtkinsDr Cockcroft: It is not only orthodontics, even the
generalist, this is the first time the PCT has had the was talking earlier on about the child list thing—
than there was relatively recently.responsibility for the whole service. A lot of
orthodontic services were provided through general
dental practitioners or specialists working in Q112 Chairman: First of all, a short apology. We
have run on a few minutes longer than we originallyprimary care before the system came in. It has been
a huge area of uncertainty for orthodontists, and said we would do on this. Thank you all very much
indeed for coming along and giving us thispart of my job since I have become Acting Chief
Dental OYcer is to go out and meet lots of people, information. I am sure it is going to be enormously
useful for us in terms of the rest of the inquiry andand I am doing that. It has been a specific issue for
orthodontists for a couple of reasons. One is because other witnesses as well, including your ministers, I
suspect. Thank you very much indeed for yourthey have to work under PDS agreements if they are
only doing orthodontics. evidence.
Witness: Mr Andrew Haldenby, Director, Reform, gave evidence.
Q113 Chairman: Could I welcome you along, and wonder if these remarks follow on slightly from
some of your recent sessions on expenditure. If Ithank you verymuch indeed. You are sat alone. I am
afraid the witness that we were getting from the may, because I would like to oVer a more positive
view about the role of charges, the tone of the sessionSocialist Health Association, we were told earlier, is
on a train with a fire on it coming from Manchester. this morning was very much that charges are a
necessary evil, if you like, but there is a more positiveIt seems to me that, unless it is a steam train, he
has got rather a diYcult problem. In those view, which is that in a world of very great funding
restraints, which I think the service is about to enter,circumstances, I am afraid, you are on your own. I
hope this is not too much of a disjointed session, additional monies, obviously organised in an
equitable way, will perhaps enable the service tobecause we wanted to strike a dialogue up with
yourselves as well as ourselves. Perhaps I could open develop new areas of treatment and new innovations
which it might not be able to do otherwise given theup by saying: what are your views on the extension
or reduction of health charges and what would be funding constraints. I might even go a little further
to say that there are perhaps existing areas of service,the eVect of greater charges on equity of access to
healthcare? existing areas of treatment, which, however much
there may seem to be a guarantee for those services,Mr Haldenby: Thank you, Chairman. I would like to
frame my remarks in the context of the overall and here I can talk a bit more, but two examples I
could raise would be audiology and strokefunding position of the service, and in that respect I
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rehabilitation, actually the service does not really Hearing Aid Audiologists from September last year.
Perhaps if I could suggest that we have in mind theprovide on any kind of level, so perhaps the
introduction of charges in those areas might be a positive development of optical services that we have
seen in a recent years since deregulation—bigway of developing a service which the NHS does not
currently provide. I would perhaps just flesh that out increase in capacity, instant treatment and so on and
then audiology—this report points out that theslightly. I do not know if you are aware of the report
that Professor Bosanquet and other wrote for us average waiting time for an NHS patient to have a
hearing-aid fitted from beginning to end ofrecently which looked at the costs pressures,
particularly in the years after 2008 when, as we treatment is rising steeply. It rose by seven weeks
over the last year and it now stands at 47 weeks, soknow, the very rapid spending increases of the last
eight years are going to come to an end, and we this is an area of the service which is barely provided,
and yet in some parts of the country they highlight,measured the funding increase between 2006 and
2010, given the fall in funding of about £11.5 billion, for example City Hospital in Birmingham, which
has, as I say, the distinction of having the longestand we looked at the cost commitments for that time
based heavily on the increases in costs in recent waiting time in the UK, patients there can expect to
wait three years for their hearing aid to be fitted, soyears—PFI schemes, extra staYng, prescribing, did
the GMS contracts, new pharmacy contracts, new this is an extraordinary diVerence in performance. If
one was to suggest, as I might, that this area ofIT schemes particularly, a number of things which
certainly I will be able to tell you I have seen in the treatment might be an area where charges might be
introduced, what can we expect to see on the basis ofreport and also new activity to meet the 18-week
target and so on—and the total cost of those the optical model? You would expect to see that
people on low incomes would move from aadditional commitments amount to over £18 billion,
so by 2010 there is a clear deficit approaching position—this is particularly elderly people—of
having to wait up to a year and rising for their£7 billion. In the responses to that report that we
have had there has been a certain amount of hearing-aids to a position where, once the new
capacity had come in they would be seen extremelydiscussion about the overall numbers, but the
picture has been accepted, and this will be a period quickly. That would seem to be a great gain in equity
and also making sense, making a reality of theof extreme financial pressure for the service.As I say,
that said, if we are looking to develop new areas of comprehensiveness of the NHS system. If I can just
quote, to emphasise the point, Malcolm Bruce,service and perhaps to look at areas of service which
are currently not being provided eVectively, it is not speaking at the British Society conference last
autumn, said he failed to understand why, when herealistic to say we should expect more resources
from the tax-payer, because that is really the had a problem with eyesight, he could walk into his
High Street optician and get a pair of spectacles butopposite of the situation in which the NHS finds
itself. To take on the second point of your question, to be fixed up with a hearing aid he has to see his GP,
be referred to a hospital and has to wait for years. ItChairman, about equity, I think it is essential that
services must be equitably provided, and that is an would seem to me that perhaps there will be an
example of a service where the introduction ofessential part of the NHS and should remain so, and
so I would say that it should remain the case that any charges with appropriate exemptions would
dramatically benefit patients, including those onsystem of charges should have a series of exemptions
for those who are unable to pay. As Dr Harvey said, low incomes.
the principle should be that those who can aVord to
pay should do so and those who cannot should not,
Q115 Dr Stoate: I have been doing a lot of work onand that seems to me to be an appropriate principle
hearing aids recently. There is already deregulation.for charges.
Anybody can ring up Siemens, go and get themselves
a hearing test and pay £2,000 for a Siemens top of the
range system, no problem at all. We have already gotQ114 Chairman: I think you were sat in on the last
session and so you will have heard, not our that. The fact of the matter is that hearing aids are
fantastically expensive in the private sector. Theyassumption but assumptions of written evidence
that have been sent to us that eVectively suggest that cost literally thousands, and certainly many
hundreds. The NHS can provide the same hearing-the greater the degree of private finance and private
payments within our system the higher the levels of aid behind the ear for £300 or less—in fact if you
bulk purchase you can get them for £150. I do not seeinequality. What does Reform say about that?
what sort of level of charges you are proposing toMr Haldenby: Let us be specific about it. The
introduce that could possibly make any meaningfulexample of optical care, for example, or, indeed,
diVerence to that, because you will probably have toprescription charges, there are clear exemptions for
introduce very significant NHS charges to providepeople who are on low incomes. The evidence this
the increased capacity in the high street availabilitymorning demonstrated that it is a very complex
that you are proposing to level them up withsystem of exemptions and perhaps a slightly illogical
opticians. I do not see how you could possibly getone and perhaps one which could be amended in
there?various diVerentways, but, nevertheless, it does exist
and so it does protect those vulnerable groups. Mr Haldenby: All I would say is that, in the context
of the current funding diYculty, what we arePerhaps I can focus on one of the specific areas of
care that I mentioned for audiology. Here I am suggesting on the basis of the status quo is that only
people who can aVord to pay £2,000 will be able toreferring to a report by the British Society of
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have a modern hearing-aid with any reasonable say, “It is not”. The diYculty is when you have got
two clinicians who disagree over the clinicallength of time for treatment. Another approach may
be, and I agree one would have to look at the necessity, because what we are talking about a lot of
the time, and what Dr Stoate was talking about, isnumbers of it, of course, to take the money that the
NHS spends at the moment on care, which I can suVering. If you do not get a decent hearing-aid, if
you do not have two grand to pay on a decentquite confidently say is not being spent very
eVectively, and use it to subsidise patients on low hearing-aid, you end up with the NHS £300 one.
You can hear a bit, but you suVer slightly becauseincomes. That would be my response.
your hearing, in many instances, is not as good.
What we are measuring is not clinical necessity orQ116 Dr Naysmith: I was going to ask this a little bit
clinical unnecessity, it is about suVering, and that islater on, but since Howard has started oV on it, at
a slope, and it is at what point you cut that line.what point would you draw the line around services
Mr Haldenby: I agree with you. As I say, I thinkfor which core payments would be required? I think
these are discussions that are being played outin your evidence you talked about, “There are many
around the country. I have not got a hard and fastservices at diVerent levels of intensity which are
answer, I am sure you agree. All I am saying is thatsubject to individual choice. Although core
it was clear from discussions that basically there are,services will be tax-funded, there will be many
we would all understand, a range of treatmentssupplementary services at diVerent levels, but there
between what is obviously core necessity and whatwill be an element of co-payment.” How do you
could be described as supplementary, and somedefine core services? I know you have perhaps done
things are on the margin of that, and those would beit already, but if this is what we focus in on how do
the areas for discussion. To talk from a slightlyyou decide which are the core services?
diVerent perspective, as it were, there are someMr Haldenby: It has been discussed a little bit
services at the moment which, I suppose, we wouldalready in the example of dental care. There was a
say would be clinically necessary, which, as I pointeddistinction made between “clinically necessarily”
out, are not being provided, and another area whichand, as it were, “desirable”. This is a matter for long
I said I would cover would be stroke rehabilitation.discussion, but it would seem to me that for services
The National Audit OYce produced a report inwhich are clearly medically definable and clinically
November of last year which pointed out thatnecessary, they will always remain, as it were, part of
rehabilitation for stroke patients is exceptionallythe core NHS tax-funded and so, there is no doubt
important if they are going to enjoy an improvedabout it, we are talking about the great majority of
quality of life after that stroke. However, it is anhealthcare, but for services on the margin of that,
example, again, of extremely poor and patchyand obviously dental care and optical care would be
provision. They pointed to data only from Southexamples of that, another example might be
London, but they thought it was representative thatinfertility treatment, where there is already—I think
only a quarter of patients receive physical andit varies by the area—but a well developed system of
occupational therapy, only a seventh of patientsco-payment.
receive speech and language therapy in the year after
their discharge. Whether this is clinically necessaryQ117 Dr Naysmith: That is when “clinically
or supplementary, it is not happening, no matternecessary” comes in. Who decides what is clinically
how much we may want it to.necessary in infertility treatment?
Mr Haldenby: I think at the moment those decisions
are being taken, for example, on the question of Q120 Dr Naysmith: The interesting thing about that
report is that it also pointed out that basic coreinfertility, on a local level, on a PCT level. Perhaps,
if they continue to be taken in that way, we would services for stroke were very fragmentary and pretty
awful in some parts of the country. Maybe if youcontinue to see something of a patchwork provision
and perhaps a variety of diVerent charges emerging, could get the core services better then there would be
more people requiring long-term rehabilitation.as we have already seen. The example of infertility
perhaps is something for NICE to consider going Mr Haldenby: Perhaps that is the case. My
grandmother has just had a stroke and has just failedforward of what should be core and supplementary.
to have any physiotherapy up in Aberdeen, and so I
am conscious of this. All I would suggest is that ifQ118 Dr Naysmith: You would have to set up
there was an opportunity to pay something towardssomething like NICE to do it.
the cost of private physiotherapy for those patientsMr Haldenby: I suppose the point I am trying to
who need it, with exemptions for those who cannotmake is that in practice some of these decisions are
aVord it, it would enable the service to oVer betterbeing taken, so maybe you need to systemise that.
treatment, I would suggest.
Q119 Anne Milton: To come in on the topic of
clinical necessity, if you could define that there Q121 Chairman: Coming back to infertility
treatment, IVF in particular. I have had a personalwould probably be a great deal of money in selling
it, because it is almost impossible to do, and a lot of interest in this as a politician over the past number of
years now. It seems to me that even the Governmentthe things that I think we as members of this House
are facing at the moment is being caught between announced two years ago about the IVF treatment
that would be brought forward in EnglandPCTs who have got huge financial problems and
clinicians who say, “This is necessary”, and PCTs particularly, England and Wales, upon the National
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Health Service, because prior to that peoplewho had funding a rather thin service, to focus more funding
on people on low incomes. That would be anactually paid wholly for IVF treatment themselves
alternative way of doing it.were then discriminated against inside the NHS
because they had paid for it and, therefore, they
could not have one of the few interventions on the Q123 Chairman: I do not want to get party political
National Health Service. Would not looking at that at all, but the last election was fought when one of
service about part-payment get us into all sorts of the major parties had a point that the National
terrible problems? How would you envisage the cost Health Service would pay for half of the cost of the
of an IVF treatment having £2,000 being part-paid private sector. Does Reform go down that road? Do
for? you think that is a feasible way of approaching
Mr Haldenby: I quote infertility as an example, I healthcare needs?
think, of where this is already happening. In Mr Haldenby: We thought that the patients passport
Lambeth PCT, for example, where I live, the PCT was a bad policy because, apart from anything else,
will pay for, I think it is, one full course of treatment for one thing it is an opt out which would only
and it will also pay for two courses of drugs for benefit some members of society, which I think was
people whowant to pay privately. Notmany couples the political point that was made, but also, without
increases in supply, all that would happen would bewho have IVF will just want to do it once, unless it
that they would increase the demand for treatmenthappens the first time, it is two or three or four times,
and that would either increase waiting lists or driveso we are already in a position where the
up the costs; so it was a badly framed policy. PerhapsGovernment, the NHS will cover what in truth is
there is another trend of policy which enables us topart of the treatment but not the whole course of
discuss these matters perhaps a little bit moretreatment, and this is already moving towards a part
positively and openly, and that is, I would say, thepaymentmodelwhere peoplewhowant to go private
change from a monopoly, uniform NHS towards anpay for the treatment and not the drugs. Clearly that
NHS full of much greater diversity. This is andoes raise questions of equity, because some people
argument rather than a fact, I suppose, but it seemsare able to aVord to pay for those extra courses of
tome that it mademore sense to have an entirely tax-treatment, but again I come back to the core point,
funded system in a smaller, more uniform, rationedand here perhaps I would disagree with my absent
service of the kind that we were used to what is nowopponent, as it were. Perhaps he might say all eVorts
one or two decades ago in 2008 when it will be ashould be made to take out the charges, all eVorts
much more diverse system with new kinds ofshould be made to have the NHS fund all those
providers, some of them private, profit making, andcourses of treatment. All I would say is that I do not
it is accepted policy for all the parties now for therethink that is a credible way forward given the
to be that variety of provision. In that world it wouldfunding position.
seem to me only to be expected that many of those
providers will be charging or oVering the
Q122 Chairman: We accept that. For IVF NICE opportunity to charge for their services and it may
recommended there should be three interventions. become a more common part of the health
experience. I think the Tory policy was wrong, butThere is only one, and that does not happen on some
the general trend of policy, I think, does perhapsoccasions because of the criteria that is laid out by
lead us particularly to this discussion.the commissioning body, the Primary Care Trust,
anyway. When you say that people pay for it
anyway, they pay for it out of the frustration of not Q124 Chairman: We have this debate now about
being able to get it on the National Health Service. patient choice and, looking at it not exactly from the
Few people would go and borrow £2,000 from the outside, it seems to extend just beyond the National
bank to pay for an IVF intervention if they were not Health Service in terms of the use of the independent
totally frustrated by the lack of ability to have it on sector. Do you foresee that co-payment would be
the NHS, even when it is recommended now for the one of the issues about patient choice and that you
last couple of years. There are issues there that are could choose an area with a co-payment that might
far wider than you can improve that particular be more eYcient or might be better for your needs,
service by a bit of co-payment, are there not? There as it were, than one of the other areas?
are issues that have to be addressed, major funding Mr Haldenby: Kingston Hospital, which I was
looking at over the last couple of days, has a privateissues, under the circumstances of what is
unit where it provides private physiotherapy.recommended as opposed to what is currently
Physiotherapy would seem to me to be one of thoseaVorded by the NHS.
services that could be provided at diVerent levels ofMr Haldenby: Of course, I accept that, and of
intensity and comfort, and so on, and so might havecourse, as I think you yourself would recognise, no
an element of co-payment.matter what the recommendation has been, and I am
sure there are equivalent recommendations in the
area of audiology and stroke rehabilitation as well, Q125 Chairman: An element of co-payment with
they have not been delivered and people may be protection for opting out?
acting out of frustration or they may have little Mr Haldenby: Absolutely. This is slightly more
alternative. There may be a way to move towards a speculative. I think the policy statement is simply
diVerent way of funding IVF treatment which again that the position is that from 2008 anyone who can
provide up to the tariV—I do not need to tell you—uses tax-payers’ funding a diVerent way. Instead of
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will be able to be chosen, but in a world of new Mr Haldenby: All I am trying to do is perhaps to try
providers, and I particularly need to emphasise the and be practical and to recognise that, certainly to
fact that they are new and they are coming along and take the two examples that I have mentioned,
oVering new treatment, that would seem to rather however much one would wish the additional
inevitably pose the question of whether patients may investment to be there to improve those services, the
want to pay a bit extra to access some of those recent years of kind of maximum spending increases,
services. and I do not think we can expect any more ever, not
ever, but for the foreseeable future on the scale, have
not solved these problems and, as I said at theQ126 Dr Naysmith: Do you accept that the
beginning, I am not sure, however much we mightproposals will mean more investment in the private
want to, we can realistically expect too much moresector?
funding, and so that might be a reason to look at aMr Haldenby: In the private sector, yes.
diVerent route.
Q127 Dr Naysmith: Developing more private
sector—
Q131 Dr Stoate: You have given examples ofMr Haldenby: Yes, as we have seen in the opposite
audiology and physiotherapy being possibles for co-core sector.
payment, but in order to make a meaningful
diVerence to the level of service provided by these
Q128 Dr Naysmith: You would the expect that to two things, we would have to have far more
happen? audiologists, far more physiotherapists. I am notMr Haldenby: In a way, I think it is almost the point against that, but the level of co-payment needed toof it really. generate that extra capacity would be enormous. We
would not be talking about £6 something for a
Q129 Dr Naysmith: Would it not be more likely that prescription, we would be talking about hundreds if
that will occur in more aZuent communities where not thousands of pounds more in order to stimulate
people are more likely to be able to aVord additional enough of a growth in these diYcult areas. I cannot
payments, and that is the exact opposite really of see anybody but the richest even vaguely being able
what we need in the National Health Service, which to pay for it, and even the Conservative Party’s
is investment in other areas where facilities are not passport scheme with 50% being paid by the NHS,
very good? we are still talking about the majority of people
Mr Haldenby: All I would say is that this will remain being priced completely out of private physio or
at the margins of NHS activity. As I tried to say at private audiology. I cannot see how co-payment
the beginning, this oVers a very positive possible would ever even begin to dent the scale of theaddition toNHS care, but the greatmajority ofNHS problem.care is going to be funded from taxation and so I
Mr Haldenby: I think one would need to look at thethink decisions over the problems of equity, which
extent of the funding that has already beenothers have identified, will remain really a question
committed to those services.for that tax-funded part of the NHS, but then, I
think, it comes back to the question of exemptions.
We have already heard that there are very wide
Q132 Dr Stoate: The answer is, not much, and thatexemptions, and so if those exemptions are
is the reason why we have got such shortages. Toconcentrated in deprived areas, those are resources
make a meaningful change to physiotherapy and athat are moving into those areas, so I do not think it
meaningful change to audiology would mean veryis quite as black and white as is suggested.
large spending and significant investment indeed,
which would have to come from somewhere, and I
Q130 Dr Naysmith: Possibly it will end up with all simply cannot see how co-payments for the rathersorts of anomalies, such as the ones we were talking better oV in society could even begin to scratch theabout earlier today for prescription charges. For surface of those areas.instances, talking about physiotherapy, if you start
Mr Haldenby: Perhaps then we are not talking aboutproviding lots of private sector physiotherapy—I
co-payment for the most expensive services, we arehappen to think that much more widely available
talking about co-payment for a certain level ofphysiotherapy available on the National Health
service which is aVordable but which cannot beService would save the National Health Service a
provided on a certain level. I am not in any wayhuge amount of money, because there have been a
suggesting that in an ideological sort of way—number of studies which have shown that if you take
everybody must be expected to pay for the mostpeople oV orthopaedics waiting lists and give them a
expensive services—not at all. All I am trying to dobit of free physiotherapy, then they come oV the
is to suggest that in this period of extreme highsurgical waiting list without the surgery, but if you
pressure, however much we may regret the reality ofare going to spread out lots more physiotherapy
services and the unlikeliness of extra funding, that isunits where people go and pay I suppose you will
the reality. I am sure there will remain services at theargue they will never get on the orthopaedic waiting
top end of the cost which almost nobody will be ablelist in the first place, but does seem like an argument
to aVord, but perhaps there may be something wefor the National Health Service to do a bit more
investment in physiotherapy. can do at the aVordable end.
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Q133 Dr Stoate: The point is that things like audiology and stroke rehab, what else could we
charge people for within the NHS, people who haveaudiology and physiotherapy are not expensive high
end services. They are actually very basic and cheap got the money? What else could we charge them for?
Mr Haldenby: I am going to stick to the examples.services. The fact of the matter is that people in this
country, I do not think, have not got a real grasp of When I was preparing my evidence, rather than
present an absolutely exhaustive list, because I thinkjust howmuch even basicNHS services cost. I do not
think many people in this country realise what a day this will always be part of negotiation and can
always be determined really by levels of fundingin hospital costs—we are not talking about a
few quid—and even though physiotherapy and almost year by year, I thought I would present those
examples, particularly in areas of service, which,audiology are basic relatively low cost services, they
are not high tech in any way, nevertheless, the true however much they appear to be guarantees to
provide at the moment, are not properly providedcost of those services is very high. I do not want to
go on. I want to look at something slightly more and that also refers to the previous remarks about
the diVerence between core and supplementaryphilosophical from the argument that you have been
putting forward, and that is that currently co- services.
payments have been used either to prevent frivolous
use of services or, for pure economics, to try and put Q135 Dr Taylor: Would you not be prepared to
theorise a little bit? There are so many other thingsa lid on expenditure or simply to generate some
income through the NHS. I want to move beyond that perhaps could be charged for: hotel charges
always come up, insurance for sports injuries, thethat and I want to ask you should charges be used as
a deliberate instrument of health policy, and if so SMF in their thing thought that prescription charges
should be linked to the therapeutic value of thehow?
Mr Haldenby: I think I would agree with the muddle medicine?
Mr Haldenby: Since you mention Social Marketto compromise that we heard about this morning.
We are where we are, and although other people will Foundation, one of the ideas they proposed was
charges for out of hours, what they call “convenientput forward the theory of charges, I suppose what I
am trying to put forward as we sit here today is why GPs appointments” as an example of an area of
service which is not currently being providedwe are having this discussion—because of the
financial position—and what might be the benefits, eVectively but which some professionalsmay wish to
pay to visit the a GP on a Sunday afternoon, whichand I do not think we are wrong to discuss this. If I
might quote one or two, but not take very long, the is more convenient for them. I do not think I am
prepared to theorise on some of the detail, but ISocial Market Foundation did a report on charges
18 months ago, and they said, no introduction, might just confine myself to my previous remarks.
“Ultimately the case for reform of the existing
charging system might seem weak in an era when the Q136 Dr Taylor: I would like to come out of this
inquiry with some ideas for other ways because theNHS is enjoying unprecedented levels of increased
funding. However, we can expect the arguments for deficits are so enormous.
Mr Haldenby: Chairman, perhaps I could saywewillreforming that we present here to take on greater
savings when this increased funding levels oV, as at give it more thought and submit written work.
some point it inevitably will.” It is not a
philosophical, it is just it is a very practical point. Q137 Chairman: We would more than appreciate
that. Already the debate has started, although weThen Patricia Hewitt, the Secretary of State for
Health, in 1996 was the Deputy Chairman of a should be asking questions and taking answers, but
I think that the areas that you have brought up arehealth commission which concluded, “We are
committed to general taxation being maintained as quite right. I have to say that I buy private
acupuncture for my problems at work that were nota political source of funding health services.
However, we believe it is not possible to expect the dealt with many years ago by the National Health
Service to my satisfaction. I do not have a problemcontinuing gap between resources and demand to be
closed through increased tax-funding alone.” This is with that, but I have the requisite income as well and
the time and availability to be able to go and havea debate which we have had before and which, it
seems to me, recurs at times of real pressure. So treatment as and when I feel fit. These areas are not
closed oV, I do not think, at all, and may be comingrather than a philosophical nature, I think it is a
more timely reason for it. out of this report when we have ideas. Can I thank
you for giving us this evidence session, particularly
because, certainly as far as you are concerned, withQ134 Dr Taylor: I want to go on really exploring
this, but, starting from what we heard in the first no other witnesses there is absolutely no respite
whatsoever, whereas at least we can sit back andsession that it is only 13% of items that are actually
charged, even though that raises 427 million, with all gather our thoughts before we ask the next question.
Thank you very much indeed—I found that verythe anomalies that we have heard about, to me the
only answer to that is to abolish those charges enjoyable—and we would appreciate any further
written submissions you could give us. Thank youaltogether. That leaves us with an even bigger gap. If
you had a blank piece of paper, you have told us we very much.
Mr Haldenby: Thank you.could raise a little bit with direct payments for
3312492002 Page Type [SE] 11-07-06 20:40:56 Pag Table: COENEW PPSysB Unit: PAG2
Ev 22 Health Committee: Evidence
Thursday 2 February 2006
Members present:
Mr Kevin Barron, in the Chair
Mr David Amess Anne Milton
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Mr Paul Burstow Dr Howard Stoate
Mr Ronnie Campbell Dr Richard Taylor
Jim Dowd
Witnesses: Dr Anthony Harrison, King’s Fund, Mr Robert Darracott, Head of Corporate and Strategic
AVairs, Royal Pharmaceutical Society of Great Britain, Dr Ellen Schafheutle, Research Fellow and
Pharmacist, Drug Usage and Pharmacy Practice Group, The University of Manchester, Dr Hamish
Meldrum, Chairman of the General Practitioners Committee, British Medical Association, gave evidence.
Q138 Chairman: Good morning. Could I welcome and inappropriate use has been tested, suggests that
you to our second evidence session on our inquiry both are aVected by charges. So charges do not
into NHS charges. I wonder if you would mind distinguish between frivolous or inappropriate or
introducing yourselves for the record. unnecessary use, they are too blunt an instrument to
Dr Schafheutle: My name is Ellen Schafheutle. I am do that.
from the University of Manchester. My colleague Mr Darracott: Based on the examples where
Peter Noyce and I have submitted written evidence. eVectively charges are being removed and the
Dr Meldrum: I am Hamish Meldrum. I am a GP in evidence we quoted in our paper of Italy in 2001,
Bridlington in East Yorkshire and I am Chairman of there was a large increase in the number of
the GPs Committee of the BMA. prescriptions that year. I was involved in some work
Dr Harrison: I am Tony Harrison. I am a Research in Italy at the time. In the January that the charges
Fellow at the King’s Fund. were removed prescription numbers increased by
Mr Darracott: I amRobertDarracott. I am Director 18% and they increased so rapidly that charges were
of Corporate and Strategic Developments at the reintroduced nine months later. Every system is a
Royal Pharmaceutical Society. I am responsible for dynamic one. It would be wrong to extrapolate too
our Policy Unit. far from that. It is not just about frivolous use, it is
about who does not get the benefit of medicines they
Q139 Chairman: Thank you. Apart from raising really need.
revenue, what contribution do charges make to
health policy?
Dr Schafheutle: It is about £450 million that comes Q140 Chairman: In terms of health policy objectives,
from prescription charges. That only makes up we are seeing some changes taking place at the
about 5.5% of the total net ingredient cost of all moment. We have had proposals earlier this week
NHS prescribed items and that is due to a high and many others about this concept of moving care
number of prescriptions actually being exempt. out of hospitals into the community. Are there any
Around about 13% of our items are exempt from issues around that in terms of NHS charges that you
prescription charges. There is no real data available can tell us about? I think all four of you agree it does
on the cost of administering the current system of not steer policy one way or another. Does it hinder
prescription charges and exemptions. In Scotland a policy?
figure of £1.5 million was quoted. I have gone Dr Meldrum: I think it probably does in that somethrough some of the Hansard records of last year
of the most hard to reach people and the people whoand tried to tot up some of the figures there and it
you would want to try and attract for treatment arecame to around about £6.5 million, but that is a
aVected by charges and are dissuaded. As othersreally rough guestimate.
have said, it is a blunt instrument. I think we haveDr Meldrum: Apart from a financial contribution,
quite a lot of evidence, both from research and alsomy own view is there is little evidence of any
personal evidence, of people who will ask me, “Do Ibeneficial contribution to health. There may be some
really need all three of these, Dr? I really can’t aVordevidence that it may reduce a little bit of
them. Which are the two most important ones?”inappropriate demand. I think the downsides of the
That is the ones who are upfront with me. I knowpresent system far outweigh that small potential
plenty of others who then ask the pharmacist thebenefit.
same question or who actually just do not cash in theDr Harrison: I cannot really enlarge on that. I
prescription. I carry on in the ignorance that I thinkcannot say what contribution charges make to any
they are taking it and they do not want to upset mehealth policy objectives. They are inconsistent with
by telling me they are not. I think, because we areobjectives which the Government has vigorously
trying to look at more preventative measures in thepromoted. Let me make just a small point on
announcements this week and focus more on thatinappropriate use. I think the general evidence, not
in this country but where the eVect on appropriate and to try and focus on under-privileged areas, the
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previously hard to reach places, the present charges do deter some people and, as Rob has
prescription charges can only tend to act against already said, mainly it is people at the lower end of
that. the income scale, although it is not those right at
the bottom.
Q141 Charlotte Atkins: Mr Darracott, based on
what you said earlier and also on your evidence, you Q143 Charlotte Atkins: The indication that there
quote various international studies about the have not been any studies done implies to me that
deterrent eVect of charges, what evidence is there out there is not a big issue here.
there in terms of the detailed evidence? Dr Harrison: Other people—and I think they will be
Mr Darracott: The Society’s review of the available giving evidence probably later on this morning—
evidence was done in large part by Dr Harrison. have collected evidence directly from individuals
What that evidence concluded is that the evidence in who say they cannot aVord three prescriptions at
this country is fairly sketchy. We collected together one and the same time, and Dr Schafheutle has donethe evidence that was available from around the a lot of work on the way people and professionalsworld on lots of diVerent sorts of systems, whether react to the existence of charges. So that work hasthey were fixed charge systems, annual maximum been done and it is strong enough to suggest thatsystems or various forms of co-payments or co- there is an issue. What we could do with are someinsurance. There is evidence around but it is fairly
more comprehensive and wide-ranging studies thanfragmented and it may only look at a particular
we have ever had in this country which do trace thecategory of patient. There are some very interesting
impact of charges through to what happens to thosestudies which suggest that the very vulnerable types
who do not take up their medicine, who do get aof people and those who are a focus for government
prescription in the first place and they spin out thepolicy are the sorts who are inordinately aVected by
prescriptions, ie making them last longer than theythis sort of work. For example, one of the stories we
should and all those eVects. What is the consequencequoted was looking at some people with mental
of that on health, hospital admissions and other usehealth problems in the US, where a cap on the
of services? That is what needs to be done.amount of costs which could be allowed in any
patient case actually led to an increase in
hospitalization and the economic examination then Q144 Charlotte Atkins: Maybe Dr Meldrum can
suggested that the total excess costs were 17 times the help us here.Have you picked up if there is a regional
cost saved by putting the cap on in the first place. dimension to the impact of charges?One might think
The other thing that is very interesting and why this that maybe in more prosperous regions there is not
particular inquiry is very timely is that we have a live such an issue and in poorer areas there is. Have you
experiment going on at the moment in Wales and picked anything up from your experience?
although we are only part-way through what is a Dr Meldrum: I recognise your anxiety about the lackstepped programme for the removal of charges to of evidence. I think some of the reason for that is thatthe people in Wales, we are now at £4 and we are
so many who are close to it feel the whole system isgoing to go down to £3 in April, there is evidence
so patently inappropriate, the anomalies within it,now beginning to emerge on how that is aVecting the
who is exempted and why they are exempted, so whynumber of prescriptions that is actually coming
spend a lot of money on getting evidence whenthrough. There is evidence around and we have tried
something seems so obviously wrong.to summarise a lot of it, but in this country, apart
from some other work done at Manchester, there is
not a lot. Q145 Charlotte Atkins: Some of us believe we should
have evidence.
Dr Meldrum: Absolutely, and as doctors we wouldQ142 Charlotte Atkins: The Committee will be
go along with that too. In terms of eVects in diVerenttaking evidence in Wales. I am interested in why
areas, certainly within a practice one knows thatthere is not any evidence in this country. It is not as
there is a certain group of patients—not those rightthough we have not had prescription charges for
quite a long time. Why is that? Has the work not at the bottom end who are often on income support
been done or is it not easy to collect? What is the and therefore exempt from prescription charges—
issue? just on the threshold where there is a real impact on
Dr Harrison: There is evidence about the impact of the uptake and the use of medicines. They are the
charges on the uptake of prescriptions. Where we ones who complain most about having prescriptions
lack evidence is on what the further impact of that is. and also wanting prescriptions to be given for six
As Rob mentioned, a particular study done months at a time so they only have to pay the
elsewhere suggested that the impact could be very prescription charges much less frequently and
considerable. Other studies have confirmed that various other things. So doctors are often under
hospital admissions may rise as a result of people not quite a bit of pressure to try and play the system in
taking up prescriptions because of costs and they order to reduce the financial impact on patients.
may find themselves going to their GP or doctor
more frequently. Those overarching studies just
Q146 Charlotte Atkins: What you are saying is thathave not been done in the UK. A few studies were
the group that is most aVected is those just on thedone on the impact of charges over the years in the
Sixties and so on. So we can be fairly confident that edge, is it not?
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Dr Meldrum: Yes. other factors that come into play in people not
picking up their prescriptions. A large percentage of
those that are cost related are where people can buyQ147 Charlotte Atkins: If you were to look at the
something over the counter. So there are quite a fewoverall figures—and I am sure the Department of
cases where adequate substitution takes placeHealth would say this—you would see that only
because an over-the-counter product is cheaper thana small fraction of the population pays for
a prescription charge, but there are still a number ofprescription charges. So is it a big issue?
prescriptions that would be deemed as necessary orDr Meldrum: Yes, 85% of prescriptions are exempt,
clinically important that people do not get dispensedbut that does not mean to say 85% of people are
because they cannot aVord the prescription charge.exempt and for those who are not exempt it is a very
big impact. Yes, we can argue that because all the
young and all the elderly are exempt—and
Q152 Dr Stoate: I think we can all agree from theparticularly in the elderly that is where the bulk of
initial answers to the questions that the currentprescriptions are—that it is not a problem, but of
system is dog’s breakfast. It is a question ofwhere wecourse you are exempt whether you are elderly and
go from there. I would like to pick up one or twoa millionaire or a pauper. It is those in between who
points about health policy. None of you seem tohave to pay where the biggest impact is and often it
have had much enthusiasm for any advantage tois at a stage in their life when you can make quite a
health policy. Is it not part of government policy thatbig impact on them if you treat them adequately.
we should be encouraging people to use pharmacies?
Is there not some evidence that a prescriptionQ148 Charlotte Atkins: You pointed out it is the charge might encourage somebody to go to theirpercentage of prescriptions we are talking about pharmacist before going to their GP and gettinghere. Is there any evidence about the percentage of something over the counter that they mightpeople who are ill, who regularly take prescriptions otherwise queue in their GP’s surgery to get? Is thatand who are not exempt? not at least a potential advantage in terms of policy?Dr Meldrum: I cannot put a figure on it. Most of my
Mr Darracott: Yes, it is potentially. The figures thatevidence in that sense is anecdotal. In terms of the
we uncovered showed that for every 1% increase innumber of occasions when patients complain to me
charges there is a 0.3% decrease in the number ofabout the number of prescriptions which are
items. You are absolutely right in that a number ofnecessary andwhether they can have them for longer
strands of government policy are promoting that.periods, that is a very frequent occurrence, and I
Not only is there a visible encouragement of peoplehave found from talking to colleagues that that
to access pharmacies, but behind that sits a policy tohappens very frequently.
examine particular medicines and to decide, for
those that are safe and eVective, to move them fromQ149 Charlotte Atkins: When you say frequently, do a prescription category and into a pharmacyyou mean at every surgery or once a week?
category and therefore widening the range ofDr Meldrum: Once or twice a week.
products that is available in that way. Yes, that is an
important part of it. We have had the system now
Q150 Charlotte Atkins: Is there any evidence that that we have got 40 years with all its illogicalities. I
anyone else would like to bring in on this issue? do not think it has been teased out as to what theDr Schafheutle: I would like to pick up on the last impact of that is on this specifically.point about patients talking to their GPs and raising
the issue of aVordability. Based on the work that we
have done at Manchester, it seems that a lot of Q153 Dr Stoate: At least potentially you could argue
people do not raise the problems they may have that there could be an advantage to government
about aVordability with their GPs as they do not see policy if more people saw the pharmacy as
it as a doctor’s job to address those issues. A lot of appropriate for them rather than waiting to have an
people who find the cost of prescription charges to appointment with their GP.
be a problem do not speak to their GP, but they may Mr Darracott: Yes. There has been an
speak a little bit more to their pharmacist because encouragement of what is called the Minor Ailment
that is the point at which they have to hand over the Scheme in which people who are exempt from
money, although a lot of it just goes on without any charges, who require advice on something that you
awareness. The things that the GPs and the put into that category can go directly to the
pharmacists see are probably an under-estimate of pharmacy and yet will be treated in the normal
what goes on. charging regime and obtain the medicines they need
without paying for it because they are automatically
Q151 Charlotte Atkins: Have there been any studies exempt. There are a number of strands of policy
to tease this out? which are supporting that.
Dr Schafheutle: We have done some work to look at
the non-dispensing at the point where people pick up
Q154 Dr Stoate: Hamish, you have talked alreadytheir prescription in commuter pharmacies to see
about the inappropriate use of GPs’ surgeries. Therewhat the impact is and how much cost comes into
may be inappropriate consultations for a number ofthis and how much other reasons play a part and it
reasons. You have already said you do not believeis quite clear from that that for those that have to
pay cost is quite an important impact. There are charges are a very good method of deterring
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inappropriate consultations. If we can agree that available dataset that we can access to set up that
kind of study in the UK. In GPs’ surgeries and oftensuch consultations exist, how would you feel the best
way of tackling them is? in pharmacies we do not hold the information on
whether somebody pays or not.Dr Meldrum: How do you make sure that people use
the health services most appropriately? That is
mainly about education. At the moment it works Q157 Dr Stoate: That is remarkable. TheGP dataset
both ways with prescription charges. I get people is probably the most comprehensive in the world in
coming to me rather than going to the chemist when terms of the fact that every single prescription is
their child is sick because they can get free Calpol logged on the computer now. Surely that data must
whereas they should really be going to the chemist be incredibly easy to access.
when he has just got the sniZes or a cold. The Dr Schafheutle: That data is probably not so diYcult
prescription charges are a pretty blunt instrument in to access. It is linking it withwhether somebody pays
terms of trying to implement what I would think is or not that is the diYculty.
cohesive and comprehensive health policy. I do not
think I would be saying we should just abolish Q158 Dr Stoate: That cannot be rocket science, canprescription charges and do nothing else. Youwould it? It is very simple to work out if somebody pays.also have to look at the system, which would Dr Meldrum: It is simple in terms of the age ones, butencourage people to make use of pharmacists and there are many other exemption categories as youperhaps have voucher systems for those who would know. As a GP, I will not always know who paysotherwise have to pay. We have talked about certainly within the age group of 16 to 60.pharmacy prescribing. The BMA is actually
supportive of pharmacy prescribing for minor
Q159 Mr Burstow: I want to ask about the researchailments and such like. There are other ways to try
that you have done, Dr Schafheutle, and how thatto address this to avoid inappropriate use of various
looks at the current system of exemptions and whatparts of the Health Service and I think it should be
eVects prescription charges are having on patients.mainly done by education rather than by a rather
What kind of things has the research revealed so far?crude tax, which is what the prescription charges are.
Dr Schafheutle: Over the years we have been
involved in a number of studies. It began with a
Q155 Dr Stoate: Dr Schafheutle, has any research European study that involved six countries all
been done on whether costs elsewhere in the Health looking at the impact of the diVerent co-payment
Service are increased purely by having charges in the systems in their countries and obviously we were
system? If somebody has to pay and does not get particularly involved with the UK side of things. We
their medication, have we any way of measuring did focus groups with patients and that included
what knock-on eVect that might have on other people with hypertension, HRT, hay fever or
Health Service costs? dyspepsia, and then we developed a survey of people
Dr Schafheutle: Unfortunately not in the UK. That who had to pay for their prescriptions in the UK.
evidence is not available for a number of reasons. Then we did a study on non-dispensing that I
We have evidence from the United States and also mentioned earlier.More recently, as part of mypost-
from Canada where a very, very large scale study doctoral Fellowship, I have been doing interviews
looked at the impact of co-payments on particularly with people who have asthma or people who have
vulnerable groups, which were the elderly and coronary heart disease or who suVer from high
welfare recipients in that country, and they found blood pressure. From all of that research we found
they reduced their use of essential medication and people do a number of things. If prescription charges
that had a direct impact on their health services use. are a problem—and we have shown that they are a
This was a cost-related impact and therefore it had problem—and if people are below the average
an impact on the increased use of acute services, income then they use a lot more strategies to cope
emergency department admissions, admissions to with costs, whereas those that are on higher incomes
hospital and also increased mortality, which they do not need to use those strategies to copewith costs.
linked directly back to an increase in co-payments in First of all, it prevents people from going to their
those vulnerable groups. general practitioner because they assume it is going
to end up in a prescription and that is going to cost
them a lot of money. The next step is not to get aQ156 Dr Stoate: Is it not rather important to know
that figure? If it turned out the figure was £450 prescription dispensed. If somebody has a number
of items on their prescription then that adds up—themillion a year it would rather wipe out the whole
benefit of prescription charges in the first place. Is it current cost of one item is £6.50—to rather a lot of
money for somebody on a relatively low income andnot rather important we do that research?
Dr Schafheutle: It is. The problem is the lack of so people try and prioritise. Some of them will ask
their GP or their pharmacist about it or they willevidence. In Canada and the United States it is
generally much easier to access large datasets decide which one they need the most without that
input. An example of that is asthma inhalers, wherethrough their insurance schemes like Medicare and
Medicaid who reimburse patients and they hold a lot people take a preventer and a reliever and then
choose the reliever at the expense of having theirof information about those patients and so they can
relatively easily assess the compliance of people, how asthma controlled well. Some people may use a
lower dose to make their medication stretch over aoften they refill, what kind of conditions they have
and draw conclusions from that.We do not have one longer period of time and in some cases that may not
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be a problem, but if it is a problem they may borrow a statin, on aspirin and other things. They are going
to need a sizeable amount of medication but they domoney from friends or family, they may use
somebody else’s medicine or they will delay it until not get that exemption. If you happen to have an
under-active thyroid at any time in your life and youthey have the money available. One mechanism that
is available for people to use is the Pre-payment are required to take thyroxine you are prescription
exempt for everything. Somebody who happened toCertificate which they can buy either to cover their
medication for four months or for 12 months. We have an under-active thyroid at 20 and who turns
out to be hypertensive in their 30s or 40s gets freehave identified a number of problems with this and
the Citizens Advice Bureau research has identified medication. Somebody else who just becomes
hypertensive and did not have the fortune to have anvery similar issues for those people on low incomes,
the ones that most need protection against under-active thyroid does not, they pay. We
have talked about conditions and my colleagueaVordability issues, in that the lump sum payment
of these Pre-payment Certificates can be a real mentioned asthma. Often that condition requires
quite a large number of drugs now and if treatedproblem. So paying out in advance over £30 for four
months or over £90 for 12 months is actually a real eVectively it can help reduce hospital admissions and
improve the quality of life, but it is not exempt andissue. Something else we have identified is the
predictability of certain conditions. After somebody it is often a condition aVecting the young and young
adults. Increasingly now we are seeing hypertension,has a heart attack, for example, they are normally on
a lot of medication which is prescribed on a monthly we are seeing heart problems, all of which there are
good therapies for which will help prevent furtherbasis, so it is very obvious to them that they will
benefit from having a Pre-payment Certificate and it complications in later life and these people are not
exempt.is very obvious to the GP and the pharmacist that
would then recommend these certificates. On the
other hand, there are conditions—and again I come
Q162 Mr Burstow: Have you put these concernsback to asthma—where this is a lot less predictable.
about how the system works and arguably theVery often for people who are feeling generally well
diversities in the way the system works to theand who pick up their inhalers every six weeks
Government and, if so, what response have you hadgetting a Pre-payment Certificate is just not worth
from the Government?their while. They do not know when they are going
Dr Meldrum: Frequently. Every government in theto have an infection that may require antibiotics and
last 30 years has probably seen that.when it is not clearing they may need another course
of antibiotics or they may need a course of steroids.
These individual charges add up very quickly. There Q163 Mr Burstow: Has the response changed over
is no way for them to go back and say, “Over the last those 30 years?
four months I have paid out far more than this £30”. Dr Meldrum: The response tends to be “We’re
That is another thing that we have identified as a looking at it and we’ll get back to you”. That is why
problem. it is quite refreshing to see somebody like yourselves
taking a real close look at this because I think we
would feel that the response so far is that it’s just tooQ160 Mr Burstow: I want to come back to the point
complicated to touch and we do not really want toabout evidence and datasets and so on. You have
change things.described the focus group work, the qualitative
work, the case study-type work that has been done
which illuminates the issues. Do the datasets that Q164 Mr Burstow: In written answers the
would be necessary to do the work that has been Department has said that the reason there has not
done in Canada and the US exist in the UK and, if been a change is because there is no consensus
not, where are the gaps? Maybe that is something about what the change should be outside of the
you can come back to us on if not now. Department. Is that a fair characterisation of
Dr Schafheutle: I would probably need to come back the position from your discussions with other
to you on that. organisations and certainly some of the others who
are giving evidence to us today?
Dr Meldrum: I think it would be fair to say that toQ161 Mr Burstow: Dr Meldrum, your evidence
suggests that the list of exempt items is out-of-date try to achieve a consensus and get a system that was
totally logical and that stood the test of time wouldin terms of the burden of disease as it is now. I just
wondered if you could say a bit about what changes be quite diYcult. There might be an argument for
saying that rather than trying to look at conditionsyou think are necessary and particularly what sort of
criteria we need to use to make decisions about what which should be exempt you should perhaps look at
drugs which should be exempt. There might be moreconditions should be added to the list and what
conditions should be taken oV the list. logic in that because it might be better for important
drugs that were needed for certain conditions to beDr Meldrum: Where do I start? There are so many
anomalies both between diseases and even within made exempt rather than conditions. I think part of
the reason why, after a lot of looking at this issue, wediseases. Diabetes is a classic one. If you have
diabetes but can control it by your diet you are not felt that probably the simplest thing would be to get
rid of prescription charges altogether is thatprescription exempt whereas if you need tablets or
insulin you are, but even diabetics on the right diet whatever system of exemptions you have there are
bound to be anomalies and unfairnesses within it.nowadays should probably be on an ACE inhibitor,
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Q165 Mr Burstow: In designing an alternative of bureaucracy which has to be filled in. If we were
to have a fully integrated IT system then an annualsystem, can I ask if there are any criteria or factors
that should be taken into account? This point about limit, presumably managed through that, as indeed
the Norwegians manage, would be necessary and solooking at exempting particular drugs is one way in
which it might be approached. Are there any others when you get to your annual limit everything else is
then free. All of the professionals in the system knowthat we should be considering?
it is free because they have an integrated IT system.Dr Harrison: Obviously the simplest thing is to
abolish charges for prescription drugs entirely and
then everybody on the receiving end of thatwould be
Q167 Mr Burstow: So come back in 15 years and wehappy. If the Government then says “Yes, but we
might have an answer, is that what you are saying?lose £450 million, what do we do to make that
Mr Darracott: Is that the current implementationgood?” I think the diYculties would arise in trying to
date?get consensus on what the best way of replacing that
Mr Burstow: I do not know.lost revenue was. I could think of other systems of
charges that would probably be more equitable and
still raise some revenue. The point has been made Q168 Dr Naysmith: I would like to return to an area
about the fact that some people with substantial that we touched on earlier and that is the question of
incomes are exempt. You can think of diVerent ways how charges might aVect the behaviour and
of capping the total sum people have to pay. People decision-making of professionals involved in the
may not know how much a course of treatment is National Health Service. I think Dr Harrison has
going to cost and so they do not take out the Pre- indicated that Dr Schafheutle had some evidence.
payment Certificate. A simple way round that is to Do you think there is any evidence that these
have a limit at a low level, for example let us say professionals make decisions which could result in
people pay up to £50 and then everything is free and suboptimal outcomes for the patient; in other words
a higher level where better oV people might pay £100 they do not perform as well as they might with their
and within a given period everything is free. You patients because of charges?
could think of other ways of raising money from Dr Schafheutle: I am not sure if it is suboptimal
prescription drugs. I guess in any system of that kind outcomes because GPs will do their best to try to
some people are going to be losers. Obviously the keep the cost as low as possible, but if the GP feels
people who are exempt now and who are well oV that a particular medication is required and they
would be losers so they are not going to be very prescribe it then there is not an awful lot else they can
happy with it. I think that is where the trouble do. If the patient cannot aVord it then I am afraid the
begins. problem is very much left with the patient. There are
a number of things that GPs will do. One example is
to prescribe a longer supply of medication. So ratherQ166Mr Burstow:Mr Darracott, have you anything
than just writing a prescription on a monthly basis,to add in terms of what we should consider? a GP could issue that prescription for two or threeMr Darracott: I would support the idea that the months, which means the supply is given at the samemethodwhich seems to be used in lots of other places charge for that longer period, which helps for thatis either an income related single threshold or person to aVord their medication. The focus groupsessentially everybody pays, but there is a safety net. that we have done with GPs have shown that theyThere areways of viewing that sort of income related may try and prescribe what they call “moreidea which could be linked to some of the issues eVectively”. So if there is a way of only prescribingaround the Pre-payment Certificate and the fact that two diVerent items rather than three, they will trythey are not terribly well used. One of the issues in and do that. There is only so much they can do.terms of the datasets is that they exist in various There is not a lot of flexibility within the system forplaces but they are not joined together. There are GPs to adapt or other people to adapt theirdatasets which are what doctors prescribe and there prescribing to bring the costs to zero or something.are then diVerent datasets of what has been supplied
which the PPA may hold and it certainly exists on
pharmacy computers, but they are not networked. Q169 Dr Naysmith: It emerged earlier on that
Then there is the other dataset, which is the hardest sometimes patients manipulate the system. If they
of all to get to, which is whether any other medicine know they cannot aVord a prescription they do not
that has been not only prescribed but also supplied go and seek advice. Is that something that you think
has ever been taken, and linking all those things people need to be warned about? Do you think
together is quite complicated. I suppose one of the professionals need to be warned that there are such
answers ought to be the long-awaited NHS super IT patients and they need to look out for them if they
systemwhich is going to connect everybody together can? If nobody turns up at the surgery then the
and put everything on a particular card and then we doctor will not know about them and they are often
might begin to make some progress. One of the chronic patients.
things I ought to observe on that is that the Pre- Dr Schafheutle: It is a good idea to alert and remind
payment Certificate itself is a complicated process as people that there may be people who have
indeed is the HC11 which my 18-year old has just aVordability issues in paying for their prescriptions.
been given a copy of. This is a 16-page document. As I said earlier, we know from some patients that
Have you ever seen an 18-year old trying to fill in a they will not raise their problems with the GPs and
yet the GPs tell us that they will try and help thedocument of that kind? It is a very complicated piece
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people, but if the two do not talk to each other then either a voucher system or a pharmacy prescribing
system certainly for minor ailments so that peoplethat is not going to happen. So to encourage the
professionals to raise the issue will be important. were not prevented from accessing appropriate
medicine but that they would not necessarily come
to see a doctor for. I think there is the potential forQ170 Dr Naysmith: Dr Meldrum, do you have
an increased workload. Perhaps only some of thatanything to add?
increased workload would be inappropriate becauseDr Meldrum: I think on most occasions GPs will try
there is plenty of evidence, as we said earlier, thatand prescribe what they think is the appropriate
people for whom it would be appropriate to attendprescription and unless the patient raises an
the doctor are dissuaded from doing so because ofobjection or a problem they will assume that
the thought of charges. Although with one hat on Ieverything is all right. I do not think—and perhaps
would not like the thought of that, in trying towe should—we routinely ask people if they are going
provide the best service and treat people well I wantto be able to aVord the prescription, we tend to rely
people for whom it is appropriate to come to see meon the patients. It is maybe not the tip of the iceberg,
to come but, at the same time, I want to try to divertbut I am not getting feedback from all the patients
those who should more appropriately be seen by thewho realise they cannot aVord it because in some
pharmacist at the pharmacy and make sure peopleways they feel they do not want to oVend me by
can access care there without additional expense.saying that and so they will either talk to the
Dr Harrison: The experience in Wales should give uspharmacist or do something else.
some clues as to what would happen in real life, but,
leaving that aside, clearly if charges were abolishedQ171 Dr Naysmith: Given what Howard was saying there would be some increase in the usage ofearlier on about the enhanced role of the pharmacist pharmacy drugs, but that is a short-term impact. Ifnowadays, maybe people would ask advice from a we believe—and we have to be careful about this—pharmacist as to which is the most important of the that studies done in other countries can transfer tomedicines. this healthcare system then the medium to long-termMr Darracott: That is right and they do. The pinch eVect might reverse that. There is no doubt therepoint comes at the point when the money has to would be a short-term impact in terms of workload,change hands. It is very easy to think £6.50 is not a but what we said in answer to the questions that welot, but if it is four items then it is £26. If you have collectively tried to answer earlier on about thejust been to the doctor and it is late in the evening overall impact of charging was we could not knowyou might not have that. In preparing for coming because the relevant studies had not been done forhere I had a very useful conversation with Gerald this country. If things worked out here as they haveAlexander, our Vice President and he gave me three done elsewhere then the medium-term impact couldexamples oV the top of his head of where that has be favourable. That is a big speculative question wehappened very recently to him as a practicing cannot answer.pharmacist, where patients have asked his advice.
Paradoxically, from the patient’s perspective,
professionals are doing a great job because they are Q173 Dr Naysmith: Finally, what do you think the
helping them make what are actually quite diYcult eVect would be on the pharmaceutical industry if
choices. One example that Gerald gave me was of a there was the abolition of prescription charges? Mr
19-year old, so someone literally just into the bracket Darracott suggested in his written evidence that the
where you start to pay charges. This was an asthma Government has a dual interest in this because it is
patient, it was a four item prescription, it was an interested both in the health of the pharmaceutical
acute episode requiring an antibiotic and a steroid as industry and the health of the population. When we
well as a preventative reliever and the question was, were doing our pharmaceutical industry report not
“I can only aVord two, which do you think I all that long ago we recommended that it would be
should have?” From the pharmacist’s perspective better to transfer the pharmaceutical industry to the
preventers are very important but that is not what Department of Trade and Industry rather than have
gives the patient immediate relief. There is a kind of it dealt with by the Department of Health, but the
trade-oV there for the patient and the pharmacist is Government did not think that was a good idea and
therefore helping the patient to make those it is not going to adopt that.Do you have any further
decisions, so from their perspective it gives the observations?
professionals an opportunity to appear even more Mr Darracott: I think it would be broadly neutral. I
helpful. They are live choices and they happen on a can think of a couple of issues that might be helped
very regular basis. by this. One of the anomalies that is in the system—
and it is a fairly minor anomaly but it takes some
explaining to patients—is that as a means ofQ172 Dr Naysmith: What do you think would
improving compliance in certain conditions thehappen to the workload of GPs and pharmacists if
industry will package sets of medicines together. Soprescription charges were abolished?
the patient to all intents and purposes receives oneDr Meldrum: One would not necessarily want to see
box but they may have to pay three charges. That isthe abolition of prescription charges and nothing
a very diYcult one to explain. So there may be anelse, I think it has to be part of a package. There
encouragement of more of that sort of activityneeds to be better education about what is
needed because there is not an immediateappropriate to go to the pharmacist or to the GP
with. At the same time I would probably want to see disincentive, as perceived by the patient, to having
3312492002 Page Type [O] 11-07-06 20:40:56 Pag Table: COENEW PPSysB Unit: PAG2
Health Committee: Evidence Ev 29
2 February 2006 Dr Anthony Harrison, Mr Robert Darracott, Dr Ellen Schafheutle and Dr Hamish Meldrum
what is eVectively better treatment all packaged whereas the rest of the NHS—I know we are not
talking about dental and sight charges at thetogether. I suppose if the overall numbers go up then
the industry is likely to be broadly interested in that. moment—is virtually free. Fewer exemptions is a
marginal improvement but I do not think it is reallyAs to the impact and whether they should research
more things, I am not entirely sure there would be solving the problem.
one. It seems to me largely neutral in that respect.
Q178DrTaylor:One of you hasmentioned thework
Q174 Dr Taylor: You have given us a huge amount in Wales. Are they going down as low as £1 a time?
of information and it is really very helpful. Mr Darracott: They are going down to £3 in April
Obviously the overall message is that prescription and then the plan is that they go to zero in 2007.
charges are a blunt instrument, inappropriate to
government policy and aims and that you would
Q179 Dr Taylor: That is going to be well worthreally like to see them abolished. Is that fair?
watching. Would there be huge administrative costsDr Meldrum: Yes.
if we had a flat rate of £1 for every prescription or
would that cut down the administrative costs?Q175 Dr Taylor: You have already given us lots and
Dr Harrison: It would be a very expensive way oflots of suggestions of changes that could be made to
raising revenue, would it not?the system that is working at the moment. Can I pick
up one or two of those specifically? We gather that
in Scandinavia they are widely used, that they have Q180 Dr Taylor: It would. Ellen, you mentioned the
lowered the prescription charge and got fewer work in the US and Canada. You have given us a
exemptions. Have you any comments on that? If we huge list of references in your evidence. Are the
cannot get rid of prescription charges, you have references to that work listed there?
given us several suggestions of what we can do. Dr Schafheutle: I can check if it is in the list of
What about a lower charge and fewer exemptions? references.
Dr Schafheutle: In the interviews that I do with
people at the moment in my work I asked them
Q181 Dr Taylor: It would be extremely useful if youabout that and I found that people are not totally
could let us have the references to that. If theagainst paying for their prescriptions. I should add
ingredients are mixed, for example hypertensivesthat these people are all paying for their
and statins, in the same pill then presumably thatprescriptions at the moment. They are very much in
only has one prescription cost.favour of the NHS. They say, “If we abolish
Mr Darracott: Yes.prescription charges, how is that going to aVect us?”
They are willing to pay, but they are saying the
problem really for them is the level of the charge, Q182 Chairman: Ellen, you talk to patients who find
especially if you are looking at more than one item. it a burden having to pay. What do they say about
Having a much lower charge would ease that. the threshold, which is eVectively not tapered at all,
it is on income and you are either over it or not?
Q176 Dr Taylor: Do you get any feeling from the Beside the pre-payment thing, do they say that there
people who do not pay that there would be some is something wrong there?
willingness to pay? Dr Schafheutle: Those that are aware of it very
Dr Schafheutle: I amafraid I cannot say that because commonly say it is important that we protect those
I have not spoken to those people as part of my people that are on a low income. They are not
study. necessarily aware of what the exact threshold is
unless I speak to somebody that really is just above
that income level.Q177 Dr Taylor: There are tremendous anomalies
amongst the people who do not pay. You mentioned
the people with hypothyroidism. Has anybody ever Q183 Chairman: So nobody says to you that this
asked them if they would pay for other things? threshold is harsh in as much as it is not tapered, you
Dr Meldrum: I do not think we have specifically. I either go under it or you go above it? Does anybodyam sure you would get a mixed response. I think ever say that to you?
some public-spirited ones would think it is not really Dr Schafheutle: Sorry?fair. Some of the elderly who are very well oV would
probably think it is not really fair. I am sure lower
charges would be better than we have got at the Q184 Chairman: The threshold for paying is you
meet a set level and then you have to pay all of that,moment, but to me it is almost a point of principle.
We supposedly have an NHS free at the point of use, there is no taper on that level at all. Does anybody
ever say that that is unfair?Many other things we getfunded from taxation. You could say should we not
have a £2 charge for people coming to see me? That from the state do have a taper.
Dr Schafheutle: I am afraid that most people do notmight help raise some revenue, it might help to
dissuade people inappropriately and yet I think the know exactly how the prescription charge system
works. Even though I may spend my life thinkingsame arguments would apply that would apply to
prescription charges and I am sure there would be all about it, most people do not, so they are not aware
exactly of where the level is and they do notthe exemptions too. It does seem a bit incongruous
that we have this system where you have a charge comment in that detail.
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Q185 Anne Milton: The level of the charge is set and promoting access and the latest White Paper is a
good example of that. In and of themselves, most ofthe exemptions, etcetera, is really diYcult to look at
until we know how much it costs to the system these initiatives look good and attractive, but they
do cost money. One way of rephrasing thisbecause there is a point at which the system is costing
more to administer than the money you are discussion is to say that improving access is a good
policy objective and here we are actually reducingcollecting. You were saying it is almost impossible to
find that out, were you not? access for albeit a small section of the population, or
a lot in terms of people, but only a small section ofDr Schafheutle: Yes.
the pharmaceutical bill, so is it consistent to open up
GP facilities in railway stations, walk-in centres,Q186 Anne Milton: Nobody has any idea because
high streets and so on which are free while imposing,the administration of the system is crucial to the
as it were, the entry fee for some people tocosts, is it not?
pharmaceuticals? Prima facie that is not consistent,Dr Meldrum: Yes.
so if the policy is to promote access, why are we
restraining access here? It is not easy to see anQ187 Anne Milton: So it is all a bit irrelevant
argument for it. More specifically, the Governmentotherwise. Just moving on to Dr Harrison, your
has quite rightly begun to focus on long-termevidence concludes that, “co-payments are generally
conditions and I think in itself everybody would sayan ineYcient way of achieving objectives which
that was a good move as well, so it is a bit ironic tocould be obtained more easily and with fewer
create a barrier for some of those people with long-undesirable consequences by other means”. I
term conditions to access the medicine they need.wonder if you could expand on “other means”.
Again there is a big inconsistency between the policyDr Harrison: I think we are just referring there to the
objective and the charging system that we have.simple point that if you want to raise income, general
taxation is a better means of doing it with a very
specific, focused charge-cum-tax and that is the Q192 Anne Milton: Mr Darracott, I would be
point we had in mind, I think. interested in your views.
Mr Darracott: I think, broadly speaking, that is
right. Our paper, I think, says we support a moveQ188 Anne Milton: Better ways of doing it with
towards abolition, that our long-standing policy isregard to prescriptions or just generally?
that there should not be a financial barrier for access,Dr Harrison: Generally.
but also we would be in favour of a major reform of
the system in a way that can be shown to have littleQ189 Anne Milton: So raise the money from
or no deterrent eVect on use, particularly focused onelsewhere, just from general taxation. Nobody else
this segment of people that tend to be veryhas anything to add to that, have they?
vulnerable where they are just into the chargingDr Meldrum: Only to say that the BMA did a very
bracket and yet they are people who are faced withbig review of how to pay for the NHS and looked at
these decisions.all the various things, whether they be insurance
schemes or whatever, and decided that the favoured
and most eVective way was to raise the money from Q193 Anne Milton: So, just to sum up, discussions
taxation. about the anomalies are really a bit irrelevant to all
of you and we should look at just forgetting the
Q190 Anne Milton: And, therefore, could cut out all charging there and to raise the money elsewhere,
sorts of charging? correct?
Dr Meldrum: Yes. Dr Meldrum: Correct.
Q191 Anne Milton: Is that without exception? Q194 Anne Milton: I am looking for you, Ellen, to
Would you all want to scrap charging? Is it just the shake your head one way or the other.
inconsistencies that bother you or is it the charging Dr Schafheutle: I think the important thing is that
in itself and, going back to what Dr Meldrum said, the vulnerable groups are protected, those on
would you rather the revenue came from general chronic medication. As a researcher, I like to make
taxation? my statements based on the evidence I have
Dr Meldrum: My own view, and there are two available, for me to say that I think you are going to
things, yes, on a point of principle, and we keep solve all problems by abolishing—
going on about an NHS which is free at the point of
use and this is an example of where it is not, so there
Q195 Anne Milton: No, I was not suggesting that.is an issue of principle there, but I think, for a lot of
Dr Schafheutle: I think the important thing, andpractical reasons as well which we have tried to
everybody has said it, is that the current system isoutline, this system is obviously full of anomalies
inequitable and the important thing is that thoseand I suspect that any alternative system might not
people that are actually deterred from accessinghave as many anomalies, but would still have several
necessary, essential medication are protected.and, therefore, I think would be seen as not being
entirely fair.
Dr Harrison: Perhaps I could make a slightly Q196 Anne Milton: I just go back to the final point,
that until we knowwhat it costs to collect the money,diVerent point from that. The Government is
spending a lot of policy eVort and a lot of money on it is all a bit daft really, utterly daft.
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Mr Darracott: Just on that point, I am sure within Q201 Dr Stoate: As a GP, one of the things that
always surprises me is the number of people who dothe reports of the PPA, the actual administrative
not actually know that there is a Pre-paymentcost of the system must be logged there somewhere.
Certificate or certainly do not know how the scheme
works. I wanted to ask Rob, if it were more widely
Q197 Anne Milton: Well, I do not know. publicised, do you think that would have a beneficial
Mr Darracott: I guess the counterpart to that is that eVect on the system?
the system of charges now is currently administered Mr Darracott: I think it would. I am not sure how it
largely by people who collect it as part of their job is publicised at the moment. The publicity which I
and the actual transfer of themoney into the revenue am familiar with is this card which you will find
is an automatic one because it is taken oV the normally situated in a pharmacy somewhere. This is
reimbursement back to those people who work for actually produced by pharmacists. This is their
the NHS, so, from that perspective, it is actually contribution to getting over this issue because it is a
quite an eYcient way of collecting money because it live issue, but it is produced by pharmacists, not the
is being administered in the high street and it comes NHS, to explain to patients. I happen to think, and
straight out and is top-sliced oV the remuneration you have asked a question, that we probably do not
and reimbursement that is going back. make as much of Pre-payment Certificates as we
Dr Meldrum: You are only indirectly paying the tax ought to on this card, but we are concentrating on
collector, whether it be the pharmacist or the the headline figure, the PST produces this card,
dispensing doctor. concentrating on the headline figure. I think, in
short, more publicity would be helpful because at theDr Schafheutle: It is probably the administrative
moment the profession itself is producing this cardcosts of administering the exemptions.
to tell patients about what the charges are.Anne Milton: Precisely, it is all the rest of it, yes.
Q202DrStoate: So certainly if wewere, for example,Q198 Chairman: Dr Meldrum, do any of your to recommend the Government put much morepatients ever get discharged from hospital with a eVort into publicising it, you think that would bemonths’ supply of eVectively a prescription drug helpful to the system?that they would normally pay for? Mr Darracott: Yes.
Dr Meldrum: Sometimes they do. I am afraid, more
often they get discharged with seven days’ supply
Q203 Dr Stoate: Another quick question on theand then come knocking on my door, wanting a
same line—do you think there should be a monthlymonth’s supply to follow on.
version of the Pre-payment Certificate? For
example, you pay for a television licence on a direct
debit monthly, so do you think the same shouldQ199 Chairman: I just wondered if you thought it
apply with the Pre-Payment Certificate and wouldwas inequitable that that can happen.
that be helpful?Dr Meldrum: Yes, and of course the reverse happens
Mr Darracott: I think it would be helpful. Intuitivelytoo, that they will go to hospital and take their
that just feels right, does it not, that, if you make ittablets in with them which they have paid for and
more available and there are more ways to pay, asfind that they disappear somewhere into the system,
there are so many ways of paying the Congestionwhich some people might view as actual theft, but
Charge, having more ways to pay just seemsnever mind.
intuitively to be right. There is this issue that it is aChairman: It is a give-and-take situation, is it? I am
big slug of money. For some people £30-odd is a lotnot familiar with that!
of money when they are faced with it in the
pharmacy right now. “I have got three items. Might
Q200 Mr Burstow: This question follows on from I use five or six over the course of the next four
that point. With the direction of travel of policy months? I do not know. Do I want to pay for three
which says more is going out of hospital in the first now or shall I find money for six now?” For some
place, will there be more instances where there will people, that is a lot of money, and the £90 is certainly
be drugs which hitherto you would have got free and a lot.
in future will be paid prescription items?
Dr Meldrum: It is possible. You are really only Q204 Jim Dowd: Just briefly on that point, is the
talking about the cost of medication while pharmacist really in a key position to promote this
somebody is in hospital or for that immediate period because most people, I imagine, get their
when they come out in terms of what they do not pay prescriptions from the same pharmacy? The
for. I think the other thing I often get when people pharmacist has the records and over time must be
come out of hospital on half a dozen diVerent drugs able to see who is going to benefit from the certificate
is that they say, “I don’t really need to keep taking all and those who will not.
of these, do I?Which ones can I cut out?” Sometimes Mr Darracott: Yes, I am glad you have asked me
there are good clinical reasons for cutting them that question because I think that is absolutely right.
down, but often there are economic pressures for Pharmacists do help people and point them in the
patients to do that as well. I am not sure that direction of the Pre-payment Certificate where that
necessarily the shift to more out-of-hospital care will seems to be an option. I think there is another point
which leads on from that, that there is a new strandhave a huge impact in that direction.
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of policy, if you like, within the new contract for Q207 Anne Milton: No, I did not say that.
Dr Meldrum: I know you did not.pharmacists in England and Wales which is about
promoting a new service which is where pharmacists
will review medicines that patients are taking where, Q208 Anne Milton: There are maybe not always
generally, people are taking several groups of well-educated prescribers actually. I think that is
medicines. Now, it would seem to be entirely an issue.
consistent with that policy that people are Dr Meldrum: Yes, and you mentioned
encouraged to use the same pharmacy over and over physiotherapy for a bad back, but unfortunately the
again because that is the way the relationship builds sort of wait I have locally for physiotherapy is about
up. We have a system, unlike the GP system, where 14 weeks and, therefore, there is not much option
patients can have free choice and they can go to but to prescribe painkillers, at least for those 14
diVerent pharmacies at diVerent times. In the weeks.
Norwegian model, the annual cap is pharmacy-
related, so if you are, for want of a better word, Q209 Anne Milton: Do any of the rest of the panelpromiscuous with your prescriptions and you go to have a view?lots of pharmacies, you might never get to the point Mr Darracott: I would just support that. I think a lotwhere you trigger the annual cap, so there is a thing of the levers around prescribing have already beenbuilt in there where patients, whilst they have a free pulled in the UK. In fact if you look at the long-runchoice, are encouraged to use the same provider of prescription growth, you can see when those leversservices over and over again and we would see that have been pulled and how eVective they have been.as being a good thing because that is how the We have the highest generic prescribing rates in
relationship builds up and that is how the health Europe, we have got lower costs, as has been
professional can help people. mentioned already today, comparing like with like,
so a lot of those levers have been pulled. In fact some
of the other countries do use a charging system as aQ205 Anne Milton: We get suggested questions and
mechanism to pull those levers, so you will findI am slightly bemused by the beginning of this
diVerential rates of charging or co-payment relatedquestion actually which says, “If the NHS enters a
to the supply of a brand versus a generic, fortime of fiscal stringency . . .” but when has it ever not
instance. Well, we have very high generic prescribingbeen in a time of fiscal stringency? You might find it
rates in this country already and that lever wasdiYcult to answer, but how would you rate the
pulled 10 or 15 years ago.abolition of prescription charges against other calls
Dr Schafheutle: Also it is worth considering that, ifon NHS funding? How important do you think it is?
some of the US and Canadian findings that weDr Meldrum: At the moment, and we have argued
talked about earlier may apply in this country, theabout the costs of collection and such like, if you
loss in revenue may actually be oVset by savingtake the actual revenue of £450 million, whatever, it
people through not using their medication due to theis less than 1% of the NHS budget, significantly less
access problem of cost, being admitted to hospitalnow, particularly with the budget having increased.
and actually using much higher-cost services thanIt is obviously going to have an impact, one cannot
the prescription charge that is saved at the outset.deny that, but it is probably less than the appropriate
accumulative deficit from certain trusts at the
Q210 Anne Milton: And we are not very long-moment and, therefore, it may be that there are ways
termist, are we, in the NHS?that one could actually compensate for that. Yes, I
Dr Schafheutle: I think it would be quite diYcult tothink I recognise that if you are going to get rid of
put a figure on it as well, so you have got a loss, aprescription charges, the money has to come from
clear figure of £450 million, but how it would thenelsewhere and, as I have said, it will have to come
translate into the improved use of resources wouldfrom central taxation. In the long run, that could
be probably diYcult, but it is worth considering thatmean a fractional rise in income tax, I suppose, but
because it may well be oVset.it would be very small.
Dr Harrison: This is the point we were on some timeJim Dowd: Or a reduction in GP contracts!
ago, that we do not know the answer to that crucial
question, so, if one is saying, “What should happen
Q206 Anne Milton: I was not going to be as harsh as now?”, I do not think I would say that we should
that, but say that it would be an opportunity to abolish it tomorrow, but I would say, “Let’s get that
encourage GPs to prescribe better. Do you prescribe work done and really prove, or otherwise, that the
painkillers or physio for a bad back? system is ineYcient in its own terms”, so prepare for
Dr Meldrum: I think I am always anxious to find that position, if you like. There is perhaps a wider
ways to make sure that we prescribe appropriately point that stems from your question which is that, if
and there have been lots of measures done to do we assume that the NHS will be in a worse financial
that. Having said all that, the UK’s drug bill crisis in two years than it is now, we might raise the
proportionately is still significantly less than question, “What role should charges have in that
many of our Western counterparts. We are not context in financing it?” If one raised that question,
particularly high medicine prescribers if you one could look across all services and I doubt
compare us to places like France and Germany and, whether one would come back and say, “Well, the
therefore, I would slightly refute the inference that best way of doing it is prescription charges”, as we
have it now, so I think this could be part of a muchwe are sort of frivolous prescribers.
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wider discussion of the general role of charges and, Q212 Chairman: And not user-specific as that
argument would—if one did look at that, one would be trying to
identify areas where charges did the least damage to Dr Harrison: That is right. I do not see that one
needs to make that connection.health because people could aVord them or one was
unaVected by them.
Q213 Chairman: Dr Meldrum, what do you think?
Dr Meldrum: I think you are really getting into quiteQ211 Chairman: Dr Harrison and maybe
Dr Meldrum as well, there is an argument that the complex arguments of health economics. If you are
talking about Herceptin and these very expensivecountry cannot aVord the rise in drug costs at the
moment and we are seeing the reaction of the Health drugs for a few, but very seriously ill, patients, then I
think there is not much link there with the argumentService, particularly PCTs, to the issue of Herceptin
just in recent weeks. We are told in the media that about prescription charges. I think you are then
talking about the overall costs of delivering a healththere are many other drugs like that, probably as
expensive, waiting in the line, waiting to come on to service andwhat is the best, fairest and most eVective
way of raising the revenue to pay for that. I think ourthe market for the treatment obviously of serious
conditions. Do you think there is an argument that argument would be that prescription charges are not
the most eVective way of doing that. We will alwaysreally needs to be put forward, that, unless users pay
more for drugs, it is a very small proportion of the have to look at priorities, what you can aVord and
what you cannot aVord and that should be done onactual drug costs, what users do actually pay at the
moment? Dr Harrison, you are suggesting that not good evidence and the value for money that you are
going to get in actually using any particular drug.unless someone is having an operation does
someone pay a little bit as well. Let’s just take an example of drugs like statins
where, yes, there is a very large, very significantDr Harrison: What I am saying is that, if the
situation is deemed to be so financially tight that you immediate cost, but you have got to look at the long-
term benefits and the potential savings, not just inneed income from the charges, you should ask the
question, “Which is the best area to raise them actual cost to theNHS, but in actually improving the
quality of life for people. It is these sorts offrom?” Just because drug costs are rising for the
reasons that you mentioned, there is no reason to arguments you have got to look at when you are
deciding priorities and then decide how you arenecessarily focus on that area. That is all I would say.
Although it is obviously relevant and sensible to going to raise the appropriate revenue. I think all we
are saying from the BMA is that we do not think thatfocus today on this particular set of charges, if you
set it against thewider financing context, then I think really part of that equation or a very logical part of
that equation is to raise a small fraction of thatyou should look, or not you, but the Government
should, at the appropriate time right across the revenue from prescription charges.
Chairman: Thanks very much for that. Could Iboard and decide where charges would impose the
least damage. thank you all very much indeed.
Witnesses: Ms Pauline Thompson, Policy Adviser, Age Concern; Ms Liz Phelps, Social Policy OYcer,
Citizens Advice; and Mr Martin Rathfelder, Director, Socialist Health Association, gave evidence.
Q214 Chairman: Could I welcome you all and I Mr Rathfelder: We are essentially concerned with
the issue of health inequalities and we see charges aswonder if you could just give us your names and the
organisations you represent. deterring particularly the lower middle classes
actually. We have a bizarre system where peopleMr Rathfelder: I am Martin Rathfelder and I am
Director of the Socialist Health Association which is with lower incomes and of middle age have to pay
aYliated to the Labour Party in the same way as and other people get them free and that does not
the Fabians. seem to us to make any sense whatsoever. The
Ms Phelps: I am Liz Phelps, Social Policy OYcer Government hasmade quite a lot of commitments to
from Citizens Advice. the idea of reducing health inequality, but the
Ms Thompson: I am Pauline Thompson, a Policy Department ofHealth does not appear to have taken
Adviser at Age Concern England. that on board because clearly, if you make a charge
on something, be it prescriptions or windows, then
the consumption of those items is likely to reduceQ215 Chairman: I think, Mr Rathfelder, we should
amongst the population least able to aVord them. Ifhave had you here last week, so I hope you have not
we are serious about encouraging people less able tobeen on the train all week and it was just a delay last
pay to use the Health Service, then forcing them toThursday!
come up with £6.50 every time they have aMr Rathfelder: Thank you very much for letting me
prescription seems counterproductive. I would alsohave another bite of the cherry.
like to say a bit perhaps later about the Hospital
Travel Costs Scheme because that is also part of
Q216 Chairman: Can I ask you, starting with you, the same—
Mr Rathfelder, in your written submission you
recommend the abolition of all charges, so why is
that? Q217 Chairman: We will move on to that.
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Mr Rathfelder:—and other things that the to spend describing the Low Income Scheme. I
Department ofHealth seem to have forgotten about, think, when we are looking at costing things, you are
like wigs and trusses. I came into this because I used not just costing what it costs the NHS to collect the
to work as a welfare rights oYcer in a teaching money, but it is really costing all of those services
hospital and I was next door to the orthopaedic that are spending hours and hours trying to help
department. People who have to have a surgical people and encourage people to go and to see the
truss have to pay for it, unless they come within the dentist when they are really quite scared to because
scope of the Low Income Scheme. Similarly, if they they are so worried about the cost. We would,
need a wig for surgical reasons, they have to pay a therefore, say exactly the same thing, that it really
charge for a rather inferior item. These are forgotten does impinge and we are very concerned about the
areas of the National Health Service and I found way it does put people oV. When you have got a
myself advising doctors, pharmacists, all sorts of government which has just issued a White Paper that
people, who had no idea about the Byzantine nature mentions the word “well-being” 179 times and you
of the system of charging, exemptions and are trying to look at the same time at charging to
reductions in charges. A system of rationing which actually try and achieve that well-being, it just seems
works essentially on ignorance seems to be the worst very strange.
possible method of rationing. Mr Rathfelder: Just to follow up on what Pauline
has said, because there is an age angle to this, it is not
widely known that the Income Support system isQ218 Chairman: Could you expand on your
age-biased. People under the age of 25 are given lesscomments about the question of charges deterring
money to live on and that is reflected in the way thepatients from seeking help? Do you know which
National Health Service Low Income Schemegroups are particularly unlikely to seek help? You
works, so for people under 25, they are expected tohave said obviously the issue of income which is
something we touched on in the earlier session and live on £44.50 a week, and that is not really a great
indeed we did last week, but are there other groups deal and, if that is all they get, they get free
beyond this question of income? prescriptions, but, if they have Incapacity Benefit or
Ms Phelps: I think from our point of view it is a some other benefit or they work, the marginal
combination of people’s chronic health problems amount above £44.50 is expected to pay part of their
and low income. It is when those two things butt up rent, their food, their heating, the costs of all their
against each other, that is the client group that we prescriptions. If they have to have any dental
find most often has problems with prescription treatment or an eye test or anything else, they are in
charges. As was mentioned earlier, the PPC actually severe financial diYculty. One other point I would
really misses out here on this highly vulnerable like to put to you is that, if we are going to continue
group because, if they cannot aVord the individual with some sort of means-tested system, why are we
charge, they cannot aVord the PPC. Particularly, I still attached to the Income Support system which
think, when you come down to people on Incapacity was designed with entirely diVerent considerations
Benefit, that is where it really hits hardest because a in mind? The point of the lower amount for people
lot of this client group were on Income Support and under 25 is that it is expected that those people will
they got free prescriptions, but then they got sick live with their parents, so they do not have as many
and, for whatever reason, got moved on to costs, which may or may not be true, but I do not see
Incapacity Benefit at a slightly higher level and now, that it is the scope of the Low Income Scheme to
thanks to a slight change in the rules in April 2004, encourage young people to stay with their parentsthere is help with the short-term lower rate, but once because that is the only way they can aVord theirthey get on to the long-term rate, which is slightly
prescriptions, nor does it make much sense for olderhigher, they lose out. You might think that
people when they get an Income Support amount ofIncapacity Benefit is paid at a higher rate, so they
£109 a week now. Why do we do that? If old peoplecan aVord it, but the point is the way Housing
need £109 to live a tolerable standard of life, whyBenefit and Council Tax Benefit impact on ICB
should young people only have half of that? Thewhich is that they pull back 80% of any income
argument for that is about incentives for work.above Income Support. I am not sure that
Chairman: That might be for a diVerent selectDepartment of Health oYcials and ministers
committee. I have some sympathy with what you aresuYciently recognise that. What that leaves is a huge
saying, but not today.poverty trap and, if you are trying to tackle health
inequalities, you are missing the boat. From our
point of view, we were very disappointed that this is
Q219 Dr Taylor: Going back to Ms Thompson,the one area in the whole NHS where money is
prescription charges are free, whereas dental andchanging hands between patients and the Health
optical are not. Are there any others that are free forService and yet, in the context of the whole health
the elderly and for co-payment?inequalities agenda, it has not been looked at.
Ms Thompson: Prescriptions is the one that is theMs Thompson: Obviously for older people
free one. Older people get free optical checks, butprescriptions is not an issue, but, where we do have
not free dental checks, so why? Teeth are incrediblyproblems, if you go to any Age Concern in the
important to older people. Malnutrition, well-being,country, they would say they are really concerned
yet they can have free optical checks, but not freeabout older people with dental charges and optical
charges, and the amount of time they actually have dental checks.
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Q220 Dr Taylor: Is there an argument that the very of issues around that which I have not had time to
look at, but I would just say that this is on the cards,rich who are elderly should not get these
exemptions? but how limited it will be and how much it will
actually meet what is needed is another matter.Ms Thompson: The problem is then that you are
going to bring in means-testing and, as soon as you Ms Phelps: I think there are two other aspects of that
which really are important. One is what we havestart bringing in means-testing, you get the whole
problem of people who are entitled but not applying been raising in relation to access to dentistry which
is a huge issue and, whilst we keep our fingersbecause they do not understand the system. You
have already said that it is a labyrinthine system of crossed that everything will be rosy after 1 April, I
think in the real world we do not expect that tomeans-testing for healthcare costs. Quite often it is a
means-test for a one-oV cost, so people think, “Oh happen. We have long been arguing that, if the PCTs
cannot deliver dentistry in the local community,well, I can’t face filling in this 16-page form for a
possible, very small charge”, but of course the other then at least there should be help through the Travel
Costs Scheme for people on low incomes whothing that is not looked at and has not been looked
at so far this morning is that actually people do not actually have to make journeys of 30 or 50 miles
because our evidence shows that that is one of thejust have one-oV costs. Overall, older people with
multiple needs will have to travel to hospital, they main reasons people have not been taking up any
dentistry that they can get hold of from the NHS,will have their dental appointment, they will
probably wear glasses, they might need a hearing that they cannot aVord to get there, so there is that
issue. Also completely forgotten is the issue of theaid, so, by the time you have added it all up, you are
into quite large costs, but on each individual costs for visitors to hospitals which is completely
outside the scheme and the only help that is availableoccasion with the problem of actually working
through the system, then quite often you have to pay is through the Social Fund. Again if you compare
that with the Assisted Visitors Scheme for prisonersand get a refund, and that is another complication.
under the Low Income Scheme, they can get help
every two weeks for a visit, yet you might have anQ221 Dr Taylor: We are coming on to the other bits,
elderly person who is long-term in hospital and herbut would you agree with the previous witnesses, I
health is very much aVected by the fact that shethink it was the witness from the King’s Fund, who
cannot get visits from her spouse because he cannotsaid that really the only way to increase the amount
aVord it. Those are exactly the kind of cases we areof money is from general taxation as being the only
getting in bureaux which are really heart-rendingfair way?
and they cannot be right.Ms Thompson: Well, we have got a free National
Ms Thompson: I think there is another issue and thatHealth Service, so you can either do that through
is that we have not talked about people who aretaxation or rejigging, the Government deciding how
getting continuing NHS care in nursing homes, yetone is spending the money and whether or not more
they cannot actually access the hospital transportshould go into the NHS, so there are two issues
scheme for patients to be visited in those situations.there.
Q223 Dr Stoate: Is it the case at the moment that, ifQ222 Dr Stoate: Let’s talk about the travel scheme someone is sent by their GP to hospital for an X-rayfor people who are able to claim travel costs back. At or a blood test, they are eligible for the scheme at thethe moment, we have found out, only people current time?attending hospital are entitled to claim on the Mr Rathfelder: No, because that is not care underscheme, but, with the Government’s latest policy to the care of the consultant.move more care out into the community, does that
not seemwrong and is there anyway of improving it?
Q224 Dr Stoate: That is what I want to clarify.Ms Thompson: Paragraph 6.67 of the White Paper
Mr Rathfelder: If I can amplify that point, I thinksort of points in slightly the right direction because
what we do not want is for people to come and seeit does actually say that they are going to extend
you in your surgery simply so you can authorisethe patient transport service to where it was
transport at the cost of £4 or whatever it might be intraditionally provided in hospital and they are also
your locality. That does not seem a very good use ofgoing to extend the eligibility for the Hospital Travel
a clinician’s time. The Social Exclusion Unit reportCosts Scheme to include people who are referred by
on transport, I thought, was very good, but thea healthcare professional for treatment in a primary
Department of Health do not seem to be in the leastcare setting. Now, I noticed in the last set of evidence
bit interested in implementing it.that there was quite a lot of discussion about the
Travel Costs Scheme and how very complicated it is
and I think this will need quite a lot of unravelling as Q225 Dr Stoate: So you would recommend a
thorough review of the system?to exactly how good or bad it will actually be. Who
is the healthcare professional who is referring for Mr Rathfelder: Yes, because it has got to take into
account the money that is spent on the patienttreatment in a primary care setting? People self-
select to go and see their GP, so does that mean to transport service at the same time which at present is
oYcially regarded as providing transport for peoplesay they would not get the Travel Costs Scheme for
their first, initial appointment and it would only be for whom it is clinically necessary, but that does not
convey any real meaning to me. If you are sendingafter the doctor says, “I’ll need to see you back here
in four weeks’ time”? There are going to be all sorts your patient to hospital, it is clinically necessary, I
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imagine, in your judgment that they should go there. well, so it is actually much more of a problem and we
have been getting more and more phone calls aboutIf they cannot aVord it, then are they entitled to the
patient transport system? It is not an ambulance it over the last few years.
service.
Q230 Anne Milton: I think the diYculty with saying
that people can or cannot use public transport,Q226 Jim Dowd: But that is not it. It is for people
who are deemed to have a medical condition which probably the truth is that everybody can, but it is just
that it will be deeply unpleasant and unacceptable.makes public transport unsuitable.
Mr Rathfelder: Well, most of them do go by the That would bemy feeling.At what point can you not
use public transport?patient transport system simply because they are
old and frail actually. Why is public transport Ms Thompson: Many people cannot use public
transport. They might have a back problem, so theyunsuitable for old, frail people?
cannot actually go and stand at the bus stop. They
might have diYculty in getting on the bus. The busesQ227 Jim Dowd: For the same reason you get oV the
do not always go to where you want and you mightCongestion Charge if you want to go to St
have to have several changes on the bus, so youThomas’s, for example. If the clinician says that you
might actually be talking of making a journey whichare unfit to use public transport, you are—
by car would be about 10/15/20 minutes into aMr Rathfelder: So we all have to go and see our
journey of an hour or an hour and a half. That indoctor so that he can certify us as being incapable of
itself for older people, who might not have a hugegoing on a bus?
amount of energy and who are, by nature, ill because
they are going to hospital, I think it is quiteQ228 Dr Stoate: Does it have any eVect, negative or
impractical for some of them to use buses andpositive, on people who are housebound? Are they
probably the majority.in any way disadvantaged or advantaged by the
current scheme?
Q231 Anne Milton: I am not actually disagreeingMs Thompson: One of the problems we come across
with you. I am saying it is a bit of a nonsense to talkis where people who are housebound, and I am not
about it because it is terribly area-dependent. A busonly talking about the Hospital Travel Costs
in a rural area is a completely diVerent prospect fromScheme here, but the patient transport service, and,
a bus in the middle of London.because they are housebound, they need to have the
Ms Thompson: Yes, but some peoplewould just havepatient transport service and it, therefore, makes
absolute diYculty in using a bus.appointments very, very long in hospital. You are
Mr Rathfelder: There are particular problems fortalking about pretty ill people and, because the
people with sick children where of course the patientambulance will come and pick them up at whatever
is not the person who is paying the costs. People whotime it suits the ambulance, quite often that is two or
have a number of children who may not havethree hours earlier than the actual appointment, so
anywhere to leave those other children may have tothe person is then sitting in a waiting room for that
take the entire family to hospital. People withlength of time to actually get seen and then quite
severely disabled children, certainly in Manchesteroften they have to wait another hour, so it is a day
when I was working there, had consultants often intrip basically if you are using the ambulances.
six diVerent hospitals and would spend their entire
lives trekking from one place to another to seeQ229 Anne Milton: Pauline, hospital car parking
Mr So-and-so for one organ and Mr So-and-so forcharges for the elderly, how great a burden do you
a diVerent organ. I had a terrible case of a Somalithink they are?
man with a child with dislocated hips and he wasMs Thompson: We are getting increasing numbers of
expected to take this child in plaster on a bus, thenphone calls from our local Age Concerns about it
change in the middle of Manchester, walk across theand from people directly. It is probably not to the
middle of Manchester from one bus station tosame level as perhaps the Macmillan evidence will
another bus station and the hospital would not paybe, but people do often have more than one
for a taxi for him and, although they accepted thatcondition, so they go into hospital for one condition
he was eligible for the Hospital Costs Travelone day and within the same week they can go to
Scheme, they would only pay his bus fare. I thoughthospital to see another person, so overall it does
that was cruel and inhumane.actually start to mount up. Because many people
cannot use public transport, then they are using their
Q232 Anne Milton: Should we pay the childcarecars to drive themselves, but more often than not
costs then, do you think?relying on friends and family to drive them, so then
Mr Rathfelder: Well, it would be more sensible thanthat person has to park in the car park. We are
dragging all these other children into the hospital.beginning to find that the charges really are going up
and it does seem to be a revenue-raising system for
hospitals. Also, the more ineYcient the hospital is, Q233 Anne Milton: Pauline, do you think we should
be building car parks at hospitals to help withthe more you are likely to be charged because, if you
are there and your outpatients appointment is at transport and letting people have it free?
Ms Thompson: Quite a few hospitals do actuallysuch-and-such a time, but you actually wait two
hours, you are then paying extra for the hospital’s have them and I know in London it is diVerent, but a
lot of hospitals do have fairly large car parks, thoughineYciency which obviously does not go down very
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there is always a problem about how many disabled cases pharmacists and health professionals told
them wrongly. They said, “Are you on benefits? Inparking places there are. Certainly I think that
hospitals need to take cognisance of the fact that that case, tick that box”.
many patients are old and are not going to easily be
able to get there, so you, therefore, do have to think Q236 Mr Campbell: That was going to be my next
of it in the round. Again in the White Paper it does question. Is there anything in the information line
very specifically look at local transport in general that is put out to get this across?
which is welcome to actually get some joined-up Ms Phelps: The Department of Health does produce
thinking between local transport and the publicity, there are leaflets and things, but I would
Department of Health, but I do not see how you can like to see all health professionals required to display
avoid car parking in the current system. Okay, I this and required to be more proactive, particularly
think we are going to raise some new issues when we at the point of the pharmacy, at the point of
go to the idea of more surgery care and again I think dispensing, to pick up whether or not people should
they are going to need to address that issue because be entitled and to help direct them towards that.
quite often surgeries will not necessarily have There is a lot more that could be done, but, having
adequate parking nearby, so it actually in some way said that, the system is burdensome, it is complex.
could compound the problems initially while people
think about how they are going to access the surgery Q237 Mr Campbell: It is not very good.
if they need to come by car. Mr Rathfelder: If it was not a system based on the
social security system but something with a simple
line which said, for example, that if your income isQ234 Anne Milton: And there are issues with
under £100 a week, then you qualify, because the keycommunity hospitals which are very good and local,
information that people need to know is whetherbut you have clearly read the White Paper in a great
they are poor enough to qualify, On the Departmentdeal more detail than I have at this stage, but I think
of Health’s website, there is a Frequently Askedthey are talking about populations of 100,000 which
Question, “What is the maximum income I canin rural areas is a huge geographical spread
receive that would still enable me to qualify for fullprobably.
help?” and what is the answer? “Each claim isMs Thompson: Yes.
assessed individually based on the information
contained in the HC1 claim form. There is no
Q235 Mr Campbell: The Low Income Scheme which maximum amount as it depends entirely upon the
was mentioned before, what are its weaknesses and circumstances of the individual or family”, which is
does it benefit those it has got to benefit? Does it of course just the information we were looking for,
benefit the people it is supposed to? is it not?
Ms Phelps: What we do not know is how much non- Ms Phelps: It is interesting, looking again at who is
take-up of it there is, but our evidence would suggest entitled to free prescriptions from that point of view
with the new Tax Credits system. It has becomethat that is a lot. It is highly complex and it is
really bizarre that, if you are entitled through that, ifdivorced from the DWP benefits, so it does not
you are in receipt of Working Tax Credit with abenefit from being piggy-backed in any way when
disability element and/or Child Tax Credit, then youyou are making claims for other benefits. It is not
get free prescriptions up to an annual income ofwell advertised. Amazingly, health providers are not
£15,050 which is about £289 a week, but, if yourequired to publicise in the GP surgeries, in
happen to be a single, unemployed person who ispharmacies, in opticians and dentists, they are not
sick and on Incapacity Benefit, then it is IS plus halfrequired to display any information about it, so it
the prescription charge, which is £59.45 a week.seems to me that was a missed opportunity with the
Now, there are just huge diVerences and it showsnew contracts which could require that, but they do
how the system has grown piecemeal and there is nonot. Then it is very complicated and, as has been
coherence to it.said, the leaflet runs to 70-odd pages and the claim
form runs to 16 pages, so it is very deterring. Our
evidence certainly shows that it does not work Q238 Mr Campbell: You have suggested tapering
insofar as a lot of people who should be getting help assistance to reduce the impact of the purchase of the
through it are not. Perhaps the worst thing that is Pre-payment Certificate, which is another promising
coming and the one thing that we did not pick up in idea as well, as well as greater passporting to treat
our 2001 report because it happened since is this benefits. Can you expand on that?
system of penalty charges which has now come into Ms Phelps: One thing you could do is say, “If you are
force. That is a very harsh system. You can entitled to a means-tested benefit, then you get your
understand you have got to police any system once free prescriptions”, so you piggy-back on to that and
you have built it and it is another admin cost. But do not have two tapers for in particular, Housing
now if you so-called fraudulently claim for a free Benefit and Council Tax Benefit, which run well
prescription and you get caught, you are subject to above Income Support levels, and that would
five times the prescription charge and, if you do not simplify it for a lot of people. The thing we have said
pay it, it doubles in 28 days. We are finding a lot of about the Pre-payment Certificate, I do not think it
clients caught in that systemwho actually could have would complicate it more, but it would just be to say
got free prescriptions under the Low Income that you bring it into the Low Income Scheme. You
would leave the system as it is, but, if you are on aScheme, but nobody told them or actually in some
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low income, your HC3 Certificate telling you how we were considering is that maybe NHS Direct
should, in the same way as it can now direct you, inmuch help you get with dentists, how much with
optical charges, et cetera, could also say, “You can theory, to your nearest local dentist, also be able to
direct you to the optician who can provide glassesget a Prescription Pre-payment Certificate for £5,
£10, £15 or whatever”. I think that is, to our mind, within the voucher value. It would also make the
Department of Health much more aware of exactlya much better way than saying that you can pay for
it on a monthly basis because then you are still where those were.
saying that people on low incomes have got to pay
£90-something over the year, whereas, if you Q242 Mr Burstow: That sounds like a useful
actually tapered the costs of the PPC, you would be suggestion. Pauline, do you have anything else to
giving people on low incomes the same advantage add on this particular point?
that people on higher incomes have who can aVord Ms Thompson: I was just thinking, and this is just oV
to cap their costs. the cuV, about the use of NHS Direct because one of
the big problems we have with the Low Income
Q239 Mr Campbell: That would be good, I think, if Scheme in general is the amount of time it takes to
that could happen. If we cannot get the charges fill the forms in and how complicated it is, so when
abolished with this Government, then obviously I you are actually looking at the costs of running the
think that which you have mentioned is a better plan scheme, it falls very much on social services and any
hopefully. You have mentioned the voucher system sort of organisation that oVers welfare rights advice,
just before for low-income groups. What are the so Age Concern, all the voluntary organisations, are
pros and cons of this voucher system? spending a lot of time helping people fill these forms
Ms Phelps: The optical voucher? in when really they could be doing better things. If
the Department of Health is going to continue
having these charges, should they not haveQ240 Mr Campbell: Yes.
responsibility also to take on the costs of actuallyMs Phelps: I think it is the bit that confuses people
helping people fill in the forms and perhaps do thismost partly because it sort of works the other way
over the phone, although that will not work forround. Instead of telling you how much you have to
everybody. It does seem quite strange, and again it ispay, it tells you howmuch help you get, so people get
partly mentioned in the White Paper, that more andvery confused about it in the first place, but the real
more GP practices are being encouraged to getproblem with it is that there is no guarantee that you
welfare benefits advisers in. In fact there has beencan actually get glasses within the cost of that
some research done by Liverpool University and thevoucher. It seems that in one part of the world the
CAB about how getting benefits advice and anDepartment of Health fixes the cost of the voucher,
increase in income did actually improve people’sand this is for people on Income Support on the
mental health and well-being and they have done alowest incomes, and in another part of the world
longitudinal study looking 12 months later at theopticians are deciding what the cost of glasses is and
people who actually did benefit from the benefitsit is never road-tested properly. So particularly if
advice. Therefore, you have one arm suggesting thatyou are living in a rural area where you cannot shop
you need more and more people to give benefitsaround so easily, you could well find that your local
advice to the well-being agenda and then, on theoptician just does not provide them within the
other arm, charging.voucher value and you have got to find the diVerence
which then immediately brings you below the
Income Support level. You may then decide maybe, Q243MrBurstow:So, as a sort of general conclusion
“I can’t aVord to go to the optician’s at all” and this from what we have heard so far today, would it be
leads to all the other health inequalities we have fair to say that there are some issues here about how
seen.We have suggested that that has to be joined up Department of Health objectives and DWP
better and that, if opticians are dispensing through objectives are met and whether they are actually
the NHS system, they should be under an obligation properly aligned?
to provide glasses within the cost of vouchers. Ms Phelps: Yes, and I think the DWP ismoving very
much towards the kind of idea of not having to claim
for each benefit separately, but pulling thoseQ241 Mr Burstow: That has partly answered a
question I was going to ask about the voucher together. If you look at HC1, a lot of the questions,
they exactly mirror those of other means-testedsystem and how we can set the value in a way which
is more sensible, and joining up the two parts of the benefits, so you should not require people to go
through that whole thing.system would make some sense. Are there any other
points you would like to make to us about how we Ms Thompson: It should be a single assessment
process as well.can set the appropriate principles when it comes to
setting the value for spectacles and vouchers? Ms Phelps: Exactly, it should be brought into that,
but that means more joining up between theMs Phelps: I know the Department of Health does
sit down and talk about this with the optical Department of Health and the DWP.
Mr Rathfelder: But the DWP makes assessments ofprofession, but so often when you get these semi-
privatised systems, what you end up with is a the take-up of the various benefits and regards
getting people to take up what they are supposedlyshortfall because the market does not actually
deliver what perhaps was the initial intention, so we entitled to as valuable. I have not seen all your
evidence, but I have not seen any sign that thehave to find a way of joining that up. The other thing
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Department of Health has made any estimate of the they have lost or damaged their dentures but they
pay the full whack of £189 if they just happen to havetake-up of the Low Income Scheme and how many
of the people who are supposedly entitled to it either had their dentures for a very long time and it is wear
and tear. TheMinister said there had been no changeknow it, know anything about it or take advantage
of it. to the system. Has there been a change to the system
in terms of how much people are paying and could
you say a bit more about that?Q244 Mr Burstow: Well, we will have the Minister
Ms Phelps: Yes. For my sins, I was on the Harrybefore us at some point and you may have helped us
Cayton group that looked at this. To start oV with,tip them oV that we might want to ask that question.
given the health inequalities agenda it is very sad thatMs Phelps: What we find particularly hard in that
the Government did set in the terms of reference ofcontext is that then you can be penalised in the
that group that they had to create the same amountcontext of not actually having maximised take-up.
of charged revenue as under the existing scheme,
although compared to other European countries it isQ245 Mr Burstow: I think that point has been very
very high with people having to pay 80% of the cost,clearlymade to us today and certainly it is something
so a huge percentage of the charges. The new systemI think we would want to come back to with other
has to deliver the same. There seems to have been awitnesses later. Can I come on to some specific
slight change in the language over time because theservices because really in a way that is the best way
brief of the group was to develop a system whichto understand how the system is working and how it
would deliver the same level of charges. We assumedmight notwork in the future. In the evidencewe have
that meant—working on 2003–04 figures—withhad from Age Concern, there was a reference to the
inflation only up to what would happen in April, butnew structure of dental charges and how that will be
in reality what appears to have happened is the newinequitable for older people. I wondered, Pauline
dental contract has proved to be much moreThompson, if you could say a bit more about how
expensive than under the old system and thethat actually is so.
Department has decided it wants to raise the sameMs Thompson: We are obviously very concerned
percentage of take from charges as under theabout dental charges because we have got loads of
previous scheme. In fact, we are going to see a veryevidence about the problems that older people have
significant increase in the amount of revenue thatwith their oral health, and again it is all part of the
comes from charges post-April, which I think isWell-being Agenda, that it is really important. The
another example of where policy is not being led byfact that people do actually have to pay for their
trying to tackle health inequalities, it is being leddental check-ups and then, once they have had their
somewhere else in the agenda. What has happeneddental check-ups, I know we have got new charges
in the end is bands two and three are significantlyand some of the worries have been slightly alleviated
higher than the Cayton group hoped would haveby the fact that the cost of replacement of lost or
happened, particularly band three at £189. If youdamaged dentures, they are making it slightly lower,
look at the cost now of a partial denture, there hasbut we do still have the question of what is going to
always been help with replacement, if you break it orhappen to the people who just have wear and tear on
lose and that has not changed. But if you are an oldertheir dentures and whether they are going to be
person who has had your dentures for a long timeexpected to find £189 for this. I think really our big
and they are not working properly any more, I amproblem is that there are real problems with dental
told that currently that will cost about £100 to get ahealth, we know that dental health can actually
new partial denture and under the new scheme thataVect people very severely, even to the extent of
is going to be £189.malnutrition, yet we are still not looking at whether
or not we are putting barriers, well, we are putting
barriers to people having good oral health. Q248 Mr Burstow: So there is a change, they are
going to be paying more.
Q246 Mr Burstow: On this point about wellbeing Ms Phelps: We knew that moving from however
and malnutrition being potential consequences of many it was to three bands would mean that there
this particular policy, how well grounded is that in will be some gainers and some losers but what we do
terms of evidence? Are we talking anecdotes here or not know is where some of those big losers will be. It
actual research? is a question of guessing, the Department has not
Ms Thompson: No. There has been quite a lot of been clear for which groups or in which situations it
research on gerontology, meeting the challenges of will cause the biggest losses. It struck me straight
oral health for older people.13 away that the partial denture was one concern.
Q247 Mr Burstow: Perhaps references could be
Q249 Mr Burstow: Maybe we need to return to thatpassed on to us so we can look at that. Can I ask Ms
again when we have the Minister. Can I ask AgePhelps from Citizens Advice, last week I asked a
Concern about free eyesight tests for the over-60s.question about dentures of Rosie Winterton, the
What is the evidence for an improvement in people’sminister responsible, about this apparent anomaly
health as a result of that? Is there any evidence?that 30% of the highest band will be charged where
Ms Thompson: I cannot honestly say. One would
sincerely hope that by having a free test you are13 Note by witness: For example, Gerondontology, vol 22
encouraging people to go along and are not putting asupplement December 2005, Meeting the Challenges of Oral
Health for Older People, A Strategic Review. barrier to them having a test where other conditions
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might well be picked up. I think that there is that nails?” Within the area people recognise what you
have just said, that you can prevent much moreproblem and across the board it is really important,
it is part of health. You have chosen some things that serious illness by clipping nails and doing minor
foot care.you are charged for and some where it is free.
Ms Thompson: A bit of help at the right time. We are
always saying it.Q250 Dr Naysmith: Can we move to another service
Dr Naysmith: So that is a hidden charge that we havethat is regarded sometimes as a bit of a Cinderella in
identified.the National Health Service, and that is chiropody,
which is mentioned in the Age Concern evidence
Q252 Jim Dowd: I want to return to Paul’s questionthey submitted to us. Particularly you talked about
about the eVect of removing the cost of eye tests. Allthe service being free in theory but patients are
of you individually have cited the deterrent eVect ofcharged by default for these services. Could you
charges generally. Why is it possible to calculate thatexpand on what you mean by that?
but not the beneficial eVect of the removal ofMs Thompson: There is some evidence which we
charges?have just picked up, a report, and some government
Ms Phelps: Certainly from our point of view we seefigures. Initial contacts with chiropodists have fallen
people come in the door who say, “I did not get myfrom over 960,000 in 1996–97 to 769,000 in 2003–04,
prescription” and the MORI work we did showedso that is nearly 200,000 less people who are being
750,000 people had not got their prescriptionsseen by chiropodists at a time when we have got
dispensed in the previous year. We see that bit of it.more older people. It is because chiropody services
We see other people driven to below poverty levelhave largely been withdrawn and their eligibility
paying them. The health impact, certainly in termscriteria are becoming much higher. We have got
of prescriptions, is I would assume it is a given thatevidence from some of our local Age Concerns that
if a health professional has decided that personeven people with really severe arthritis who are blind
needs that drug and they do not take it, to my mindcannot access chiropody services, they have to go
that is enough, is it not?and have their toenails cut and feet looked at either
by a private chiropodist or local Age Concerns who
in some areas are picking up the lower end, the Q253 Jim Dowd: I am asking you .
toenail cutting service but, again, it is a cost to us to Ms Phelps: To measure the health outcome would
provide this service and sometimes we have to pass not be something thatwewould be able to do around
it on to the individuals. It is really charging by any this table, you would have to do it further down the
other name. Basically, how much is chiropody part line. As Pauline said, the nearest bit is the evidence
of the Health Service and how much is it health, how we got on the impact of just having CAB advice in
much is it social care. It is back to the old bath GPs’ surgeries and how that led to a reduction in
syndrome: when is toenail cutting a health service or prescriptions. Yes, it is possible.
a social service? One of our Age Concerns has been Mr Rathfelder: Does this not take us further towards
very concerned because they have done a huge what is the essential point of charging? When
tightening of the criteria and they feel that older charges were first introduced they were clearly
people should not be put in the undignified position designed to reduce the consumption of medication
of having to plead for basic foot care. They had a but that no longer seems to be an objective of the
case where somebody could not aVord to go to a present Government. Certainly in Manchester they
chiropodist and they ended up pleading with the are encouraging GPs to prescribe more in order to
health authority to go to the NHS chiropodist. They reduce other costs. It makes no sense to continue
also, quite rightly I think, say it is a short-sighted with charges.Whatmaymake sense is amore refined
policy because money might be saved initially but argument about what the National Health Service
not in the long-term. We did a document some years ought to be providing. The decision should not be
ago called On your Feet but I think we would have made by individual patients who can or cannot
to call it OV your Feet now because things have got aVord £6.25 or whatever it is to have their teeth,
so much worse. In her letter she ended up saying: “If toenails or whatever other part of the body is not
the people who make decisions could come face-to- included looked after. We have a system now for
face with some of the toenails we have seen they evaluating the cost-eVectiveness of interventions
might change their mind”. It is really charging by and that was not in existence in 1950 or in 1968 when
stealth. we had charges. We should have NICE investigating
the cost-eVectiveness of chiropody, eye tests, dental
tests and deciding whether they are worth doing, notQ251 Dr Naysmith: Certainly it is something where
rationing them by paying for them.I imagine most MPs around this table have had a
Chairman: I think you have answeredRichard’s nextsimilar experience to me where you get people
question.coming and saying, “We used to have our toenails
clipped and now we do not”. In my constituency,
which spans two diVerent primary care trusts and Q254 Dr Taylor: That is a very interesting point as
to what the NHS ought to be providing because ittwo diVerent local authorities, there are a number of
ways of dealing with that situation. You are right. I raises the whole question of healthcare rationing
which is something that I personally feel we shouldhad a case two years ago where the health authority,
after exchanging letters, said, “Has the person be facing up to. My question is the really huge
question: if each one of you started with a blankconcerned asked her neighbour if he will cut her
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piece of paper what would you have on it as ways of instantly make a positive contribution to tackling
poverty and ill-heath because those on lowerraising the money that has got to be raised other
than these charges that we have been talking about? incomes would pay less. We know that they are
likely to be in higher health need so currently theyEverybodywants to abolish prescription charges but
we have got to raise the £450 million they make. We are likely to pay more. It supports the prevention
agenda and you cut those admin costs and penaltywant to abolish the other charges but where is the
money going to come from? charges.
Ms Thompson: I can only say I would agree withMr Rathfelder: Either we put the money on higher
rates of tax—I do not understand why people who what has been said.
earn more than £100,000 should pay less per pound
Q258 Mr Amess: I just want Mr Rathfelder to clarifythan poor people do on their income—or we work
something. The Socialist Health Association isout something that we want to deter. I would put a
aYliated to the Labour Party, so you supporttax on hydrogenated vegetable oil personally.
Labour. I have been listening very carefully to what
you have been saying. How successful are you andQ255 Dr Taylor: So we increase specific taxes on
have you been in influencing the Government’scertain things. Anything else?
health policy?Mr Rathfelder: No, I think that is enough. I do not
Mr Rathfelder: This one or its predecessors? We likesee that there is any point in trying to raise money
to claim some credit for the establishment of thethrough the National Health Service, that is not the
National Health Service in 1945. More recently Ipoint. The whole point about the National Health
think this Committee has been doing a better jobService is that it is supposed to be free at the point of
than we have.need. We can have discussions about what it ought
Jim Dowd: So the answer is nothing.to be providing. Personally I have no qualms with
Chairman: The answer is no comment on that.some things you can pay for as an optional extra,
although I do not knowwhethermy colleagues in the
Q259 Mr Burstow: This comes back to the questionSocialist Health Association would agree with that.
of drawing the line between what is free and what is
not free. Last week in the High Court a judicialQ256 Dr Stoate: I certainly would not and I am a review decision in the Grogan case decided that themember of it. guidance issued by the Department in respect ofMr Rathfelder: If you are admitted to hospital and NHS continuing care was flawed. Paulinethey say, “You can have wine with your meals but Thompson, do you think that the framework that is
you have got to pay for it, but you can have tea for long awaited, that is being put forward as the next
free”, that does not seem to me to be— step to try and deal with problems of NHS
Dr Stoate: I think that is important because that continuing care, is an answer to the criticisms that
is a slippery slope argument. Queen Charlotte’s the court made last week?
Hospital, which we have been looking at this Ms Thompson: I think the judge did say it was the
morning in terms of an article, are saying you can local criteria that was fatally flawed but he certainly
have a decent midwife if you pay four thousand quid had lots of criticisms about the Department of
or you can have an NHS one if you do not and— Health guidance as well. It is going to be a step—it
Anne Milton: No, it was not saying that. is only a step—in that if you have one national set of
Dr Stoate: It was not quite saying that. criteria you have still got lots of diVerent people
Chairman: Can we leave that point until we see the applying it and it depends how the assessment tools
actual papers and then we will come back to that are sorted out. All I can say is it really depends. I still
with another set of witnesses. feel very strongly that unless we have sorted out the
Anne Milton: That needs to be challenged. It did not registered nurse care bands and what is considered
say “decent”. to be incidental and ancillary nursing care then I do
Dr Taylor: Can we go to the other two to get not think we are going to be very much further
answers. forward. It will be very interesting to see whether or
Anne Milton: That is very derogatory. not there is an application to appeal the case and
what happens after that.
Q257 Chairman: Where does the money come from Chairman: Can I thank you very much indeed. Can
if it is not charges? I just say one thing: if any of you know of any study
Ms Phelps: I have to agree, I think it has to come that has been done in recent years about the actual
through general taxation. The reason for that is I eVects on charges due to the changes in benefits,
think all of us would rather pay over our lifespan Family Tax Credits and things like that, I would be
according to our means rather than face sudden very appreciative if you could direct it to us. It would
large sums at a point when we are ill when that be interesting to see exactly how quick or not the
means our income has dropped for those very Department of Health reacts to these changes in the
reasons. It is not the best way to do it. If you took it state benefit system. Thank you all very much
indeed. I am sorry it has gone on so long.through the income tax system then you could
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Q260 Chairman: I have to now say good afternoon, Mr Cardy: The eVect of the change in the pattern of
it should have been good morning. I am sorry for the cancer treatment, which is wholly desirable, that
further delay we have had in this morning’s session. people spend their time principally at home rather
I wonder if you could introduce yourselves for the than in hospital has been to shift costs on to patients.
record. Previously the Health Service would have paid hotel
Dr Fraser: I am Moira Fraser. I am Policy OYcer costs which now would run at about £200 a night per
at Mind. patient but those costs are met by patients and they
Ms Beswick: Lynsey Beswick, I am an Expert are met in the form of travel, transport and
Patient Advisor and also a cystic fibrosis patient parking costs.
working for the Cystic Fibrosis Trust.
Mrs Barnes: Rosie Barnes, Chief Executive of the
Q263 Charlotte Atkins: If we could just expand onCystic Fibrosis Trust.
that. You are saying that previously the NHS wouldMr Meadowcroft: I am Robert Meadowcroft of the
have paid for an hotel?Parkinson’s disease Society.
Mr Cardy: I mean the hotel costs of hospitalisationMr Cardy: Peter Cardy, Chief Executive of
because that is where cancer treatment is carried out.Macmillan Cancer Relief.
Q264 Charlotte Atkins: You are not just talkingQ261 Chairman: Thank you very much. Could I ask
about the patient, you are also talking about thea general question to all of you. Which groups of
family and friends as well when you are talkingpatients are most disadvantaged by charges? Is it
about severe treatment over a period of time. Whatmainly a question of poor take-up of services or of
I am asking you is do you think that the NHS shouldhardship by those who actually pay for treatment?
be paying for things like car parking, hotel costs? IfMr Cardy: I can certainly illustrate for you the
we are talking about the regionalisation of a healthimpact of charges on people with cancer. If we take
service we could well be talking about patientsa typical cancer career of perhaps nine months
having to stay overnight in an hotel rather than inor so, from suspicion of cancer to referral for
the hospital. Do you think these are the sorts ofinvestigations to eventual admission for surgery
things that should be paid for by the state?perhaps and then repeat treatments, radiotherapy or
Mr Cardy: In Scotland, because of travel distanceschemotherapy, which would be the norm, we would
involved, it is by no means uncommon for hostelsee the costs to the patient piling up during the
course of that time. In the course of hospitalisation accommodation to be provided for people who have
they will be paying charges in hospital, they will to travel long distances.
be paying travel costs, which because of the
concentration of specialities in cancer centres, which
Q265 Charlotte Atkins: What you do you mean?is a perfectly proper and desirable move, means that
Mr Cardy: Provided and subsidised.people are often travelling long distances, sometimes
very long distances, for treatment, and they will be
paying car parking charges. When discharged from
Q266 Charlotte Atkins: Provided by?hospital they will be paying prescription charges. So
Mr Cardy: The NHS.costs, each of which is modest in itself, will be piling
up very considerably for people who have this quite
typical trajectory. That often results in very Q267 Charlotte Atkins: What you are saying is that
considerable hardship. We have quite a lot of survey they provide hotel accommodation or they pay for it
data, which you have seen in our submission, but we in the private sector?
also have the surrogate data that comes from our Mr Cardy: Provide hostel accommodation. If I canown grants. Last year we gave small grants to over take up your other point, the thrust of health policy20,000 people in financial distress because of cancer. for the last 10 years since the publication of theThat is a very small proportion of thosewhowill find Calman-Hine report, which has had a very high levelthemselves in financial diYculty. Quite a large of support from Government and from all parties,proportion of those grants were for travel costs and has been to address the rather dire situation we wereassociated matters. Costs for people with cancer in with cancer treatment and cancer survival. Themount up, they become very considerable and very direction of travel has been to increase the number ofburdensome. We have evidence of people having to people surviving cancer, which has been successfullymake a choice between eating and being treated,
done, to shorten the waiting times, to extend thewhich seems a shameful state of aVairs to us.
number of people who are able to stay at home, to
extend oral therapy so that people are able to take
those at home. The goal of health policy as far asQ262 Charlotte Atkins: Do you think this is the sort
cancer is concerned and the direction of travel is veryof thing the NHS should be dealing with, these sorts
clear but these additional costs, which are borne byof costs? It opens up a whole range of things. What
patients and, indeed, their families, work against thehappens if someone needs a hotel stay, maybe the
NHS should pay for that too? direction of this policy.
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Q268 Charlotte Atkins: Does one not even out the in full-time education and a third are too ill to work
and are on Income Support and are exempt. It is theother? You are saying there are some developments
which mean that people can be treated at home, remaining 1,000–1,500 we are very concerned about.
These are people who have had poor health sincetherefore there are less travel costs, less car parking
charges and no need for an hotel. birth and tend to be on very low income jobs because
their education has been disrupted by healthMr Cardy: If you are treated at home with, say,
hormonal treatments, and a lot of older men who problems. However, they are young and they know
they are not likely to live all that long and live life indevelop prostate cancer will be treated with
hormonal treatments, and women increasingly can the fast lane. They have a high cost of living because
they have to eat far more than most of us eat evenbe treated with oral therapies at home, you will be
paying prescription costs for those drugs. The drugs to retain a very low body mass index. They are very
slender people because they find it diYcult to absorbthat manage side-eVects are extremely important,
anti-nausea drugs for example, painkillers, drugs to food, which is part of the condition. Also, they have
deteriorating lung function so they tend to rely onmanage things like damage to salivary glands and
tear ducts and so forth. All of those will have to be cars and taxis more than the average simply because
they cannot walk, they get very breathless.met by patients as prescription charges at home.
Had they been treated in hospital they would not Although, of course, they can pay the annual cost
which would be cheaper than paying by item,have been paying those costs.
because these are youngsters and they want to pack
what they can into their short lives they do not haveQ269 Charlotte Atkins: Until they got out of
very much money and £100 at that time seems ahospital?
great deal so many of them do not pay it and thenMr Cardy: Until they got out of hospital.
we do have the problem of knowing they are being
prescribed drugs, particularly after a period inQ270 Charlotte Atkins: Obviously if they take the
hospital. They take dozens of drugs. Lynsey, who iscertificate there will be a maximum for the year.
with me today, has brought an example of the sortsMr Cardy: Yes, of course.
of things she would take on an everyday basis. If she
brought all of her equipment and all her drugs she
Q271 Chairman: Back to the general question. would need a suitcase and people would think that
Mr Meadowcroft? is a year’s supply but that may be a week’s or a
Mr Meadowcroft: Parkinson’s disease is a long-term fortnight’s supply. It is those people who we feel are
neurological condition for which there is no cure. very disadvantaged by the current system.
The main form of treatment is drug therapies and
drug treatment is the mainstay of treatment. The
average age of diagnosis is around 60–62, so most Q273 Chairman: Moira, do you have anything to
people with Parkinson’s will be turned 60 and will be add?
exempt. It is the substantial number of younger Dr Fraser: From a mental health point of view, the
people for whom the prescription charges are a people who are most significantly disadvantaged are
problem. How many people are aVected by this, the people on low incomes who do not meet the
about 8,000 below the age of 60 with Parkinson’s exemption criteria either because they are on
disease. Although they are a small group, at times Incapacity Benefit which brings them over the limit
they are facing real hardship. We consult our or because they are in low paid employment or part-
members each year onwhat theirmajor priorities are time employment. I think that is quite significant
for changes in health and social care and this issue of currently with the push towards moving people back
prescription charges and what is seen as being unfair into employment. We are going to see a rising
since the 1968 list of exempt conditions always number of people who are on the peripheral edges of
comes up in the top four or five and it is there now employment who no longer qualify for free
as a major priority for younger people with prescriptions and who are also liable now for
Parkinson’s. Because the 1968 list was drawn up things like council tax and full rents on their
when it was most drug treatments for Parkinson’s accommodation, et cetera, and this can be quite a
have been introduced since then and there are more burden and can result in people having to make
recent treatments with more drugs coming through. invidious choices: do I cash in my prescription or do
Most people take several drugs at once, four or five I not? Also, people with mental health problems
is quite normal, and the costs are quite excessive. tend to have physical health conditions more
That is where the real pressure for change is coming commonly than the general population, so it is not
from from our membership who wish to see this uncommon for somebody to be on four or five
iniquitous system changed. diVerent kinds of medication, which is often
prescribed monthly but in mental health sometimes
things are prescribed weekly, typically anti-Q272 Chairman: Rosie, in general terms which
depressants but also other things, tranquilizers, forgroups of patients are most disadvantaged by
example, or sleeping tablets. If you are on a lowcharges?
income and are being prescribed a drug weekly youMrs Barnes: In the case of cystic fibrosis it tends to
are talking about £30 a month for one drug. If yoube very young adults, late teenagers and early
multiply that with the other prescriptions it becomestwenties. Of the 3,500 or so adults with cystic
fibrosis, it is estimated that roughly a third are still out of the range of many people.
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Q274 Chairman: Could I ask you a specific question, how the charges work, where the problems are, what
Lynsey, in your unique role in a sense as a witness the disincentives are and, most importantly of all,
today. Could you give us an illustration of the eVects any solutions?
on household budgets of paying for medicines to Dr Fraser: In relation to prescription charging—
manage cystic fibrosis. Particularly, does this have there are a number of other areas of charging which
an impact in terms of people seeking employment or are also problematic—the particular problems are
pursuing education or training? that it is very easy to go over the threshold and,
Ms Beswick: Firstly, I would just like to point out therefore, no longer be eligible for free prescriptions.
that this is how many tablets I have. There are about If someone is unable to purchase their prescriptions
85 tablets, plus nebulisers three times a day. 85 obviously this can have an eVect on their mental
tablets are what I have to take daily. I am surprised health. I have a letter with me that was sent to me by
I do not rattle really. The basic costs that we incur one of our local Mind associations because they
every day are everyday things that most young were being asked by social services if they could help.
people face, apart from the fact that because of our A young man they were in contact with, who has a
health we are sometimes limited as to the career diagnosis of schizophrenia, had been hospitalised
pathways that we can choose which may have an for a number of months and was now in the
eVect on our jobs which may mean that we have community being supported by a community
quite low incomes. I am on lower support DLA but psychiatric nurse. He was in employment but very
that barely covers mydietary requirements. I have to low paid employment and had periods oV sick
have a high fat, high calorie diet. I have parking fees, unpaid and could not aVord his anti-psychotic
parking charges, travelling to and from specialised medication and, in fact, had only filled three of his
clinics, along with all the regular things that people monthly prescriptions in the last year. They were
my age have, such as a student loan and on top of asking a local Mind association, a charitable fund,
thatmaybe setting up a house, rent or mortgage, and for money from the crisis fund to pay for these,
other costs, just generally going out and having a which they did. When we are moving towards a
good time. If you add to that that you have to pay system where Government has indicated its
for a pre-prescription certificate every year, and it is intention to try and potentially force people to take
guaranteed every year for life, for this vast amount medication in the community, here is a man who is
of pills that I did not even want to take, there is not quite happy to take his medication but cannot aVord
any incentive. Obviously if I do not take these pills it because he falls over the threshold. That seems to
it will have a detrimental eVect onmyhealth and also me exactly the type of situation that just should not
decrease my life expectancy overall. I do feel that it happen. There must be a more robust system which
is such a shame that I have to pay for something can be in place which can support people who are
where I have a life threatening illness and this willing to take drugs that the doctor prescribes for
medicine is keeping me alive but I have to pay for it them, not just for mental health conditions but also
and I have got to make allowances in my yearly for their physical health, but cannot aVord to do so.
budget for that. It seems to me it is entirely counterproductive. The
ultimate consequence of that presumably is that he
Q275 Chairman: Presumably you must do in terms may well end up back in hospital if he does not have
of the actual amount as far as the medicines are his medication. Medication is not the only thing
concerned. You have mentioned travel, travelling to which supports somebody with a mental health
and from specialised clinics. What is your travel problem but for some people it helps. The cost of
pattern in any one week or month? maintaining somebody in an inpatient hospital is
Ms Beswick: It varies from patient to patient. enormous. For the cost of paying for his medication,
a small cost, we could well have prevented it from
leading to him needing hospitalisation. That is theQ276 Chairman: I realise that.
kind of situation we need to start looking at. It is notMs Beswick: Personally, I travel to my specialised
only people with things like schizophrenia, I amclinic. I live in York and that is in Leeds. Typically I
particularly concerned about people with chronicwill travel every six weeks to two months to my local
centre for specialist care and on top of that maybe depression and anxiety, for example, who are likely
every few weeks to my GP to pick up my to be on low income, who are likely to be on the
prescriptions and so forth. margins of employment or Incapacity Benefit and
who may well have poor physical health. For them,
getting access to help when they need it, by which IQ277 Mr Amess: Rosie, your colleague is certainly
mean the drugs which will help them stay well, begiving powerful evidence to the Committee. It still
those for mental health or physical health, is veryseems strange to see you that side and not on those
important. If we do not provide those people withgreen benches next to David Owen, those glorious
those drugs they are likely to become more unwelldays. If I can put my question to Mind because
and require more care and treatment at great cost toobviously everything theCommittee has heard in the
themselves personally as well. That is the situationlast couple of hours is saying that all is not well with
on prescription charging. There are also people whocharging but we have got to try to come up with
have been detained under the Mental Health Actsome solutions. There is probably no more diYcult
who should receive care and treatment under sectionarea in terms of charging than for those people with
mental health problems. Can you tell the Committee 117 after discharge from section 3 of the Mental
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Health Act but that system is very poorly anything at all. For some people not having
anything at all is not really an option because inunderstood. There is no failsafe means of enabling
people to access that meaning that unless they fall order to continue to function and keep their job and
do all the things we do in life, bring up your kids,into the low income bracket people do not get their
medication free. Also, with the possibility of moving they have to function so they make really diYcult
choices about what to pay for. We did a survey twoto a future situation where people could be
compelled to take medication, we very much hope years ago on what people were paying for and we
found that 45% of the group said they were payingthat situation will be looked at because surely you
cannot compel people to take medication and then for some aspect of their care and treatment and of
those more than 20%, so in total more than 10% ofcharge them for it. On the other side of the charging
issue, there aremany people who need to use services the group, were paying for talking treatments which
their doctor had recommended but were notwhich are a long way from home, not only the high
secure services, the high secure hospitals and accessible through the NHS. Given that the NICE
guidelines say that for mild to moderate depression/medium secure hospitals. I was recently at a mother
and baby unit in Welwyn Garden City, a fantastic anxiety talking treatments should be the first line it
is fairly shocking that those are not available andunit and a much needed service. These services keep
families together. They have families there who have people have to pay for those.
come from as far away as Ipswich, which is a long
way away, and it is absolutely vital for dads to come
Q281 Mr Campbell: It is costing more at the end ofand visit regularly but it is too far to come on the bus,
the day.you cannot really get there unless you have a car, and
Dr Fraser: Absolutely. If people do not get the helpyou need to stay overnight. If you are on a low
they need at primary care level we will end up withincome it becomes very diYcult. Without the family
people much further down the line needing muchbeing able to spend time together it completely
greater intervention.defeats the purpose of the whole service. The Social
Inclusion and Mental Health report from last year
laid out these issues very clearly. Social inclusion in Q282 Mr Campbell: Do you have any figures of such
mental health is absolutely vital to recovery. You patients that you could give to the Committee, a
need people to be involved in their communities and rundown of how many patients fall under this net?
to continue to engage with family members whilst Dr Fraser: I can give you copies of the research we
they are away from home in hospital. We need to did. I am not sure we have anything on how many
support people to do that where they do not people could have been helped at primary care level
otherwise have the income to do so otherwise there and ended up in secondary care because that is
is no point in spending a lot of money on inpatient probably everybody. Everybody in secondary care
services if the things are not there to support them could probably have had more help in primary care
when they are discharged from services. and it might have helped. For some people it might
not have helped, it is very hard to tell. We are told
very, very frequently, “I asked for help early, I wasQ278 Mr Amess: Thank you for that. To summarise:
given nothing”. What happens is that people arenot much commonsense in the way the charges
given nothing and they end up going oV sick at workoperate in your particular field and for short-term
and from there on it is a vicious circle and after yougain long-termneeds are really suVering in that there
are oV work for more than six months there is a veryare all sorts of extra costs.
small chance of ever being back in permanent work.Dr Fraser: Exactly.
The trick is to provide support at primary care level
so that people can be supported and get the help thatQ279 Mr Campbell: To what extent is there evidence
they need then before they get into the situation ofof patients paying for treatment recommended by
needing to be oV work, having problems withtheir local doctor, such as counselling?
money, et cetera, et cetera. There just is not theDr Fraser: I have got anecdotal evidence as long as
resource there to provide the talking treatments thatmy arm. Every day I get calls in saying, “my doctor
people need and it is one of the things where wehas said I should be able to get cognitive behavioural
really need much more investment in resource.therapy, counselling psychotherapy, but the list is
Mr Campbell: That is certainly a point that needstoo long”, or “they are not even going to put me on
taking up. Thank you very much.the list because the list is too long”. There is evidence
of services closing the list at a six month deadline, so
if the list is more than six months long they just close Q283 Chairman: Moira, can I ask you one brief
the list and do not take any more referrals so that question. You have talked about people in the
they can say their list is six months long. primary sector having to go to the acute sector, or
avoiding it. Give us your view on what is happening
now on the non-residential treatment orders whereQ280 Mr Campbell: So those who cannot aVord to
pay further down the line may cost the National people will be asked (a) to stay in the community
under certain orders and (b) directed to takeHealth Service more money?
Dr Fraser: That person then has to choose. They can prescriptions andwill have to pay for them. What do
you think about that? Presumably if it waseither wait in the hope that they might get on the
waiting list or they can pay privately or not have residential it would be free.
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Dr Fraser: Yes. It is something which has been Q286 Dr Taylor: Have you any idea how many
people are aVected?indicated in the draft Mental Health Bill that that is
Mr Cardy: In the sense of?what the Government’s intention is. We have yet to
see what that would look like. Mind is opposed to
non-resident treatment orders entirely, full stop. Q287 Dr Taylor: In that they are caught in this trap.However, if they were introduced it seems to me Mr Cardy: I do not think we can tell you the answercompletely counter to natural justice that you to what. What we are clear about is that Disabilityshould require someone to pay for something on Living Allowance and Attendance Allowance are
which their freedom depends.We have no indication critical benefits for people with cancer who very
of how the system would work. We have no frequently develop disabilities that make them
indication of whether it would only be certain drugs eligible for these benefits which are compensation
that would be laid out by the Mental Health for some of the costs of disability.
Tribunal that would be exempt because it is the
Mental Health Tribunal who will set the care plan
Q288 Dr Taylor: So how should we deal with thefor that person. Would the Tribunal say, “These
problem?particular drugs at these particular dosages are the
Mr Cardy: Quite simply by removing the down-ones that are to be exempt”? That is all very well but
rating requirement. It works very, very adversely tomedication changes very frequently and you are not
people with cancer in particular who have thesegoing to be able to go back to the Tribunal. How are
patterns of treatment. The down-rating waswe to know which are to be exempt?As I said before,
removed from all other benefits in last March’speople have physical health problems as well, so are
Budget and takes eVect this April. I am surewe to be in a situation where some drugs are exempt
somebody knows why it has not been applied toand some are not? In that situation, if it were to come
DLA and AA but it seems frankly bizarre to us.in, which I hope it does not, the only thing would be
Dr Taylor: Another peculiarity. Thank you veryto make those people exempt from all prescription
much.charges because by nature they are a very vulnerable
group and their health is compromised as it is
so it would seem to be sensible to make them Q289 Dr Naysmith: I have got a couple of slightly
completely exempt. unrelated points to make and questions to ask from
Chairman: Thank you for that. them. How do you see this situation developing in
the future and are there new problems which might
emerge with charges which can impact on patients?Q284 Dr Taylor: Mr Cardy, in your written evidence Moira has just referred to one under the Mentalin the summary you have got this sentence: “The Health Act that might come in and produce a new
Disability Living Allowance and Attendance situation. I wonder if I could ask Rosie first of all.
Allowance hospital down-rating rules should be The last time we met was when you were at the
relaxed in recognition of the additional costs, oYcial opening of the cystic fibrosis unit at BRI in
including phone and TV charges incurred by Bristol and we are very grateful to the Cystic
hospital inpatients”. Can you expand on that and Fibrosis Trust for all that happened there. Do you
explain that a little bit more to us? see anything happening in the future?
Mr Cardy: I am not an expert on the benefit system Mrs Barnes: A bit like cancer, cystic fibrosis is a
but let me do my best. The down-rating rule means victim of its own success in its ability to treat patients
that people who spend 28 days in hospital, either as a at home. Because those with cystic fibrosis are
single period or over a period, will have their benefit primarily children, adolescents and young adults
withdrawn. We think this is quite wrong because there did not seem any point in the extensive
costs do not cease, the costs of being in hospital treatment regimes to keep them alive if they had to
continue, and we draw particular attention to be in hospital all that time. We have worked very
telephone costs and so forth. We have given you hard to ensure that with very expert support patients
evidence in our submission of the sort of scale of can stay at home most of the time. They will do their
own physiotherapy, they will take their ownthose costs. People in eVect suVer double jeopardy.
nebulisers, and they will do their own intravenousThe onus of having a series of visits to hospital to
antibiotics. We do suVer from a situation wherereport that they have had 28 days in hospital falls
what people get depends on where they live in termsupon the patient and their benefit will be stopped
of extra support. We do see that the treatmentand an overpayment will be reclaimed if they are
regime we have introduced which is keeping themdiscovered to have inadvertently not let them know.
alive will continue and will continue to make
improvements until such time as we find a cure. The
Q285 Dr Taylor: It is cumulative, is it, if you spend problem we have is that, as Lynsey has explained, it
four separate weeks? is a costly disease to live with. They have to eat a lot
Mr Cardy: If you spend 28 days, each of which is not of food, they need a lot of transport help. Unless
separated by more than 28 days from the next then some of the hidden costs as well as the direct costs
it mounts up. It may be over a short period with of prescription charges are dealt with people will not
several long spells in hospital, it may be over a long take the treatment that they need and it will shorten
their length of life and reduce their quality of life.period with many short spells in hospital.
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Q290 Dr Naysmith: Anybody else? exempt list based on severity of condition and need
for medication there is absolutely no reason forMr Cardy: Yes. In our submission we indicated that
cystic fibrosis not to be on it. As you will havethe demography and epidemiology of cancer has
gathered, the only reason it is not on it is that whenchanged and the patterns of treatment have changed
it was drawn up most people with cystic fibrosis didvery much. Four out of five people now receive
not live until adulthood so they were covered by theradiotherapy as outpatients rather than as
fact that they were a child. The considerable ill-inpatients, similarly with chemotherapy. The five
feeling that those with cystic fibrosis bear on thisyear survival rates—five years is normally regarded
matter is the fact that they were promised that thisas the test for survival of cancer—have risen
would be reviewed—itwas cited as an example—andconsiderably, happily, so 80% of women who
it seems a huge injustice compared with thedevelop breast cancer can now expect to live five
conditions that are on the list.years or more whereas 30 years ago it was only 50%.
These trends are going to continue. This is all very
good news. The eVect of the way in which costs are Q292 Dr Naysmith: Have you put it to the
incurred mean that these are being transferred, so Government and asked themwhy it is not on the list?
patients have to incur large and increasing costs in Mrs Barnes: Repeatedly.
order to undertake life saving treatment, which to us
seems morally wrong that that should be the case. Q293 Dr Naysmith: I have done it as well and I get
Mr Meadowcroft: I think in the future much the the same answer. They are constantly reviewing it.
same will apply to Parkinson’s disease. We are Mrs Barnes: I have asked them have they ever been
looking at new drug therapies coming on stream to given any medical evidence by any authoritative
deal with the symptoms today. There is a huge bodywhich says that cystic fibrosis does notmeet the
research push for breakthrough therapies. There is criteria to go on the exempt list and they have not
cell therapy, stem cell research at places like answered that question.
Frenchay and other places, or in neuro protection,
trying to identify those most at risk and to find a Q294 Jim Dowd: I am sure it is here somewhere, but
medication that will stop the disease progressing. has the list changed much over time?
There are real problems today living with the Mrs Barnes: It has not changed.
condition below the age of 60 but longer term the
new treatments, and there will be breakthroughs, Q295 Jim Dowd: At all?will have a cost to them as well, inevitably so. Mrs Barnes: They have not reviewed it.
Q296 Jim Dowd: Since?Q291 Dr Naysmith: The other point I want to check
Mrs Barnes: 1968. The only reason I can possiblyon is we will obviously be looking at the list of
put forward as to why it has not been changed is thatconditionswhere therewill be exemptions because of
there are conditions on it which perhaps aVect athe fact that it is a bit of a muddle at the moment.
great many more people than cystic fibrosis whoWe want to get an idea of what the likely costs of any
should no longer be on it and they would all bechanges would be. Can you estimate what it might
terribly aggrieved if they were taken oV. If youcost the NHS to add the conditions that your
opened the list there would be a queue of conditionsorganisations deal with in these four rather diverse
wanting to go on it and there may be some that wereareas of disability and disease? What would the costs
eligible in 1968 but for which treatment hasbe if you came along and said, “We want exemptions
improved so dramatically they no longer need to befor some of our people” and how many people
on it. Of course, once you are on it you getwould be involved now?
everything free, it does not matter whether you haveMr Meadowcroft: I cannot give you a precise figure
got bunions, the flu or whatever it is, whereas cysticbut I can give you a ballpark figure. There are
fibrosis patients, who have to have this hugearound 8,000 people with Parkinson’s disease below
quantity of daily medication, are not on the list. Itthe age of 60 aVected by this, some would have an
does cause them a disproportionate amount ofexemption anyway if they receive Income Support.
anger. They are always sending me petitions andIf we take the assumption that most of those would
writing letters and wanting to come and march onbenefit, we would have a figure of around £1 million
Downing Street.a year. That is the best figure I can give you. It is not
robust but it is about £1 million a year, I think.
Mrs Barnes: For cystic fibrosis not much over Q297 Jim Dowd: Let us ask Lynsey what she thinks
£100,000 calculating it at the annual rate which about it.
people are paying currently if they are on the annual Ms Beswick: There are other illnesses that are
rate. It seems ludicrous to have caused so much ill- related to cystic fibrosis. For instance, I suVer from
feeling for a cost of around £100,000 on a drug arthritis which is related to my cystic fibrosis
budget which is over £6 billion. It seems ludicrous and that requires extra medication and extra
that the exempt list has not been reviewed. I think hospitalisation time due to my cystic fibrosis and
the Cystic Fibrosis Trust and those aVected by cystic that is an extra cost caused by cystic fibrosis that I
fibrosis would accept the situation if it was decided have to pick up the tab for. I do think it is a crying
to abolish the exempt list and treat the whole shame that we cannot get our prescriptions free
when we are having all this medication every day.situation diVerently, but if there is going to be an
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We do not want to take it, we did not ask to be born have the strange situation where this is one of the
freedoms that hospital trusts have to fix car parkingwith cystic fibrosis. I think it should be reviewed, it
charges and some of them use it as an importantis ludicrous that it has not been before now.
revenue stream at the expense of patients and, as weMrs Barnes: As well, 15% of adults with cystic
point out, at the considerable expense of cancerfibrosis develop diabetes which is another sting in
patients. The other is the Hospital Travel Coststhe tail and another horrible thing to have to deal
Scheme. The cost of parking is very often wellwith, but that is on the list. The minute they get
publicised in hospitals but the existence of thediabetes they then get all the rest of their cystic
Hospital Travel Costs Scheme is not. In manyfibrosis drugs free. The doctor breaking the news
hospitals there is no enthusiasm for making peoplesays, “You have now got cystic fibrosis related
aware that the scheme is available and it is very, verydiabetes. That is the bad news. The good news is you
tightly means-tested. Our view is that eligibility fordo not have to pay for your prescriptions anymore”.
the scheme should be liberalised and that it shouldSome nurses and doctors who are a bit more
be much more widely available to people aVectedimaginative tell them to tick the box to say they have
by cancer.got a fistula. There are people here who probably
know better than I do what a medical fistula is.
Many people with cystic fibrosis have something Q298 Charlotte Atkins: You have all argued for
called a portacath which is a device implanted into exemptions in various forms, how would you raise
the chest to access the veins more easily for money without charges?
intravenous antibiotics or they will have PEG Mr Cardy: Perhaps I could respond to that by saying
feeding whereby they have a permanent tube fixed that I think the decision making is not joined-up.
into their stomach so they can be fed overnight to With the change in the pattern of cancer treatment
maintain a more reasonable bodyweight. The more that I have described, that others have related to the
imaginative nurses will say, “As far as I am conditions with which they are concerned too, it is
concerned that is a fistula”. I do not think it is clear that it is part of the policy and practice of
actually but the pharmacists do not get into the hospital trusts to save money by delivering
nitty-gritty. The doctors and nurses do try and help treatment outpatient rather than inpatient. There is
them because they are so young and they know there really no connection made between that saving and
is a danger to them if they do not take what they are the cost that is transferred to patients. I do not
prescribed. believe in the end that there is any other place to go
Dr Fraser: In terms of the cost, obviously mental other than general taxation, except I would say this:
health is of a diVerent scale from the two kinds of in the course of last year Macmillan Cancer Relief
conditions you have heard about. One in four of the put about £70 million into the development of NHS
population experience mental distress at some point cancer services, so we do feel that we have made a
in their lives. Not all of those end up being a contribution.
diagnosable mental health problem that is ongoing. Mr Meadowcroft: I think I would make the same
You are talking about a significant number of case too from the Parkinson’s Disease Society’s
people. I think we have got to look at it in the round. point of view. We have funded nurse specialists in
What is it that we are trying to achieve with the Parkinson’s to the tune of £4.5 million over five
National Health Service? Are we just patching years, so we do input. In terms of an equitable
people up who have got to a critical stage in their approach I think it should be through general
lives, who have got to the point of being on a low taxation that would avoid means-testing and it
income or are chronically unwell, or are we trying to would reach more people. We would support that.
support people’s health and wellbeing and support Mrs Barnes: The Cystic Fibrosis Trust has not
people who are potentially very vulnerable to stop argued for prescription charges to be abolished
them from getting more unwell in the future? I know altogether simply based on our own experience. We
it does not come from the same budget and it is not provide a lot of free services for those with cystic
easy to count but the costs of prevention far fibrosis, including conferences. If we have a
outweigh the costs of things like hospitalisation later conference and we ask people if they would like to
on. Whilst the cost in terms of revenue that is not come, we might get a list of 300 or 400 and we
clawed back from people may be relatively high, the organise the day and pay for their food for the day
saved cost is much, much higher, not only in terms and only 200 turn up perhaps and we have paid for
of hospitalisation but in terms of benefit levels, in 300 lunches and people have not come. If we charge
terms of contribution to the community and all the them £5, which is only a token amount, we get a
other factors that we know about. much more realistic list. We have viewed
Mr Cardy: As far as prescription charges for people prescription charges in very much the sameway. For
with cancer are concerned, the DH tells us that it routine and occasional matters people should be
does not keep that data but it has recently estimated able to pay and it makes sense in feeling you are
that exempting terminally ill people from getting something of value, you are not taking it
prescription charges would cost about £2 million frivolously, you are taking it seriously. In terms of
which in terms of the overall cost of cancer treatment reducing the costs for those with cystic fibrosis, if
and care is a very modest amount indeed. Perhaps I they were exempt from prescription charges it would
could just allude to a couple of things that we have probably have the eVect of keeping many of them
out of hospital for longer because those with cysticnotmentioned yet. One is the cost of car parking.We
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fibrosis get very ill, they throw themselves on the have heard from other people today, the amount
mercy of their CF team who immediately admit that people are required to come up with to get that
them for a week or two to look after them properly Pre-payment Certificate is prohibitive. A scheme
and that will mean giving them all the drugs and which would make that easier would help. There is
medication they need, giving them in-hospital an example I know of, somebody pays £2 a week to
physiotherapy twice a day and ensuring that they get a local Mind group and at the end of the year they
a high calorie diet. Many hospitals go to a lot of give them a cheque to pay for their annual Pre-
trouble to make sure that those with CF can eat payment Certificate. £2 a weekmight bemanageable
properly. They tend to eat later in the day than most but even £10 a month might be too much to come up
people, partly reflecting the fact that they are so with at once. If you are on a very low income these
young but partly reflecting their condition. For are considerable amounts of money. I think we need
example, in the Bristol Royal Infirmary all cystic a tapered approach so it is not all or nothing. At the
fibrosis patients are allowed to go to the doctors and moment we have got a “you are either in or you arenurses’ dining room if they want to during the night out” approach and for those people who are on theto eat. There is never many of them but it gives them margins that is very inequitable. Having some kindan opportunity to be fed. If you think of hospitals
of tapered approach where you can pay a little bittaking patients in for a week or two at considerable
but not the full lot might be better than the systemcost, £1,000 for the hotel and catering aspect of it
that we have now.never mind for the drugs, to look after them better
Chairman: Could I thank you all very much indeedat home would save the NHS money in the fullness
and apologise for the lateness of the ending of thisof time.
session. It has been a very good session. Thank youDr Fraser: One of the things we can do is look better
for bringing your experience to us, I hope it will beat the pre-payment system. We would argue for free
prescriptions for all but in the absence of that, as we well-used in the next few weeks. Thank you.
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Members present:
Mr Kevin Barron, in the Chair
Mr David Amess Anne Milton
Charlotte Atkins Mike Penning
Mr Ronnie Campbell Dr Howard Stoate
Jim Dowd Dr Richard Taylor
Witnesses: Dr Lester Ellman, Chairman of the General Dental Practice Committee, British Dental
Association, Dr Maureen Baker, Honorary Secretary of Council, Royal College of General Practitioners,
Mrs Lynn Hansford, Chairman, Association of Optometrists, and Mr David Cartwright, President of the
College of Optometrists and Director of Professional Services for Boots, gave evidence.
Q299 Chairman: Good morning, ladies and Q301 Chairman: I think in general terms we are
saying it is probably the prescription charges thatgentlemen. May I welcome you to what is now our
may deter people from taking them up. Is there anythird evidence session in relation to the inquiry we
particular area of concern in relation to that or doare doing on NHS charges. I wonder if I could ask
you think it is across the board? People on lowyou to introduce yourselves for the record and say
incomes are exempt from prescription charges sowhat organisation you represent.
why do we have this type of problem?Dr Baker: I am Maureen Baker. I am the Honorary
Dr Baker: If someone has an acute illness and theySecretary of the Royal College of GPs.
have not been on regular prescriptions and so theyDr Ellman: I am Lester Ellman. I am the Chair of the
have not paid their “season ticket”, so they have toGeneral Dental Practice Committee of the BDA.
pay for each item, and they come along and they areMr Cartwright: Good morning. I am David
prescribed a number of items that relate to thatCartwright, an optometrist with Boots Opticians
particular acute illness, then three or fourand also President of the College of Optometrists.
prescriptions soon mount up. Yes, people on lowMrs Hansford: I am Lynn Hansford. I am an
incomes are exempt, but if you are just over theindependent optometrist and I am the Chairman of
threshold then it can be quite a hit if you are notthe Association of Optometrists.
expecting it and so it can have an eVect.
Q302 Chairman: Has the Royal College ever done
any studies of this as opposed to the anecdotal things
we hear about of people not being able to aVord four
Q300 Chairman: I want to ask a general question to prescriptions?
all of you about NHS charges. Do you think charges Dr Baker: Not to my knowledge.
deter patients from seeking the services that you
provide? We had evidence last week from the CAB Q303 Chairman: So we have no evidence base for
saying that they believe people do make choices on this?
occasions about what they can and cannot aVord if Dr Baker: No.
they have more than one prescription to pay for. Do
you think that is the case? Q304 Chairman: We just think that it happens and
Dr Baker: Yes, I do think that is the case. We have pharmacists say that it does.
heard, particularly from pharmacist colleagues, of Dr Baker: That is right.
patients bringing in a prescription and saying, “I’ll
have that one but I’ll not have that one”, or, “I’ll Q305 Chairman: Dr Ellman, in your evidence you
come back next week and get that one”. I am sure talk about the widening gap in the dental health of
that it does happen, yes. the population. Why is this?
Dr Ellman: Certainly in dentistry the patient’s choice Dr Ellman: It is very diYcult to answer directly and
range is now huge and a lot of them do opt to take say we have got absolute evidence of why it is. There
choices that are not within the standard framework is no doubt that some socio-economic groups
of the NHS. That is because there are a lot of things particularly are more at risk and that some priorities
out there which are not covered by the NHS. are given in diVerent directions by diVerent people,
Mr Cartwright: I think in optical services it is slightly and there are some cultural diVerences too. If you
diVerent in that we do not have charges, so a patient have not grown up in a culture of looking after your
does not come in and pay something. What happens teeth and regarding that aspect of your healthcare as
is if they are eligible for an eye examination they being particularly important then it tends to lapse to
have a voucher which should cover the cost of some extent and you only seek emergency care when
spectacles. I think the issue is that people are not there is some problem. So there is that widening gap.
deterred by the charges, but perhaps they are not A tiny bit is related to the people who are not in the
adequately aware of what is on oVer. supported group but who are on the threshold of
being who may find charges inhibitive to them. IMrs Hansford: I would agree with David.
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have no evidence for that. I worked in inner-city about the importance of good vision and how good
vision can maintain your independence and makeManchester for 30 years and I ran a practice there
and we have certainly got some of that, but I cannot sure that you function properly through your life.
identify it entirely.
Q311 Anne Milton: The evidence about elderly
people falling over because they do not see well IQ306 Chairman: Is there any conclusive evidence
have heard before. Dr Ellman, could you give me anthat suggests that those who do not consult dentists
example in dentistry of what will cost more if you doearly on for check-ups can end up costing the NHS
not get it treated early?more in the long run as it were?
Dr Ellman: If you leave a tooth which has decayed itDr Ellman: That must be so. I am not sure that we
may well progress into requiring more extensivehave done any studies on it directly. If you take the
treatment like root canal therapy which is a lot moresimple evidence that if you can get to the problem
expensive than a simple filling restoration, and thatthat the patient has before it becomes a major
is not uncommon. If it does not particularly hurt atproblem and moves on—because dental disease is
the beginning and they do not seek help, althoughprogressive—then obviously it has got to be less
they may know it is there, then it may well progressexpensive in the long run. I am not sure it is entirely
and become a much larger problem and theas simple as that, but that is a fair estimate.
restoration may be much more diYcult.
Q307 Chairman: Has your Association argued with Q312 Anne Milton: I am no expert, but it feels as
government that that is what you ought to be doing though if dentistry does not treat you early then you
when you have been looking at issues around a new just end up having your teeth out. Do you see what
contract and things like that? I mean?
Dr Ellman: We have talked in terms of prevention as Dr Ellman: I do not, sorry.
being something that we would very much like to see
heavily espoused by the new contract. Q313 Anne Milton: By not treating a dental problem
early there is a limit to how much it can cost you in
the long run. In your example about root canalQ308 Chairman: Is the same true for patients who
work, if you take the tooth out it costs money—delay or avoid having sight tests, that in the end it
Dr Ellman: Under the current system there is a limitcould be that there would be increased costs because
to what the patient can pay, but that does not limitof that delay to the National Health Service?
what the NHS will have to pay, it is merely a limit toMr Cartwright: Yes, it is. If you take many of the
the patient charge. Similarly, even in the new systemcommon eye conditions, if they are diagnosed early
which the Government is introducing in April,and are treated they will not lead to visual loss in the
although there will be a capped ceiling on what thefuture. For instance, glaucoma would be a good
patient’s charge would be, in fact it will cost theNHSexample where the patient is not immediately aware
more because it will take the dentist’s time awaythat their vision or the visual field might be getting
from being able to treat other patients just because itworse until it is often too late to treat. So it is
is a more expensive and time-consuming procedure.essential to diagnose that early and treat it early and
that would lead to savings later on in the ongoing
Q314 Dr Stoate: I think what Anne is trying to saycare of that patient. There is some evidence from the
is that if you do not get an optical test done you canUniversity of York to say that about 10% of falls in
go blind and that can have huge consequences. Ifthe elderly are due to visual disability, much of
you do not get your teeth fixed the worst that canwhich is preventable and that costs about
happen is you lose your teeth. Are we saying there is£250 million a year.
more that can happen to you than losing your teeth
and, if so, what?
Q309 Chairman: The elderly are not charged for Dr Ellman: Obviously losing your teeth is now a
sight tests any longer, are they? social stigma in this country to a large extent.
Mr Cartwright: That is correct.
Q315 Dr Stoate: What is the big deal with losing
your teeth?Q310 Chairman: It is the deterrence of the NHS
Dr Ellman: You have got to have dentures replacedcharges that we would like to look at, where that
regularly.shows that because of these charges people do not go
along for eye tests and consequently it costs more
Q316 Dr Stoate: Are there chronic long-term healthmoney in the long run. Do you think York may have
implications apart from losing your teeth?looked at that?
Dr Ellman: Not once they have been taken out!Mrs Hansford: There is no evidence that the cost of
eye care does put people oV going. When free eye
examinations were introduced for the over-60s there Q317 Chairman: I want to ask the optometrists
about young children. When I was at school I usedwas not a huge increase in the uptake of eye
examinations; it stayed pretty stable. That would to have eye tests. They may not have been that
scientific, but I do remember having an eye test atindicate that it is not a deterrent for people to come
and have their eyes tested. What it is is they do not school. That has stopped now. Do you think that is
a disadvantage?understand because there is not enough publicity
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Mr Cartwright: Certainly in my view there should be anything that relates to that question. I personally
a more universal screening programme for children am not aware of any studies that have looked at that
before the age of eight because if you catch specifically.
something before the age of eight you have a chance
of treating it, but if it is after the age of eight you
Q324 Dr Stoate: If your Information Servicescannot. Children under-19 in full-time education are
Department does have any evidence, I would be veryeligible for an NHS examination.
grateful if you would submit it to us because we need
to have a good evidence base if we are going to makeQ318 Chairman: How many of them take it up?
a sensible report to Government.Mr Cartwright: Out of 11.7 million NHS
Dr Baker: We did have a publication by our healthexaminations, around 25% are children so around
inequalities group called “Hard Lives” which is an2.5 million would be children.
overall look at some health inequalities issues. IChairman: We do not know what the population of
would certainly be happy to send that on and I canunder-16s is at any one time.
make a specific request around the literature
regarding charging and deterring people fromQ319 Mike Penning: Perhaps you could let us now.
treatment.Mrs Hansford: In an ideal world all children should
have their eyes examined before they start school
because the formative years, as David said, are up to Q325 Dr Stoate: Obviously everyone resents paying
age eight, so you need to detect any developmental charges. What we need to know is how much of
problems before that time and the earlier the better people’s reluctance to pay is just simply resentment
because the earlier you pick it up the more easily you at having to pay for what ought to be a free service
can deal with it and the better the outcome at the and how much of it is because they are having aend. You wear spectacles and so you understand genuine hardship eVect. We need to have somethat if you cannot see properly you do not perform evidence for that if possible.properly. It really is important that all children, in
Dr Baker: The evidence we will find for you if it isorder to reach their educational potential, ought to
there. In my own experience as a GP, I have peoplebe able to see properly at all times. So we would
say to me, “Don’t prescribe me this and this becausereally feel that that would be a major health benefit.
I cannot aVord it”.Chairman: A member of my family has just found
out at 14-years old that they have got a sight
deficiency. I think that may have been picked up Q326 Dr Stoate: I am sure that happens. What weearlier if it had happened to me as a child. need to try and gauge is a measure of how prevalent
that is. I want to move on to non-emergency
Q320 Dr Stoate: I am surprised that you are so transport. Do you think that the cost of transport
benign about your age of eight because in my for people to get to hospitals and to clinics can aVect
experience as a GP, if you do not diagnose the way they access the service?
strabismus before the age of 18months you are never Dr Baker: Yes, I do. In fact, the Royal College of
going to get binocular vision and that in itself is quite GPs is currently writing a paper with colleagues in
a handicap. Eight is far too late if you are going to the Royal College of Physicians and we are looking
diagnose a squint. at the best way in which generalists and specialistsMrs Hansford: I would agree with you. Eight is the can work together so that patients can get the bestcut-oV time. access to treatment. That is one of the issues that
have come up. We have been hearing of cases where
Q321 Dr Stoate: It is much too late by eight. people may have a number of chronic conditions
Mrs Hansford: You could pick them up at four. and they attend outpatient clinics for that, but
because of a number of factors, ie they are more ill,
Q322 Dr Stoate: Four is too late. they are poor and they either rely on public transport
Mrs Hansford: It is too late. A child with a or it is a question of can they drive, can they park,
strabismus like you are speaking of most parents do they pay parking charges, people default from
would be aware of. ongoing treatment for those chronic conditions and
that leads to poorer outcomes for important chronic
conditions.Q323 Dr Stoate: I would like to put on the record
that I am a Fellow of the Royal College of GPs and
a former College examiner. Dr Baker, we have had
Q327 Dr Stoate: Do you have any evidence youa lot of anecdotal evidence that prescription charges
could submit on exactly how prevalent that is?put patients oV receiving treatment. Is there any
Dr Baker: Again, I am not aware of any evidence.concrete evidence that prescription charges aVect
We are looking to see what there is in terms ofthe way that GPs treat their patients?
referencing this paper. If we find specific referencesDr Baker: I am not aware of any literature that
we can send that to you and I would be also be verywould provide that evidence, but that is not to say it
happy to send the paper to the Committee once thatis not there. I try to keep up particularly with the
has been launched.health inequalities issues. We can certainly ask our
Information Services Department to see if there is Dr Stoate: Thank you very much.
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Q328 Charlotte Atkins: Dr Ellman, what are your Dr Ellman: Most dentists who go private do not go
main criticisms of the new system of dental charges private just for the income. They go private to allow
and what do you think will be the impact on the them to spend time to produce the quality of
uptake of treatment? dentistry they think they want to produce and they
Dr Ellman: The impact on patient behaviour is feel patients deserve. The two things do go together.
absolutely unknown. This is one of the biggest The new system does not really provide them with
problemswe have. The problem that arises from that that time and it does not provide them with a
is you cannot then model the system to make sure generation towards a quality of service and a quality
that it brings in the appropriate amount of money. of outcome which we all want. The intangible factor
The remit of the Cayton committee14 that looked at is that of job satisfaction and that is one that dentists
it was that it should bring in the same proportion of do not get when they are pushed really hard in terms
money as the current system does. The current of a lack of time to deal with patients. So when you
system brings in about £487 million out of a total get the average dentist out there working on the
spend of £1.8 billion, so it is about 28%. What we do NHS seeing 40 patients a day, they do not feel that
not know is when you change charging regimes as they can form a good working relationship with
drastically and dramatically as this particular those patients, they have not got the time to
change is happening what that will do to patient encourage prevention to take place and that is a
attendance and patterns and nobody else can tell continual reinforcement process.
you. The bits that we do not like about the charging
are the massive steps which are diYcult for patients
to get their heads round. For one simple filling they Q332 Charlotte Atkins: If they want to get oV the
move froma band of £15.50 to £42.40. I do not know drill-and-fill treadmill, would not the best way of
what the patient is going to say about that. Theymay doing that be by increasing the input of fluoridation
opt to get additional treatment done or they may in terms of particularly young people’s health?
save it for some time. Dr Ellman: The scientific evidence is that
fluoridation makes a massive impact particularly on
young people’s dental health, yes, but this has issuesQ329 Charlotte Atkins: What you are saying is that
that you know a lot more about in this House thanpatients may wait until they have more than one
pain in their mouth to ensure that they fit nicely into I know about it to do with the resistance to it. That
the middle band as opposed to just missing the first is not in my gift but it is there.
band, is it not?
Dr Ellman: It is a possibility. I have no handle on
Q333 Charlotte Atkins: What is your view about thethis. I have no way of knowing what patients will
issue of dentists who are requiring parents to goactually do. Some will progress as they have always
private while they treat their children on the NHS? Iprogressed but many will be unsure.
understand under the new contract that will not be
acceptable.
Q330 Charlotte Atkins: Is the new contract going to Dr Ellman: I have no evidence that this actuallybe profitable for dentists or are a lot of dentists going happens. I am not denying that it does.to go down the completely private route?
Dr Ellman: There is some evidence from the plan
providers particularly, because they are the people Q334 Charlotte Atkins: You should see my postbag
who have people signed up, that quite a number of in that case because I can assure you it does.
dentists are moving outside the NHS because they Dr Ellman: I will take your evidence. I think it is
do not see the reforms being satisfactory for their wrong that patients are treated in that way. It is not
particular practice. How workable it is remains to be something we do in our own practice. You could say
seen. I know that the Department of Health is fairly we only treat adults privately and we will happily
confident that they think they have got it right, but take your children on the NHS, but I do not think
a lot of my colleagues are confident they have not. one should be a condition of the other. I find that
The one really big item that is missing is the drive unacceptable.
towards prevention. I think the drive towards
prevention is the one that I would really like to have
seen in place. That is there as a token more than as Q335 Charlotte Atkins: Is it not diYcult to separate
a positive driver. that? You could have a dentist saying, “I don’t make
it conditional”, but we know some say on a nod and
a wink, “I will not take your children unless you goQ331 Charlotte Atkins: So by going private they
on Denplan”, or some other private system and it isthink they could do more preventative work, do
very diYcult to prove one way or the other, is it not?they?
Dr Ellman: I would imagine it is.
14 Note by witness: In 2003, Harry Cayton, the Director for
Patient Involvement at the Department of Health,
Q336 Charlotte Atkins: If you heard that some ofestablished a working group to review patient charges. He
submitted the group’s report to Ministers on 31 March your members were going down this route you
2004. The report was published on 7 July 2005. The BDA would condemn them for that, would you?
were present on the committee as expert advisors and
Dr Ellman: I think wewouldwant to advise themnotconcentrated on two key issues for dentists of bad debt and
missed appointments. to do so.
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Q337 Charlotte Atkins: Mr Cartwright, based on Q342 Charlotte Atkins: What do you think the
future for the sight test should be? What would youwhat I hear and see from your own evidence, you are
recommend?concerned about the cross-subsidy to sight test fees
Mr Cartwright: We would recommend that wefrom people who require spectacles, is that right?
should have an expanded eye examination as anMr Cartwright: That is correct, yes.
essential service that is available in all areas.
Q338 Charlotte Atkins: Is that because you think
Q343 Charlotte Atkins: So that you are pulling inthat the present sight fee does not cover the extensive
youngsters who at the moment are not getting thatsight test that most optometrists embark on?
full cover?Mr Cartwright: The current sight test paid for by the
Mr Cartwright: Certainly there should be a muchNHS, which is £18.39, does not cover the real cost of
greater awareness of the importance of eyeproviding that examination, which is around £37.
examinations and eye health and preventative eyeThere is this cross-subsidy from the sale of spectacles
care. There would then be optometrists being inand contact lenses which in eVect is a tax in some eVect the GP for eye services. So any eye conditionways on the wearer of spectacles who is then paying would initially come to the optometrist for diagnosisfor part of that examination. and monitoring to decide what it is and to
potentially treat and then we would also be engaged
locally in glaucoma schemes, diabetic retinopathyQ339 Charlotte Atkins: Just because you have a sight
monitoring schemes, the treatment of age relatedtest at one particular practice does not mean you
macular degeneration or the diagnosis of age relatedcannot take that sight test oV and go and buy your
macular degeneration and advice and guidancespectacles somewhere else, is that right?
there.Mr Cartwright: That is correct.
Q344 Charlotte Atkins: The Department does notQ340 Charlotte Atkins: In the future you could have seem to think that the sight fee itself really mattersa basic sight test, a medium one and one that is far because it is negotiated in a competitive framework.more expensive. Could you have a diVerent level of What is your view about that?sight test and follow-on care in the future? Mr Cartwright: Absolutely not. The cross-subsidy is
Mr Cartwright: Absolutely. The optical profession not a good example where the one who wears
has published its view of what could be done in the spectacles then has to pay for part of the eye
future where there was a much wider role for examination for somebody who potentially has not
optometrists in providing that essential eye got to wear spectacles, so there is a hidden cost to a
examination. The role of the optometrist could be third party.
expanded within that to some extent, but then we
would also have an additional service where the
Q345 Charlotte Atkins: The other issue is to do withoptometrist is eVectively the first port of call for
the NHS voucher and the fact that many practicesanybody who has a problem with their eyes. So if it
do not seem to stock spectacles which are fullyis a red eye conjunctivitis then that would go to the
covered by an NHS voucher. Does that mean that aoptometrist and the vast majority of cases the
number of people either do not come for a sight testoptometrist would be able to treat. We could also
or they decide that they will not buy a pair ofhave glaucoma monitoring and diabetic monitoring
spectacles simply because they cannot aVord the gapwhere the optometrist should be fully engaged as
between the voucher and the cost of the spectacles?well. If optometry was doing that those services
Mr Cartwright: Two-thirds of optical practices doshould be remunerated at a realistic level.
supply spectacles like single vision or bifocals or two
pairs covered by the cost of the voucher. There is not
any evidence—that does not mean to say that itQ341 Charlotte Atkins: Would it make sense to oVer
definitely does not happen—to say that people area diVerential service to diVerent people depending
deterred from an eye examination or from comingon age and general health? At the moment you have
along to an optical practice because of the cost ofa standard sight test that everybody who comes
spectacles. There needs to be greater awareness ofthrough the door has, although I have been very
the fact that people can come along that are eligibleimpressed by some of the sight tests I have been
for an eye examination and that it is an importantoVered because they seem incredibly extensive. In
part of monitoring for eye conditions which if foundfact, they normally convince you you are blind and
early can be treated, but in two-thirds of practicesyou are so relieved by the end of it that you are not
the voucher will cover the cost of the spectacles.that you are willing to accept anything!
Mr Cartwright: Over the last 10 years the diagnostic
tests that are available have expanded quite Q346 Mike Penning: Dr Ellman, I was astonished to
markedly and optometrists are involved in that. At hear you were not aware of this blackmailing which
the moment there is this cross-subsidy and actually is going on within dentists about how you cannot
it would be something that the Government is keep your children on theNHS unless you go private
missing out on in not taking advantage of that yourself. Not only is that an issue for my
resource that is available to free up resource constituents, but my dentist wrote to me (obviously
he does not realise I sit on this Committee) sayingelsewhere.
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that if I wanted to stay with him I had to go private Dr Ellman: They would, you are quite right.
Unfortunately dentists do not work that way. Theyand my children would get NHS services if I stayed.
Are you saying you have never heard of this before? are independent contractors and the word
independent comes to the fore.Dr Ellman: I said I have no evidence that that is
happening. You are giving me some. Can I just
correct the position that your dentist seems to have Q353 Chairman: Do dentists take a collective view
taken which says he will happily treat your children through your Association on issues like new
on the NHS but you must go private? He did not use contracts? Do they have a vote?
that as a lever. Dr Ellman: No. We do not do that because we did
not negotiate the contract; it was imposed on us.16 It
is a Department of Health contract that has beenQ347 Mike Penning: He did. He said he would
pushed forward. All we have done is talk about it,remove me from his list as an NHS patient unless I
advise them and chip away at some of the things thatwent private.
are wrong. Some of the things that are still wrongDr Ellman: He did not say he would not treat your
make it a very disadvantageous contract in somechildren on the NHS unless you go private.
respects.
Q348 Mike Penning: Yes, he did. Q354 Chairman: As an Association representingDr Ellman: In that case, I am sorry, I would not dentists you have not negotiated the new contractagree with that. with the Department like the BMA negotiated with
the new GP contract, have you?
Q349 Mike Penning: I will supply you with that Dr Ellman: That is correct.
letter. Are you for the contract? Are you happy with
it? Are you going to sign the contract that is being Q355 Chairman: You have not done that and
oVered to you or are you going to reject it? therefore you do not have a collective view on
Dr Ellman: I do not have powers to reject on behalf whether it is good or not.
of the dentists. Dr Ellman: It may have been done previously but it
has not been done on this occasion.
Chairman: I hope my two colleagues will be able toQ350 Mike Penning: But you are going to advise
send you information about this other issue and thenthem on whether it is good or bad for them.
you can respond to that.17 I am sure we wouldDr Ellman: Yes, we do advise them. We have just
appreciate that during the course of our inquiry. Wesaid that at the present time this contract is an
are going to move back now to vouchers for glasses.absolute mess. That was in our press release the
other day. The contract needs to be looked at in a
much more serious manner than it has been looked Q356 Mr Campbell:Citizens Advice told us that they
at because there are serious flaws in it. had evidence that a lot of people who go for an eye
test cannot aVord to pay the diVerence between the
voucher and the price of the glasses. What is yourQ351 Mike Penning: If they do not change the flaws
take on that? Is the voucher system wrong? Do theyyou are going to advise your members not—
need to increase that or take it away altogether?Dr Ellman: They will probably have to live with it
Mrs Hansford: As David said, two-thirds of opticalbecause quite a lot of our practitioners on two
practices in the UK oVer spectacles within thegrounds want to remain within the NHS. One is that
voucher value. I think you will always be able to findthey are in areas where to move outside the NHS
people who fall outside that or who perhaps havewould be inappropriate and the other is that a lot of
not understood it. When I read that I did feel thatdentists are actually wedded to the concept of the
perhaps we need to work with Age Concern and theNHS; that is what they want to do. Those who move
CAB to see if we cannot resolve that. It sounds likeaway rarely do it on grounds of the economics of the
it is small pockets of a problem. What you have tosituation, but rather the fact that job satisfaction of
understand is there is no such thing as an NHS pairspending longer with patients, has been removed.15
of glasses anymore. What happens is that all
Q352 Mike Penning: NHS dentistry could not 16 Note by witness: As a result of primary legislation—the
survive without your members being fully involved Health andSocial Care (Community Health and Standards)
Act 2003—the new General Dental Services contract wasin that. If your members said “No, we’re not happy
outlined in this Act. The Act was an enabling act for thewith his contract” the Government would have to
Department of Health to implement the contract. It was notlook again, would they not? designed as a negotiated contract between the Government
and the profession. The BDA were privy to discussions with
the dentistry Minister, Rosie Winterton MP and her15 Note by witness: An independent survey carried out for
departmental oYcials about the contract. The BDADoctors’ and Dentists’ Remuneration Review Body in 2002
constructively inputted into these discussions, but the finallooked at the reasons why dentists were turning away from
details of the contract lie with the Department of Health.NHS dentistry: about 70% said they felt rushed when
Debate about the precise details of the contract cametreating NHS patients; around 60% said that their workload
through secondary legislation—the NationalHealth Servicedid not allow them to provide the professional standard of
(General Dental Services contract) Regulations 2005care with which they were comfortable; while at present 60%
of dentists spend at least 90% or more of their time working 17 See Ev 137. The BDA has also written to Charlotte Atkins
MP and Mike Penning MP to help clarify theirin the General Dental Services, only about 16% expected to
be so committed in five years’ time. constituency cases.
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spectacles are provided as a private contract and the Mr Cartwright: It is a fact that two-thirds of
practices will provide spectacles of the voucherDepartment of Health provide a voucher to help
people who are on low incomes towards the cost of value, so at no extra cost at all and with a range of
spectacles. We are not going back to the old NHSa private pair of spectacles. It is up to the patient to
decide what spectacles they want to buy, whether days of brown or black glasses where there was a
badge of poverty—they want to buy a budget pair or a more expensive
pair. Maybe there are misunderstandings about Mr Campbell: There is not a great choice. I have
looked at them when I have been in there. For thewhether there are cheaper pairs available, I would
not know and it is diYcult to talk about specific best glasses there are three or four cases.
cases. There is plenty of opportunity to buy
spectacles within the voucher value. Q362 Jim Dowd: Go to another optician, Ronnie!
Mr Cartwright: I beg to diVer because it is a very
competitive market and there is choice, so peopleQ357 Mr Campbell: There must be a big diVerence
will be able to go in and there will be a number ofbetween the worth of the voucher and the price of
frames that are available for that person.the glasses.
Mrs Hansford: There can be. If you buy a pair of
Q363 Mr Campbell: I have not got a problem withspectacles like I am wearing there will be a huge
that. My point is about the diVerence between thediVerence between the voucher value and the
voucher they get and the price of the good glasses. Ispectacles. You would expect me to be wearing top
am talking about poor people on Income Supportof the range spectacles, would you not? If I had a
getting a good pair of glasses.voucher it would make a very small dent in the cost
Mr Cartwright: These would still be good glasses,of this pair of glasses, but I did not have to choose
they would be good lenses and they would still bethis pair of glasses, I could have chosen a budget pair
backed by that professional service. There is noand I could have had a pair of bifocals instead of a
diVerence in the oVering to the patient.pair of varifocals, but that is my choice. One of the
Anne Milton: My child has worn glasses since he wasstrengths of the optical market is that it has complete
18-months old and I have never paid for them. Theand utter patient choice. There are no restrictions to
choice has been fantastic. I live in Surrey and if therethe optical market whatsoever. You can have 10
was any way of going to the opticians where you didoptical practices in a row in a street. Whilst that is
not have to pay for glasses it would be there, but invery uncomfortable for us sometimes as business
fact every optician has distributed them. They arepeople, it is a driver for excellence. If you have got
fantastic glasses. You are using the words good andlots of competition you have to be good to make sure
bad prejudicially and it is not fair. If you want athat you keep your head above water and that your
GiorgioArmani pair of glasses you are going to havebusiness is a success.
to pay for it like you would a suit.
Mr Campbell: The voucher system only applies to
Q358 Mr Campbell: Would it not be better to do some frames.
away with the voucher system and have an income Anne Milton: And they are absolutely fine.
cut-oV rather than a voucher system and give them Mr Campbell: They should go beyond that.
a good pair of glasses?
Mrs Hansford: I do not understand what you mean. Q364 Chairman: Maybe you should have that
debate in a private session. Would the issue of the
value of the voucher be the diVerence in this debate?Q359 Mr Campbell: So instead of having a voucher
Mrs Hansford: There is not any such thing as freesystem they would have to declare if they are on
glasses and then the next pair of glasses cost youIncome Support or low wages. Would that not be a
£200. You might pay £5, £10 or £15 to havebetter system, where the Government would give
something a little bit better. We are not talkingthem a good pair of glasses rather than the budget
about huge amounts of money to have a biggerpair?
choice. You can spend a lot of money on spectaclesMrs Hansford: But a budget pair does not mean it is
just the same as you can spend a lot money on a suit,a bad pair of glasses, it just means that it is not a
but you can also get an oV-the-peg suit that isdesigner pair of glasses.
perfectly reasonable, that can be thrown in the
washing machine and look good for years that you
Q360 Mr Campbell: A lot of people would not wear do not pay a lot of money for, and you can have a
a budget pair. They may say, “I’m not going to pay pair of glasses that you do not pay a lot of money for
the diVerence just for a budget pair of glasses, but if that look perfectly good and do the job.
I had a bit more money I would go for a good pair”. Mr Campbell: A good pair of glasses costs about
Even the poor want to have glasses like my own. £100.
Mrs Hansford: There is plenty of selection in Chairman: This is a very interesting but anecdotal
spectacles. debate in many ways. I would like to move on now.
Q365 Mr Amess: Chairman, just for a moment IQ361 Mr Campbell: I do not know about that. I go
to my optician’s and I look at the little case with the want to join in the free-for-all and go completely oV
the script. About 45 minutes ago we had thisbudget pairs and there are only about 12 pairs in
there. interesting exchange betweenDr Ellman andmy two
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colleagues about what happens when you neglect detecting eye disease early, then I think that would
be a huge health gain for patients and for the NHSyour teeth, what is the ultimate eVect of it and all the
as a whole.rest of it. Surely you end up with dentures. Not
everyone is successful in wearing dentures. You need
teeth to eat and chew your food. You cannot just sit Q368 Mr Amess: If this were to be eVective you
there sucking boiled sweets all day. I would have would systematically have to monitor the situation.
thought you could even die through it. Never mind How would you get the information across to the
your remark about the aesthetic result, I would have public and private sector? What would be the
thought it was very, very important that you keep mechanism to make this national service framework
your own teeth. a reality?
Dr Ellman: There is no doubt whatsoever that in Mr Cartwright: We are currently about to embark
today’s world more and more and more people wish on negotiating the new GOS contract and we would
to retain their teeth for as long as they live and that propose that the essential services, the additional
is where the additional expenditure will come in. If and enhanced services within that and they should
their teeth are taken out and they wear dentures then be properly funded. Much of this information would
that will reduce that eVect to some extent. go through the Department of Health. We would
have payments and all that sort of information
would be there. Is that the sort of things you are
Q366 Mr Amess: Believe it or not, I am trying to help thinking of?
you with the answers. Dentists no longer pull out
teeth unnecessarily. They do everything they can to
Q369 Mr Amess: Given that there is public andsave them. Let us come on to the opticians and the
private provision, how would you collect it all? Hownational service framework.
would you get everyone to agree? You are suggestingMrs Hansford: We never pull out eyes!
that the Department controls the thing overall.
There seems to be a bit of a contradiction.
Mr Cartwright: If we were thinking about awarenessQ367 Mr Amess: In your written evidence you say
and if we had a framework—and they do exist inthat General Optical Services are “not underpinned
some areas of the country and Wales is a goodby a national service framework for improving
example—where a patient who has an eye problemhealth in the optical field”. Obviously you feel that
is going to their GP but then they no longer go tothis is a big issue. Given that it is a big issue and given
their GP but to an optometrist locally. That actuallythat there are all these diVerent contractors, there is
would raise awareness very quickly that if I have gotcertainly some resistance as a result of the charges.
a problem with my eyes I will go to my optometrist.Why is it so important, and how could you achieve
At a GP’s surgery you would be told to go to see thethis national service framework in practice?
optometrist. When you ring up for an appointmentMrs Hansford: That is all laid out in this document
and they ask you what it is about, you would say itthat I waved around when David was talking. We
is to do with your eyes and you would be referred todid present this document to Rosie Winterton in the
the optometrist. We do not need to talk to every GP,autumn of last year and it does lay out our vision of
although that might be a useful thing to do, but ifthe future for primary eye care and David did
that was a nationally set framework which was setexplain it in quite a lot of detail, ie the essential
centrally and then PCTs were picking that up thenservice, the additional services and the enhanced
that would happen naturally.service. It is pretty much the same as we have in Mr Amess: The Committee will reflect on yourWales. My practice is in Wales. You are probably evidence. I think Boots is splendid!aware that we have enhanced primary eye care in
Wales where we provide an acute referral scheme
Q370 Jim Dowd: It is a German company that haswhich is in eVect a triaging system and where
just bought them!patients with eye problems can come to the
Mr Cartwright: It is Italian.optometrist. About two-thirds of the practitioners in
Wales are accredited to deliver those charges. There
is the Low Vision Scheme and other things like that. Q371 Jim Dowd: I want to raise the comparatively
We feel quite strongly that there ought to be a recent development of people being able to buy
glasses oV the rack from supermarkets. I justnational service framework and a publicity
wondered what your view of that was.campaign so that everybody understands the
Mr Cartwright: Supermarkets have entered theimportance of vision. If you speak to anybody about
market and it is very competitive. In thethe importance of vision and they think about it for
supermarkets it is a registered practice so you willmore than 10 seconds, it is obvious that you cannot
have an optometrist or a professionally qualifiedfunction unless you can see properly, but it is never
person there to help.a thought that is prominent in people’s mind. The
children’s NSF does not mention eye care for
children and the older people’s NSF does not Q372 Jim Dowd: I am not talking about that, I am
mention eye care for older people and yet when I say talking about the fact they are on the shelves
that you think that is mad. If we had an NSF for alongside any other product. What is the percentage
vision so that everybody understood the importance of people buying glasses without professional
guidance?of vision, the importance of eye care, seeing well and
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Mr Cartwright: This has been there for 20 years and Q377 Jim Dowd: I bought a pair in Sainsbury’s
largely because I could not read the label onI think at the time the profession thought it was
something I was going to buy and thought theyappropriate. There is also unregistered spectacle
would help.dispensing. Both of those have regulation behind
Mrs Hansford: As long as you went and had yourthem. If it is a readymade pair of readers and it is to
eyes examined by the optometrist the next day thatcorrect presbyopia, that is glasses for near work, you
would not be a problem.should not be able to go in and buy them for driving
for instance. There is an age limit set so that children
Q378 Jim Dowd: I have not.cannot go and buy these to correct their distance
Mrs Hansford: Well, you need to. How do you knowvision. It is acceptable if there is background
you have not got glaucoma?regulation. Also, for unregistered dispensing, so
Jim Dowd: You are right.somebody can set up without the professional
service, the regulation says that there has got to be a
prescription datedwithin two years. There has got to Q379 Dr Taylor: I am going to follow the rather
be measurements taken. I think it is acceptable if rumbustious precedent of not sticking to the script
there is some background to it. certainly for the moment. I am really quite staggered
to hear that the BDA has not expressed a collective
view about the contract because I really thought it
Q373 Jim Dowd: But there is not. They are just on had.18 Are local dental committees aYliated to you?
racks. People go in and pick up a pair and they go to They are part of you, are they not?
the cashier and that is it. Dr Ellman: No, they are not. They are statutory
Mrs Hansford: That is why we need the national bodies that represent the profession locally and
service framework. present the views and they are there to assist primary
care trusts and the like in formulating policy and
dealing with things on the ground. They are notQ374 Jim Dowd: I was asking your view about that
dissociated from us but they are not part of theas a practice.
British Dental Association.Mr Cartwright: It certainly has its dangers but in a
lot of places there will be responsible promotional
Q380 Dr Taylor: The Birmingham Local Dentalmaterial with it saying an eye examination is
Committee is convinced that the BDA has reallyimportant and you should do that every two years,
given up and is really trying to persuade local dentalso that would be a responsible way of doing it. There
committees to make the best of a bad job, evenare some places where you can just go and buy them.
actively advising members to convert to privateYou can imagine that for somebody whose sight is
dentistry. Does that accord with what you havefailing they may think, “I’ll just go and get myself a
heard?slightly stronger pair of glasses”, and actually they Dr Ellman: Yes, indeed. I am aware of whathave got a medical problem and they should be Birmingham LDC has done.going to have their eyes examined to correct that.
Q381 Dr Taylor: We went to Wales yesterday and we
Q375 Jim Dowd: So the supermarkets should adopt were told by the minister that they had made distinct
changes to the dental contract in Wales which madea more responsible and active role, is that what you
it more acceptable to the Welsh dentists. Do youare saying?
know about that?Mr Cartwright: It would be unfair to pick on
Dr Ellman: I am not familiar with the details of thesupermarkets. There are some places where you can
changes in Wales. I am aware that they are makingjust go and buy readymade reading spectacles. The
diVerences between England and Wales, but I amimportant point is to raise awareness so that people
not entirely sure that I understand all the nuances ofthink, “Okay, I can get these, but I need to make sure
it so I cannot comment.19they are right for me and I need to back that up with
an eye examination”.
Q382 Dr Taylor: Let us come on now to help andMrs Hansford: There is a lot of evidence to show that
information that is available to patients. Firstly, Drpeople who buy “ready readers” are quite often
Ellman, in your written evidence you have said, “asbuying them as a backup pair to their prescription
with many co-payments in the NHS exemptions arepair. So they have had their eyes examined and they
absolute. Consequently there will be a largehave bought their prescription specs. That may not
proportion of the population on the cusp ofbe every case.
exemption criteria.” Have you any idea what could
be done to help these sorts of people?
Q376 Mike Penning: When you are in the opticians Dr Ellman: It is really a matter for government. It is
having your eye test they give you the prescription possible to work on the basis of a partial subsidy in
and they try and sell you glasses while you are there, relation to the income level that is there and
but if you get out the door like I did you can buy therefore in a way means tested. You could support
them elsewhere for £10. it in stages.
Mrs Hansford: As long as you have had your eye
examination and as long as you are buying a pair of 18 See Ev 137
19 See Ev 137.reading glasses that suit you that is not a problem.
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Q383 Dr Taylor: Would you like us to put that sort Q390 Dr Taylor: I am referring to HC11, Help With
Health Costs.of suggestion forward?
Dr Ellman: I have no reason not to. It would be very Dr Ellman: That is a big form that is published by the
Department of Health, I think, which means that, ifhelpful for many who are on the lower economic
scale but not supported by benefits of any sort. you are on a low income, but not on Jobseekers
Allowance or one of these benefits, it will allow you
to claim the money or the support from the relevantQ384 Dr Taylor: Can I just clarify some detail about
authority. That is a big, complex document, as youthe actual charging. Have I got it right that you pay
rightly say. We would like that simplified because it£42 for one filling and, if you have 10 fillings, you
makes it very diYcult for patients to deal with andpay exactly the same?
some, I am sure, are deterred by the fact that it is aDr Ellman: Yes, £42.40 is the current—
big jargony form.
Q385 Dr Taylor: So one filling is exactly the same?
Dr Ellman: Yes, it will be. That is exactly how it Q391 Dr Taylor: So, and this is really to everybody,works. should we be suggesting that that document is sort
of fragmented into separate documents for eachQ386 Dr Taylor: Surely, if patients know about that, particular service? Obviously the dentists wouldas we have rather been hinting before, they are going say yes.to delay and have a few fillings to get their money’s Dr Ellman: I think it is the same document for everyworth rather than just pay the 42 quid for one and service, is it not, that applies? I am not sure.then go back and pay another 42 quid for another?
Dr Ellman: Yes, that is a possibility. I have no idea.
I suppose, to some extent, it depends on how diYcult Q392 Dr Taylor: I rather imagined, although, I have
the problem is. If it is causing you acute distress, then to admit, I have not seen it, that it actually explained
you are obviously going to seek help straightaway. details of the charges.
Dr Ellman: No, it does not. It is a form that is used
Q387 Dr Taylor: Before I come to the others, how for you to claim repayments or payments of the
are you setting about letting people know, and really dental charges in this particular instance.
it is supposed to be a simple banding system, but, if
one crown costs you the same as several crowns, one
Q393 Dr Taylor: So how are you and the otherstooth on a denture the same as a whole denture, how
trying to draw patients’ attention to the range ofare you setting about explaining it to people? Is it
costs? Is it your job to tell them what it is going toyour job to explain to the person in the chair how
cost?much it is going to cost? How do you set about that?
Mr Cartwright: If I could pick this up for optics,Dr Ellman: We put out some advice leaflets for
many practices have this sort of leaflet which is adentists to help them explain the charges and the
guide to NHS entitlements because we are slightlychanges to the patients, so we have gone in that
diVerent in that we do not have charges, we havedirection. That has only recently been published and
entitlements. Practices would also have posters,it is actually on the BDA’s website now, together
saying what the entitlements are and on the PCT,with a poster that they can download and put in the
primary care trust, visit, the ophthalmic advisor willwaiting room, which explains as simply as we can
pick that up if there is not one there and say, “Well,what the changes will mean for patients, so we have
you should have one. You should have leaflets”, anddone that. Dentists are aware of what is going on
staV would be aware of that as well.and most of them do explain to their patients what
is involved.20
Q394 Dr Taylor: So you would accept that it is a part
Q388 Dr Taylor: Again, in your evidence, you draw of your role to hand out the information?
attention to the document Help With Health Costs, Mr Cartwright: Certainly, and we do so, yes.
and, as other people have told us, and I forget how Dr Ellman: We do likewise.
many pages it is, but it is terribly complex. Dr Baker: Anyone who has been to a GP surgerywill
Dr Ellman: Yes. know there are racks and racks of leaflets and there
are normally leaflets explaining prescription charges
Q389 Dr Taylor: You say here that you want to go available for people to pick up.
out with your own paper. Is this what you have
actually done already?
Q395 Mr Campbell: Back to the opticians again, IDr Ellman: No, we are not allowed to. Sorry, are you
have a thing about opticians! Scotland and Walesreferring to that form that you can claim on?21
have introduced a new eye test examination.
Basically can it come here? Can it come to England20 Note by witness: As part of the National Health Service
and how much will it cost?(General Dental Services contract) Regulations 2005,
dentists must display an NHS-sponsored poster in their Mr Cartwright: We would certainly be delighted if it
waiting rooms explaining the new dental charges regime. were to come here or a very similar sort of system
21 Note by witness: The BDAhas produced leaflets and posters and I think it can come here. That would be part of
for dentists to display in their surgeries explaining the new what the general ophthalmic services review shoulddental charging regime and which patients are exempt from
be about. We would need to look at the cost and Idental charges. The Department of Health have produced
their own patients leaflets which build on the HC11 form. think certainly it would cost more, but I think, if that
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was looked at in terms of the value of the longer- be interested in looking at. What are actually the
costs and benefits of such an initiative like that? Hasterm savings, that would clearly make the case for
that sort of system coming here. it been costed in any way?
Dr Ellman: Not as far as I am aware, but it has notMrs Hansford: Someone has just whispered in my
ear that, if the Scottish scheme were introduced in been developed properly yet either.22 There is an
outline being developed, but there is no IT system toEngland, it would cost £92 million according to the
Department of Health. support it currently. A full oral health assessment
has been used by other people in private plans, for
instance, to give guidance to get a full picture ofQ396 Mr Campbell: So that is a lot of money. somebody’s oral health, not just the fillings, but theMrs Hansford: In NHS terms, it is a drop in the whole picture. That would be beneficial because youocean. could see and again you could do the one thing we
have never really done much of in dentistry and that
Q397 Mr Campbell: A drop in the ocean of course, is to measure the health gain, the eVects in terms of
yes. what we do. We know what the immediate eVects
Mr Cartwright: If we were saying that the current are, but we do not know the long-term eVects. It
expenditure is £350 million and that includes would also enable patients to be encouraged along
vouchers and eye examinations, and I think we had the prevention route by doing oral health scores, so
a figure of nearly £2 billion earlier, you can replace you would know exactly where you were in terms of
teeth, but not eyes. relationship. This has been trialled outside the NHS
by Denplan actually who did it as part of one of their
schemes with a fair degree of success, so I think weQ398 Mr Campbell: Are you getting more money for
are not reinventing the wheel from that viewpoint.better tests?
Mr Cartwright: There is a wider range of services,
Q402 Chairman: Have you got reports fromyes.
Denplan on that which perhaps the Committee
could look at?
Q399 Mr Campbell: And of course available to all? Dr Ellman: I can try and ask them if they could
Mr Cartwright: Yes. supply us with some for you. I have not any.
Mrs Hansford: I wanted to interject when we were
talking about patients travelling to hospital and
Q403 Chairman: The other thing I would just like topaying car parking fees. Of course the beauty of an
ask you, Dr Ellman, was not really about NHSoptometrist delivering services in the community is
charges, but it does come into what you have justthat there are no car parking fees, there are no
said there to some extent. It is this issue ofhospital trips, there is no transport because they can
fluoridation of the public water supply. What is theget on the bus, they can walk round the corner and
BDA’s position on that?the optometrist is there. That is one of the benefits
Dr Ellman: Absolutely solidly in favour. We ran aof delivering more optometric services in optometric
massive campaign here at Parliament for that somepractices. It is an under-used resource.
18 months ago and that was very successful. TheMr Campbell: I will have to get on my bike then!
BDA is very much in favour of that and the science
is very much in favour of that. There are entrenched
Q400 Chairman: I have just one more question to views in the diVerent directions, but there we are.23
you about the issue of domiciliary eye tests when we
were talking earlier about elderly people falling and Q404 Chairman: We have heard them over the years,everything else and sort of the added cost to theNHS but, with our new regulations in situ now, we do notfor that. What is the current position with know when or who is going to operate them. Coulddomiciliary eye tests? I just move back to the opticians. How do you seeMr Cartwright: Domiciliary eye examinations are the new general ophthalmic services contractavailable, and there are many practices who do them developing in the future, not in terms of you wouldand some companies which specialise in domiciliary like it set in the National Service Framework andeye care. I believe that one of the issues there is that everything else, as I am sure you would, but in termsthere is a fee for the first patient and then a lower fee of charges? Do you think there is going to be anyfor subsequent patients. There should be a higher fee great change?for the first and second patients and then perhaps a
tail-oV, whereas it happens at the moment after just
22 In 2003, the BDA produced a report, Oral Healthcare forone patient. Older People: 2020 Vision, which made a number of
recommendations in this area. See Ev 137.
23 Note by witness: Water fluoridation is the most eVectiveQ401 Chairman: If you had this National Service
public health measure in reducing dental decay and forFramework which was mentioned earlier, obviously tackling oral health inequalities. Tooth decay is a significant
issues like that would be in there and hopefully problem in the UK and the dental health inequalities are
widening. In socially deprived communities as many as onewould be accepted throughout the UK. Could I
in three children under the age of five will have one or moremove on to Dr Ellman. You advocate an automatic,
decayed teeth extracted.As part of theWater Act 2004,MPsfree oral health risk assessment programme which I voted in favour of local communities being oVered the
would have thought, in terms of last week’s White change to decide whether they wanted targeted water
fluoridation schemes in their locality.Paper, was something that the Government would
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Mr Cartwright: I think, in the ideal situation, there Q405 Chairman: Well, could I thank all of you for
coming along this morning. It has been quite anwould be eligibility, so an eye examination would be
enjoyable session with the little bit of entertainmentsomething that everybody could access. I think we
in the middle of it all! Thank you very much indeedhave to be realistic and say that there are certain
and hopefully it will not be too long before we aregroups that are more at risk than others, such as
actually reporting to Parliament in relation to this.children, elderly people, suVerers of medical
Any further papers you have on these issues we willconditions and those on low income, so that is
bemore than happy to look at beforewe come to anyabsolutely right. Personally, I would then put more
firm conclusions.eVort into extending the role of the optometrist to be
Mrs Hansford: Would you like us to send copies ofable to deal with specific situations that would free
these documents to the Committee?up resource elsewhere. We have talked about where,
Chairman: Yes, indeed we would. I think Davidif somebody has red eye or conjunctivitis, that would
would in particular. Thank you.go into the optometric practice and, perhaps rather
than extend eye examination eligibility to absolutely
everybody, I would put some money into that side.
Witnesses: Mr Derek Lewis, Chairman, Patientline, Dame Gill Morgan, Chief Executive, NHS
Confederation; and Ms Maggie Elliot, President, Royal College of Midwives, and Head, Midwifery and
Women’s Services, Queen Charlotte’s and Chelsea Hospital, gave evidence.
Q406 Chairman: Good morning. Could I welcome Q409 Anne Milton: So what you are suggesting is
that, if you cannot aVord to pay for it, you do not getyou to the Committee and thank you for coming
along to help us with our third evidence session in the reassurance in the middle of the night?
looking at the issue of NHS charges. I wonder if I Ms Elliot: Yes, you do, but you do not get the same
could just ask you to introduce yourselves and what person to do that. Of course the relationship builds
organisations you represent. up with that one midwife, so, as soon as the woman
calls her, she knows immediately who it is, what herMs Elliot: I am Maggie Elliot. I am representing the
Hammersmith Hospitals NHS Trust. issues are and provides very reassuring advice or tells
her to come into the hospital or whatever. Yes, otherDame Gill Morgan: I am Gill Morgan and I
women are able to call the hospital, but they speakrepresent the NHS Confederation.
to either a midwife on the delivery suite or they speakMr Lewis: Derek Lewis and I am the Chairman of
to a community midwife basically.Patientline.
Q410 Anne Milton: There has been evidence aroundQ407 Anne Milton: My first question really is
for years and years and years about the outcomes foraddressed to Maggie. Perhaps you could tell us a bit
women in pregnancy if they have a named midwifemore about the scheme in place at Queen Charlotte’s
and certainly organisations like the NCT have beenHospital where expectant mothers can pay for NHS
calling for that for years, so in fact your access tocare. Maybe you can expand on that and tell us a
somebody you know is quite important when youlittle bit about why it was developed in the first place.
are pregnant?Ms Elliot: First of all, the mothers do not pay for
Ms Elliot: It absolutely is and we would moveNHS care and we are quite clear about that. The
towards that for everybody, particularly if it is partmothers actually book in to the hospital normally
of the NSF, so it is planned for the future, butfirst, so they actually are entitled to, and absolutely
currently we do not provide the absolute midwife forwould receive, NHS care if they themselves did not
that woman. The other thing of course is that thechoose to go private. The scheme started about two
scheme has allowed us to provide this service foryears ago or the concept was two years ago, but the
women with a clinical need, so, as well as thisactual commencement of the scheme was about 18
midwife and now another one and a half actuallymonths ago. One particular midwife came to me
providing that service for the women who pay for it,very, very keen to provide 24-hour on-call service to
we actually now can provide it for women withreassure women that everything is all right and that
severe clinical need, and she takes on women free ofsort of thing, so it was started as a result of that
charge which we would not have been able to haveconversation. She had also been aware of a very
done if we had not actually started this scheme.similar, but not the same, scheme in another trust.
There was a demand from women, so we looked into
it fully and started.
Q411 Anne Milton: What would be the clinical need?
Ms Elliot: It is people who may have had a very
traumatic experience with their first birth, so theyQ408 Anne Milton: So, just for the record, mothers
would come to me and I would have a conversationpay for that?
with them on the telephone and then I would referMs Elliot: Mothers pay for the 24-hour on-call
them on to the Jentle Midwifery Scheme becauseservice that this midwife and now, since then, one
they basically need the reassurance of one, singleand a half others actually provide which is not
available to other women basically. midwife.
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Q412 Anne Milton: You talk about diYcult socio- be the test of whether anybody challenges it in court
which will finally encourage organisations to do it. Ieconomic circumstances as well. What do you mean
by that? think people will be looking at this, but not
necessarily intending to go down the route at theMs Elliot: Well, that could be somebody who had a
history of domestic violence. Basically anybody who moment.
needs the reassurance of a midwife who absolutely
knows their history from start to finish are the Q418 Anne Milton: Just to come back to you,
people who are referred to this scheme. Maggie, do you have any figures of the people who
pay for this, how many of them have the sort of need
that you would have identified?Q413 Anne Milton: So clinical or socio-economic,
people whose pregnancy is flagged up as maybe Ms Elliot: Well, first of all, anyone who had a need
would have had our one-to-one midwifery servicebeing complicated for a number of reasons?
Ms Elliot: Yes. To put this into context, because it is anyway, so it is actually a want absolutely rather
than a need. They pay for something they want.a pregnancy from start to finish, this is called a
“caseload”, so the Jentle Midwifery Scheme have
actually taken 51 women who have actually Q419 Anne Milton: So they are paying for something
delivered with them who have actually paid. they want, not something that they need?
Additional to that, they have taken on an extra 25 Ms Elliot: That is right.
who have not paid, and they were able to expand
that number as well, but they also provide Q420 Anne Milton: And, in doing so, they cross-
reassurance and care to other women as well. subsidise the service for the people who need it?
Ms Elliot: Yes.
Q414 Anne Milton: Are you comfortable with it? Dame Gill Morgan: I suppose the other thing we
Ms Elliot: Absolutely, yes. should point out is that these sorts of services have
been available by independent midwifery practices
for a long time. What is unusual about it is oVeringQ415 Anne Milton: I need to ask you that because it
could be seen very much as a two-tier system. that sort of independent service within an NHS
hospital and, therefore, using the money to cross-Ms Elliot: It is not a two-tier system because all
women at Queen Charlotte’s, I hope, have a high subsidise, and that is unusual.
quality of care. These women do not actually receive
a better quality of care, but they simply pay for the Q421 Anne Milton: Are you comfortable with it,
reassurance of one midwife and nobody else will Gill? You look wary. I can see wariness on your face.
get that. Dame Gill Morgan: I think this is right at the cusp of
some real challenge and I am not really sure how
comfortable I feel about it because I feel, I think, aQ416 Anne Milton: You are subsidising, richer
people are subsidising the needs of a group of people little bit like you. There is a real benefit if you get
additional resources in to boost the services which isyou have flagged up as having exceptional needs
during their pregnancy? Yes? why I feel comfortable about private services
provided within the NHS because that money hasMs Elliot: We are able to reinvest the money back
into the NHS, yes. always gone back into the NHS and I suspect, if this
had been presented as a private service, I would have
had no diYculty whatsoever. In one way, you couldQ417 Anne Milton: Quite. Just moving on to Gill, do
present it as a private service if you are quiteyou think this kind of scheme will be introduced
comfortable about it, but I think the way that it iselsewhere?
presented leaves me personally feeling slightlyDame Gill Morgan: I think the challenge for schemes
uneasy, but that is a personal view, not anlike this is that they are right on the cusp between the
organisational view.private sector and the NHS which makes it, I think
as you have been exploring, really quite diYcult to
know how far people will take them. We are not Q422 Chairman: Could you just answer this: how
diVerent is this payment in principle from a paymentaware of a large number of schemes of people trying
these sorts of things, but we are aware of individual for a prescription charge?
Dame Gill Morgan: I think the thing that is diVerentorganisations trying them. This is really quite
diVerent, I think, from the other one which has had about this is partly the scale, but I also think this is
about the choices individual people can make toa lot of publicity recently which is the dermatology
clinic which is quite clearly a private service run in have something which, as I say, could have been
presented as private and I would see it asNHS hospitals. We have always been able to run
private services in NHS hospitals and we have fundamentally diVerent from a prescription charge.
I think part of this and the discomfort is just thealways been able to oVer extra amenity in terms of
beds and hotels right back to 1948. This is really presentational issues for someone who is used to the
way the NHS has traditionally worked. Theexploring a new territory and I think we are not
going to know, and this is one of the problems for prescription charge is diVerent. That is a payment
that everybody contributes to, so it is a diVerent sortorganisations, quite how acceptable it is until at
some point it gets tested in law because it is right at of thing forme. Briefly, while we are on prescriptions
because I know that is not the purpose of today, butthe boundary, I think, in terms of position. You will
have tested it before you actually set it up, but it will I know you have been wrestling with what evidence
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there is about how many people fail to use Q426 Dr Stoate: Well, that is not what is being said
in the papers. It is specific women being interviewedprescription charges, I have brought with me a paper
from a Commonwealth survey which compared the and I want to know whether these newspaper stories
in fact are true. The women being interviewed areUK with five countries which gives some answers
around prescription and dentistry. I will leave that saying, “It’s marvellous. I get ante-natal classes with
one or two couples only, instead of the 30 I would getfor you.
otherwise, and I have got this practice birthing
session where the whole thing is done in practice onQ423 Chairman: You do not then see a prescription
a one-to-one basis”. Is that not happening?charge as being a part-payment for getting a service
Ms Elliot: That happens within the Jentle Midwiferyfrom the NHS? Is that what you are saying?
Scheme absolutely.Dame Gill Morgan: It is a co-payment, but it is a
diVerent co-payment because it is really focused the
Q427 Dr Stoate: Right, so that is what they areother way round and it has so many exclusions to it.
getting for their £4,000 and not just reassurance overMy personal view again about prescription charges
the phone.is that we are not very sophisticated about how we
Ms Elliot: Yes, but that actually goes back to the factapply them, so we do not think about what we are
that that is a want and not a need and that is whattrying to achieve as a policy context and I do not
they are paying for.think we have fundamentally thought about the
challenge of where we are today with expensive
drugs. One of the things we have been thinking Q428 Dr Stoate: But what I am trying to say is that
about internally which we have not sort of launched that is a two-tier service. They are getting something
for a wider public is what I have seen in other which is completely unavailable to women who are
countries which is that, if you want to make drugs not paying £4,000.
available to everybody on an equity basis, but you Ms Elliot: It is unavailable to those women, but the
also want to oVer some choice for people, what other women that are not paying £4,000 receive an
countries do ismake generic drugs free and then only absolute high level of care that is acceptable and
charge a co-payment if somebody wants a branded within the NHS.
drug. For example, if you take a drug used to make
you pass water, the generic name is furosemide Q429 Dr Stoate: But not within the NSF. The NSFwhich would be free with no prescription charge, but standards only reach those people who pay.somepeople, however, like the branded name, Lasix, Ms Elliot: Yes, but then you could go on then andbecause it comes in a green colour and they like that, add on separate things which women actually payso you are charged for the branded name and, in that for that are not available within the NHS.way, you drive two policies, one being equity and the
other being the issue that we want more generics
Q430 Dr Stoate: What I am trying to get at veryprescribed.
simply is that they are paying for a servicewhich they
cannot get on the NHS if they have not got theQ424 Dr Stoate: I have a couple of very serious money.points I want to raise. You say it is not a two-tier Ms Elliot: Yes, but then nobody gets those servicesservice and you also say you are just giving on the NHS. It is not something that is available.reassurance, yet, according to the newspapers, and I There is not another scheme that provides onehave given the articles to the Clerk to look at, they midwife total care within the NHS. That is notare not just getting reassurance, but what they are available.getting is one-to-one ante-natal classes and they are
getting practice birthing sessions on a one-to-one
Q431 Dr Stoate: You are right, but it is an NHSbasis. That is not about just giving reassurance over
service which is only available to those who have gotthe phone 24 hours a day; that is about a completely
£4,000 over and above the ordinary NHS standard.separate type of service which is not available, except
Ms Elliot: It is not an NHS service.to the 25 people who have got clinical need, unless
you have got 4,000 quid. That is the reality surely.
Ms Elliot: First of all, I cannot comment on what the Q432 Dr Stoate: Well, you have just said that it is
newspapers have said. part of the NHS.
Ms Elliot: No, the women who are in our one-to-one
midwifery service actually receive a very similarQ425 Dr Stoate: They are wrong, are they, the
service, but these women pay for extra things whichnewspapers? The £4,000 does not include the
are not clinical need. They are things that they want,birthing classes, the practice sessions and the one-to-
not things that they need.one ante-natal sessions? That is not what is
happening?
Ms Elliot: First of all, other women that we actually Q433 Dr Stoate: Okay, I will leave it there. You have
said that you seem to support or seem to have somegive care to do actually receive that type of care
throughout the one-to-one midwifery service, so we sympathy for a scheme whereby, if you want a
generic drug, you get it for free, but not if you wantdo have a service that actually gives exactly the same
type of care, the only diVerence being that they do the branded drug. What is the diVerence then if I
were to say to a schizophrenic, “You can havenot get one named midwife throughout the whole of
their care. largactyl or Chlorpromazine for free, but, if you
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want Olanzapine, one of the typical anti-psychotics, when you add up all the charges that come into the
NHS, it is a significant contribution to the runningit is going to cost you 50 quid”? Would that not be
the same thing? costs of the NHS, but we could be doing it in a way
which does not actually compromise equity andDame Gill Morgan: No, I do not think it would
because there you are not comparing like with like which does not actually compromise another policy
which is to get actually more generics prescribed. Itbecause the more modern anti-psychotics are
clinically more eVective and they have been shown is a suggestion that we need to begin to think
diVerently about it rather than the way we haveby NICE to be. It is not like for like and that, to me,
is fundamentally diVerent. always thought about it.
Q436 Dr Taylor: We are coming back to prescriptionQ434 Dr Stoate: Why is that fundamentally
charges later, but I am afraid I wanted to talk todiVerent? What is the diVerence between saying that
Maggie a little bit more because, when we did anthe basic NHS midwifery service is okay, but not up
inquiry on midwifery in the last session, it camethe NSF standards, whereas, if you are going to pay
absolutely clearly out that why mums like midwife-£4,000, you can have the NSF standard because that
led birth centres is because they have a very highis not like for like either?
chance of having one-to-one care from the sameDame Gill Morgan: Well, that is where you go back
midwife throughout. Now, I have to say that I thinkto where I think, if this is presented as a completely
it is entirely wrong, and I hope the Committee willprivate scheme, which is what the NHS has already
say it is entirely wrong, to do it the way you are doingbeen allowed to do, it would not be causing some of
it because these people are in fact getting private carethis heartache as it does sit right in this middle bit
at half price. What does it cost to have a babyand the NHS has been allowed, even in Barbara
privately, to have the whole shooting matchCastle’s day, to provide some private practice. I
privately? How much does it cost?think part of the issue here, which is why there is so
Ms Elliot: Well, between £4,000 and £5,000 with amuch interest in it, is that it is stirring up this
private obstetrician, depending on the service theyquestion of how far you mix private work with
have, whether they have a caesarean section or not,public work on the same ward and you get the
whether—benefits accruing to the NHS, and that is very
diYcult.
Q437 Dr Taylor: So they can have a baby privately
for £4,000 or £5,000 and they can come into theNHSQ435 Dr Stoate: Are we not just going straight down unit and pay £4,000?a slippery slope? Okay, you could argue that the new Ms Elliot: Actually I need to take advice on that.anti-psychotics are clinically diVerent from the old
anti-psychotics, though other people might not
Q438 Dr Taylor: It strikes me that this is cut-pricenecessarily agree with that, and maybe the anti-
private medicine.psychotics are not a very good example, but maybe
Ms Elliot: Sorry, depending on the actual service, itwe could come up with many other examples, and I
is £7,000 to £8,000.am sure it would not take me long to come up with
other examples, where a drug might be okay, but
Q439 Dr Taylor: In a hospital like Queenactually there is a “rather better one” and NICE
Charlotte’s, your delivery will be high-class, so youmight think it is a rather more sophisticated drug,
do not need to pay to make sure that you get theand it does not make that much diVerence, but you
right obstetrician to do it. What you do need to paycan have that if you pay for it. Is that not the same
for is the superb comfort of having the same midwifething and how far would you take it?
all the time, so here you are giving people who canDame Gill Morgan: Some countries have done that
aVord it a better class of care, and I hope theof course. If you go to New Zealand, that is the way
Committee will come out and say that it is entirelythey have handled their prescribing costs. I am not
wrong without somebody having to take it to courtadvocating that because I think there is a duty to use
to prove that it is wrong.the best, and most appropriate, drug and that is
Ms Elliot: It is not—what NICE gives us. It gives us a view about what is
the best drug to use at a particular time. However,
Q440 Dr Taylor: Do not try and defend it!within that, there is a great diVerence between the
Ms Elliot: It is not a better level of care than thegeneric version of the drug and the branded version
women on the NHS receive.of the drug when things come oV patent and the cost
Dr Taylor: Of course it is. What they want is thediVerence can be absolutely phenomenal. Now, it
same midwife—seems to me that that is not the same because you
would not be withdrawing a service from people,
you would actually be putting in a top-up for people Q441 Chairman: Let her answer the question.
Ms Elliot: We do have a one-to-one midwiferywho wanted a particular branded version rather
than the generic. Now, I have not done any scheme and that does provide a named midwife, but
that midwife cannot be guaranteed, because ofmodelling and I am not presenting this as a
hypothesis of what we should do, but what I am annual leave and because of other reasons, to
provide that level of care. This midwife and now thetrying to suggest is that we could be looking at some
of these charges in diVerent ways and then maybe two whole-time midwives give that guarantee to
them that it will be them that actually will deliverboth ways of bringing some resource in because,
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that baby because they arrange their annual leave Ms Elliot: There is a huge demand for this andwe are
turning people away all the time.around those women, so they will not go on annual
leave when they have got women booked, so it is a
guaranteed service. The women actually want that.
Q450 Anne Milton: But I can say that it is exploitingThey want the reassurance of a midwife and it truly
them and encouraging them to believe, because theyis not a better level than women with clinical need
will believe, I would guess, that they need this.actually get.
Ms Elliot: We absolutely do not advertise it in anyDr Taylor: I think you have dug the hole deep
shape, form or description. It is the women that askenough. Thank you.
for it and for a long time they have always said that
they cannot provide it, but this midwife had actuallyQ442 Chairman: Obviously the individual
had experience of a very similar scheme and knewconcerned can arrange holidays in terms of days of
that it worked very well, so we were asked for it. Shethe week, but the actual day, as I understand it, can
came to me with the proposal and, I have to say, thebe quite a long process in terms of hours and
women that actually go on to the scheme actuallyeverything else.
have to be booked with us first, so, because we are inMs Elliot: Yes.
London and there are capacity issues, we cannot
take women from Timbuktu, but they actually haveQ443 Chairman: Indeed on a couple of occasions I to be booked with us and live within our local areahave sat through those long hours, waiting! in order for us to accept them on to the scheme. WeObviously it will disrupt that day, particularly the are currently turning a lot of women away from itday of birth, for these individuals in terms of going because we just cannot provide the demand.back perhaps to their families and everything else at
the times they would normally have been able to, so
is there any personal gain in those individuals’ Q451 Chairman: Gill, can I just ask you about this
income, as it were? issue of purchasing beyond a generic prescription. It
Ms Elliot: For the midwives? is a form of choice, is it not?
Dame Gill Morgan: Yes.
Q444 Chairman: Yes.
Ms Elliot: No, they receive the NHS salary.
Q452 Chairman: “Choice” is the sort of buzzword
now certainly in terms of patients, though I am notQ445 Chairman: And that is it?
sure about the people who are providers who workMs Elliot: Yes, and of course including all of the on-
in the Health Service. I know this is not acall allowances that the NHS provides as well.
confederation view, but just your personal view—
Dame Gill Morgan: This is just a discussion, yes.Q446 Chairman: So they will get that whether it was
somebody who had £4,000 sitting alongside them or
not? That would be the same? Q453 Chairman: Do you see choice, which has
Ms Elliot: Yes, so, whether the women are either eVectively a co-payment in that respect, as being
paying for the extra services or not, the midwifes something that is consistent with the NHS as it has
would receive exactly the same salary. been in the past or indeed is now or could be in the
future?
Q447 Anne Milton: I would just make a comment Dame Gill Morgan: My personal view is that, where
really about when you were talking about co-payment is necessary for something which is
prescribing, Gill. I think one of the issues, and where essential, we should not be charging co-payments.
it gets very complicated, is that compliance is a big That does not fit with the NHS and the ethos of the
issue, so, even if there is no diVerence in the tablet, NHS, but, where this is something which is about
but I would like Lasix and I do not like that ghastly preference, I think you could begin to explore
furosemide, that comes into it, and also there is the diVerent ways of thinking about co-payments. For
placebo eVect of drugs where, if somebody perceives example, we have always made amenity beds
that Lasix will be better for them, then they are more available where people have been able to pay an
likely to get better if they take the Lasix actually? additional sum to have a private room. It seems to
Dame Gill Morgan: Sure. me that there are opportunities in that sort of zone
to think diVerently because there is some choice and
that is why some of my response to this is that it isQ448 Anne Milton: But just to come back to Maggie,
and I think you were given a particularly hard time right at the edge of things that we have always done.
by Dr Taylor actually, what these women are paying You could argue that having a private room, for
for is a guaranteed person? which we charge an amenity charge, is some sort of
Ms Elliot: That is right. way where you could only do it if you have got the
money, it is unfair, but at the same time you know
that, if the private room is needed for an individualQ449 Anne Milton: If you believe, therefore, that
patient for a clinical need, there will not be anthey are not getting anything that they need, but it is
amenity bed available. I just think we need to besomething that they want, and I am sorry to be
thinking diVerently about some of these charges andcontroversial, it is going to be said, therefore, that
whether there are ways that we can do it where weyou are exploiting women at a very vulnerable time
in their lives. are not co-paying for fundamental treatment
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because I personally feel very strongly that that is essentially a PC at every bedside and it is a specially
designed PC for the hospital environment, as a resultnot the ethos of the NHS or the way we should be
going. of which the cost of installation is high. It is typically
about £1,750 per bed, all of which is funded by the
providers who install them who additionally fundQ454 Chairman: I have got in mind the situation
the operating costs and that involves having staV inwhere, if you look at the Calman-Hine report of
each hospital, typically about five people in eachquite a long time ago now about surgery, and cancer
hospital, who keep them clean, who maintain themsurgery in particular it was looking at, we had
and who look after patient needs in relation to them.hospitals and clinicians who were identified as being
That inevitably results in a substantial amount ofbetter skilled at saving somebody who had to have
cost being incurred. The UK is unique in that thissurgery for cancer than other establishments. It
particular type of sophisticated system is funded inwould be very tempting for somebody to say, “I’d
this country in a way that it is not anywhere else andlike to co-pay on the NHS to go to that hospital with
that is that at this point it is funded entirely throughthat surgeon”, which Calman-Hine identified where
payments by patients and by their friends andthe chance of surviving that cancer is quite a few
relatives who make calls to patients. As you may bepercentage points higher than not going there. What
aware, Ofcom, which was still investigating the costswould you say to that?
of incoming calls at the time we submitted ourDame Gill Morgan: I would find that completely
evidence to the Committee, has subsequentlyunacceptable, on personal grounds. As far as our
reported and has concluded that the charges formembers are concerned, it would be very hard and
incoming calls were essentially an unavoidablewe have never surveyed our members collectively on
consequence of the way the funding structure hasthat, so I cannot speak on behalf of the NHS.
been set up in the UK where the providers, as wasChairman: I understand that and it is not in our
recognised by the NHS at the time, had little choicescript either, but it is just something I thought I
but to recover the bulk of their costs from chargeswould like to test out with you. We will move on to
for incoming calls. The great opportunity, weDavid Lewis now.
believe, and we welcome the Ofcom report, is toMr Amess: Before that, poor Maggie! She has had a
extend the use of these systems for the purposes forterrible time in this Committee and even Richard has
which they were originally designed and selected sobeen sticking the boot in. I am so sorry the opticians
that the benefits extend well beyond those of patienthave gone because I just wanted to say to you,
entertainment and communication. We hope thatMaggie, that I think your glasses are splendid! I bet
the review group that is now being established by thethey were not taken oV the shelf!
Department of Health will indeed explore thoseMr Campbell: More importantly though, how much
further uses so that we can achieve a much moredid they cost!
equitable spread of the cost of the systems between
diVerent users.
Q455 Mr Amess: We have with us now this morning
Mr Lewis and I am sure that what the Committee
Q456 Mr Amess: You have really sort of guessedwould really like to know is what really went
many of my questions really, including talking abouton between him, Michael Howard and Miss
Ofcom. In terms of the volume of complaints, haveWiddecombe, but we are not going to pursue those
you had a lot of complaints about the cost of chargesmatters and we are going to talk about Patientline.
not only from patients, but from Member ofNow, there has been some very, very tough stuV in
Parliament?terms of the criticism of Patientline, huge criticism
Mr Lewis: I think it is important to say, first of all,about the costs of installation when you think that,
that, by and large, there is a remarkably high level ofwith the technology developing, they are practically
satisfaction with these services on the part ofgiving TVs and phones away, et cetera, so I think the
patients, and the NHS itself conducted researchfirst thing the Committee would like you to address
about a year ago which indicated that 90% oris how you can defend the very, very high costs of
thereabouts of patients were satisfied with theinstallation.
services that they received. There are obviouslyMr Lewis: Well, of course these systems are
concerns about having to pay at all in the hospitalvery sophisticated systems. These are not simply
environment within the NHS, but again, by andtelevisions and telephones at the bedside. When the
large, the majority of patients feel that the chargesso-called Patient Power programme, under which
for television and for outgoing calls, which werethey are installed, was specified back in 2005 as part
deliberately capped as part of the originalof the NHS Plan, what the NHS was then looking
programme, are reasonable and they are happy tofor was a device that would not only provide
pay those. There have been complaints, and theretelephone, television, radio and so on, but would
has been quite a significant volume of complaints,have the capability of doing a lot of other things,
about the costs of incoming calls which are set at aproviding interactive services for patients at the
much higher level and which are now higher than thebedside, being capable of providing access to
norm for telephone calls generally, and thoseelectronic patient clinical records at the bedside for
complaints come from callers, friends and relativesuse by nurses and doctors, and being able to provide
who call patients and indeed from Member ofthe mechanism for patients to order their food at the
Parliament who are reflecting the views of theirbedside for dietary management and so on.
Therefore, the systems that have been installed are constituents.
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Q457 Mr Amess: In terms of the technology that you operation on the boundaries between the services
that the providers oVer and the things that thehave available, would you share with the Committee
what other services you feel you could provide and hospital does. Our belief is that, if there is an open
mind in approaching those issues, there are acan you try and seduce us by saying that, if you did
provide these extra services, in actual fact you would number of ways in which those charges can be
reduced and we very much hope that it will operatebe saving money for the National Health Service?
Mr Lewis: A number of these services not only, in to a very tight timetable as it is not something we
would like to see drift on for any great length of timeour view, would save money, but produce some
significant improvements in patient care, patient and we would like it to work to conclusions within a
few months so that we can actually implement somesatisfaction and indeed patient choice, but, with a
PCat the bedside, the scope is very considerable. For changes quickly.
example, and these are all things which are now
being done, but not to the extent that we would like
Q461 Mr Amess: This may be a bit diYcult for youto see them done, there are two hospitals in the UK
to answer, but how much money do you think wouldwhere patients now order their food on the system.
have to be generated from the National Health
Service to reduce the charges to a reasonable level?
Q458 Mr Amess: Which are those hospitals? Mr Lewis: It is extremely diYcult to answer that
Mr Lewis: They are in the north-east, North Tees question because it depends entirely on the mix of
and Hartlepool, the first two hospitals to do so. That services provided and what some of the additional
brings a number of benefits: the information about costs are of providing those services. We do not see a
the menu and its dietary parameters is easily single solution to this, but we do see, if you like, there
available to the patient; they can order their food a being a menu of actions which, brought together,
very short time before the meal is actually delivered; should enable incoming call charges to be reduced to
it arrives at the right bed because they have not a level that callers would consider to be acceptable
moved bed in the interim and that brings significant and would remove a number of other irritations, one
reductions in food wastage; it completely eliminates of which is the need at present for the warning at the
the need to print menu cards; changes to the menu beginning of all incoming calls about the cost of
can be done instantly; and it is a means of providing those calls.
information about what food patients have ordered
for the monitoring of their diet. In those two
Q462 Mr Amess: Finally, and you have sort ofhospitals and the other hospitals that are now
already answered this, Ofcom and the criticisms—looking at it, there are some very tangible savings
what is it your intention to do about these criticisms?and clinical benefits.
Mr Lewis: Well, I am not usually someone who
would make complimentary remarks about aQ459 Mr Amess: Will you answer the direct charge
regulator, but they did actually, I think, do a quitethough that one of the reasons your expenses are so
thorough job to a reasonably tight timetable. Theirhigh is that you are not getting that which you
conclusions were that the level of incoming callthought you would from the National Health
charges, which was the specific bit they wereService and it is the poor old patient who is lumbered
investigating, were a cause for concern, they were awith these costs?
source of complaints and they looked out of lineMr Lewis: I think there is an element of truth in that.
with other telecoms charges. However, they didWhen this programme was conceived, it was
conclude, first of all, that the level of those chargesanticipated that things like food-ordering and access
was heavily influenced by the specifications that hadto clinical records at the bedside would be widely
been set by the NHS for these systems back in 2000:used and would generate a significant source of
the highly sophisticated technology; the requirementincome for the providers. The development of that
to put one of these units at every bed even though itincome has been much slower than was originally
is uneconomic; and the requirement to provide aexpected. Had that income developed at the pace
range of free services for the NHS, such as free radio,that everyone expected at the time, we would have
free information services and so on. They concluded,expected to have been able to reduce the level of
as a consequence of that and combined with the capincoming call charges by now.
that has been established on charges to patients, that
the providers had very little choice other than to
Q460 Mr Amess: Do you think the current charging eVectively charge these higher prices to incoming
agreement does actually have a viable future or do callers, and they described the charges as being the
you think the whole thing is going to have to be result of a “complex web of government policy and
looked at again? agreements”. In addition to the published report—
Mr Lewis: We believe it is viable, but unsatisfactory
at present and wewould very much like to see change
and we hope, therefore, that this review group that Q463 Mr Amess: What does that mean, do you
think?is being set up by the Department of Health will, first
of all, consider a wide range of options, will look at Mr Lewis: I think you would probably have to ask
Ofcom, but I think it relates back to the policy whenthe way these services are funded in other countries
which do not involve high levels of charges for the programme was set up and the way it was
funded. They have published a report and they haveincoming calls, will consider ways of encouraging
other uses to the system, and also more eVective also written to the Secretary of State with a series of
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recommendations, we understand, although we leading edge, and hospitals in the United States, for
example, are bearing the full capital costs of thehave not seen that letter as yet, but hope to do so as
part of the work of the review party. magnitude you have just described in order to install
these systems because they see a very wide range of
benefits from them. In a US hospital there is alreadyQ464 Dr Taylor: Is it fair to say, Mr Lewis, because
television and telephone there and US hospitals areyou have said that your system will have a computer
paying up to £2,000 a bed in order to provide devicesby the bedside which would show an electronic
which will provide the full range of clinical servicespatient record, that the relatives who are paying 49p
and other services that I have been talking about.a minute for their incoming calls are in some way
subsidising the national programme for IT?
Mr Lewis: Not at present because at present the Q469 Charlotte Atkins: But it is a white elephant if it
usage of the system— is not being used. That is the point. It is not a white
elephant in the sense that it is being used in other
countries, but it is a white elephant if it is not beingQ465 Dr Taylor: But it is there.
appropriately used and the full system is not beingMr Lewis: Well, indeed. The usage of the system for
exploited, which means in fact, as Richard wasthat purpose is at present very limited. There is just
saying, that patients’ friends and relatives, by andone hospital, Chelsea & Westminster, which is using
large, because they are ringing the hospital and theyour system to access an electronic clinical record at
are the ones that are being charged excessively,the bedside, and very successfully so, so eVectively—
are subsidising a system which is not being
appropriately used in the NHS.Q466 Dr Taylor: Does your warning message say,
Mr Lewis: In that sense, I would agree with you. I“Thank you very much for using this service. It is
think the solution to that is to ensure that they aregoing to cost you 49p, but you are helping the NHS
fully used. This investment is now largely a sunktowards its aim of having readily available electronic
investment; it has been made and the systems arepatient records at the bedside”?
there. The challenge, I think, is to make sure that theMr Lewis: In principle, that is a correct conclusion.
full potential of it is used to improve patient care, toWe do not include that in the message for fear of
generate the sort of cost savings we were talkinglengthening it further.
about, to reduce medical errors and so on, for which
there is considerable potential.Q467 Jim Dowd: Because that would cost them a
further 49p! We are actually talking about the kind
Q470 Charlotte Atkins: But the contract was agreedof charges for incoming calls that people were
when, in 2000?desperate to pay 10 or 15 years ago in the early days
Mr Lewis: The contracts were specified in 2000, yes.of mobile technology, but I will put that to one side.
I am sure it is diYcult to estimate, but what
Q471 Charlotte Atkins: So presumably technologyproportion of inpatients take advantage of your
has now moved on and you presumably have stageservices?
two, stage three of your systems which presumably,Mr Lewis: A very high proportion do.
given that the cost of computers and otherApproximately 70% of the terminals we have at the
technology is coming down, are not as expensive asbedside at any one time have a patient registered to
they were back in 2000?them and about half of those on any one day will be
Mr Lewis: The actual capital cost is very similar.paying for a service or people will be paying to call
Technology has moved on and it has become slightlythem. The other half will be making use of the free
more sophisticated but the core costs, which are inservices, radio, television, if they are children or have
designing the physical hardware that goes in at thespecial needs, or may not be using the service on that
bedside and all the cabling, have not changedparticular day, so it does have a very high level of
significantly in that period.usage.
Q468 Charlotte Atkins: You have said here that the Q472 Charlotte Atkins: And as to the people who are
being exploited eVectively when they ring in, are youinstallation costs are something up to £2,000. Given
the changes in technology, is there the opportunity doing any sort of analysis about what sort of people
are facing these huge charges, because it seems to mefor these costs to come down? It seems to me that
you have got something a bit like a white elephant in that the people who are more likely to use the system
are the ones who cannot visit the relative, who aremany situations because the full range of services
which are provided in these units are not being ringing in as a substitute for a visit, and therefore my
instinct tells me that the people who face these highexploited, so people are having to pay the cost of
more than actually ringing Australia to access a charges are more likely to be the people who are less
likely to be able to aVord them?friend or relative in hospital, and I speak with
experience here, having ended up with a charge of Mr Lewis: The evidence we have is anecdotal but it
is that the people who use the service to call in do£60 when a member of my family used your service.
It seems to me that they are paying for something cover a very wide range of both friends and relatives.
They certainly do include those who are on lowerwhich is not being fully exploited.
Mr Lewis: I think the answer to that is that they are incomes and those who may not be able to make the
trip into hospital and for whom it is an importantnot white elephants by any means. In fact our
technology is regarded outside the UK as being means of contact, and I think that is a further
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compelling reason for the need to change the Mr Lewis: A number of hospitals have also asked us
to provide access to a variety of diVerentstructure of the provision of these services to enable
a reduction in those charges. information sources that they have quality control
over, which may indeed include NHS Direct online.
Q473 Charlotte Atkins: And also, of course, because Q478 Dr Taylor: I shall be very well informedthe charges come on your normal phone bill, it is because I am going to visit one of the hospitals in thequite likely that complaints will not be made direct recess. Coming back to Gill and going back toto yourselves because it is just a nasty shock when prescription charges, could you tell us again what
your quarterly bill comes through the door. the piece of paper you have handed over tells us?
Mr Lewis: That is true and that is one of the reasons Dame Gill Morgan: There was a Commonwealth
why the NHS has insisted and we have wanted to Fund survey of five diVerent countries in 2002 that
make sure there is a warning at the beginning of asked the question had you ever not cashed a
every call so that there is less risk of there being an prescription or not had dental treatment, and a
unpleasant shock when callers receive their bill, but whole range of things, and it just showed that in the
it is an inherent problem with this type of service. UK we had some people who had not done things
because of money but it gives a comparator
internationally.Q474 Charlotte Atkins: We all know that if you are
ringing someone whom you are very worried about
Q479 Dr Taylor: So it does give us a bit of fact?the likelihood of you listening very closely to that
Dame Gill Morgan: It gives you a bit of fact, yes.particular warning message is not going to be great.
Mr Lewis: We do have five to six million people who
Q480 Dr Taylor: We have heard rumours that therecall using Patientline systems each year and the
are problems with free prescriptions in A&E.proportion of those who get an unpleasant shock
Dame Gill Morgan: I have not heard anything aboutwhen they receive their telephone bill and are
problems with free prescriptions in A&E.unaware of what they are being charged is quite
small.
Q481 Dr Taylor: One really important argument in
favour of abolition to me seems to be that with the
Q475 Charlotte Atkins: Thank you. Gill, did you greater shift of patients from inpatient care to
want to come in? outpatient care and care in the community, even
Dame Gill Morgan: Quite a few of those complaints chemotherapy for cancers and things like that, some
that come do come to individual organisations and very deserving patients are losing the free
it is one of the strands in hospitals, complaints about prescriptions from hospital care and are having to
the charges when the bill comes in. There are a pick them up with outpatient care. Is that not going
number of reasons why the NHS is not getting the against the whole of the White Paper’s aim and is
functionality. The first is that when Patientline that not an extra strong reason for abolition?
started it was an orphan project. It was an idea about Dame Gill Morgan: It depends. There are diVerent
improving accessibility for patients and linking into ways of funding those. What a significant number of
things but I do not think at the time, in the way that hospitals do is buy the package which provides the
it was introduced into the NHS, anyone had begun free prescription and the home therapy so that
to grasp these other functionalities. Where the NHS people are still treated as an outreach from hospital,
is now is that it is not quite ready to get these inwhich case those drugs are not charged through an
functionalities because they really do depend, as NHS prescription. It is provided in the same way it
Richard has pointed out, on having some of would be provided if you were admitted as an
the functionality from Connecting for Health inpatient on that oncology ward.
universally available. That is why projects like
Chelsea and Westminster, which are showing how Q482 Dr Taylor: Is that widely known?
you can begin to link these things together, saving Dame Gill Morgan: It varies from drug to drug.
staV time, giving patients much more information Obviously, if it is a drug that you can take orally then
about themselves, giving much more information you may be in a diVerent position, but what we are
about individual conditions, are the model for the trying to do is take more of the infusions of cancer
future. I think things will change but you have to drugs into people’s homes because if you are feeling
have something to link that system in and that is not pretty rotten, you are feeling pretty sick, you are
yet available uniformly across every hospital in the better oV feeling pretty rotten and sick in your own
country. home and having care provided in your own home,
but it is outreach.
Q476 Dr Taylor: Can they look up on Google all
Q483 Dr Taylor: It was oral agents I was talkingabout their illness while they are lying in bed?
about because there are more and moreMr Lewis: They can indeed. We provide internet
chemotherapy agents transferring from intravenousaccess.
to oral.
Dame Gill Morgan: Yes, but you are again in the
Q477 Dr Taylor: Internet access as well? position that if you are going to do that, and
particularly through a GP’s prescription, the GP hasDame Gill Morgan: Yes.
3312492003 Page Type [E] 11-07-06 20:48:22 Pag Table: COENEW PPSysB Unit: PAG3
Ev 70 Health Committee: Evidence
9 February 2006 Mr Derek Lewis, Dame Gill Morgan and Ms Maggie Elliot
to feel comfortable and competent about using those been done show that 88% of patients really love these
things, and certainly have found the availability of adrugs, and therefore it depends whatever shared
protocols are developed locally. For many of the bedside personal phone of great benefit to them.
There is very high patient satisfaction and, you aremore complicated drugs I think it is quite
appropriate if GPs say, “We are not prepared to be quite right: this is a problem outside the hospital and
for relatives rather than for patients. The patientspart of a share-care protocol”, and therefore the care
is still provided as hospital care even though it is like it and value it.
provided on an outpatient basis.
Q488 Chairman: Could I move on to this issue we
Q484 Dr Taylor: Correct me if I am wrong but if a were talking about earlier on the change in
consultant gives an outpatient prescription to an treatment, the acute sector coming out into the
outpatient, that still calls for a charge, does it not? community in terms of people’s homes? The other
Dame Gill Morgan: It depends on how it is change in pattern that we have had very much in the
prescribed. A lot of outpatient prescriptions are still last few years is people going in now for things like
taken within the hospital and people still come in to day surgery or even for day chemotherapy treatment
take some of the therapy. If they are on continuous where at one time they would have been an inpatient.
oral treatment that would be prescribed as a script With regard to travel costs, do you feel that there is
either by the consultant or by the GP who will a burden there because of the changing pattern of
continue that. There is a range, depending on treatment that people have in the Health Service?
whether it an oral type of therapy or whether it is Dame Gill Morgan: Again, we have never surveyed
maintenance. It is much more complicated because our members about it but I can talk about a personal
where in the system you will come depends on the position, which is that certainly, when we looked at
drug, the disease, the stage and a whole set of things. travel costs in a health authority I was involved in,
we exempted people who had to come for
chemotherapy, for renal dialysis or for repeatedQ485 Dr Taylor: So do you not think the Welsh
issues. There were no patient transport charges forAssembly is right to aim to abolish prescription
any of those patients and there were also no carcharges entirely as this is raising extra
parking charges for those patients because it wascomplications?
recognised that those things were a great burden ifDame Gill Morgan: Again, this is a personal view; I
you were routinely coming to a hospital or needinghave never tested it with the members, but my
care, which is quite diVerent than if you go once inpersonal view is that if we did not have prescription
a while.charges that would help because we have some costs.
The downside of that is that we would have to find
some way of getting that money into the NHS in Q489 Chairman: In terms of the assistance people
some other way and then you have got a political can get with travel costs, are you happy that people
debate about whether it should be taxation based. get to know about these schemes or with the take-up
Dr Taylor: I am not asking now but could we have a of these schemes?
written note of other ways of raising £450 million? Dame Gill Morgan: Yes. Certainly one of the most
interesting debates which generated most discussion
at a local level was about patient transport becauseQ486 Chairman: Last week’s answer was general
patients were very well aware of the issues. It istaxation by most of the witnesses. We are not at that
widely advertised in the majority of hospitals.stage of the inquiry.
Again, I do not think we have been quite asDame Gill Morgan: Exactly.
imaginative about patient transport as a service asJim Dowd: Could you give us the next set of lottery
we might have been, so one of the things that somenumbers as well?
authorities have done is get joint agreements with
local government because local government areQ487 Chairman: I would just like to say one thing on
paying for lots of patient transport, particularly towhat you have said about this issue that inpatients
bring children into special schools and things likenormally would not pay for any charges, and that is
that, and in many places there is no connectionthe potential inequity. I asked this question last week
between the transport plans of all the diVerentand it did not seem that it was true, that people can
organisations, so you have vehicles sitting unusedbe discharged from hospital with a month’s supply
during the day somewhere but another service isof something where other people would have to pay
using them elsewhere. Quite a lot of healthor they would have to pay in diVerent circumstances.
organisations, particularly in rural areas, haveIs that inequitable, do you think? I know it is people
funded co-ordination schemes jointly with localbeing kind but is it inequitable?
government to begin to look at how you get a muchDame Gill Morgan: It probably is inequitable but
more sensible use of something which is veryyou would have to look at what the conditions and
important in rural areas.the types of reasons were and I have no knowledge
aboutwhowould get a month’s prescription free and
who would not, so I would only be guessing. I have Q490 Chairman: Should hospitals be encouraged to
see car parking as a means of raising revenue?not got any evidence on that. One thing I should also
say about Patientline, because I do think it is Dame Gill Morgan: I understand why hospitals have
gone down that route. Very many hospitals haveimportant to look at the other bit, which is what the
patients say about this, is that the surveys that have gone down that route because they are centrally sited
3312492003 Page Type [O] 11-07-06 20:48:22 Pag Table: COENEW PPSysB Unit: PAG3
Health Committee: Evidence Ev 71
9 February 2006 Mr Derek Lewis, Dame Gill Morgan and Ms Maggie Elliot
and, as you have picked up in one of your other car parking spaces because of the impact on roads. I
have even heard councillors say things like, “Wediscussions, large numbers of people on the street
use hospital car parks to avoid paying council cannot possibly have extra car parking spaces
because it will encouragemore people to travel to thecharges. I think we are at a point of real change
because if you look at why patients choose hospitals, hospital”, and I have sat on the other side of the desk
saying, “Actually, we want people to come to theuniformly towards the top of the list is car parking,
so I am now aware of a number of hospitals which hospital when they need the treatment”. There is
another side to this, which is that in many hospitalsare not only reducing their car parking costs and fees
but are also taking their staV out to park and ride car parking places are in real shortage and a scarce
amenity, which is why people are looking at oV-schemes so that the whole of the car parking on site,
other than for night staV or unsocial hours, is placing their staV and having park and ride schemes.
There are now some interesting models of peopleavailable to patients. If you want to market your
hospital the things that patients will go on is who are thinking of new ways of putting in multi-
storey car parks which are actually very cheap inaccessibility, car parking and availability, and then
one or two clinical indicators, but it is the car capital terms and very safe, but it would boost the
car parking availability for patients, and I think weparking which is the biggest drive. I think we are
going to see a change and more hospitals making car will see more drives to get those sorts of issues in,
which will bring some conflict in terms of planningparking free because that will be a competitive edge
for them. I think we are at a point now where we are rules.
going to see a significant change.
Q493 Mr Amess: I think you have probably already
answered the question, but obviously it is very toughQ491 Jim Dowd: Representing an inner London
seat, as I do, even there the issue of car parking is on patients who have to go back regularly for
treatment. Could you just articulate what the case isimportant though the transport links to, say,
Lewisham or King’s are very good. At Lewisham for a voucher system?
Dame Gill Morgan: I am aware of hospitals wherethere was a period when it was free and it was being
used by commuters from Kent to access Catford and people going for chemotherapy or renal treatment
have special car parks with barriers and they issue athen coming here. This is my point: if we remove
charges how do you stop (a) that recurring or (b) all card for people to come in so that you actually have
the access for the treatment. I think again that thatthe spaces being consumed by staV?
Dame Gill Morgan: Exactly, and that is why some of is a sort of interim stage between completely moving
to a complex administrative system and charges, andthe charges have come in. What you would have to
do is have some system for people who are recurrent. people already do that sort of thing but it varies
because every organisation will be in a diVerentYou could issue a pass when an outpatient invitation
was sent. There are ways you can begin to think context in the environment and therefore what you
might want to do in an inner city area is going to beabout handling it diVerently, but most people are
not yet at the stage of thinking about that because fundamentally diVerent from what you might want
to do in a rural area.they are not yet thinking, “What are we going to do
to get the competitive advantage?”. Once that is on
the agenda, as it already is for foundation trusts, I Q494 Mr Amess: In addition to the midwifery
think you are going to see a massive change in car service apparently a dermatology clinic will soon be
parking. opened by Harrogate District NHS Foundation
Trust. NHS patients will be able to pay the trust to
remove moles and warts, to screen moles or—and IQ492 Jim Dowd: So what you are saying is that if
you just abandoned car parking charges and left it as think this is very interesting—to have Botox
injections to reduce heavy sweating. Perhaps thea free-for-all that would have no administrative cost,
whereas if you abandoned charges but still had a Labour leader would take advantage of thatwhen he
takes oV his jacket. Can you think of any extra non-managed system that would just add to the
overheads of the trust, would it not? clinical services that might be made available in
hospitals in the future? Are we going to be sittingDame Gill Morgan: Indeed, but if it gives you a
competitive advantage, and that is why I am linking round having a se´ance?
Dame Gill Morgan: That one I think is very simple.it with patient choice and people choosing where to
go, that is oVset by extra patients who will come to That is a private service providing the things that
NHS patients no longer have access to because mostyou, because knowing they have got guaranteed car
parking when they come, and patients go to organisations have reduced the availability of purely
cosmetic therapy.What the hospital is doing is fillinghospitals when they are ill, is going to be a massive
competitive advantage for organisations, much a niche and providing a competitive private service
for patients who just want to come to the hospital.more direct and understandable than any other
clinical indicators that hospitals will present. It will In terms of other things you might want to charge
for, the sorts of things I think people might bebe car parking right up there, I think. The other issue
which I think is really interesting about car parking interested in, if you assume that the NHS has to
provide treatment and therapies that work and haveand why a lot of organisations have had to charge
for car parking is that in a number of cities in been demonstrated to work, and this will be
contentious and we will probably get moreparticular there have been planning rules which have
not allowed hospitals to build or to have suYcient comments about this than the rest of the things I
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have said, you might want to say complementary the problems we have with alcohol but it is those
sorts of extra things, you could say. In the Statestherapies. There is no evidence for the majority of
complementary therapies. Therefore you could very they call it jacuzzi competition because a lot of the
hospitals compete by having en-suite jacuzzis whichwell see people oVering complementary therapies
and charging for them within an NHS setting. The are better than the en-suite showers and you get into
that sort of thing which people start to charge for,reality is that for things like cancer therapy, HIV
care, a lot of those services already provide which are not clinical and they do not impact on the
clinical care you get. That is the sort of area I thinkcomplementary therapy as part of an overall holistic
package for people, and you could see that you people will be looking at.
Mr Amess: Thank you. That is very interesting.might want to oVer that sort of thing. The other
opportunity I think is around things like hotel type Chairman: I would like to thank you all and
particularly you, Maggie, for answering ourfacilities. If you went to the private sector you would
be oVered awine list, a better menu.You could begin questions earlier and helping us in this inquiry, and
hopefully in the next few months we will have anto see charges being raised in that sort of way, none
of which would actually impact on the clinical care inquiry so that you can see if your evidence this
morning has influenced us in any way. We will haveof other people. I think it would be very diYcult to
oVer a wine list within an NHS hospital because of to wait and see about these issues. Thank you.
Witnesses: Mr Bernie Hurn, Research and Strategy Manager, Simplyhealth Group Ltd (previously HSA
Group), and Mr Michael Hall, Chief Executive, Standard Life, gave evidence.
Q495 Chairman: Thank you very much for coming. Mr Hall: As far as the private medical insurance
market is concerned, there are just over 3.6 millionCould I first of all apologise for the lateness of the
subscribers to private medical insurance, but thosehour. We were expecting to be into this third session
3.6 million cover a total of over 6.5 million lives, 6.57a little earlier. For the record I wonder if you could
million to be precise, which equates to about 11% ofgive me your names and the organisations you are
the total population. In terms of charges, my view isfrom.
that because charges have been developed in a fairlyMr Hurn: My name is Bernie Hurn. I am the
piecemeal fashion over the course of the last 50 yearsResearch and Strategy Manager for the
I do not think they pass the test of fairness andSimplyhealth Group, formerly known as HSA.
equity. When I retire my understanding is that I willMr Hall: My name is Mike Hall. I am the Chief
become entitled to free prescriptions. I do not thinkExecutive of Standard Life Healthcare and, just for
that passes that test. I would be more than happy tothe information of the Committee, you can probably
pay for my prescriptions if that meant that thetell from the lines on my forehead that I have had 30
money I am paying goes back into the NHS to payyears’ experience in healthcare, 12 of which were in
for other people in a less privileged position than I.the NHS and nine of which have been in the private
I think that fairness and equity test is diYcult now tohospital sector before moving to the insurance side.
prove. There is evidence to the contrary, and I think
it is diYcult for people now to understand the range
Q496 Chairman: Once again, thanks for coming of charges that are now made because they
along. I wonder if I could ask both of you what are themselves have not chosen to pay for those; they
the major problems that people experience with have been decided elsewhere. The success of our
NHS charges andwhat proportion of the population business is made up of providing services, obviously
is covered by insurance that helps them to access at a charge, that people want to buy and our
NHS provided services? evidence suggests that there is a willingness by
Mr Hurn: It is a substantial proportion of the people to pay charges. They may not necessarily be
population, in the sense that today are represented the ones that are currently charged for.
here by private medical insurance, cash plans,
complementary products and so on. About six and Q498 Chairman: Would you, for instance,
a half million people industry-wide are covered by compensate somebody if they had prescription
cash plans and an even larger figure by private charges or glasses charges under your scheme?
medical insurance. It is in excess of 10 million people Mr Hall: We would not, no.
today and Simplyhealth represent about two and a
half million lives as a mutual organisation which in
Q499 Chairman: But you would, Mr Hurn?essence has a public concern in that regard. What we
Mr Hurn: We do indeed, and that is 73% of what werepresent is predominantly blue collar workers and
pay out across the cash plan industry but, becausethese people have issues in the cash flow impacts of
we are also the largest representation within thatcharges on their monthly cash flow and what we
group, we are indicative of the industry standard.provide is a tool for smoothing that out and enabling
About 73% of what we pay back is directly related tothem to access NHS services and services
NHS charges, that is, dental, optical, hospitalsurrounding that.
inpatient stay. The rest of that is made up in what we
call POCAH, which is physiotherapy, osteopathy,
chiropractic, acupuncture and homeopathy,Q497 Chairman: Mr Hall?
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something that the previous speakers alluded to. with an en suite because they knew they were going
Those are services that people choose to access to be there for some time. Given the choice most of
which they take responsibility for and we help them our customers would rather not spend any more
to access those services as well. What we look at is time in any hospital than they absolutely need to, so
what the NHS provides, what the major impact of being able to be treated quickly and eYciently with
that is and also, being a mutual, we are driven by good outcomes, either on an outpatient basis or as a
what our members need to create a format for access day case, is a preference.
to the rest of those services.
Q503 Chairman: In the medium to long term is that
Q500 Chairman: Being a mutual, do you see trends a threat to your business?
in terms of the money that you are paying out for Mr Hurn: No.NHS charges? Are they reducing, are they Mr Hall: No, not at all. In fact, if anything, if theincreasing? Are there any diVerentials that you move is towards more cost eVective treatment in ameasure now when 10 years ago it was not like that? more appropriate setting, then obviously theMr Hurn: Cash plans pre-date the NHS and have premiums we charge for access to that may be lower.been in existence since 1922, some of them since
1895, so the premise for paying charges has existed
for a very long period of time. What we see is that Q504 Charlotte Atkins: Mr Hurn, we were looking
as Government policy is changing and NHS at your evidence and obviously you say that
behaviours are changing the needs of our members payments should be aVordable to all. You
and their claims behaviour changes. I will give you a recommend a broadening of charges or the
couple of examples. One is dentistry and another one establishment of an aVordable shared responsibility
is that, just over a year ago when the four hours in premise-based charge. I am not quite sure what that
A&E targets were introduced and people were being means. Can you extrapolate for me?
admitted to the ward, we saw a corresponding Mr Hurn: If you put it in the context of what we do,
increase in hospital inpatient stay. What we paid for we have people contributing to a fund of money and
traditionally was when people used to have loss of these are people who are employed and who tend to
income but these days it covers not only loss of be blue collared workers. People have access to that
income but also a number of the other charges that fund on pre-agreed terms and therefore what they
have been spoken about—telephone charges, car have access to they have full knowledge of and it is
parking charges, so we help to mitigate the impact of clear and easy to understand. This is not only driven
those costs. by our values but also by the FSA, whereby we have
to be fair and open to our customers, so therefore
Q501 Chairman: Do you expect, with this concept of they know and realise the implications of them
out-of-hospital care, to see changes in that way, that making a claim, not only as to what they are entitled
people will not be staying in hospital as long, or to but also as to the impact on the rest of the group.
indeed may not even be going in in a few years’ time They therefore have an understanding that there are
compared to five years ago? not unlimited funds, that this is not open-ended, and
Mr Hurn: I think there is a diVerence there in that we an understanding of what they are entitled to as a
pay for the event, not necessarily the location. We do form of responsibility to the rest of the group who
have a hospital inpatient stay plan but we also have are contributing to that. I do think that sometimes
outpatients and day surgery, so whatever the public perception of what the NHS entitles them to,
location of that service is we will still pay for the of what the open-ended cost would be, is misguided,
event. We pay for what the member needs, so especially looking at future funding of the NHS and
whenever the member accesses that within an NHS extra services being provided. It is not open-ended.
trust setting or at home or in a GP surgery, whatever There must be a realisation by people that there is
the case may be in the future, we will still pay for only so much money that we can utilise in one way
those. EVectively what we will see is a change of or another. I think it is part education but it is also
location but not necessarily a huge change in part understanding of their behaviour that needs to
behaviour. be brought to people’s attention.
Mr Hall: My experience is that we have seen average
length of stay in hospital change quite dramatically
over the last decade or so from probably seven and a Q505 Charlotte Atkins: So you would very much
half to eight days, if we go back about 15 years, now favour keeping NHS charges and not going to a fully
down to about two and a half days and that is funded system out of general taxation?
predicated by the growth in outpatient treatment Mr Hurn: We think there is an existing premise for
and day case surgery. NHS charges and, as I have said, charges pre-date
the NHS, but I do think we ought to look at
mitigating the impact of those charges because thereQ502 Chairman: Do you think that there is going to
are a number of people in society who do presentlybe any major change as far as your insuring the
find themselves hugely impacted by charges becausepatient side is concerned in the future with the
they are not on certain benefits but they are not topproposed changes that are about to take place?
earners in society and therefore £189 for dentistry,Mr Hall: Yes, I suspect so. Originally, because
for instance, canmake a tremendous impact on thempeople were hospitalised for longer periods, there
was an expectation that they wanted a private room come the end of the month.
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Q506 Charlotte Atkins: Would you like to make a Q511 Jim Dowd: Let us clarify that. The truth of the
matter is that we all pay for healthcare. The questioncomment, Mr Hall?
Mr Hall: The issue for us goes back to the customer is, by which route. Are you saying that survey was
your policy holders or the general public?or, in the case of the NHS, the patient. Our view is
that we should conduct research amongst the Mr Hall: The general public.
customer base, the general public. We know from
research we have done that the majority of a cross-
Q512 Jim Dowd: Just so that I am perfectly clearsection of people we researched, and that is the
about this, is it a variation on the theme that peoplegeneral public, not our customers, favoured
actually value more things they pay for rather thancharging as a means of accessing better quality
things that they get, ostensibly, for nothing?healthcare. There is a strong vote in favour of paying
Mr Hall: I think that is a truism in life generally. Onecharges. Only 25% of them thought that taxation
of the issues that I believe exists is that there is nowas the best way to do it so more than double that
notion of value currently.believed that having control of paying charges
themselves was a better solution. The issue is that
no-one actually knows what the public would value Q513 Jim Dowd: Why? Because the service is free at
in terms of charges, which services they would pay the point of use?
for and under what circumstances. Our view is that Mr Hall: Yes. That is not an argument to say it
any charges should be tapered. To have a position should not be; it is an argument to say that people
where there is a very fine line between when you pay should have the notion of value, so when we
and when you do not pay does not seem equitable to reimburse our customers’ costs, even though they do
us either, so our view is that it should be tapered not pay, we do send them a copy of the bill so that
according to their income and their situation. It they understand the value of the healthcare they
should not just be that you pay 100% or you pay have consumed. We have done separate research to
nothing. try and ascertain the extent to which the public do
understand the costs of healthcare, not just ours but
Q507 Mr Campbell: In the survey that you took of in the NHS as well, and that would seem strongly to
the general public, are we looking at a case of, “I am indicate that there is no notion of value. I think only
prepared to pay if I can get in quickly and get my about one in 10 of the people we surveyed had
operation before everybody else”? anywhere close to the cost in the NHS of doing a hip
Mr Hall: It was not the question we asked them. replacement, for example. Most of those other nine
were woefully low in their estimation of the total
resource cost of providing that service. I think thatQ508 Mr Campbell: Why did you not ask them that
is a problem. It is a problem that we are consumingbecause that does happen when you are paying? If
something that we have no good notion of valuesomebody asked me that I would say, “Yes, I will
about.pay for it if I can get in quick”, because people have
to wait a long time.
Mr Hall: That may well be true, that that was the
Q514 Dr Taylor: I was going to ask you what sortsmotivation for some people’s answers to would they
of things the public would be prepared to pay for butcontribute.
you have said you cannot answer that. Is one of your
ideas of the open public consultation you mention in
Q509 Mr Campbell: I am sure it was. your memorandum to get at just that, what people
Mr Hall: But that is my point, I think, about asking would be prepared to pay for?
them what services under what conditions they Mr Hall: Absolutely. We are a strong advocate for
would pay for, and if a more timely service was having a system by which the public can contribute
something that people would contribute to, thus themselves to the debate in saying, “These are the
raising money within the NHS to pay for improved things Iwould value, these are the things I would pay
services for everyone, that would seem to me to for”. It must be a better system to have people
be a fairly equitable way of distributing those contributing to the things that they think make a
contributions. diVerence and that they would personally value
rather than the current system, as I said before,
Q510 Mr Campbell: What you are saying there which has been developed in a piecemeal way, which
though is that they who can pay get it done and they people do not understand and which lacks that
who cannot have to wait and hope they get the element of equity.
money out to get them there.
Mr Hall: The question we asked them was how they
Q515 Dr Taylor: You mentioned that chargeswould want the issue of increasing healthcare costs
should be tapered. Would that be on a means testedto be dealt with, so it was in the context of a
method or how would that be?recognition that the cost of healthcare generally was
Mr Hall: I am not an expert in terms of how oneincreasing. As I say, over half of them answered in
would taper it but it does not seem logical to me thatthe positive, that they would deal with the increased
I could get free prescriptions and somebody else on acosts of healthcare by making personal
lower income, simply because they were not retired,contributions. It was the increased costs of
could not. Likewise, it would not seem logical to mehealthcare per se rather than the issue of waiting
times or waiting lists. that somebody who was unemployed could get
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access to services at no charge, yet somebody on a Mr Hall: I suspect that it is inescapable that, because
of the demands on healthcare and the increasinglow wage would have to pay the full charge rather
than only part of the charge. costs of delivering healthcare, charging will be with
us. At the moment my understanding is that current
charges accrue at something like just over a billion
Q516 Dr Taylor: This point has been made to us by pounds a year. That is obviously a significant sum of
many people. Health savings accounts: are these one money and with the changing demographics of this
of your ideas and, if so, could you tell us a little country and the growing elderly population I think
about them? I am right in saying that in the next 25 years the
Mr Hall: Yes. It is premised on a number of things. number of people over 70 is going to increase by
The first one is that we tend to have been a society 70%. That is a fairly frightening statistic and that
fixated on delivering the results of ill health rather debate has already started in terms of pensions but
than focusing on the benefits of good health. I do not is probably under-discussed publicly in terms of the
think we have a society where health and wellbeing impact on healthcare. I do believe that charging in
play enough of a prominent role. I think it makes some way, shape or form, which retains those
sense to find ways to incentivise people to take more elements of fairness and equity, will be with us in the
responsibility for their own health and wellbeing, long term. I think that is likely to increase rather
and that is easier said than done, of course. One of than reduce, and therefore I think more innovative
those ways, we are suggesting, could be through the ways of identifying what should be charged for and
notion of the health savings account, a tax eYcient having a mix of other companies, whether they be
way, in the same way that cash ISAs are a tax not-for-profit companies or commercial private
eYcient way of saving, that could be used in part or sector companies making provisions in those areas,
in whole to contribute either to the consumption of is a reality.
healthcare that is charged for or for other health
related services that are deemed by the Department
Q519 Anne Milton: It makes it more likely?of Health or the Government to be beneficial to
Mr Hall: Yes.health and wellbeing. Whether that is gym
membership, whether that is diet or other elements
Q520 Anne Milton: Mr Hurn?of exercise is not my area of expertise, but it is the
Mr Hurn: I would concur, that there is a likelihoodnotion of encouraging people to save and to spend
of charges coming in and that we find at the momentfrom those tax eYcient savings in that way. We also
that the NHS reforms have seen an increase inconsidered the concept of a health incentive card. In
demand. The King’s Fund this morning said we arethe same way that commercial enterprises use cards
spending more money but we are not necessarilyfor loyalty schemes why should it not be that you
seeing a return on investment. People are going tocould earn points on, for example, buying fruit and
increase demand and they have also got an increasedvegetables? That would attract points, and maybe
expectation of what the NHS can deliver. Whethergym membership would attract points or other
that is sustainable or not is probably not for thisthings deemed to be contributing to health and
debate but poses the question then: if people want itwellbeing could earn points that could be redeemed
but it is not available on the NHS would they beeither in terms of the health savings account as a cash
willing to pay for an extra service, an NHS-plusincentive to that account or in some other way. I
service? I do think, in view of foundation truststhink at the moment there is a complete lack of
having to generate an income, having to competeincentive to address the issue of health and wellbeing
against practice-based commissioning, that there isor saving against the costs of healthcare.
a high likelihood of charges coming in.
Q517 Jim Dowd: Would you get your card taken oV
Q521 Anne Milton: So, on the premise that theyou for going to McDonald’s?
demand for healthcare is infinite, which it probablyMr Hall: No, but you would get points taken oV.
is, with increasing expectations and decreasingChairman: Thank you very much for that, Mr Hall.
tolerance the choices are stark. It is either increasedI am quite interested in that type of concept in terms
general taxation to an infinite level—demand isof a potential lifestyle influence.
infinite—or you charge?
Mr Hall: That would absolutely be my opinion. It is
not just the fact that everybody wants access,Q518 Anne Milton: Mr Hall, the point you raise
about people being unaware of the costs is very valid understandably, to the best quality healthcare but
we are as consumers far better informed now onand the big bee in my bonnet is prescriptions, that if
people were aware how much the tablets in the bottle healthcare than we have probably ever been and the
internet has been one of the main reasons for that. Icost (a) I think it would increase compliance because
it would encourage people to finish the course and know many doctors who find themselves presented
with patients armed with printouts from the internet(b) they would be aware of the huge cost of some
drugs that are prescribed. I wanted to ask you both where they are sometimes better informed than the
doctor in terms of what the latest drug or treatmentabout the White Paper and the use of the private and
not-for-profit sectors and whether you feel that in is. We are seeing a huge change in that. I am sure you
have probably already had evidence about some ofthe light of theWhite Paper and the mention of those
things it is more or less likely that charges will start the pharmaceutical developments and some of the
new classes of drugs that are now starting to becomecreeping in?
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available, of which Herseptin is just one. There are how do you respond to the Government’s avowed
many more in the pipeline and if research shows that intention to put the private healthcare business out
they are as eYcacious as Herseptin is that will of business and what impact would that have on
present even more major challenges to the whole of your business?
this country. It is not just about the NHS but also in Mr Hall: The private healthcare business has been
terms of the aVordability of those drugs and with a around longer than the NHS so I do not know how
growing elderly population, and in that same time realistic it is to assume that we will be out of
period I spoke about the 30–34 age group is going to business, but if we ever do go out of business I do not
shrink, then the balance of people paying tax to believe it will be because of the Government; it will
support those in retirement is going to change and be because of our customers. Our customers keep us
that is why I think taxation alone becomes a solution in business because we deliver products and services
that is in a cul-de-sac. that they want to buy and that seems to me the way
in which the western world works. You stay in
Q522 Chairman: Both of you and other witnesses business for as long as you have products and
have criticised the current NHS charges. I think the services which are valued by the people who
opening shot was that the King’s Fund said they purchase them. 11% of the population value the
were a dog’s dinner in terms of how they are at the services that we oVer. We give people choice and
moment. You were asked earlier to tempt into areas people exercise that choice and they have done for
where maybe charging should be expanded or be the last 50-plus years.
made more equitable and that leads on from what
you have just said. Are there any areas where you
would care to speculate on, say, what NHS charges Q525 Jim Dowd: Regardless of the levels of
would be like in 10 years’ time in healthcare on performance in the National Health Service?
things that will have charges as opposed to what we Mr Hall: Absolutely. One of the strange things is
know at the moment have charges? that you cannot correlate the number of people
Mr Hall: I would not, actually, and the reason I covered by private medical insurance with the ups
would not is that I do not think I am a representative and downs of the NHS. I worked in the NHS in thesample of the British public because of my 1970s when waiting lists were probably amongst theknowledge. I would most heavily rely on worst that they have ever been and that was duringundertaking that research and that debate on a
a period when private medical insurance saw themuch wider scale. If you fit the charges to things
largest growth, not because of the waiting lists butpeople are willing to pay for and would value that
because of the building of modern private facilitiescould take us anywhere, but if it is what people
where people could get treatment. When thosewould be willing to pay for then I think that makes
hospitals were completed the numbers stayed thecharging acceptable. It is really a question of how
same even when the waiting lists went down, andmuch additional resource our health services will
what we see at the moment are numbers covered byneed in the future, the willingness of people to pay
private medical insurance ever so slightly increasing,for those, how they wish to pay for them and the
very marginally, I have to say, but at a time when weamounts they are willing to pay. Until that research
have seen the biggest decrease in waiting lists. I dois done we will not know whether the equation
not think it is possible to correlate one precisely withbalances out or whether we have a gap.
the other. In fact, they do not correlate. It really does
come down to the perception of the public and theQ523 Chairman: Mr Hurn, do you have a view on
choices that they make.that?
Mr Hurn: We do. It is diYcult speculating into the
future and it is probably not our place to do so, but
Q526 Jim Dowd: Would it be reasonable to assumeit probably comes to stating what a minimum level
that the profile of your policy holders is healthierof treatment would be and then what sits beyond
than the average?that that people would like to have as, again using
Mr Hall: That is a very good question. If you look atthe phrase, an NHS-plus service, in other words that
the socio-economic split of people who have privatethen becomes chargeable and the state would
medical insurance it is probably not what you wouldunderwrite for the catastrophe, for the inability to
expect to see. 18% of the professional employers andaVord, but people who can aVord would then
managers group have private medical insurance. Iproactively look at ways of being able to aVord that.
think most people would probably believe that thatThis is not creating a two-tier system but a basic level
of what is acceptable for everyone but the ability for was an awful lot higher than that. 14% of the self-
people to step up should they want to and should employed have private medical insurance and by
they be able to aVord to. and large the self-employed are sole traders or are
maybe employing one or two other people. If you go
to the unskilled, 6% of those are covered by privateQ524 Jim Dowd: The truth is that in 10 years’ time
medical insurance, most normally through theirthe NHS charging regime will be logical, reasonable,
employer. I would say probably, taking yourrational and understandable because, of course, the
average of the total population, that ours would bebig event between now and then will be the
slightly healthier but probably not by asmuch as onepublication of the report of this Committee which
will deal with it all. Can I just say to Mr Hall first, would imagine.
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Q527 Jim Dowd: But that is not because of anything Mr Hurn: The normal growth in payouts across the
industry when you look at our average claims ratioyou do. It is just a simple fact. Finally, Mr Hurn, are
HSA the same people who are the shirt sponsors of will sit somewhere between 75% and 85%. That
means that most of the money that comes in goesBlackburn Rovers Football Club?
Mr Hurn: They used to be. back out—
Q530 Jim Dowd: No, I am talking about theQ528 Jim Dowd: I do not hold that against you, by
the way. In the note that I have here it says that you annual change.
Mr Hurn: That would be about 6%.paid out claims of approximately £166 million in
2004 and that figure was projected to rise by Chairman: Simplyhealth Group Ltd does not ring a
bell with me but I think HSA does and I and my wifesomething over 20% to £200 million-plus in 2005. Is
the normal rate of growth, above 20%? may be covered by one of your policies. I declare that
right at the end. Can I say to both of you thanks veryMr Hurn: No. We have been through a period of
mergers and acquisitions which has meant that the much indeed for coming along and answering our
questions. It has been a very interesting session oncegroup has grown.
again this morning. All three of the sessions have
been very interesting and hopefully it is going to helpQ529 Jim Dowd: So that is exceptional? What would
be the normal growth in payouts? us to come to some conclusions on this matter.
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Members present:
Mr Kevin Barron, in the Chair
Mr David Amess Mr Ronnie Campbell
Charlotte Atkins Dr Howard Stoate
Mr Paul Burstow Dr Richard Taylor
Witnesses:Mr SeanWilliams,Board Member and Partner forCompetition, andMrDavid Stewart,Director
of Investigations, Ofcom, gave evidence.
Q531 Chairman: Good morning. May I welcome has set up a Patient Power Review Group to work
with providers to provide a better solution andyou to the fourth evidence session we are taking in
relation to our inquiry into the National Health hopefully to address these particular problems.
Service charges. I wonder if I could ask you to
introduce yourselves for the record and tell us the Q533 Chairman: Would it be fair to say that you
positions that you hold. thought it was unfair in the sense that patients’
Mr Williams: Thank you very much, Chairman. I friends and relatives should be subsidising this
am Sean Williams. I am a Board Director of Ofcom. system?
I am also responsible for the competition group in Mr Williams: I would say that we remain concerned
Ofcom, which is where we enforce competition law about the high prices. We think the high prices are,
in the communications markets. I have with me as I say, a result of the way the contracts and the
today my colleague David Stewart, who can arrangements are structured. The concession
introduce himself. agreements and the overall framework agreement
Mr Stewart: My name is David Stewart, I am cap the charges for various services, so it is really a
Ofcom’s Director of Investigations, which means matter for the Department, the NHS and the
that I am responsible for our Competition Law providers to work out the fairest way to recover
Enforcement Team which conducts investigations these costs, I think.
and reaches conclusions on those
Q534 Chairman: Nowadays an enormous number of
people use mobile phones. There are someQ532 Chairman: Thank you very much, again, for
coming. There are no surprises as to why you are allegations made that pressure has been put onto
NHS Trusts to maintain a mobile phone ban withinhere, of course. I would just like to ask you if you
could describe your concerns about the lawfulness their establishments. Would we get rid of this
problem if that sort of ban were lifted?of the contractual arrangements made between
the NHS Trusts and the providers of Mr Williams: I will bring my colleague on this one,
but, in general terms, our findings were that theretelecommunication services to patients. We have
obviously seen your letter to the Secretary of State was nothing in the agreements as such which
prevented in an inappropriate way the use of mobileand understand that you are hoping they are going
to take some action. Could you tell us your views phones. But it is a bit more complicated than that.
Mr Stewart: The agreements between NHS Trustson this?
Mr Williams: Yes, indeed. As I say, Ofcom is the and the providers reflect a general requirement in the
model agreement, which is that there be a provisioncompetition authority in communications markets.
We became aware of the consumer concerns about saying that the hospitals, to the extent that there are
good clinical reasons to do so, will restrict the use ofhigh charges for calls to hospital patients. We
opened an investigation under competition law to mobile phones. That is not a blanket ban on the use
of mobile phones in hospitals, and, amongst othersee whether or not the high charges were the result of
anti-competitive behaviour in breach of competition things, we looked at the way in which in a number of
cases that provision had been given eVect in practice.law. We found in our investigation that they were
not a breach of competition law, and that the high One of the things that is clear to us is that it is not a
simple or straightforward issue: there are clearlyprices which we remain concerned about were the
result of the arrangements put in place by various some very important clinical reasons related not
only to the need to give patients time undisturbedbodies in the Government and the NHS. In
particular they arise, I think, from a combination of during their care but also, more recently, with the
development of camera phones, some issues aroundmatters ofGovernment policy, matters related to the
implementation of that policy by the NHS estates, patient privacy. There are some good reasons why
hospitals should have and do have the right toand by the particular concession agreements and
their terms which the providers have agreed with restrict the use of mobile technology and we have
suggested that one of the roles the Departmentparticular NHS Trusts. While we remain concerned
about the high prices, our view is that it is a matter might play is helping the NHS Trusts to understand
their rights and responsibilities so that an eVectivefor the Government to take into consideration and
is not a matter of breach of competition law in any balance can be struck.
Chairman: Thank you for that.way. Following our investigation the Government
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Q535 Mr Amess: Gentlemen, I might look as if I am back to the Government and back to the
Department. I certainly would not agree with thein splendid isolation on this side this morning, but I
am very much with you. Is that an Australian assessment that we have in any way been involved in
making an assessment, as Sean says, about the policyaccent?
or how it has been implemented. That is certainlyMr Stewart: It is.
not the way we see our remit.Mr Amess: Okay.
Chairman: That one was not in my brief! Carry on,
anyway. Q537 Mr Amess: Thank you for rebutting that. I did
say I would ask two questions, but, as we have a little
bit of time, let us go for a third—and you
Q536 Mr Amess: Gentlemen, it seems to the are Australian: Has Ofcom identified funding
Committee that the fact that you are having the arrangements in other countries for these types of
review is pointing directly towards National Health systems that avoid high incoming-call charges? If so,
Service incompetence. I wonder if you could answer could you help the Committee and tell us where
that charge. The other thing I wanted to put to you these examples are?
is this: In your report you blamed high incoming call Mr Williams: At a high level we are aware that there
prices on “a complex web of Government policy”. are alternative bases for recovering the costs of
That is a marvellous expression. Could you also the investment necessarily to roll out bedside
enlarge on this complex web of Government policy? communications units. I do not know whether my
Mr Williams: The complex web really has three colleague has any further information on that.
kinds of component. The first level is Government Mr Stewart: The biggest single diVerence is between
policy, the Patient Power Programme and the those countries where hospitals decide to undertake
aspiration in Government policy to roll out bedside the capital cost directly—and therefore are not
communications on a national basis to all bedsides. simply recovering the capital cost of these systems
There is then the second level, which is the NHS purely on a particular group of users, in the way that
Trust licence, national licenses or framework applies in the UK.We know from evidencewhich we
agreements, which then implement that intention by gathered in our investigation of a number of
means of a framework agreement that specifies the countries where that is the case—
kinds of services, the functionality of these beside
communications units, the prices that have to be
Q538 Mr Amess: Where are these countries?observed or the caps on the prices that have to be
Mr Stewart: Holland and the US, for example, bothobserved. The third level is the specific concession
have systems that are funded, as I understand it, onagreements or contracts that the providers have
that basis.agreed with particular NHS Trusts which then
specify further how the particular charges for the
Q539 Mr Amess: Are they good examples to applyactual services are going to be levied. It is in the
to England?interplay between those three levels of these
Mr Stewart: In a sense, it is a financial trade-oV. Doarrangements that the result is manifest, which
you make an investment directly using public fundsappears to us to be high call prices, particularly for
and secure a benefit that can then be managed alongincoming calls, which, in a sense, are necessary for
with all of the other assets in the hospital?the providers in order to recover the costs of these
rather sophisticated units which they put in at
Q540 Mr Amess: I just wondered. Holland is a tinybedsides. That is, in a sense, what the complexity is
little country andwe are tinywith a huge population.all about. I do not think we are in a position to judge
America has a state system. I am trying to think howwhether or not it is a good implementation of a good
you would apply those two examples.or bad policy intention—that really is a matter for
Mr Williams: I think it is just a matter ofthe Government—but I think it is worth the
Government policy. You can take a view that theproviders and the Government getting together to
cost of these services, which are to provide facilitieswork out whether or not this is the most appropriate
for patients, should be recovered through away to recover the cost of these services.
commercial payment by patients or not. To beMr Stewart: I would add to that. I think it is perhaps
honest, it is not a matter for Ofcom to take auseful to clarify that our role is as a national
judgment on that.competition authority, and one of the things that is
Mr Stewart: To answer the question behind youraxiomatic in looking at someone’s conduct—in this
question: I am not sure what the situation is incase that of the providers—under competition law,
Australia.is that the conduct that is under investigation is
conduct that is unilateral conduct or something for
which, in eVect, they can be held accountable. Once Q541 Dr Taylor: I would like to go on a little bit
you reach the point where it is clear that is not the longer because I too was intrigued by the complex
case, there are a number of other factors; in web. I think really we are discovering that the
particular, when those factors involve Government Government ordered a Rolls Royce with absolutely
policy, then the responsibility of the national every extra, when there was no way all those extras
competition authority is to stand back from using could be used. If you are having the electronic
what in those circumstances is the rather blunt patient record available, when it is not available
instrument of competition law and hand the issue of (because the NHS computer system is so far behind
schedule), they have made Trusts buy a system thathow the various interests are meant to be traded oV
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cannot possibly be used. Is that not right? As we put Mr Williams: That is my understanding.
Mr Stewart: That is right.it to Patientline last week, their message at the
beginning of the phone call should have said,
“Thank you very much for using this service. It is
Q547 Dr Taylor: By the Department of Health.going to cost you 49p but you are helping the NHS
Mr Stewart: That is right, and I believe it is due totowards its aim of having readily available electronic
report in June this year.patient records at the bedside” and Patientline
Dr Taylor: Thank you.agreed. Are we not within our right to condemn the
Department of Health for ordering something as
complex as we have which could not be used? Q548 Chairman: Mr Williams, you said it is really
Mr Williams: I think it is not for Ofcom to make a not for you to comment, and I accept that to some
judgment about the state of the system.We could say extent. Your report was quite hard-hitting. I am
that it is clear to us that it is a highly specified system looking at the letter you sent to the Secretary of
and that it is costly to install and that the State, in which you said, “Currently there is no skip
consequence of the costs and the fact that all those facility enabling repeat callers having to hear the
costs have to be recovered through charges is that same message each time they call. This further raises
consumers will pay higher prices. the cost of each call.” That is pretty tough stuV.
People reading that will think only one thing: that
they are getting ripped oV. In the message thatQ542 Dr Taylor: Right. I would like just to get a bit
Richard just read out, they do not have to listen toof detail. We believe that Chelsea and Westminster
that or pay to listen to it for more than one occasion.are using some of the capability. Can you give us
Would you not say that is right?detail? Are they using all the capability?
Mr Williams: We have remitted to the DepartmentMr Stewart: We are aware of a few cases where there
to consider whether or not a skip facility should beare services being used by hospitals rather than end-
instituted in order to skip that message.users.We did not look in huge detail at this question,
but our understanding is that that relates to issues
like gathering orders for patients’ food and other Q549 Chairman: Technically there is no problem
distribution of information of that kind. I am happy with that.
to come back to the Committee with details, but the Mr Stewart: That is right and we welcome the
other point to make, I guess, is that that is a question commitment on all sides to discuss that issue. We
you might put to them. have pushed in our discussions with them that it be
on the agenda, so we are very pleased that it is.
Chairman: Okay.Q543 Dr Taylor: You would not know about any
other hospitals that are using the service a bit more
fully. Q550 Charlotte Atkins: You have not really found
Mr Stewart: It is certainly not widespread. There are any wrongdoing, as such. How worthwhile was your
a number of instances where it is going on, but it is investigation?
certainly a handful of hospitals. Mr Williams: We have our own statutory duties to
Mr Williams: Again, I think it is really for the look after the interests of citizens and consumers in
providers and the Department to answer that. the communications markets. It was clearly a matter
of public concern that these call prices should be so
high. It was clearly, therefore, appropriate for us toQ544 Dr Taylor: Would you know if the capability
look into the matter and I think it was anwould be there to order pathological investigations,
investigation that was definitely worthwhile. Wex-rays on the system?
invested a certain amount of resource, not untypicalMr Williams: I think you would need to ask the
of such investigations. In this particular instance weother providers in the Department.
found that it was not a matter of the application for
competition law but a matter of Government policy.
It might have turned out otherwise. It is often theQ545 Dr Taylor: Right. Could you see the telecom
system in hospitals developing further? In what way case that we open investigations into matters of
concern and at the outset we do not know what thewould you think it is possible for it to go further—
or is this, for the moment, the ultimate if it were outcome is going to be.
fully used?
Mr Williams: I think it is something that the Patient
Q551 Charlotte Atkins: Any investigation that youPower Review Group will have to work through
do will obviously preclude you doing otherbecause there is now a considerable investment in
investigations if you have limited resources. Wehavebedside communications. They therefore have an
heard from the NHS Confederation that these unitsestablished position and it will be for the providers
are very popular with patients.and the Department to work out how they can best
Mr Williams: Yes, indeed. I think we would endorsebe used and what further functionality and
the view that they provide valued services todevelopments there could be.
patients. All I would say is that I do not think we
have not done something else in our investigations
programme because we have done this. Within theQ546 Dr Taylor: This review group has been
constituted already, has it? discretion we have over what things we should
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investigate and should not, I think we are of the view Mr Williams: It is certainly the case that the issue
about the balance of charges between the diVerentthat we have investigated all those things that we
should have done and this was one of them. users is something that the review group should
look at.Mr Stewart: You are right, of course, to observe that
we do have limited resources, but, as Sean said, you
do not know when you begin an investigation quite Q554 Charlotte Atkins: Especially, presumably, as
where that might lead. You do know that there is an when people are calling in they do not get the shock
issue of consumer concern and that you have a of the overall cost until they get their telephone bill.
responsibility to choose from amongst the issues of Mr Stewart:
consumer concern that you see which issues you
need to explore further. Having crossed that first Q555 Charlotte Atkins: Whereas the patient
hurdle—in other words, having realised that there presumably pays upfront for the use of those calls.
was a reason to suspect an issue of competition law Mr Stewart: That is certainly a common theme
in this case—we then investigated that, but we did so running through the complaints that have been
in a way which I think reflects the fact that, as soon made to Ofcom.
as we were able to reach a conclusion that this was
not one to take further forward, the right thing for Q556 Charlotte Atkins: And you have made
us to do was to package up those findings and hand recommendations to the NHS that something
those issues back to the Department and back to the should be done about the fact that, very often,
providers to see if they could come up with some despite the message—which presumably people do
data solutions. So we have not carried forward the not listen to very carefully—they are not aware they
investigation past the point when it was apparent are going to be charged so hugely for a call to a
that that was the best way forward, and I think we friend or relative in hospital.
are satisfied that that means that the investment of Mr Williams: In a sense, our letter to the Secretary
resources has been that which is necessary eVectively of State is our suggestion that they should look at
to discharge our duties and hopefully make some exactly those kinds of issues.
contribution to a way forward but not an over- Charlotte Atkins: Thank you.
investment. I think the most telling outcome really is
that, as a consequence of our investigation, there is Q557 Chairman: Could I thank you both very muchnow a Patient Power Review Group that will be indeed for coming along and helping us with ourlooking at these issues. inquiry. I have no doubt that we will be reporting on
this in due course—hopefully it will not too longQ552 Charlotte Atkins: The main issue that comes
anyway.out of your investigation is the huge cost of incoming
Mr Williams: Thank you very much, Chairman, forcalls to patients. Would you see that as one of the
the invitation to come along and help you. We areareas which the NHS should be looking at most
very happy to help.acutely?
Mr Stewart: Yes.
Q558 Chairman: Hopefully your investigation is
going to be helpful in the next few months.Q553 Charlotte Atkins: This tax on friends and
relatives having to pay for this extraordinarily
expensive system. Mr Williams: We hope so too.
Witnesses: Rt Hon Jane Kennedy, a Member of the House, Minster of State for Quality and Patient Safety,
MsRosieWinterton, aMember of theHouse,Minister of State forHealth Services, DrFelicityHarvey,Head
of Medicines, Pharmacy and Industry Group, and Mr Ben Dyson, Head ofDental andOphthalmic Services,
Department of Health, gave evidence.
Q559 Chairman: I was going to say welcome back— Q560 Chairman: Thank you very much. Welcome to
I think three of you have been in front of us just a few the fourth session of our investigation into NHS
weeks ago—but good morning anyway. I wonder if charges. You have probably heard this quote on
I could just ask you to introduce yourselves for the many occasions before. Lord Lipsey, the Social
record, please. Market Foundation described NHS charges as a
Mr Dyson: I am Ben Dyson. I am Head of Dental “dog’s dinner lacking any basis in fairness or logic”.
and Ophthalmic Services at the Department of One of the areas, of course, is the issue that the
Health. prescription charges exemptions have not been
Ms Winterton: Rosie Winterton, Minister of State at properly reviewed since 1968. The oYcials told us
the Department of Health. when they came in that this was for historical
Jane Kennedy: Jane Kennedy, Minster of State, reasons, as it were. Does historical inertia justify
Department of Health. maintaining a system that is unfair and clearly is not
Dr Harvey: Felicity Harvey, Head of Medicines, working?Manywitnesses have told us that in the last
Pharmacy and Industry Group within the few weeks.
Department of Health.
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Jane Kennedy: For the avoidance of any doubt on writing, feel the system should not be left alone. If
you are saying that it should be, I have to say thatthis, we are very firmly of the view that charges and
prescription charges are a valuable and legitimate you are in the minority with that view.
Jane Kennedy: Yes. Probably. I have found thesource of revenue for the National Health Service.
We have sought to develop a system in which those preparation for this inquiry, and the requirement, as
you do prepare, to look at the system, very useful.people who can aVord to pay are required to
contribute, but those people who cannot aVord to We will look at the recommendations the Select
Committee brings forward and we will considerpay are exempt—and many other people in fact who
could aVord to pay are also exempt. We know the those carefully, but I get representations from
patients with a whole range of diVerent conditionsway in which prescription charges have arisen—and
you will have heard a lot of evidence about that— who believe they should be exempt from
prescription charges, and if you took that route youand they are part and parcel of the way in which we
manage the health service and they are a valuable would eVectively abolish prescription charges.
Dr Stoate: I appreciate that.source of resources. Probably the areas of exemption
and the changes that we have been making to the
low-income scheme and to the prepayment
Q564 Chairman: On that, Minister, we had a witnesscertificate scheme have been areas in which we have
last week, a young adult now, who is a cystic fibrosisbeen able to help people on the margins.
suVerer. Twenty-five years ago, when the list wasChairman: You will look into that a little bit further.
drawn up about long-term conditions, it would have
been the case that people with cystic fibrosis would
Q561 Dr Stoate: As a brief supplementary on that, not have survived childhood and consequently there
Minister you said that you felt he principle was right would never have been a question of them having to
that people who could aVord to pay should be made pay what are multiple prescription costs for their
to pay—and I do not entirely disagree with that particular condition. It seems completely unfair that
principle—but if that is the case why do they not that particular case has not been reviewed. It seems
simply remove the mildly illogical exemptions for that a system that cannot review that—because
people, for example, with under-active thyroid medical science is moving on—has somethingwrong
compared with those with an over-active thyroid, or with it. But you think it is best left alone.
exemptions for people who need oral medication for Jane Kennedy: If we were to review it and look at the
their diabetes as compared with people who do not medical exemptions—but if wewere to do it from the
need oral medication for their diabetes? If you point of view of staying cost neutral overall—as I
simply want to base it on ability to pay, why have say, youwould have to take some conditions out and
any exemptions at all for those rather arcane put others in, and we have taken the view from the
conditions, which do not bear much relationship to outset, when we first reviewed it, that actually the
modern medicine? contribution that prescription charges makes to
Jane Kennedy: Because to abolish exemptions would the health service is a valuable one. We have
have cost implications. If we were to have a diVerent other priorities that we would rather spend the
set of exemptions, there would be some conditions resource on than giving relief in particular cases
that we may determine were not suitable to be like this.
exempt.
Q565 Dr Stoate: But even were it cost neutral, youQ562 Dr Stoate: Why have exemptions at all? Why
could still come up with a system that wasnot simply reduce the cost, say, to a fiver and remove
considered to be fairer. The suggestion I have made,all the exemptions? At least it would be a level
for example, of reducing the overall prescriptionplaying field for all medical conditions. I am not
charge for each item but removing some of thesaying you should do that but what is wrong with
exemptions, would be cost neutral, but at least itthat?
would be a more level playing field if we are reallyJane Kennedy: We reviewed prescription charges
trying to stick to the principle that those who canthrough the CSR 1998. We looked at the
aVord to pay should pay. At the moment, that is notprescription charging system and, having looked at
the case.it, decided that we would not make changes to it. We
Jane Kennedy: It will be interesting to see what yourwere not the first government to have done that:
formula is, Dr Stoate. We will have a look at that.since they were introduced, they have been looked at
many times, and on each occasion it has been
concluded that, whilst there are anomalies in the Q566 Mr Burstow: Could I pick up on this issue of
system—and we accept that—the system we have is reviews. With the current scheme of exemptions,
probably best left as it is. Therewill always be groups 1968, various written answers that I have seen on
of patients who feel that their condition should be this refer back to theCSR as being one of the reviews
exempt. I hear the point you are making, but every that took place. When the Committee took evidence
time we do that there is a cost implication. from oYcials a few weeks ago, we were rather given
the impression that there had not been a major, if
you like, root and branch examination of the schemeQ563 Dr Stoate: Minister, you said that it is your
view that things should be left alone. You are at all. Can you tell me a little bit more about how
thorough the examination of the scheme was whenprobably fairly unique in thinking that, because all
the witnesses we have heard from, either orally or in the CSR review took place?
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Jane Kennedy: I cannot go into detail but it was clearly think it requires, because we believe that by
doing that we will create as much upset and disquieta serious examination of the scheme. It was
as we would satisfy.determined that, if we were to begin, for example, to
Chairman: That leads very well into our visit lastreview the list of medical exemptions, you would
week to a devolved assembly and what they aregenerate as many losers as winners.
doing and the wonders of having devolved powers inMs Winterton: I can add to that.During the evidence
the United Kingdom now. Richard.it was said that ministers had looked at it, and I did
used to have responsibility for this area. I think,
frankly, that every minister who comes in then gets Q569 Dr Taylor: Thank you very much. We really
the postbags of letters from people saying why can heard exactly the same argument from the people in
this condition, that condition, the other condition CardiV leading to the diametrically opposite
not be added to it? Because medical science has conclusion. Because they told us that any review
changed, and, as you said, Chairman, people with would simply lead to a diVerent set of anomalies and
cystic fibrosis are living longer, and there are other complications—which is really exactly what you
conditions, some cancer conditions, that are almost have said—but from that they took the jump and
long-term conditions now as opposed to killers. It is said the only fair thing to do is to abolish the charges,
something that I think ministers look at. As Jane which they are working on at the moment.
Kennedy has said, one of the issues is that within Obviously it is going to cost them less, but,
that there will always be losers. People who have had proportionately, we worked it out and it is about the
an expectation, and perhaps for 20 or 30 years have same—so their proportion is about the same as the
received medication, if all the exemptions were £450million inEngland. It is very, very hard, I think,
removed would lose that. That is obviously to argue it your way round. You are attacking it at
the margin: prepayment certificates, the low-incomesomething that I am sure the Committee would want
scheme. Do you not really think the only fair thingto consider.
is to abolish and then work desperately on how we
can make the £450 million with a diVerent route?
Q567 Mr Burstow: Just to be clear, it is one thing to Jane Kennedy: Frankly, no, because we have higher
have a look at; it is another thing to issue priorities for the health budget. That is the answer.
instructions to oYcials to come up with workable
options along the lines that Dr Stoate has put
Q570 Dr Taylor: Absolutely.forward that will enable you to make a judgment as
Jane Kennedy: In the end, both the Welsh Assemblyto whether or not there are better ways of achieving
and we have come to similar conclusions, if you like,your objectives than the current 1968 exemption
in terms of the evidence that we have been giving toscheme. Have you done that, and had specific
you, but we have taken diVerent decisions as a resultoptions looked at and costed?
of that. It is a question of how you prioritise and thatMs Winterton: That was, I believe, the 1998 review.
is why the Welsh Assembly have made that decision.Jane Kennedy: As I have said, there are anomalies in
the current system, but it was diYcult to make a case
Q571 Dr Taylor:Another really dramatic suggestionfor removing exemption from one group of patients
they were looking at in Wales was getting a Welsh(however we do it) and extending it to another
national formulary. We have the British Nationalgroup.
Formulary at the moment which is absolutely
superb, but what we need and what they were
Q568 Chairman: What about when somebody has a looking at in Wales is a sort of breakdown of that
long-term condition which they are given a free into the drugs that the NHS would pay for—
prescription for, but then something else in their probably leaving out some of the ones that it would
health crops up—which it could potentially in all of not, because there were perfectly eVective
us—and they get a free prescription for that which alternatives. Could you see anything like that
is nothing to do with their long-term condition? It is happening here, a review to produce a national
formulary of the drugs that would be aVorded byhardly fair, is it?
the NHS?Jane Kennedy: As I have said, there are anomalies
Jane Kennedy: As Rosie says, the National Instituteand it is not the perfect system. I mean, 87% of
for Health and Clinical Excellence performs thatprescriptions are exempt from charges and that has
role for new medicines and for treatments. You areincreased since 1997. The cost of prescriptions has
saying that we should look at the way that thebeen increasing by 10p a year since 1997, and,
national formulary works and use that. It would betherefore, in comparison to inflation, the increases
interesting. I want to think about it.have been much lower than inflation. The numbers
of people who are helped by the low-income scheme
and who now use the prepayment certificate Q572 Dr Taylor: NICE is superb, as fast as it can go
approach are increasing—or, rather, the numbers on new medicines, but really I am looking at
being helped by the low-income scheme are not, but everything that is in the BNF. Should there be a
we believe they are being exempted by other means. limitation on some of those, for which there are
We have been seeking to improve the current system alternatives that are perhaps cheaper?
without going through the wholesale root and Jane Kennedy: I do not know if Felicity has a view
on that.branch review that members of the Committee
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Dr Harvey: I think the BNF includes all licensed charging at all. Certainly, in the dental field, since
1951 there have always been charges for dentaldrugs.
work. We wanted to see a system that was much
simpler. As I say, if you say, “Should we have thisQ573 Dr Taylor: Absolutely.
system at all?” you do then have to look at theDr Harvey: In terms of paying for licensed drugs, a
revenue implications of taking that away, which indoctor, as you well know, can prescribe any licensed
the dental service would be about £600 million.drug and, indeed, any unlicensed drug. In fact, as
Again, as Jane Kennedy has said, when you aresoon as a new drug comes on the market and has
reviewing this, those are the kinds of issues you gobeen licensed, then they can be prescribed. There is
back to. During the course of the review of dentalno wait for reimbursement agreements, because that
charges, we did say, “Well, this is something whichhappens automatically through the PPRS.
has existed for a long time”—and I think successive
governments, frankly, have looked at and decided itQ574 Dr Taylor: I am getting at an examination of
is, in a sense, inbuilt now in these areas. There mightthis very basic right of a doctor to prescribe
be all kinds of reasons why you would considerabsolutely anything that is in the BNF regardless of
taking it away, but you would then have to look atprice if there is a cheaper alternative.
the revenue coming from elsewhere, so, overall, IDr Harvey: I think that has always been a matter of
suppose one would go back to the original 1951clinical freedom based on the clinician’s decision as
decision to introduce it. Once you have got there,to what medication is required for a particular
then the considerations that govern changing thepatient.
system obviously come into play, and some of those
are the amount of revenue that is collected from that.Q575 Dr Taylor: Have we not got to the point,
because the financial problems are so intense in so
Q579 Mr Burstow: To summarise, the reason we aremany places, where this form of health care
doing it is because we have always done it that way.rationing has to be considered?—however politically
Ms Winterton: If you are looking at it and you aredangerous it is.
reviewing it, as we did with the dental charges—andJane Kennedy: I want to give some thought to what
of course it crosses your mind: Do you reverse whatyou are saying. It would be quite a major step.
has been happening for 50 years?—you have to be
realistic and say, “This is something that has gone onQ576 Dr Taylor: I know.
for 50 years. People to a certain extent do accept it.”Jane Kennedy: It would be interesting to see if the
And if you look at comparisons with otherWelsh Assembly finally does take that step. I would
countries, I think we spend more in public money onbe reluctant to consider such a step at this stage, but
dentistry than any other of a comparable nature.I want to think about what the Committee has got
You have to say, given all those circumstances, givento say.
the history, in particular, of dentistry and charging,Dr Taylor: Thank you.
do you want to take it away and find the money from
elsewhere?Q577 Mr Burstow: Before I come on to my question,
with reference to the 1998 review it would be very
Q580 Mr Burstow: Just to expand it beyondhelpful if we could possibly have a note which sets
dentistry, is that the rationalisation of the positionout the options that were considered; the costings, if
that would apply to all of the health care chargesany, that were done; and the conclusions that were
that we currently have within the NHS?reached. We know the main conclusion—the
Ms Winterton: There are those considerations, yes. Iconclusion was not to change it—but it would be
think there are those considerations that if this hasvery helpful., if possible to have a note on that. Is
been something that, as I have said, successivethat okay?
governments have looked at, I am sure—Jane Kennedy: Yes.
Jane Kennedy: But there are other charges which you
face. If you go to hospital, to park your car you veryQ578 Mr Burstow: Thank you. We have been
often, these days, pay a car-parking fee. These areexploring this and in the opening statement from
valuable sources of revenue—but they are not just aJane Kennedy we have had some sense of it, but
valuable source of revenue: they also help hospitalswhat is the point of health charges? What criteria
manage space, which is at a premium, around theguide the Government’s policy? We have heard
hospital; they help them manage the flows ofraising revenue is seen as a good purpose. Is that one
traYc—and I think it is perfectly legitimate way inof the reasons? We have heard it is. Is it also, though,
which—to limit demand for services?
Ms Winterton: Could I come in here, Chairman?
Going back to your previous quote from Lord Q581 Mr Burstow: We are coming on to car-park
charges a bit later, so I am not going to trample onLipsey, I have to say that the systemwe had of dental
charges, for example, was extremely complicated for that ground, but I dowant to ask one other question.
It is this: If we did start with a blank piece of paperdentists and for patients: 400 diVerent items of
service. In the reforms, we have tried to take that and the question was being asked: “We have to raise
one billion pounds of revenue from the operations ofdown to a much simpler system, but, of course, in
undertaking that review, obviously the questions the NHS, and currently we are trying to raise that
through charging people with life-threateningarose as to whether you should have any system of
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conditions, by charging for access to their medicines wear and tear, they are seeing an increase fromabout
£100 to £189, so that is directly increasing the cost,and, in some cases, for their dentistry, would it be
appropriate to consider switching, for example, a potentially increasing the incentive either to carry on
using very inadequate and unsatisfactory worn outmuch greater emphasis on to the hotel cost sides of
the NHS (the cost of being accommodated, the costs dentures or not to have anything at all.
Ms Winterton: I think there are a number of issuesof, as we are seeing increasingly, the introduction of
the telephone service)?” the provision of those sorts here. I am not sure of the actual figures of people
who have no teeth at all.of services is nothing to do with the direct treatment
and health of the individual but is the hotel and
accommodation costs, is that not a more legitimate Q583 Mr Burstow: The figure we have had supplied
area to look into to raise revenue, rather than as evidence is up to 45% of older adults.
directly on the provision of health care? Ms Winterton: I would look atwhether that is people
Jane Kennedy: Certainly if you were comparing it to who actually have no teeth. I understood that the
prescription charges, I do not necessarily agree with figures for people who have no teeth is relatively
that. If you have to go into hospital and you have to small and that it is more likely that dentures are for
go into hospital for treatment, I do not think you partial dentures, in which case you look at the figure
should be charged for the care that you receive and in the higher band, band 3, of £189. Within that
the hospital services that you receive. I think if there band would be included not only preventative health
are enhancements, that is perhaps a diVerent advice but looking at the other teeth, checking up
matter—and we will come on to talk about the any fillings, any other work that needed to be done,
telephone services and the TV services that are so the whole course of treatment including
provided—but I think it is important to remember replacement dentures, would be included in that.
on the prescription charging scheme, for example, if That is a cut, from £384, which was the maximum
we are dealing with that, that the payment for that is you could pay previously, down to £189. The reason
income based. And, whilst there are anomalies in the we made that top band much cheaper than it had
scheme, those people who cannot aVord to pay or been before—and Age Concern were particularly
who are on the margins of aVordability are exempt pleased that we made that change—was because
from payment and they are not prevented from older people do tend to require more treatment and
getting access to their medicines. It is only those they do tend to be at the higher end of the payment
people who are in a position to be able to pay who spectrum—as is the case, as well, with people on
we ask to contribute to the cost—and they do not lower incomes. We had to strike that balance.
pay the full cost: the prescription charge is a Within the system that we have established, there
contribution to the cost of the medicine. will be some winners and losers, but, overall—and I
Ms Winterton: I think it is a balance between think that is why the scheme has been welcomed by
ensuring that the people who might be deterred groups representing older people—we have been
because of the cost are protected. Certainly the able to lower that higher price. Also, referring to
evidence in the dental field (what people say and your point about the 30%, there is actually no
surveys that have been carried out) it is not charging diVerence in the current system. I know we have had
which prevents people going to a dentist. I think it is this exchange before, but, eVectively, if somebody
about getting that balance right, between saying that loses their dentures, there is a decision made that it is
if there is a contribution that is going to be made, let probably through no fault of their own—one would
us make sure that we protect the people who might hope that people do not go around throwing their
be deterred from going by things such as the low- dentures in a fit of pique or something—and they
income scheme or in certain instances in introducing only have to pay 30% of the replacement costs. We
these prepayment certificates. can have arguments about whether that is the right
thing or the wrong thing, but it is an attempt, I think,
to be fair in the assumption that people are not beingQ582 Mr Burstow: I think Howard is going to ask
careless with them or just being irresponsible. It is asome more about that in a minute. I just want to end
judgment. But we have kept the system as it is at thewith this issue of dentistry one more time, and
moment, because some people would think it wasparticularly the question of the provision of
rather mean to have taken it away.dentures, which is something that I raised with the
minister at the session we had with you back in
January. It is this concern we have had put to us both Q584 Dr Stoate: I would like to explore some
by Citizens Advice and Age Concern, that, for as alternative ways to raise revenue from the NHS.
many as 45% of older people who have no natural Jane, you mentioned that you were not in favour at
teeth, the issue of having access to dentures is very all of hotel charges for hospital patients—and I have
important to them in terms of their health and to say I entirely agree with that. As I understand it
welfare. At the moment, with the new scheme, there you are not having any plans to introduce hotel
is an increase in the amount that an individual will charges. But, as a GP, if I have an elderly person
have to pay for replacing dentures that are needing recovering from a chest infection and I have decided
replacement simply because of wear and tear which that person can no longer manage in the community
is higher than in the situation where someone has and really needs some sort of residential care, if I
lost their dentures, where they are only going to have send that person into hospital they do not pay
to pay 30% of the new highest rate. If they got to the anything at all; if I send that person into a respite
home or social services care home they may wellpoint where they are no longer any good through
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have to pay for that care. What is the logic in saying Where there is a possibility of extending or
increasing entitlement to free prescriptions, we doto that elderly person, “If I get you into the geriatric
unit down the road it will be free; if I get you into the have to balance the needs of those patients who
might benefit from that, against those who wouldold folks’ home down the road you may have to pay
for some of those charges—not the nursing element lose as a result, and there would always be some who
would—not necessarily if we were to deal withbut the hotel charges.” Where is the logic of charging
hotel charges for nursing home patients and no hotel prescription charges in the way that you should, not
just around prescription charges, but somewherecharges for hospital patients for the same condition?
Jane Kennedy: Again, it comes back to the same else in the health service there would be a cost that
would have to be made.argument we have been having, which is that when
you have a system and you consider a reform of that
nature, you consider the pros and cons of the Q587 Dr Stoate: I accept that, but, to tie you down
proposal, and you have to determine where in your a bit, I gather you did not answer the beginning of
list of priorities for reform and change such a my question—I have been reminded by the
proposal fits. The costs of such a proposal would be advisers—on alternative countries.Have you looked
very significant. Our view has been that we have at alternative countries? If so, which ones, and, if
other priorities that we will use the revenue that we not, why not? I would like to know about the work
have, which is finite— the Department has done on alternative structures,
because there are plenty of good examples from
across the world that you could have looked at. AreQ585 Dr Stoate: I have no problem with your views
there any you have looked at, and, if so, what haveon priorities of finance, and I entirely accept that the
you found? If you have not looked at them, why not?NHS needs to raise money from somewhere to
Jane Kennedy: We have looked at others. We havedevelop and to improve services. I take issue with
obviously been following developments in the twowhether this is the right way. Are there not
devolved administrations. We have looked atalternative ways that could be found to raise
Ireland and the experience in Ireland. Lookingprecisely the same amount of money? Can we not
through my notes, if you will allow me, we havecome upwith alternativeways?Have other countries
looked at the system inGermany, and in Italy, wherenot come up with alternative ways that look fairer
the systems are regionally based and regionallythan ours? If that is the case, why are we not
determined.We have looked at the system inFrance,pursuing those alternatives?
in Spain—right across Europe—in Sweden,Jane Kennedy: I would be interested to see the
Denmark, Finland and the Netherlands. We haveexamples that the Committee might have of
tended to look across Europe for comparators.alternative ways of raising revenue. In the
circumstances that we are in at themoment, our view
has been that we should not make that change. I am Q588 Chairman: What have you learned from those
aware that it has been something that has been hotly comparators?
debated: it was debated very much at the last general Jane Kennedy: There are quite a variety of ways in
election and it has been something that we have which they system operates. If you look at Italy, as
considered, but consistently, having considered it, I have said it is a regionally based system and the
we have taken the view that it is not a high enough amount that is charged is charged per pack of
priority for us to believe we need to do something medicines and not per prescription item. Some
about. regions do not have any charge at all but all regions
do pay a degree . . . I will get you the detail.
Dr Harvey: They pay the diVerence between theQ586 Dr Stoate: I have this nagging feeling about
reference price and the actual price, because theyunfairness and I hate unfairness. I will give you
have reference pricing.another very simple example. I have two patients in
Jane Kennedy: It is similar in France. In Spainmy surgery: one has an under-active thyroid, one has
they have, quite interestingly, diVerent systemsan over-active thyroid, they both have throat
depending on whether you are a civil servant orinfections. I say to patient (a) with the under-active
not—which I found intriguing. I see some interestthyroid, “Here’s your fee prescription” and I say to
from the advisers at that. Those who are chronicallypatient (b) with an over-active thyroid, “You’ve got
sick in Spain do pay a maximum charge. Theto go and pay £6.50 for that prescription,” despite
equivalent in the UK would be about £1.80, but,the fact that neither condition has anything to do
again, that is around the definition of illness. We canwith their thyroid disease and the patients are in all
provide you with this sort of detail if it would help.other respect identical. It sounds like a DirectLine
advert, but the fact is that that literally does happen.
That is just unfair and there has to be a way of Q589 Dr Stoate: It would be helpful. There is written
evidence that the BMA suggested a nominal charge,reducing unfairness at that level.
Jane Kennedy: As I have said, the anomalies in this say, of £1 for everybody except children. Do you
have a response to the BMA’s suggestion?system are clear. The benefits have changed over
time and for those who are entitled to relief from Jane Kennedy: Again, you would be withdrawing an
entitlement from a large number of people to achieveprescription charging the definitions have changed
over time. Wherever we have made those changes, that. I would want to look at the findings of this
Committee and to look at the recommendations thatthe intention has been to preserve an existing
entitlement; it has never been to take one away. the Committee makes, but our view is that a review
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of that nature would produce as many people who Q592 Charlotte Atkins: For the 13% who do pay,
what is the Government’s policy? Is it to raisewould be discontent with the outcome as those who
would be pleased with it. So we would have some charges in line with inflation or to keep the income
from the charges at generally the same proportion ofconcerns.
the NHS budget?
Jane Kennedy: Our policy has been to have a
Q590 Chairman: I accept that entirely, that you nominal increase, almost, in prescription charges
would have a situation where, if you were to restrict since we were elected in 1997. Year on year it has
somebody with a long-term condition just to have only gone up by 10p per year. The view that we have
free prescriptions for that condition, they would taken is that to abolish them would be too big a step,
have to pay—and that would be a simple change— but we acknowledge the burden that it can be for
for other conditions that came along, but that is those at the margins, just above the low-income
taking unfairness out of the system as most people scheme level and so on. We have accepted, overall,
would see it. There cannot be anything wrong with the contribution that prescription charges costs are
that, can there? making is reducing.
Jane Kennedy: Again, it depends how you define
long-term condition. You would be extending
Q593 Charlotte Atkins: Basically, the answer to thatexemptions in some areas which would have cost
question is neither—neither to keep it in line withimplications, and if we were extending it in some
inflation, nor as a proportion of the NHS budget. Iareas and trying to do it in a way which was cost
understood that in reviewing the system of NHSneutral you have other areas which would face an
dentistry charges the new system was required toincrease or a loss of entitlement or the costs would be
raise the same proportion of funds as the old one. Isborne somewhere else within the health service. We
that correct?keep coming back to that point. We have not been
Jane Kennedy: Yes.able to find a solution which protects current
Ms Winterton: Yes.entitlement and does not bring about a significant
cost to the health service.
Q594 Charlotte Atkins: Therefore, did you decideMs Winterton: Chairman, I can also send some
how this new banded charging system would aVectinformation about dentistry in other countries.
patient behaviour, because we have heard in a
previous inquiry, when we were talking to you,
Q591 Chairman: We would greatly appreciate that if Rosie, that people are predicting that patient
you could do that. Could I ask both of you, while on behaviour will change and that they will store up
this issue: a crude interpretation would be, “We are treatments, get into a higher band, get greater value
going to keep it like this because it has been like this for money. When you were looking at that did you
for 50 years, other than this three year blip, on make those predictions?
prescription charges” but that is not a rule of thumb, Ms Winterton: What we looked at in terms of the
that you look at the NHS and say, “We’re going to new charging system and the relationship between
leave it like that because it has been like that for 50 patient behaviour is that, because of the reform
years,” is it? It is far from it, is it not? You are system and because of the changes in the NICE
looking at other areas that you would probably like guidelines, which mean that instead of going back
to change before NHS charges. every six months, if the dentist decides that
Jane Kennedy: That is the key, and in the end that somebody does not need to come back within six
months but could wait maybe one or two years, thenhas been how we have determined our approach to
the patient behaviour, the patient pattern, if youit.
like, changes. I do challenge this idea that people areMs Winterton: There is also an issue in dental care
going to store up their fillings to get into diVerentas well. People very often, at the moment, mix NHS
bands, frankly.care with cosmetic care. There have been a lot of
changes that, in a sense, even further complicate that
particular system. We have tried to make it clearer to Q595 Charlotte Atkins: Everyone loves a bargain!
people what they can get on the NHS, with the Ms Winterton: I find it very diYcult to think that
charge that goes with that, and what they are then people would say, “If I hang on six months to get
charged for privately on top of that. But it has been another filling, I can get that one in the same band.”
a growing, if you like, mixed economy in terms of Do you know what I mean? It is an argument that
dental care. people make. I find it quite a curious assumption,
Jane Kennedy: One more point, where we are having because I do think that if people were in that bad a
that general discussion, just to reiterate: the numbers position there would be assistance given through the
of prescriptions that are now exempt from payment various schemes. The Committee may have a
is 87%. Of the 13% for which charges are raised, diVerent view, but I just find it a bit bizarre that
about 5% are now paid under the prepayment people would behave like that. I also think that when
certificate, so there is a maximum that is paid in any a person goes for their initial examination under the
one year on that. We have improved the low-income new system, within one cost, they can have a check-
scheme and the PPA, the authority who administer up, they can have a scale and polish, they can have
the scheme, are looking at introducing monthly preventative advice and they can have, if necessary,
payments which would ease the burden on those x-rays as well all within that first band. If the dentist
were to say (and Ben may correct me if I am wrongwho do have to pay.
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here), “Look, there is an immediate filling but there Q597 Mr Burstow: I would like to come on to the
way in which diVerent policies interact with eachis one that will need a little bit of attention within
other, particularly the very clear policy directiontwo or three months”, then that would count as a
that came from the White Paper about a greatercourse of treatment. If the dentist says, “This is what
emphasis on community-based treatment. This isis clinically necessary”, then it can extend over that
going mean that more patients who currently receivetime. I would challenge some of the assumptions
free medicines in hospitals will in future have to paythat are being made about patient behaviour, but I
for them. Is that reasonable?would say that there are diVerences in the way the
Jane Kennedy: We will want to look at that. Clearlysystem will operate, and the charging system was
it is going to be something we are going to be lookingmeant to take into account some of those changes,
at as we take forward the work and the developmentbut overall the system was designed, frankly, just to
of the White Paper. There will be implications forbe simpler for patients to understand, because too
other areas of cost as well, including travel costs, asmany times—and I think I have said this before—
we allow people to choose where they are beingconstituents have come to me and said, “That NHS
treated, so all of this field is under review.is terrible. I have just paid a thousand pounds to
have my teeth done.” I say, “No, you have not,
because all you can pay on the NHS, as is it stands Q598 Mr Burstow: So that we are clear, is there a
at the moment, is £384. You should go back to your time line to which that review is working, and when
dentist and say, ‘Wait a minute.What have I paid for might decisions be made as a result of such a review?
on the NHS and what have I paid for privately?’” Jane Kennedy: The development of the services that
This system means that there are only three possible we said we would want to encourage in the White
Paper will be taken forward over the coming monthspayments that people can make, and the dentist,
and years, and the impact of those services uponunder our regulations, has to make absolutely clear
patients, and particularly, as you say, if theywhat is NHS and what is private. I think that that is
are being prescribed more frequently by GPsa good change for patients and also, frankly, the
performing diVerent roles than they are at thesystem is less complicated for dentists.
moment or even by pharmacists, then we will want
to ensure that they are not disadvantaged.
Q596 Charlotte Atkins: That is great if you can find
an NHS dentist to apply those charges. What the Q599 Mr Burstow: The danger, of course, is that
Committee would be concerned about is to make there is never a clear point where a decision is
sure that the charges were not operating against a absolutely necessary, because each part of the NHS
preventative dentistry system, to actually encourage will reconfigure and rearrange its services at diVerent
people (which is diYcult anyway) to go to a dentist paces, and so there will never be a point where the
for preventative work. That is the important thing, whole of the NHS has got to where you want it to be,
to make sure that charges do not get in the way of certainly not in the next few years, and yet this must
that. Did you consider that when you were drawing have, on a locality by locality basis, impacts on the
up the new system? way in which the current prescription policy and
Ms Winterton: Absolutely. You will notice, I am exemptions will operate, meaning that some people
sure, that within the first band there is an allowance who hitherto were getting their treatment in hospital
for preventative work. If you move into the second may suddenly find themselves confronted with the
band, the first band comes with you. You are not fact that what was originally free simply because
they were in a building, because they are now in theirpaying one charge of £15.50 and then another charge
home taking the medication, they are having to payof £42.50. It is all encompassed, and so preventative
for it.work is allowed for. In terms of the contract itself in
Jane Kennedy: These are issues that we are keepingsaying that the number of treatments can be reduced
closely under review as we take forward the work inby 5%, the level of activity, that again is to take into
developing the services. We will want to ensure that,account preventative work. I think there is a wider
as we are seeking to improve the services that peopleissue, though, about the whole reforms when it
receive by delivering itmore locally, that they are notcomes to preventative/public health work that, as we
disadvantaged in the way that you have said.allow local commissioning within some of the
schemes that are already working, it does allow
dentists to be able to do more work, for example in Q600 Mr Burstow: There is one other specific to
schools, giving oral health advice. I have visited consider perhaps in that regard. We have had some
Newham recently which, extraordinarily, has an evidence indirectly from the British Association of
incredibly low rate of registration but NHS dentists Day Surgery, and they tell us that day case patients
who are longing for people to come through the are being required to take pay for painkillers which
door, and what the primary care trust has decided to they take once they return home, and this is as a
do is to use some of them to go out into schools to result of a policy that was promulgated from the
say, “Please come and register with a dentist. This is Department. Is this policy of charging for painkillers
why you should do it”, and at the same time is able to for people who have had day surgery consistent with
give some oral health advice. Under the new system a policy of trying to encourage an increased
there is much more flexibility about allowing that emphasis on people opting for a day surgery rather
than becoming inpatients?kind of work to take place.
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Ms Winterton: I think we have got to be realistic from their prescription, but we have been reluctant
about what is a deterrent. I had day surgery on my to extrapolate from that because it has been a
foot and had to buy painkillers, but I think that was relatively small study. Professor Peter Noyce
preferable to spending four days in a hospital. If you conducted that, but it was only 14 pharmacies. What
are looking at saying: is that going to stop people he found was that, yes, people who were being asked
going for surgery? Are they going to take an overall to pay a charge were discussing with the pharmacist
view of what they prefer? The usual complaint is that which items on the prescription were necessary and
people say that they are having to go unnecessarily were there alternatives, over the counter medicines,
into a hospital setting or are staying there too long. that might have provided a cheaper alternative, but
I think that, on balance, it is about saying there are he found that a very low proportion within that
some very, very clear advantages to having the day small studywere at risk of not taking amedicine that
surgery option and probably, if you balanced out all was actually important to them for medical reasons,
the costs of that to the individual themselves, they but that is the only study we have on that front.
might still say they would prefer to take a day
surgery approach than have to go into hospital for a
week or so with all the attendant costs that theremay Q604 Chairman: We had some evidence from the
be to them in that. I think it is a balance. pharmacists last week in relation to that. I am more
concerned about this issue of the threshold where
Q601 Mr Burstow: Presumably you would be you have to pay or do not have to pay. If you go into
concerned if that behaviour was stimulated by this low-paid work from being unemployed altogether
new charge for painkillers, if people were making on a diVerent benefit, you then would have to pay
part of their decision about whether they opted for your prescriptions. There is no taper in this. You are
day surgery. Would you actually know? Would you either exempted from paying prescription charges
be in a position to have information that would because of your age or income or condition, in some
inform on such a situation? cases, or you have to pay the full cost of the
Ms Winterton: Patient surveys very often show how prescription. What they were saying to us in CardiV
people react, and I think the evidence from patient is that they believe, and I do not think they have
surgeries is that people like to have the minimal time done any great study into this, that it was potentiallyin hospital. I have not seen any evidence. I do not a disincentive for somebody to go back into work,know whether that has been specifically asked in because, even in low-paid work, they would have topatient surveys, but I have not seen any evidence of
pay the full cost of their prescriptions and not bepeople saying, “I much prefer to go into hospital
exempted from paying in that work situation. Whatbecause I can get a free painkiller.”
worries me about that, Minister, is the potential forJane Kennedy: Do not forget, it is not a new charge.
social exclusion not to be broken down in society. OfIt is a charge that has come about because of the
all the areas that this Government wants to work atdiVerent way in which the medicine is being
to bring people back into society, to get them backprescribed. There are only 13% of prescriptions that
into work, this particular area might be aface a charge, and of those 13% there are ways in
disincentive for some people to do that. I do notwhich you can ameliorate the cost of that.
know if any studies have been done in England
about that.Q602 Mr Burstow: My point is that, as a result of
Jane Kennedy: I would share your concern. We havepolicy decisions and choices you have made, a new
not commissioned a study specifically on that, butset of anomalies start to emerge from something that
we do work very closely with the Department forhas not been changed since 1968. Surely that does
Work and Pensions and we are, as you will know,behove a further examination of the 1968
joint partners with them in the schemes in which weexemptions in the light of other policy changes.
are seeking to help people who are on incapacityJane Kennedy: And it is something we want to look
benefit return work, and this sort of issue has veryat carefully as we take the work on the White
much informed the policies as we have beenPaper forward.
developing them in that scheme. It is one of the
reasons why the Low Income Scheme was extendedQ603 Chairman: Can I ask about the issue of low
to 12 months rather than six months, so that, evenincome families in particular. We heard when we
if you have gone back into work and the particularwere in CardiV last week that one of the reasons why
condition for which you got the exemption in thetheyweremoving in the way that they are is that they
first place is ameliorated and goes away, you can stillbelieve that prescription charges may act as a form
get relief on prescription charges for the rest of theof poverty trap, that people would be deterred from
year. It is that kind of work that we have been doinggoing back into work because of the cost of the
to try and deal with that problem, should it arise.prescriptionwhen they are in work as opposed to the
exemption that they get because they are on means-
tested state benefit. Have you any evidence of that?
Q605 Chairman: Do you have any regular meetingsJane Kennedy: There have been a number of studies.
yourself with ministers from the Department forThere was a study conducted in Manchester some
Work and Pensions?two or three years ago which was a relatively small
Jane Kennedy: I have not. That is not to say otherstudy of the impact of charges on those people who
had to pay and what they took as a result of that colleagues across the Department have not.
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Q606 Dr Taylor: I am coming on to the age-based the things directly related to their diabetes. If you
can do it for war disablement pensioners, could youexemptions, because they do not really seem to make
sense when there are lots of people who are retired not do it more across the board?
Jane Kennedy: I am reluctant to begin that sortand well oV who do not need those exemptions.
Have you any comments on that? of review, which would inevitably lead to
representations from every patient group whoMs Winterton: There obviously have been manifesto
commitments, discussions with organisations believed that they were a case that should be
considered for exemption. We have really discussedrepresenting older people and reintroducing free
eye-tests for the over 60s was a very popular that earlier. It is not a policy discussion that is
enticing us. It is not high on our priority list.measure, widely welcomed and very good in terms of
ensuring that a particular group of people who
probably did need regular eye-tests were able to get Q614 Dr Taylor: No, we are back to the very strong
them. That is a debate, in a sense, about how we argument for the abolition and not the review. One
decide to treat older people, frankly. other final question. Is it true that a directive came
from the Department of Health about out-patient
charges that anybody who had been in hospital forQ607 Dr Taylor: In any possible review would there
less than 24 hours should pay a prescription chargebe a question of looking at the multi-millionaires in
for the drugs that they take away with them? As I amtheir 60s and 70s and reckoning that they should
sure you know, one of the rather odd definitions ispay?
that if you manage to get a patient out of hospital atMs Winterton: I do not see, particularly on the eye-
23 hours, rather than 24, they count as a day casetests for over 60s, a change in that policy in the
and therefore they would have to pay prescriptionnear future.
charges, whereas, if they managed to stay 24 and a
half hours, they would count as an inpatient and so
Q608 Dr Taylor: And prescription charges? they would be exempt?
Jane Kennedy: We have no plans to do with Jane Kennedy: I have to apologise. I am not cited on
prescription charges either. You will remember, the that. I would want to look into that and see.
largest number of prescriptions is written for people
in that older age group. Something like 57% of all
Q615 Chairman: I think since 1948 the definition ofprescriptions go to people in that age group. You are
an “inpatient” is one who was occupying a bed atmore likely as you age to require medical support,
midnight.medical treatment and medicines, and we have taken
Jane Kennedy: As far as I know, there have been nothe view that we should not take away entitlements,
recent changes to the rules, but I would want to lookand that is the position that we hold.
at what you say.Ms Winterton: I suspect that Parliament, having
voted in some of these changes, would be rather
Q616 Dr Taylor: We were told there was a directiveloath to remove them.
sent round from the Department of Health about
charging for people who were in for less than 24
Q609 Dr Taylor: But you have said that one of the hours.
principles is that those who can aVord should pay. Jane Kennedy: It is not something of which I am
Are you not now contradicting that? aware.
Jane Kennedy: No, because we have exempted those
who are in retirement and are not working.
Q617 Chairman: I hear what you say about the issue
of conditions exemptions, and, indeed, it was put to
Q610 Dr Taylor: But you have also exempted a lot us that is not somebody suVering from depression a
who could aVord to pay? long-term condition as well and where do you stop?
Jane Kennedy: That is true. We heard that in CardiV last week. Would it not be
easier to say that, given in 1951 there probably were
not as many millionaires living into their retirement,Q611 Dr Taylor: Which goes against your principle?
in fact there were not as many millionaires full stopJane Kennedy: If you like, we have refined the
as well as people living into their retirement, andprinciple.
given an exemption on age nowadays when we have
got a massive amount of millionaires who are able to
Q612 Chairman: Do we not have a problem with get free prescriptions I think from the age of 60 now,
extending principles that are in manifestos! is that not something that could be reviewed and
Jane Kennedy: We do not mind refining, but stood on its own? I know it sounds like we are into
extending is more diYcult. class-bashing, and it is not meant in that respect.
NHS charges are another form of tax, in a sense, and
these people could well aVord to pay £6.50, couldQ613 Dr Taylor: I want you to refine another one.
War disablement pensioners do not have to pay they not?
Jane Kennedy: The thing is that you would notprescription charges but only in respect of the
medication for their disablement. Could not the introduce a system where you started saying people
who had an income or asset base of a million poundssystem be refined so that these lucky patients with an
under-active thyroid only get free prescriptions for or more had to start paying more or had to start
paying for their prescriptions. The vast majority oftheir thyroid, diabetics only get free prescriptions for
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older people who are on acknowledged good Q623 Mr Campbell: Coming back to the charges
again. Should eye-tests and dental checks not be freepensions have planned for their retirement and
taken into account that they will not have to pay for everyone on the basis that if you do it early things
like oral cancer could be caught early, costing theprescription charges perhaps to a certain age, and to
remove that would be just as controversial as some NHS less in the long run?
Ms Winterton: In terms of the eye-tests—as youof the issues that you are asking us to consider in a
diVerent context. know, there are various groups who are entitled to
free eye-tests—there is not any evidence that paying
for an eye-test is deterring people. What we do try toQ618 Chairman: What about doing it for people
do is to make sure that we have schemes in place, andwho pay the top rate in income tax when they retire?
we have looked at this, particularly, for example,Ms Winterton: Sometimes it can be quite diYcult,
schemes with pharmacists, to actually encouragewhen you look at those systems. The cost of
people to go for eye-tests if they are in at-risk groups.administering something like that can actually
remove from the amount of revenue that you raise.
Q624 Mr Campbell: It is a trait that we have got that
if they have got to pay they are more reluctant. If IQ619 Chairman: Have you looked at the costs of
have got to pay for it I will not go.administration?
Ms Winterton: Your instinct might say that. I thinkJane Kennedy: No, I must admit, we have not.
the reality is, certainly if people feel they are havingMs Winterton: I remember looking at the general
problems with their eyes or their eyesight is fading,admin costs and, at the time when I looked at
they will go and have an eye-test. There is nothem—this is all from my own interest, by the way,
evidence that people, frankly, just do not go becausenot some kind of fundamental review—it was fairly
they could not aVord it, because again there are theclear that the systemwas relatively simple at the time
exemptions in there for people who would be onand the balance of administration was quite low, but
particularly low incomes, and, of course, again, forI did think from that that, once you started
the over 60s, we have reintroduced free eye-tests, butintroducing various diVerent levels, it might become
we do try to encourage groups at risk to be able tomore complicated.
go forward for that. Of course in some areas we have
introduced regular eye-checks for people withQ620 Chairman: I accept that from your point of
particular long-term conditions.view, but looked at through the Inland Revenue’s
eyes it could be quite diVerent, because you are easily
picked out if you are on the top rate of income tax. Q625 Mr Campbell: You have not done any costings
Jane Kennedy: People who pay the top rate of to say that it is cost-eVective by making it free
income tax would argue that they already contribute earlier?
by paying more tax. All of this is a fine balance. I was Ms Winterton: I think everybody knows that,
going to say, if Rosie had not said it, that when you obviously, if it is caught early—. As I say, the key to
start to have to work at how you administer such a this is not saying to people, “You can have a free eye-
scheme, the benefits that you get from it diminish. It test” necessarily. The key is getting a message to
sounds a simple thing to do, but actually doing it and people that they might be in an at-risk group. If we
doing it fairly is far more diYcult to achieve. put adverts everywhere and said there are free eye-
tests, people who needed it would not necessarily
know. That is the key that you have to crack whenQ621 Chairman: You have not discussed this with
you are dealing with the type of conditions that youthe Treasury then?
are talking about. It is actually identifying people,Jane Kennedy: No.
getting the message through to them that they need
to have an eye-test because they are in an at-riskQ622 Mr Burstow: The Department for Work and
group, which is in a sense the answer to saving thePensions and the Government as a whole are
on-going costs further down the line. It is the peopleconsidering issues around pensions and pension
who do not come forward that is the problem, but Iwages in terms of basic state pension entitlement. Is
do not think it is connected to the fact that they feelthat something which the Department will be
they might have to pay for an eye-test, it is morekeeping in mind in terms of the age at which free
likely because they do not realise they are in an at-prescription, free eye, free dental and other checks
risk group.become available? In other words, will the age be
kept aligned?
Ms Winterton: I am sure that thosewill be part of the Q626 Mr Campbell: Can I follow on with a question
in regard to Mind, people with stress and peoplediscussions that take place if any changes do occur.
You mentioned the DWP. I wanted to say that one with mental problems. We had a witness last week
from Mind who came in and when we asked herof the things that was highlighted in the recent Pack
report was that people are not claiming some of the some questions it was amazing what she had to say.
What she did have to say was basically that when abenefits, and this particularly related to cancer
patients. I did check up on that, and we do try to doctor gives a prescription to a patient who has a
problem they went on a list, but the list was closedensure that “pounds departments” within hospitals
and GPs surgeries, and so on, are given leaflets in because it was as long as your arm. It was closed up
to six months, she said, and so most patients, whenorder to make sure that people can take up the
benefits that they are entitled to. they could aVord it, had to go and get their own
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consultation and pay for it, and those that could not eVective. What there is evidence about is that, if
people do not understand the possible side-eVects ofpay for it just did not, and, of course, further down
the line it was going to cost more money because their medication, they can almost stop taking them
without going back to, for example, a pharmacisttheir condition never got better.
Ms Winterton: I do not know whether she would be and saying, “Is this right?”, and sometimes the
pharmacist will say, “Take it at a diVerent time oftalking about—. Is she talking about a waiting list to
see a psychiatrist? day and that might reduce it.”
Mr Campbell: Yes.
Q632 Dr Stoate: I am more concerned about the
Q627 Dr Stoate: Psychotherapy, I think? eVect of charges on people. We have had
Ms Winterton: There are certainly shortages of pharmacists, and we have interviewed them, saying
alternative counselling, and that is why in the that they had first-hand experience of patients
manifesto we made a commitment to extend those saying, “I cannot aVord three drugs”, or, “I cannot
kinds of services. We have trained more aVord two drugs. Can you tell me which one I do not
psychotherapists, and we are looking at the moment need?” and the pharmacists are finding themselves in
as to how we can extend that even further. We said an extremely diYcult position. Do we have any
in the recent White Paper that we would be looking evidence, any research on the scale of the problem
at two demonstration sites to look at how you can and the eVects it might have?
provide some of those wider psychological Jane Kennedy: Other than the study that I referred
therapists, because, you are absolutely right, there is to earlier, no, we do not. We have, of course, the
a problem. Citizen’s Advice Bureau work that was done a little
while ago, in which they estimated about 100,000
people were not getting their medicine. We areQ628 Mr Campbell: It is a modern day disease?
looking at some of the representations that they haveMs Winterton: Yes.
made and we are working with them to study that.
There has also been a MORI poll, I think, but we doQ629 Mr Campbell: It could happen to anybody in
not know the scale of the poll.this day and age?
Ms Winterton: Yes, and it is something, it is
Q633 Dr Stoate: Is it not important that we do someabsolutely true, which needs to be expanded.
research? We had Hamish Meldrum, for example,
from the BMA last week, who is a GP, who felt thatQ630 Mr Campbell: It is pretty shocking when you
it was a significant problem, but he had no way ofhave a list and it is closed after six months and the
measuring the scale of it. Is it not something that thedoctor cannot get anybody on the list.
Department should be measuring?Ms Winterton: Certainly there are longwaiting times
Ms Winterton: Some of the evidence, or some offor psychotherapy at the moment, but that is why we
anecdotal evidence, put it that way, is that people areare taking the action that we are doing.One of things
not always told about the fact that there are Lowthat we have to do in expanding the counselling
Income Schemes, that there are exemptionservices is to make sure that we have got an adequate
certificates, and so on.way of monitoring, or regulating those who are
carrying out the services, and that is why we are
Q634 Dr Stoate: With respect, pharmacies willtalking at the moment with organisations like the
always tell a patient when they are entitled to a freeBritish Association of Psychotherapists and
prescription or not. The list is very clear in theCounsellors, I think it is called, to say how canwe get
pharmacy. They have got details, they have gotsome agreement about the diVerent types of
literature and it the pharmacist’s job is to make surecounselling that could be, in a sense, accredited so
that patients get free prescriptions if they are entitledthat if PCTs are commissioning it they know what
to them. I am talking about people who are notthey are commissioning, because you will find this
entitled to free prescriptions who will then say to thevaries from area to area. Some PCTs, for example,
pharmacist, “I cannot aVord three drugs. I can onlywill provide bereavement services, others will not.
aVord two, or one. Which one can I aVord to drop?”Sometimes that is because some of them are not
Surely that must have an implication on health, andquite sure about some of the issues around
why is not the Department doing some research onaccreditation.
the scale of that potential problem?
Jane Kennedy: As I say, we have that small studyQ631 Dr Stoate: I would like to focus a bit more on
which indicated that for that small group ofthe eVects on health of charges. We have had quite a
pharmacists the scale of the problemwas not as greatbit of evidence from pharmacists, from GPs and
as you might have feared. We have no plans at theacademics that groups of people simply choose
moment to commission any further evidence, but wewhich drugs to get from their pharmacist because
want to consider that in the light of what thethey cannot aVord them all and some patients do not
Committee might say.take their drugs at all. Does the Department have
any evidence of the eVect this might have on
people’s health? Q635 Dr Stoate: Mr Dyson, you are responsible for
optical services. Being a GP, and it is well-known,Ms Winterton: With regard to pharmacists, that is
exactly why we introduced the use your medicines for example, and any optician will tell you, that
certain condition such as glaucoma, hypertension,properly schemes, which I think have been extremely
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diabetes can be picked up from an eye examination, “You ought to think about going and having an eye-
and they are often conditions which have no test if X, Y, Z.” As I say, I think that for most people
symptoms whatever for many years and not until who perhaps are in that age range where their sight
sometimes it is far too late to prevent long-term begins to fade a little, there is no evidence that they
damage. Do we have any evidence that optical are not going because of a sight-test. I do not think
charges are putting people oV attending for routine it would be patient behaviour, frankly, because if
optical tests who may have those conditions but may you feel that there is something wrong you do tend
have absolutely no inkling that they have got them to go.
unless they have an eye-test, and is there anything to
show that might be a problem?
Q639 Dr Stoate: I am not talking about people withMr Dyson: It is perhaps first worth mentioning that
any symptoms whatever. I am talking about peoplediabetics and those diagnosed as having or being at
who are otherwise, as far as they are concerned,risk of glaucoma are entitled to free sight-tests.
completely fit and well who may well know they
should have a dental check-up every year or two,
Q636 Dr Stoate: I am talking about people who have and that is fine, but they have no reason to think that
not been diagnosed with diabetes or glaucoma.Once they need an optical test. I was simply concerned
they have been diagnosed they are in the system. I about some of those people who might think, “Why
am talking about otherwise fit, healthy adults who would I want to shell out £25 for an eye-test if I have
may have very high blood pressure, who may have not got any symptoms?” They are the ones I am
diabetes, who may have glaucoma and be absolutely concerned about, who may store up considerable
unaware of that because, as you know, those damage to themselves before somebody says, “You
conditions do not manifest themselves unless they have probably had diabetes for years”, and that can
show signs. I am talking about people who easily happen before any symptoms develop. You
potentially could be diagnosed. I am sent patients, may have had high blood pressure for years and you
on a fairly regular basis, by opticians because they may not be aware of it until you have a stroke, buthave had an eye-test and the optician says, “You it may be that it could have been picked up by anmay have high blood pressure. You may have optician earlier.diabetes. Go and see your doctor.” I am talking
Ms Winterton: Yes. As you say, the key is to get toabout people who have no idea they have got these
people who are in at-risk groups and say, “Evenconditions, and I am concerned about the eVect that
though you may not be feeling something, it mightthe charge may have on preventing such people
be worth you going to do that”. It is something that,coming forward for an eye-test?
whilst an eye-test may not be part of the new life-Mr Dyson: We are not aware of any evidence to
checks in itself, at least it would help to identifyshow that the fact of having to pay for a sight-test
people that you would be saying, “Even if you arehas deterred people from coming forward. As we
not having problems with your eyes, because of yourhave put forward in evidence before, certainly the
family history, this is something that you shouldexperience when free sight-tests were reintroduced
seriously consider doing.”for over 60s the overall volume of sight-tests as
between the private and the NHS did not change
significantly as a result, which implies certainly that Q640 Mr Campbell: I heard Jane mention the
the fact that some older people were having to pay monthly prepayment certificate before. You just
for sight-tests privately had not deterred them. mentioned that. I just caught the end of what you
said.
Jane Kennedy: It is not monthly at the moment. WeQ637 Dr Stoate: But with so many diVerent
are looking at that.providers in the field, can you possibly know how
many people out there have or have not had a
sight-test? Q641 Mr Campbell: Could you expand on that?Mr Dyson: We know the overall volume of NHS
Jane Kennedy: The Prescription Pricing Authority,sight-tests and the overall volume of private tests,
who are the responsible body for administeringand that did not change significantly as a result of
the whole scheme and for making sure thatintroducing free sight-tests for over 60s.
reimbursement of prescriptions takes place, are
looking at how they could develop such a scheme,
Q638 Dr Stoate: But you have absolutely no and they will be reporting to me shortly on that.
research evidence whatever to back-up any Mr Campbell: That is good.
assertions as to whether the charge does or does not
put people oV taking care?
Q642 Mr Burstow: In addition to that, are thereMr Dyson: Our view is that the very fact that there
other options being looked at? Are they essentiallywas not a significant increase across the board was
looking at potentially a charging cap, so that, oncequite compelling evidence that, on the whole, people
you have paid a certain amount in a given period ofhad not been put oV by having to have a private
time, you do not pay any more? Is that anothersight-test before the change was introduced.
option that is being considered?Ms Winterton: I go back to the point that the key to
Jane Kennedy: It is capped anyway, and at thethis is actually reaching people who may be in at-risk
groups and persuading them, as you obviously have, moment they are looking at both.
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Dr Harvey: It is a four-monthly certificate, but they circumstances the family could visit, which could be
very much for therapeutic reasons, and assist andare looking at monthly payments towards that, and
they are also looking at the other thing that was certainly help a mother to see her daughter, and yet
she does not get any assistance in being able to doraised by Citizens Advice, which was a reduced price
PPC for those holding an HC3. that. Is that something that you could look at when
you are looking at the issue of long-term care?
Jane Kennedy: It is something that we could look at.Q643 Chairman: What about the issue of somebody
I think we have focused the help in terms ofwho may not at the beginning of the year, or at any
transport on the patient so that the hospitalone time, know that they are going into a situation
transport scheme is focused on helping patients whoof long-term conditions that is going to mean a lot
have travel costs. This is a fair point, and I canof medication but, probably three or six months
appreciate the diYculties that some families ofdown the road, suddenly realise that the amount of
patients in those circumstances face. We would beexpenditure is quite high? I think one country we had
happy to consider what the Committee has to sayevidence from put an annual cap on what somebody
on this.would pay on prescriptions and, if they met that cap,
Chairman: If somebody in the family had donethey would not pay any more for the following three
wrong to society and been under lock and key, theymonths. Have you looked at anything like that?
could get assistance to go see them.Dr Harvey: We are certainly aware of the situations,
particularly in the Scandinavian countries, where
that applies. There is the issue of the administration Q646 Mr Burstow: Can I pick up this point. There
cost around all of that, but I think that is also why was a report done a couple of years ago by the Social
we are looking more at the monthly payments for Exclusion Unit, Looking at Making Connections. It
PPCs and issues around the HC3 low-income was published in 2003. It estimated that about 1.4
scheme. million people are put oV taking up healthcare
because of issues of access to transport and
aVordability of transport and so on. Preparing forQ644 Chairman: Okay. Another area we would like
this inquiry, what we have found it very diYcult toto look at is the cost of travel but in diVerent
do is to discern quite how the Department wentcircumstances than going to your local hospital. I
about responding to the recommendations of thathave a constituency case I have been dealing with
Social Exclusion Unit report. Can you tell us whatnow for a number of years. One of my constituent’s
you did with the recommendations to try anddaughters was living in SheYeld, which is next door
improve information for patients about how theyto me, and has ended up suVering from mental
could access transport and, indeed, this issue of howillness. She had to go into long-term care, and she is
relatives can also have access to transport?still in long-term care now. She was sent initially to
Ms Winterton: There are two things. There areMilton Keynes. Her mother could not get down to
instances where people can apply for a social careMilton Keynes to see her. She is an elderly lady and
grant for travel to see relatives in those situations. II do not think she has got a lot of income. I
think there is also an issue that is being looked at ineventually got the system to move her a bit nearer.
terms of the wider expansion of the Choose andShe is now in North Nottinghamshire, but she
Book programme, and within that there is a lookcertainly could not get on a bus to go and see her.
being taken at transport for visitors as well and IWhy dowe allow this situation? If it might have been
think, particularly in terms of mental health, that isa member of a family who went to prison, they could
something that we can look at within that.actually get travel costs to go and visit that person in
prison. I had a letter from her a few weeks ago saying
could we get her even nearer to North Q647 Mr Burstow: Specifically the Social Exclusion
Nottinghamshire. If we could move her back to Unit report from three years ago. How was that
SheYeld she could go and see her on the bus a lot taken forward?
more. Why is it that we pay for people to go and visit Jane Kennedy: First of all, the White Paper that we
prisoners and yet we cannot do that for people in have just published sets out ways in which we
long-term care in situations like that? respond to the recommendations of that report.
Ms Winterton: Can I, first of all, make a general They had one specific recommendation, which was
point about the mental healthcare provision. It is that we should abolish the hospital transport
something that I am looking at, the general scheme, which we have resisted because we actually
commissioning of mental healthcare, particularly in think there is a value in helping those patients who
the relationship between the public sector and the would otherwise face costs specifically. However,
private sector and how we can strengthen there is a broad responsibility for ensuring that, as
commissioning so that it is, in fact, closer to home we are developing services and moving forward with
in general. our programme of taking services closer to people in
the communities, local transport plans will also be
required to play a role in making sure that transportQ645 Chairman: It is very likely that these people
will go into a place because of the status of that arrangements in any given area take into account the
accessibility of health service and health serviceplace, in terms of whether it is a secure unit or not,
and, under those circumstances, we are not going to provision. It is not just a health department
responsibility to make sure that health facilities arehave one in every borough. I accept that entirely. I
just think that it is very unfair that under those accessible.
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Q648 Mr Burstow: On that last point—the model of Q651 Chairman: Could I ask you if you are happy
that patients have adequate access to informationcare of having healthcare closer to home—one of the
problems that can arise, and certainly in my own regarding eligibility for assistance with health
charges and if theDepartment do any checks on this.area where that model of care has now been put
forward and has been taken forward, you may have Last week we had in Citizen’s Advice who said that
health providers are not required to displayvery localised care facilities but they will not be able
to provide the full range of diagnostics. Although information about the NHS Low Income Scheme. I
know when you go into a GP’s surgery there areyou may have a local care hospital or a local facility
on your door step, you still have to go right the other leaflets and all sorts of things in there, but they do
not have to provide this information on the NHSside of my local authority area, or further afield, still
to get to the one that provides the service that you Low Income Scheme. They described it as quite
amazing that they did not. Do you have any viewsneed. In some cases that may wind up with far more
complex journeys than the original journey to the on that?
local key hospital. How is that going to be picked Jane Kennedy: The Prescription Pricing Authority is
up? Is that simply going to be left very much to local working with the Citizen’s Advice Bureau. They
transport plans and an interaction between the NHS have taken that finding very seriously and they are
locally and transport providers? working with them to providemore information and
Jane Kennedy: No, because if a patient requires, for working with the NUS to make sure there is
medical reasons, to travel a distance for a diagnostic information available to students on healthcare and
such as that and they fall within a category of patient health advice, so it is something that they are
for which the patient transport service will be able to responding to.
provide transport, then they will be transported, so Ms Winterton: I am not sure if you make something
that will be provided. As I say, the other element of a requirement, if somebody says that they were not
it is that for those patients who are not so critically then given it, whether you get into some legal
ill that they require transport or have a condition diYculties. I am not sure whether that might be an
which does not qualify for that support, there is the issue if you put a requirement and then somebody
other scheme, which we have defended, which is the says, “Yes, but I was not actually told it”—the
hospital transport scheme. definition of how you have displayed some
information and whether it was drawn to their
attention but there is certainly very heavy guidance,Q649 Mr Burstow: So why are 1.4 million people a
I think, on good practice as to how people’syear turning down healthcare because of transport
attention should be drawn to it.issues according to the Social Exclusion Unit?
Jane Kennedy: For example, pharmacists are notJane Kennedy: As I say, our response to the Social
contractually obliged to do it but good practiceExclusion Unit report is contained within the White
dictates that it would be something they should do.Paper, and if we take services more locally and
provide services more locally, for example
Clatterbridge Hospital in my area, a big cancer unit, Q652 Chairman: I suppose that is one of the issues
well respected, has been developing for many years with new GP contracts and everything else as to
a system in which consultants go out and run clinics whether or not you could make it a provision. Whatin localities around Merseyside and Cheshire and you are saying is if somebody says it falls short youNorth Merseyside, so they will take their services to then get into a mess of proving or disproving thatpatients in Southport and deliver chemotherapy information was available at the time whenservices in Southport. The patient does not have to somebody went into a surgery. Is that what yougo all the way through Liverpool to the Wirral to are saying?receive the treatment at the hospital. This is not
Ms Winterton: It occurs to me that might be an issuerocket science, it is a simple process. It is a very
around it and trying to do it through good practicesensible process of taking services out to where
may be the preferable route.people want them, which is as close to home as they
Jane Kennedy: The HC11 form that does givecan have them.
guidance on the support that is available and on
the Pre-payment Certificate is available from
Q650 Mr Burstow: That is a good example of where pharmacists and GPs and contractors. It is also
that will work, but the point that I am making is available in JobCentre Plus and two major
again from practical work of modelling a better supermarkets, I understand.
healthcare closer to home model of care. In my area Chairman: You are not prepared to name them.
they have recognised that there will be some services Richard has got a question about that.
that will be provided in satellite facilities, but only
one of them. They will not be moving around. There
Q653 Dr Taylor: That is the next question about thewill still be peoplewhohave to travel further to get to
HC11. I am ashamed to say I have not looked at onethose facilities. It is how those people are addressed
myself but we are told it has got 77 pages and it is thewhen we know already 1.4million people a year turn
major part of AgeConcern’s volunteers’ work, to trydown access to healthcare because of transport
to help people fill in this form. How could this bediYculties. I am not clear how that is being fixed
simplified? I think it was the CAB who said, “Onethrough what is being put forward.
thing you could do is say if you are entitled to aJane Kennedy: We are taking services closer to
people. That is how we are fixing it. means-tested benefit then you get your free
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prescriptions”. That would be so easy and it would to be looking at is how to raise awareness of theHC2
and HC3 for the Low Income Scheme help withsave so many people so much time as opposed to this
77 page form. Is it 77 pages? travel costs for both staV and patients.
Jane Kennedy: Yes. 79. But it does cover all the costs
and all the help that you can get that is available, so Q662 Chairman: We are moving on to another area
it is of necessity detailed. However, there is a quick now. You probably know that last week we had
guide which my glamorous assistant will show you! Patientline in here and questioned them, and earlier
today we had Ofcom questioning them as well about
Q654 Dr Taylor: Does the quick guide separate each their report and their letter that was sent to the
of the sorts of things that you can claim for? Secretary of State in relation to the policy on
Jane Kennedy: It gives details of what benefits would telecommunications in hospitals. Could you
passport you through to receiving free prescriptions. comment on the failings of the Department in
regards to its policy on telecommunications services
Q655 Dr Taylor: Is there a short form on that that and what clearly most people would say is an
they have to fill in to claim it or do they still have to inability to protect patients’ relatives particularly
go back to the 79 page book? and friends from unreasonably high charges? Ofcom
Ms Winterton: The form is HC1. were very diplomatic this morning but it is quite
Jane Kennedy: This is the advice booklet which clear from the contents of the letter they sent to the
explains what is available. Secretary of State on incoming telephone charges
that they are extortionate—my words, not theirs—
Q656 Dr Taylor: How diYcult is the form because in terms of what people have to pay to phone a
Age Concern pointed out the extensive amount of relative. How wrong do you think coming to a
time their members spend helping older adults contract with these people was?
complete the form? How many pages is the form? Jane Kennedy: First of all, I would say Ofcom had
Jane Kennedy: I do not have an answer on that but undertaken an investigation into the provision of
we can find out. However, the patient partnerships these services. They have now dropped that
have done a survey of opinion on the form. I think investigation because the Department and the
94% of those who responded to the survey said contractors have expressed a willingness to work
they found the form easy to fill in. We need to with Ofcom to address some of these criticisms that
check because you have obviously got diVerent have been raised. There were about 70 complaints
information from us. raised, which is a significant number, but when you
think of the total number of people who have been
Q657 Dr Taylor: It is just from Age Concern. using the services actually it is a relatively small
Jane Kennedy: The HC1 form is 16 pages. number of people who are complaining. The
majority of the complaints were about the costs.
Q658 Dr Taylor: The form is 16 pages? Among those peoplewhohave been using the service
Jane Kennedy: Yes, 16, one-six.24 there is quite a high customer satisfaction rate with
the services that they are receiving. In comparison
Q659 Dr Taylor: Could you possibly leave us a form with what was there before the services are seen as a
because I think it would be terribly useful if we saw very big improvement.
it.
Ms Winterton: Would you like this quick guide?
Q663 Chairman: I accept that, but Ofcom stated inDr Taylor: Absolutely. Yes, please.
their letter to the Secretary of State that they had:
“not therefore reached a final conclusion in respectQ660 Chairman: He is all right, he does not need
of the lawfulness under competition law of thethem anyway. Can I ask you about best practice
contractual arrangement entered into by the NHSwithin the NHS for getting information about the
Trusts and the providers”. That does suggest thisLow Income Scheme. Could we take it as read that
particular contract is suspicious, even to suggest itwould be the case for the private providers that the
may or may not have been lawful in their view. It wasNHS do now contract with, that we are likely to see
not against competition law, they have clearly saidthese things in the areas where people go for private
that, but they have not passed it back to you withprovision as well?
any glowing references about the scheme. TheyJane Kennedy: Yes. Certainly we will look to make
made it quite clear you need to do a critical analysissure it is understood that such advice should be
of what people have signed up for here.available.
Jane Kennedy: On the day that Ofcom
communicated with us to say that they were notQ661 Chairman: We may be going on a visit to one
taking their inquiry forward we made quite clearly aor two of these so we look forward to seeing them
statement to say we accepted we need to review thedisplayed in these areas.
arrangements and that is what we are doing and weDr Harvey: In terms of the transport scheme, as part
will be in a position to announce the membership ofof the consultation that will be taking place over a
the review group very shortly. It would be wrong ofthree month period one of the issues they are going
me to go into too much detail about what the
perceived shortcomings might be in the current24 Note by witness: The Prescription Pricing Authority (PPA)
scheme. I need to let that group of people do theiroVer an HC1 form completion service which is available
by phone. work.
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Q664 Chairman: You do not think that in any way their costs but the point is they are recouping their
costs for a very expensive bit of kit which is not beingthe Department was duped into buying what some
people would say is an expensive toy? fully used by the NHS?
Jane Kennedy: One of the criticisms which I heardJane Kennedy: I take comfort from the fact that a lot
of the users of the service have said that they think was that when people ring in, the first 25 seconds or
so is a message that says you are going to be chargedthey are getting a good service.
at premium rate and this is how much it is going to
cost you. If you are ringing in regularly that is notQ665 Chairman: I have to say my niece, who has just
only irritating but also quite an expense. We arehad a child, is in Rotherham Hospital and I was
going to look at all of this and I just want to give thethere Sunday evening and she said the system they
Committee—have got there is wonderful, but I am not sure the
relatives who have been phoning in will think that
when they get the phone bills. Q669 Charlotte Atkins: It costs more to ring in than
Jane Kennedy: If I can just add one further point. it does to ringAustralia. When you are given the cost
The reason why I think these services are important in a message when you are anxious to talk to a friend
is my elderly father-in-law went into hospital and or relative it does not always sink in what the total
spent a long time in hospital in his declining months. price will be. Of course, you are right, it is an
His one pleasure in life was watching Liverpool irritation to have that message especially if you are
Football Club. His daughter took a television set in a repeat caller who constantly has to pay to hear this
so he could watch the FA Cup Final when Liverpool irritating message.
were playing in a recent FA Cup Final, as they often Jane Kennedy: I am one of those people who is very
do, and she was told she could not plug the TV in irritated by telephone menus anyway, so I have a lot
until it was checked by an electrician. She left the TV of sympathy for callers in those circumstances. I
with the hospital ward for them to do that, it was really cannot say much more at this point other than
never plugged in and the old gentleman did not get we are working with Ofcom and the companies and
to see the last FA Cup that he would have been able I will be announcing the membership of the review
to see with Liverpool playing. To have a service that group soon.
is there that they can purchase that is there to
provide that kind of service to patients is infinitely
Q670 Charlotte Atkins: Will you also be looking atbetter than that kind of experience. If we have not
whether the NHS is going to have any prospect ofgot it right here we are working with the contractors
using this expensive kit or will it just be not a toy butto see what we can do to improve it.
an expensive white elephant?
Jane Kennedy: It has got about 40% usage, soQ666 Mr Campbell: Sometimes it is a bit of a rip-
perhaps part of the review may well look at how weoV though.
can promote use of it. There are alternatives. ThereJane Kennedy: I hear that criticism.
are payphones still in most hospital wards and veryChairman: I have to say I was hospitalised in 1992
often TV rooms too. There are alternatives to thisand I hired a television at the bottom of my bed and
service if patients or relatives choose not to use it.it kept me sane in a sense. I did not like visitors
The basis on which we allowed it to go forward wasbecause they were interrupting my viewing pattern!
that it should not cost theHealth Service anymoney.
Working through that sort of detailed contract,Q667 Charlotte Atkins: I think we are being a little there have to be ways of paying for it.bit complacent here. Yes, of course the system is
great for patients but it is a nasty shock for people
who are ringing in when they get a huge bill. Maybe Q671 Charlotte Atkins: Real competition would be
the complaints are not very high because they get it the use of a mobile phone. Are you going to be
in their quarterly telephone bill three months later. looking at the issues around the use of mobile
That is the issue, is it not? phones? I appreciate that there are clinical reasons
Jane Kennedy: You have to appreciate that when we why mobile phones should not be used but that
said we would develop this scheme it was to be at no would be the alternative choice for most relatives
cost to the NHS, therefore the contractors are and patients.
investing significant sums in the roll-out and Jane Kennedy: I had not intended that this review
development of this facility for patients. Part of the would look at the extended use of mobile phones in
quid pro quo of that is that they have to recover their hospitals. I am told yes, we will be looking at
costs. These are all issues that we will want to look mobile phones.
at. We have taken the Ofcom comments very Charlotte Atkins:Excellent. An immediate change of
seriously and we want to review the arrangements. policy, marvellous.
Q668 Charlotte Atkins: Maybe you could have a Q672 Dr Stoate: It is called manifesto-plus.
look at the people who are calling in and are being Jane Kennedy: But not as part of this review.
subjected to these very high costs. It may well be that
you are talking about poorer friends and relatives of
people in hospital who cannot aVord to visit them in Q673 Chairman: I think that was one of the things in
the Ofcom letter to the Secretary of State, the issuehospital or are unable to for whatever reason. Is it
not the case also that, yes, they have got to recoup of mobile phone usage in hospitals. Could I move on
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to another areawhich is the issue of hospitals and car Ms Winterton: I know in my constituency the
parking. Should hospitals use parking to raise constant complaint is there is not enough parking
money? and the residents nearby say “people visiting the
Jane Kennedy: I see absolutely nothing wrong with hospital park outside our house” and visitors and
it. others say it is diYcult. I think it is quite important
that hospitals do respond to that. If people are
saying this is making life diYcult not only for themQ674 Chairman: Do you think that Trusts are
but for people who might want to come and seeproviding enough free parking for regular attendees,
them, making life diYcult for local residents, I thinksuch as cancer patients? We have gone from 10 years
what she may be getting at is if hospitals feel that isago when you would probably go into the acute
something that patients are asking for they willsector for a week or a fortnight to now where you go
respond to it. I think that is quite good, it can makein every day for an hour a day. Do you think Trusts
people feel quite valued if they think the hospital isought to be issuedwith guidelines saying that regular
responding to the points they have been makingpatients like that should be exempt from charges?
Jane Kennedy: It is very much for local Trusts to about the facilities available.
determine how they are going to manage their car
parking facilities. The vast majority do have
exemptions from charges. Hospital staV are pretty Q679 Charlotte Atkins: One of the areas which I am
good usually at advising patients when they might concerned about is chiropody. It increasingly seems
get exemptions from car parking. It is very much a to be moving into the private sector so elderly
matter for local determination. people, who rely very much on chiropody and it can
have a real impact on their mobility, are being
charged for that valuable service by default.Q675 Chairman:Do you keep a check on them at all?
Ms Winterton: I think there has been a longstandingJane Kennedy: I think we are content that the
argument about chiropody services. What I havepolicies are being applied properly. Most hospitals
been impressed with is the way that nowadays,will say it is enabling them to manage, as I said
earlier on this morning, the space around them more particularly for people with diabetes, for example,
eYciently, it discourages other people who are not who do need very good chiropody services, and
using the hospital from using the car parking space, beyond that podiatric services, increasingly in the
which in an inner city area is quite a problem for way some of the centres are operating they do
hospitals, and there are exemptions in place. provide that. There are always issues between
Obviously nothing is ever perfect but I think they are whether people in terms of having their nails cut
getting it broadly right. have that on the NHS or whether you ensure that
because of the terrible long-term eVects of
something like diabetes and you do not have properQ676 Chairman: No concerns about having it on a
corresponding chiropody services, you look atpro rata basis? Some of these car parking charges are
exactly what might happen if it is not treated. It isvery high, as high as airports and everything else. I
important to think we do target our resources whereknow you are not there for 24 hours but they are
there is going to be the most eVect, in a sense, andquite high charges for a short stay on occasions. You
do not really have a view, that is a matter for the where it is going to make a real clinical diVerence.
Trust, is it?
Jane Kennedy: I would pay easily—I am not sure
what it is in Liverpool now—a pound an hour to Q680 Charlotte Atkins: I can understand that, but if
park in the city centre to go shopping. I think these you are elderly and are unable to cut your own
are comparative charges and, therefore, fair in that toenails, the impact of that can be as devastating as
context. if you have a condition which requires you to have
professional help. If you literally cannot cut your
toenails then it will aVect your ability to walk andQ677 Chairman: Dame Gill Morgan from the NHS
mobility. I have had constituents who have said theyConfederation last week was sitting where you are
are unwilling to go to a chiropodist to have theirsitting and she said that car parking will increasingly
toenails cut because they do not think this isbe used as a competitive lever by hospitals to attract
something they should be doing on the NHSpatients. Would you be happy to see hospitals build
sometimes, and some who can aVord to will golarge car parks to win patients over?
Jane Kennedy: I do not see it as a draw for patients, private but there are others who will not be able to
I see it as a service for patients, and I am sure that aVord to do that on a regular basis.
staV would welcome it as well. Ms Winterton: I think there may be some examples
where PCTs may commission those kinds of services
for particular groups and perhaps it might be helpfulQ678 Chairman: Looked at through eyes like that, in
if we look intowhere there are good examples of thatview of what you said earlier about this issue of a
for the Committee.sustainable transport system and taking things out
Charlotte Atkins: I think so otherwise we are talkinginto the community, it could have an adverse eVect
about a whole group of elderly people beingif we were to see this type of competition as far as
housebound when there is no need for that totransport was concerned, forget the health side of it.
Do you think that there is a danger of that? happen.
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Q681 Chairman: Could I ask you about the likely provide within that Trust faster than their expansion
of service delivery through NHS provision. There iseVect of changes in the NHS to the structures of
charging. This “greater diversity of providers” a private patient cap.
Chairman: You will know where this is goingmentioned in the White Paper, does that not suggest
there is likely to be an extension of charges? because we took evidence on this last week from a
National Health Service Foundation Trust. I amMs Winterton: I do not think that should
automatically follow from that. The White Paper is going to bring Charlotte in now.
about looking at how we can provide more NHS
services in the community, making it more Q685 Charlotte Atkins: I would be interested to
convenient to people, making it closer to home, but know what your view is of the Jentle midwifery
it is not allowing within that an ability to say if you scheme at Queen Charlotte’s. We had evidence from
have day care surgery that comes under a diVerent Dame Gill Morgan who said it made her feel slightly
provider—I accept the point about the following uneasy and she described it as an “uncomfortable
medication—that provider would be allowed to situation”. What is your view?
charge for the service. It is about NHS services being Jane Kennedy: I would share that view. I have asked
oVered in a diVerent setting. for a report arising from the evidence you have
received about this and I am looking for oYcials to
investigate what has been developed at QueenQ682 Chairman: I have not got the White Paper with
Charlotte’s. The other response to make is one-to-me but what about areas of alternative medicine? I
one midwifery support is part of the Nationalgo along to a private sector person for acupuncture.
Service Framework, it is a commitment we made inI know you can get it in some pain clinics in hospitals
our manifesto. The brake on us delivering that is thebut I decided to do that myself. It is mainstream in
lack of midwives and we are working hard, as insome parts of the NHS and I could foresee a
other areas, to increase the numbers of people in thatsituation where a GP could turn round and say,
area. I think it has increased by 2,200. Progress is“Maybe acupuncture is a way of doing it. My
being made on that score but it is slow. In thecommissioning says I can give you one hour and we
meantime I want to really understand what iswill see how that goes”, whereas somebody might
happening in this particular case because I am alsothen go along and say, “For a small charge I will
uncomfortable with what I have heard about thisextend what the GP has commissioned”. Do you see
example.things like that could happen?
Jane Kennedy: GPs are limited in what they can
Q686 Charlotte Atkins: In your view, a one-to-onecharge for NHS patients who are on their list. It is a
midwifery service should be available to people onvery limited range of services that they can charge
the NHS?for and we have not got any plans to change that. If
Jane Kennedy: Yes.somebody like yourself was looking for acupuncture
provided through a referral from a GP you would
Q687 Charlotte Atkins: It should not be seen as anot be able to be charged for it unless it was on that
way of getting half price private treatment?very narrow list. In eVect, the patient would have to
Jane Kennedy: It is what we believe should be thecome oV the NHS list for the doctor to then say, “If
service that women should get from the Healthyou want to go privately”—
Service, yes. The only reason they are not getting itMs Winterton: I think NICE is looking at some of
is because we do not have enough midwives to bethe alternative therapies that are available.
able to provide it and that is why we are increasing
the numbers and trying to raise the profile of
Q683 Chairman: The White Paper suggests that will midwifery as a career and promoting it as a career.
be part and parcel of looking after people’s
wellbeing. Q688 Charlotte Atkins: Schemes such as the Jentle
Ms Winterton: If NICE looks at therapies that it midwifery scheme could reduce the number of
thinks are eVective it can, in a sense, recommend midwives still further.
those. It might be up to individual PCTs as to Jane Kennedy: It has caused a degree of concern to
whether they want to fund them completely in the me, yes.
first instance.
Q689 Chairman: Could I ask you a question I asked
a witness last week. Do you think there is anythingQ684 Chairman: What would you say if you had a
private provider who was in deficit and they said diVerent in principle from that additional charge
that there is in Chelsea Hospital to the charge for athey would like to develop some chargeable services
at the margins of their activities? Presumably you prescription?
Ms Winterton: In a sensewhere you have to draw thewould not be able to stop them. In the case of a
Foundation Trust, if they were to oVer services like line is if we were in a situation whereby something
that should be provided because it is clinicallythis would you say that was simply a matter for the
independent regulator? necessary is being charged for quite independently,
that would be very diYcult. The issue of aJane Kennedy: FoundationTrusts are strictly limited
in how much private work, if you want to call it that, prescription charge is that it is something which is in
law for whatever for reason but it has been acceptedthey can do. They are specifically prevented in law
from expanding the private provision that they as a generalised way of operation, it is a national
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scheme that applies everywhere. The general oVer private or add-on facilities. If there was felt to
be something going outside of that then it is possibleprinciples outwith that are that it is sometimes
possible for people to provide extra facilities but it is for ministers, in this case it would be Norman
Warner, to draw that to the attention of Monitor,a very fine line when it comes to what is clinical
treatment. That would be my instinct. particularly if it had been raised by Members of
Parliament, the public and so on.Jane Kennedy: I think as far as this particular case is
concerned, if you are a youngwoman pregnancy and
childbirth is probably the single greatest risk to your
Q694 Chairman: The other one that we gothealth that you are going to face in that period of
information on was a dermatology clinic inyour life and, therefore, if we have established what
Harrogate. I cannot remember exactly, I have notwe believe should be the national standard of service
got the letter with me, but they were removing molesthat you should get when you are facing that level of
and what was described to us as “cosmetic things”risk I think we should be providing that and that
and they were charging for that whilst other thingsshould be a provision the Health Service should
were being done on the National Health Service. Doprovide. In this case what is of particular concern is
you have any views on that?that what is being oVered is the national standard as
Ms Winterton: Again, that is something Normanopposed to an additional service.
Warner has asked for further information aboutChairman: I think we were told that the only
because it is not quite clear in terms of what I havediVerence—they are both deemed to be NHS
seen whether in a sense that was cosmetic surgerypatients—is you would have a named midwife who
being oVered or it is something which should be partwould be with you in all prenatal situations and with
of the clinical pathway, if you like.you at the birth as opposed to having a midwife with
you at the birth.
Charlotte Atkins: They have extras as well, that was Q695 Chairman: One of the things in the letter was
obviously clear. about botox. There are botox clinics up and down
the land now. If they are oVering that service in an
NHS establishment but charging for it, what wouldQ690 Chairman: That was my next question. In
your feelings be about that? Obviously it is cosmetic.principle is that what your initial thoughts are about
You would not be against that, would you?the uneasiness on this?
Jane Kennedy: I am less concerned about that than IJane Kennedy: I want to look in detail at what has
am the maternity example. I do not have thehappened here before coming to any judgment on it.
thorough detail but what I understand of the second
example is they are oVering services that otherwiseQ691 Chairman: The other thing that was said to us,
would not be available on the NHS because it isand I would just like your views on this, and it is
treatments that are not being done for clinicalquite cold, I accept this, was that this scheme has
reasons and in those circumstances it does not seemraised quite a large amount of money for that
to me too unreasonable for a Trust to do that.particular hospital which they have reinvested back
into employing people in there and improving their
service, as it were, presumably for everybody as Q696 Chairman: It is a bit like a large part of
opposed to just these people who are paying this dentistry which is cosmetic as opposed to a medical
extra money. What do you feel about that? or clinical need.
Jane Kennedy: We are going to face this kind of Ms Winterton: It may well be. As I say, I do not
initiative happening. We want to be sure that when know the complete details of it. I know that Norman
such initiatives are being taken forward by NHS Warner has asked for more information about it.
Trusts, they are doing it in a way which does not set Chairman: We will be interested to hear your views
precedents for other examples that we would not on that.
wish to see happen. We do need to be well informed
about what exactly is being developed.
Q697 Mr Campbell: Now that we have got a lot of
private providers coming into the Health Service, doQ692 Charlotte Atkins: Can you just outline what
you see the charges increasing over this period ofthe Government responsibilities are in terms of these
time?sorts of services being oVered by independent
Ms Winterton: As we have said, the key to the wayhospital Trusts? What responsibilities do you have?
that we invited private providers in is to always sayThey operate independently, so what is the role of
that these are services which are provided free tothe Government in this respect?
NHS patients. That is the way the contracts areMs Winterton: In this particular instance I presume
drawn up. There is no question of saying in any senseit is a Foundation Trust.
the patient has to contribute to the cost of theirJane Kennedy: No, this one is not.
operation.
Q693 Charlotte Atkins: In general, if it
was an independent Trust, what would your Q698 Mr Campbell: If I want to go to a hospital with
a gourmet meal with a glass of wine, a pint of beer inresponsibilities be?
Ms Winterton: If it was a Foundation Trust then my case, would I have to pay for that?
Ms Winterton: I suspect you might, yes. Free beer onobviously Monitor are given guidelines, as Jane
Kennedy set out, as to the extent to which they can the NHS is not necessarily the point.
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Q699 Mr Campbell: These private people are getting Ms Winterton: It is about saying if people want some
of those extras, if you like, that not everybody wantsin there and doing the business and I expect over
all the time, they can have those. The very basictime we will get these gourmet meals in hospital but
principle is that clinically necessary treatment is freewill there be a cap put on it?
and will remain so under this Government.Ms Winterton: There are issues here that if a private
Jane Kennedy: On the point Mr Campbell raisedhospital was oVering a service, it would not be able
about the gourmet meal and drink, the whole trendto charge back for the beer because it would be on
of hospital treatment these days is towards a shorterthe tariV as would take place in any other. It might
and shorter stay in hospital. You could expect to besay to you that it was making beer available and you
genuinely asked the question if you are being oVeredmight want a pint, if it was allowed in the
a gourmet meal in hospital, what are you doing incircumstances. That might be something that would
hospital when you could be at home? The Healthmake you say, “Iwould quite like to go there because
Service is going through a huge amount of change,I get a free pint”. Howard is looking horrified by
not just the reforms that we are bringing to it but thethis.
way in which treatments are being delivered is being
transformed by the way in which new medicines and
Q700 Dr Stoate: Just the opposite. When I was a treatments are being developed and the new
junior doctor we used to prescribe sherry and brandy innovations that are coming down the road. We
for medicinal purposes. Long may it continue. have to have a service, a public service, that responds
Ms Winterton: Put that in a review. to that as well as providing a service that protects
and provides the quality of service that we all expect
and demand.Q701 Mr Amess: I think these Ministers have done
a brilliant job of blocking everything that we have
slung at them. Q704 Mr Amess: Finally, looking into your crystal
Ms Winterton: You always say that. ball, surely it must be the case that in five years’ time
there will be more charging because the way things
are goingwith the endless demand there is noway weQ702 Mr Amess: They have even managed to can keep collecting it all from taxation. Surely it willsurvive the vicious attacks of Dr Richard Taylor this be the case that in five years there will have to be aafternoon! I shall always remember that expression lot of charges.“refine the principles”. On that very point, as far as Ms Winterton: Do you mean demands for diVerentthe National Health Service is concerned, does the treatments?Government think that the NHS will have to be
redefined so that there will be a core package of
services provided by the NHS above which you Q705 Mr Amess: Yes.
could have varying degrees of payments according Ms Winterton: In a sense that is the system that we
to the income of the patient? This would be the have where drugs and treatments are looked at as to
bottom line of what you could get on the NHS and whether they are eVective, whether they are safe,
the rest of it, depending on what money the patient whether it is something that should be widespread
had, you could be charged for all sorts of other across the whole of the NHS. There is a system
services. which does look at those issues as to exactly what we
Jane Kennedy: I do not think I accept that scenario. can expect the National Health Service to provide
We have brought forward and established National but, as I say, that is rather diVerent from what one
Service Frameworks in a wide range of fields and might talk about as added extras that are not to do
they set a national standard by which we expect the with a clinical treatment.
NHS to deliver services. What we have done is say it
does not always have to be provided through an
Q706 Mr Amess: Surely there is a worry that with anNHS organisation, it is possible to allow other
ageing population, okay not in five years but ten, 15,organisations to provide these services albeit paid
20 years, with less of a proportion working I do notfor by the NHS. In a sense we already have a
quite see where the money is going to come from justdefinition of what services should be available
through taxation because of the huge demands.through the NHS. What we have been discussing
Jane Kennedy: The prescription charge, if we takethis morning is where on the edge of that definition it
that as an example, was 45p in 1979. It rose to aboutmight be possible forNHSorganisations and others,
£5.80 in 1998 and it has gone up by 10p a year sinceand indeed the state, to raise resources by charging.
then. That is a slowing down in the overall chargeThat is the debate that we are having today and we
rate. When you couple that with the reduction in thewill continue to have, I am sure.
number of people who are having to pay, or ratherMs Winterton: I think it goes back to theChairman’s
the growing number of people being exempt, thenpoint about the television that he rented during his
the experience of people in the prescription chargetime in hospital because in a sense that was
field is that charges are declining in the sense that wesomething that gave a great deal of comfort and
are charging fewer people. In the end it is clearly arelieved the boredom perhaps or whatever.
matter of political judgment as to how far you allow
the boundary of charging to encroach. Our position
is quite clear: patients should receive the treatmentQ703 Chairman: I was in traction at the time.
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that they need at the point they need it and it should Q708 Dr Taylor: A very quick question. Having
be free and not dependent upon their ability to pay, looked at HC1 I am absolutely horrified. It is the
with the exception of prescription charges. most impossible form anybody could ever have to fill
Chairman: And dental charges and optician’s in even if they were 50 with an IQ of 150. Could you
charges. consider the Citizens Advice Bureau’s suggestion to
“simply state anyone on a means-tested benefit
Q707 Mr Amess: I am sure that I speak on behalf of should be eligible for exemption from charges” and
everyone, all those who were here last week to hear look into that and see what that would mean inthe evidence from the lady who was suVering from financial terms. This is horrifying.cystic fibrosis, when I say if anything comes out of
Jane Kennedy: I am happy to look at what thethis inquiry we really, really, really hope that when
Citizens Advice Bureau recommended on that score.you look at our report—I understand the reasons for
Chairman: Ministers, could I thank you for coming.not changing anything but the evidence that we were
I know we have had quite a long session again todaygiven last week really moved us.
but thank you very much indeed. I hope we will beMs Winterton: Did you have a private Member’s bill
able to make some recommendations that go beyondon that?
Mr Amess: Might have! the review that we have had for the last 25 years.
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Written evidence
Supplementary memoranda from the Department of Health (CP 01A)
During the session with Department of Health oYcials on NHS charges on 19 January, the Committee
asked for two additional pieces of information in relation to optical services.
First, they asked for confirmation of the assurances which have been given by the Minister of State for
Health Services in relation to the implications of the ophthalmic clauses of the Health Bill. These have been
put on the record in Hansard on 11 January.1
Second, the Committee asked for the figures for the real terms increase in expenditure on NHS funded
sight tests. These figures are set out in the attached table which is drawn from a recently published Statistical
Bulletin for 2004–05 prepared by the Health and Social Care Information Centre. These figures show a 68%
real terms increase in expenditure on NHS sight tests between 1994–95 and 2004–05.
Table
GENERAL OPHTHALMIC SERVICES EXPENDITURE, ENGLAND, AT 2004–05 PRICES
£ million
Total gross Cost of sight test Cost of glasses
Financial Year expenditure2, 3, 4 provision5 provision6
1994–95 275.0 112.6 162.1
1995–96 279.7 113.4 166.0
1996–97 286.7 117.4 169.0
1997–98 285.5 121.3 163.9
1998–99 277.4 119.5 157.5
1999–2000 321.1 166.9 153.5
2000–01 321.3 171.5 149.3
2001–02 327.0 176.0 150.3
2002–037 318.6 171.4 146.5
2003–04 328.5 178.0 149.4
2004–05 340.0 189.1 149.7
Re-used with the permission of the:
Family Health Services Authority Annual Accounts (1992–93 to 1995–96), Health Authority Annual
Accounts (1996–97 to 1998–99), Health Authority Audited Summarisation Forms (1999–2000 to 2001–02),
Strategic Health Authority Audited Summarisation Forms (2002–03), Primary Care Trust Audited
Summarisation Schedules (2002–03 to 2004–05)
I hope that this provides the Committee with the information sought.
Department of Health
1 February 2006
1 HC Deb, 11 January 2006, col 721W.
2 Expenditure is on a resource or accruals basis.
3 Revalued to 2004–05 prices using GDP deflators (December 2005).
4 Includes; cost of grants to supervisors of ophthalmic optical graduate trainees, not counted in the cost of sight tests or the
cost of glasses provision.
5 An estimated proportion of total expenditure based on more detailed breakdown of costs available in same year’s cash
monitoring data. Comprises fees paid to OOs and OMPs, including payments for domiciliary visits, help given towards private
sight tests and employers’ superannuation contributions.
6 An estimated proportion of total expenditure based on more detailed breakdown of costs available in same year’s cash
monitoring data. Comprises the cost of vouchers and repairs and replacements.
7 The consistency of data may have been aVected by the changeover in accounting responsibilities from Strategic Health
Authorities to Primary Care Trusts from 1 October 2002. Cost of sight tests and glasses estimated, assuming same proportions
as in 2001–02.
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PATIENT CHARGES FOR MEDICINES IN SOME OTHER EUROPEAN COUNTRIES
General
1. Co-payment systems for medicines vary considerably from country to country within the EU. The
diVerent co-payment arrangements are related to the relevant country’s health care system, and the
country’s pricing and reimbursement policies for pharmaceuticals. It is therefore diYcult to make direct
comparisons between countries.
2. Broadly speaking the systems can be divided into (1) countries with cap based systems (Sweden,
Denmark, Ireland), (2) countries with a fixed charge (UK, Italy), (3) countries with a percentage based
charge (Spain, France), and (4) countries which use a mixture of the three (Germany, Finland).
3. However, these are very broad categories, and most systems have an element of other systems in them.
For example, in the UK where patients purchase a pre-payment certificate, this places a maximum on the
prescription charges that an individual pays in a year. In Denmark and Sweden, patients pay the full cost
of their medicines until they reach a threshold and the cap kicks in. The caps usually relate to the maximum
amount spent in a month or over a year.
4. In addition, most systems operate with reduced co-payments and exemptions for certain groups.
Germany and France exempt the chronically ill, while Spain operates with reduced co-payments for the
same group. Other countries also have some form of reduced co-payment or exemptions for certain medical
conditions and age.
Country Reduced co-payment and Exemptions
Germany Under 18 year olds, chronically ill
Spain Chronically ill, over 65 year olds, the disabled, those injured at work or suVering
from toxic syndrome
France Certain serious diseases, chronic conditions, invalids, expectant mothers, the
unemployed, those on low income
Ireland Long Term Illness Scheme—covers certain medical conditions (diabetes, cystic
fibrosis, multiple sclerosis)
UK Medical exemptions, over 60 years old, under 16 year olds, people on low income,
expectant mothers.
5. In all the countries looked at patients must contribute towards their medication, except in the
Netherlands where relatively few medicines actually attract a co-payment.
6. Below is a more detailed description of each country’s co-payment system. All information is based
on the IMS publication “Concise Guide: Pharmaceutical Pricing & Reimbursement”, published in 2005.
There may have been policy changes aVecting the co-payment systems in these countries subsequent to the
IMS publication, hence, the information may not be one hundred percent accurate.
Germany
7. According to the 2004 healthcare reform bill, patients have to pay 10% of the cost of their prescribed
drugs. However, the minimum patient co-payment per pack is £3.40 (ƒ5) and the maximum is £6.70 (ƒ10).
The co-payment can never be more than the price of the drug. Patients are also obliged to pay any diVerence
between the reference price and the actual price of the product dispensed.
8. Only the following patients qualify for exemption from co-payments;
— Under 18 year olds;
— chronically ill patients who have paid out as least 1% of gross family income for medical treatment
and services in any full year. Chronically ill persons are defined as those needing to see a doctor
at least once every quarter for the same condition, and who also fall into one of the following
groupings: patients in nursing care; patients who are severely handicapped or have diminished
ability to work; patients in need of continual medical treatment; and
— anyone who has paid out at least 2% of their gross income on co-payment charges.
9. Social benefit recipients and families benefit from reduced maximum co-payments.
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Italy
10. Co-payments diVer from region to region.
11. The most common systems are:
— co-payments per pack—they usually range from £0.70 (ƒ1) to £1.40 (ƒ2), with a maximum of
between £2 (ƒ3) to £3.70 (ƒ5.5) per prescription; and
— co-payments per prescription—usually £0.70 (ƒ1) per prescription.
Some regions have no prescription charges.
11. In all regions, patients are obliged to pay any diVerence between the reference price and the actual
price to secure a drug priced about the reference price level.
Spain
12. Patients pay nothing for drugs dispensed in hospitals, 10% for drugs for certain chronic conditions,
40% for the majority of prescription drugs, and 100% for non-reimbursed products and advertisable OTCs.
13. There is amaximumcharge for the chronically sick of £1.80 (ƒ2.63) per prescription. Pensioners (over
65), the disabled (with more than 33% disability), as well as those who have been injured at work or suVer
from toxic syndrome, are all exempted from any form of co-payment. In 2003, these groups accounted for
69% of reimbursed prescriptions.
14. Under the reference price system all patients who reject substitution and insist on receiving a
medication priced above the reference price are obliged to pay the full price of the drug. In reality, this is
largely theoretical, as manufacturers have cut their prices.
France
15. Patients are liable for the non-reimbursed portion of the drug price (0%, 35% or 65%), although 92%
of the population takes out complementary health insurance, provided byMutuelles or commercial insurers,
to cover the cost of co-payments.
16. Full reimbursement is granted for:
— drugs prescribed for the treatment of 30 serious diseases;
— the treatment of other chronic conditions;
— patients requiring multiple therapies; and
— exempt patients: invalids, expectant mothers and the unemployed, and those on low incomes with
universal sickness coverage.
17. For dugs included in the reference price reimbursement system, patients are required to pay any
diVerence between the reference price and the price of the drug dispensed. Few complementary insurance
schemes cover the excess over the reference price.
Sweden
18. Patients are required to pay the full cost of all reimbursable medicines (except insulin) until they reach
a threshold of £63 (SKr 900) over a one-year period from the date of first purchase. Patients then pay a
proportion of costs up to £302 (SKr 4,300), above which any additional medicines prescribed are free of
charge for the remainder of the year.
19. Around 10–15% of the population qualify under this scheme each year. The cost of prescriptions for
children under 18 within a family may be added together. Patients are also liable for any excess if they refuse
to accept substitution of the prescribed product. This is not included in the annual accumulated total spend.
20. Patients are issued with an Apoteket card, which is used to access a database storing information on
the reimbursement status of the patients.
Denmark
21. All reimbursable medicines have equal reimbursement status. Patients are required to pay the full cost
of all reimbursable medicines until they reach a threshold of £47 (DKr 520) over a one-year period from the
date of first purchase. Patients then pay a proportion of costs up to £343 (DKr 3,805), above which any
additional medicines prescribed are free of charge for the remainder of the year.
22. Patients under 18 years of age are not covered by the lower limit of £47. Instead, a reimbursement
rate of 50% applies for all expenditure up to £114, before the rates for over 18s kick in. There are no general
exemptions, although the poor and pensioners in financial need can get help paying for their medicine from
the local authority.
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23. Each pharmacy uses the Danish Medicines Agency’s nationwide database, the Central
Reimbursement Register, which ensures that patients receive the correct reimbursement rate.
24. Hospital patients are not required to pay for their medicines.
Finland
25. Patients are required to contribute the following:
— drugs in the basic refund category: £6.70 (ƒ10), plus 50% of the remaining cost;
— lower special reimbursement category: £3.40 (ƒ5), plus 25% of the remaining cost; and
— upper special reimbursement category: £3.40 (ƒ5).
26. The co-payment is valid for all prescriptions in the same reimbursement category collected by the
patient at the same time. For instance, if a patient has three diVerent prescriptions for the basic refund
category, there is a single charge of £6.70 (ƒ10) and reimbursement is 50% of the total sum exceeding £6.70.
27. The annual limit for a patient’s expenses on reimbursable drugs was set at £407 (ƒ604.72) in 2004. If
this sum is exceeded by more than £11 (ƒ16.82), the patient receives full reimbursement.
28. The reimbursement scheme reimbursed 64.5% of medicine expenses in 2003.
Ireland
29. Medical cards, held by around 29% of the population, entitle patients to free medication. A smaller
proportion of people (2%) are also eligible to receive free medication through the LongTerm Illness Scheme,
which covers 15 listed medical conditions, including diabetes, cystic fibrosis and multiple sclerosis. Only
drugs for the treatment of the patient’s listed conditions are provided without a co-payment.
30. Patients who do not qualify for a medical card and are required to pay their prescription drug costs
in full can apply for a Drugs Payment Scheme Card on an individual or family basis. Under the scheme,
patients contribute up to £52 (ƒ78) a month towards the cost of their prescriptions. Once this threshold is
exceeded, the Health Board pays the remainder of the bill. 36% of the population applied for the card in
2003.
Netherlands
31. Under the reimbursement scheme, only products listed Annex 1A of the positive list require patients
to make a co-payment. (Annex 1A: similar interchangeable products reimbursed according to a reference
price system.) Even in Annex 1A patients receive reimbursed medical products free of charge unless the
product is priced above the maximum reimbursement level. As manufacturers tend to bring the price of their
products down to the reimbursement level to maintain market share by avoiding patients having to pay out-
of-pocket, relatively few products attract a co-payment. Patient’s co-payment constituted 0.5% of total
pharmaceutical expenditure in 2003. Including payment for OTC products, the proportion rose to 3.5%.
Department of Health
February 2006
CHARGING OPTIONS FOR PRESCRIPTION CHARGES, DENTAL AND OPTICAL CHARGES
CONSIDERED AS PART OF THE 1998 CSR
PRESCRIPTION CHARGES
Introduction
This paper sets out the scenarios that were analysed in relation to prescription charges, dental charges and
eligibility for optical services as part of the Comprehensive Spending Review in 1998. Ministers decided to
make no change to prescription charges and dental charges as a result of the review. Free sight tests for those
aged 60 and over were re-introduced in 1999.
Medical exemptions
— Restriction of medical exemption to items intended to treat the qualifying condition—estimated
savings of £15–£20 million per year.
— Increasing the list of exemptions to include other exemptions—it was concluded that it was not
possible to estimate the cost prior to agreement on the additional conditions to be included and
an assessment of the medicine utilisation of the groups concerned.
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Prescription charge for over 60s as income threshold
— Introduce prescription charges for those aged 60 or over with an income above a defined income
threshold—the savings would depend upon the threshold above which those aged 60 or over were
required to pay charge.
Low flat rate charge with no exemptions with annual pre-payment certificate charge available at 25 times
the prescription charge.
— A flat rate of £1 per item with no exemptions would save £120 million.
— A £2 charge per item would produce additional charge income of £410 million.
A medium flat rate charge (eg £4.00) with exemptions for all children up to age 18 and for non disablement
pensioners, possibly with a more generous low income exemption, but without automatic exemptions for
other exempt groups.
— A charge of £4.00 was estimated to produce additional income for the NHS of around £250 million
a year.
Introduce a system of co-payments which linked the charge payable to the cost and/or relative
eVectiveness of the item dispensed.
— The increase or reduction for such a system would depend upon the level of the charge and the
exemptions from that charge.
Charge per prescription rather than by item
— A charge per script would limit outlay for patients requiring more than one item. It was estimated
that this would reduce prescription charge income by £50 million. It was estimated that other costs
would result from a change in patient behaviour such as where medicines that otherwise were
purchased over the counter would be added to a prescription.
Dental charges
— Free dental examinations for all NHS patients—estimated cost £120 million per annum.
— Free dental examinations for those aged 60 or more—estimated cost £20 million a year.
Sight tests
— Universal eligibility for NHS sight tests—estimated cost £120 million per annum.
— Free sight tests for those aged 60 or more—estimated cost £30 million.
Cross cutting issue
— Extend exemption for free prescriptions, dental treatment, sight tests and optical vouchers
available to 16 to 18 olds in full time education to all young people in this age range.
— The cost of this option was estimated to be £5 million per annum.
Review the low income scheme
— This was discussed in principle but no details were considered.
Department of Health
February 2006
PRESCRIPTION CHARGES FOR HOSPITAL PATIENTS
The Committee raised the question of a directive from the Department about out-patient charges and
that anyone who had been in hospital less than 24 hours should pay a charge for the drugs they take away
with them.
The position is that no “directive” has been issued. The 1977 NHS Act itself provides that no charge shall
be made for a patient who is residing in hospital. We do not have a definition of “residing” in the Charges
Legislation but if asked we advise that this would involve an overnight stay. We do not mention “less than
24 hours”. If the patient has had an overnight stay, their discharge medication would be free of charge
because it was supplied to them while they were still residing in hospital.
It would be for the Trust to apply the Charges Legislation and to decide if a patient was “residing” at the
time medication was supplied to them.
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HOSPITAL PARKING SPACES AND INCOME
Income Income
Total from staV from visitor
parking Parking Parking
spaces £ £
England 378,720 15,130,961 62,755,934
Notes:
Figures provided on a voluntary basis. 80% of NHS Hospital Trusts responded.
Source
Estates Return Information Collection 2004–05.
Total
parking
Total spaces
parking available for Income
spaces patients/ Income from
available visitors from staV visitors
Trust Name No No £ £
New Forest PCT 322 322 — —
Norwich PCT 996 215 — 48,615
South Gloucestershire PCT 416 296 — —
Havering PCT 553 — —
Kingston PCT 211 164 — —
Bromley PCT 301 52 — —
Greenwich PCT 359 142 — —
Barnet PCT 671 158 — —
South Manchester PCT 166 173 — —
Daventry and South Northamptonshire PCT 204 175 — —
North Peterborough PCT 50 50 — —
South Peterborough PCT 21 21 — —
Tendring PCT 554 — — —
Epping Forest PCT 51 49 — —
Southend-on-Sea PCT 283 — — —
Central Derby PCT 86 59 — —
Mansfield District PCT 444 287 — —
North East Lincolnshire PCT 88
Newark and Sherwood PCT 64 61 — —
Hillingdon PCT 571 299 — —
Airedale PCT 223 211 — —
Enfield PCT 1,219 550 4,680 —
Barking and Dagenham PCT
City and Hackney PCT 210 210 — —
Tower Hamlets PCT 218 2 14,003 5,110
Newham PCT 254 229 — —
Haringey Teaching PCT 426 407 — —
Blackburn with Darwen PCT 333 287 — —
North Dorset PCT 486 405 — —
Bournemouth PCT 59 12 — —
Bradford City PCT 290 — — —
Bradford South and West PCT 190 207 — —
North Bradford PCT 179 138 — —
Doncaster Central PCT 111 111 — —
Central Manchester PCT 299 — — —
Dartford Gravesham and Swanley PCT 397 382 — —
Herefordshire PCT 415 2 — —
Hertsmere PCT 70
Milton Keynes PCT 516 199 — —
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Total
parking
Total spaces
parking available for Income
spaces patients/ Income from
available visitors from staV visitors
Trust Name No No £ £
North Manchester PCT 219 226 — —
South Hams and West Devon PCT 208 178 — 1,856
Torbay PCT 143 82 — —
TraVord South PCT 209 143 — —
West Norfolk PCT 256 260 — —
Solihull PCT 462 107 13,646 —
West Lincolnshire PCT 284 153 — —
Lincolnshire South West Teaching PCT 132 67 — —
Carlisle and District PCT 137 51 — —
Eden Valley PCT 324 324 — —
West Cumbria PCT 518 262 — —
Newcastle PCT —
North Tyneside PCT
Hartlepool PCT 50 25 — —
Harlow PCT 94 12 — —
Morecambe Bay PCT 756
North Hampshire PCT 361 360 — —
Isle of Wight PCT 25 25 — —
West Wiltshire PCT 501 — — —
South Wiltshire PCT 75 — — —
Newbury and Community PCT 273 158 — —
Reading PCT 343 343 — —
Slough PCT 330 330 — —
Wokingham PCT 170 170 — —
Vale of Aylesbury PCT 221 219 — —
Burntwood Lichfield and Tamworth PCT 586 — — —
Wyre Forest PCT 169 101 — —
North East Oxfordshire PCT 29 25 — —
Cherwell Vale PCT 123 94 — —
Oxford City PCT 123 62 — —
South East Oxfordshire PCT 153 129 — —
South West Oxfordshire PCT 435 344 — —
North Tees PCT 172 138 — —
Selby and York PCT 641 251 — —
East Yorkshire PCT 352 207 — —
Yorkshire Wolds and Coast PCT 196 132 — —
Eastern Hull PCT 306 306 — —
West Hull PCT 124 119 — —
Eastern Wakefield PCT 207 207 — —
Wakefield West PCT 141 131 2,400 —
Mid-Hampshire PCT 40 2 — —
Chesterfield PCT 545 541 — —
Gedling PCT 48 — — —
Amber Valley PCT 349 343 — —
North SheYeld PCT 32 32 — —
North Lincolnshire PCT 252 252 — —
North Eastern Derbyshire PCT 363 354 — —
Melton Rutland and Harborough PCT 900 884 — —
Leicester City West PCT 190 — — —
Doncaster East PCT 193 193 — —
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Total
parking
Total spaces
parking available for Income
spaces patients/ Income from
available visitors from staV visitors
Trust Name No No £ £
Doncaster West PCT 127 127 — —
Nottingham City PCT — — — —
SheYeld West PCT 50 15 — —
SheYeld South West PCT 92 92 — —
South East SheYeld PCT 67 67 — —
Erewash PCT 290 243 — —
Bassetlaw PCT 147 127 — —
Broxtowe and Hucknall PCT 227 174 — —
Greater Derby PCT 226 19 — —
Eastern Leicester PCT 208 — — —
Plymouth PCT 878 878 — —
Chorley and South Ribble PCT 226
West Lancashire PCT 358 278 10,821 6,573
Heywood and Middleton PCT 36 36 — —
Salford PCT 170
TraVord North PCT 238 119 — —
Stockport PCT 384 — — —
Bebington and West Wirral PCT 136 — — —
Southport and Formby PCT 173 — — —
Ashfield PCT 130 92 — —
RushcliVe PCT 174 — — —
East Hampshire PCT 388
Portsmouth City PCT 773 381 — —
South West Kent PCT 276 184 — —
Bexhill and Rother PCT 126 — — —
Hastings and St Leonards PCT 52 — — —
Mid-Sussex PCT 263 263 — —
Bath and North East Somerset PCT 448 339 — —
West of Cornwall PCT 535 388 — —
South and East Dorset PCT 607 207 — —
South West Dorset PCT 402 382 133 11,193
North Devon PCT 250 80 — 13,000
Exeter PCT 332 313 9,019 7,382
East Devon PCT 650 567 — —
Mid Devon PCT 365 335 — —
Somerset Coast PCT 194 91 4,500 14,600
Mendip PCT 119
Teignbridge PCT 241 163 — —
Southern Norfolk PCT 215 59 — —
Bracknell Forest PCT 92 92 — —
Windsor Ascot and Maidenhead PCT 500 500 — —
Chiltern and South Bucks PCT 119 119 — —
Blackwater Valley and Hart PCT 155
Hyndburn and Ribble Valley PCT 340 282 — —
Burnley Pendle and Rossendale PCT — — —
North Liverpool PCT 56 25 — —
Luton PCT 102 69 — —
Bedford PCT 353 348 — —
Bedfordshire Heartlands PCT 213 158 — —
Huntingdonshire PCT
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Welwyn Hatfield PCT 152 52 20,872 —
North Hertfordshire and Stevenage PCT 191 191 — —
South East Hertfordshire PCT —
Royston Buntingford and Bishop’s Stortford PCT 280 282 — 47,906
Maldon and South Chelmsford PCT 153 93 — —
Colchester PCT 1,069
Uttlesford PCT 122 122 — —
Billericay Brentwood and Wickford PCT 213 — — —
Thurrock PCT 122 64 — —
Basildon PCT 151
Great Yarmouth PCT 50 43 — —
Watford and Three Rivers PCT 310 200 — —
Dacorum PCT 57 21 — —
St Albans and Harpenden PCT 72
Hammersmith and Fulham PCT 43
Birkenhead and Wallasey PCT 632 506 — —
Cheshire West PCT 337
Central Cheshire PCT 345
Eastern Cheshire PCT 49
Ellesmere Port and Neston PCT 178
Derbyshire Dales and South Derbyshire PCT 101 57 — —
Rotherham PCT 368 368 — —
East Lincolnshire PCT 491 192 — 14,350
Central Liverpool PCT 491 156 — —
South Liverpool PCT 212 49 — —
Preston PCT 857 857 — —
Fylde PCT 289 — — —
Wyre PCT 66 66 — —
Ashton Leigh and Wigan PCT 171 113 5,640 —
Leeds West PCT 120 31 — —
Leeds North East PCT 144 144 — —
East Leeds PCT — — — —
South Leeds PCT 140 34 — —
Leeds North West PCT 211 144 — —
High Peak and Dales PCT 388 388 — —
Blackpool PCT 137 137 — —
Bolton PCT 506 — — —
StaVordshire Moorlands PCT 289 138 — —
Dudley South PCT 485 — — —
Dudley Beacon and Castle PCT 438 — — —
Newcastle-under-Lyme PCT 300
Ealing PCT 414
Hounslow PCT 473
Halton PCT 275
Warrington PCT 535 330 — —
St Helens PCT 350 165 — —
Knowsley PCT 340 120 — —
Oldham PCT 505 148 — —
Calderdale PCT 236 — — —
North Kirklees PCT 177 58 — —
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Durham Dales PCT 160 130 — —
Darlington PCT 176 23 22,776 —
Hinckley and Bosworth PCT 155 155 — —
Charnwood and North West Leicestershire PCT 990 — — —
South Leicestershire PCT 114 — — —
Barnsley PCT 780 — — —
Bristol North PCT 384 224 — —
Bristol South and West PCT 387 180 — —
Cambridge City PCT 198 198 — —
South Cambridgeshire PCT 152 152 — —
East Cambridgeshire and Fenland PCT 447 447 — —
Broadland PCT 219 61 — —
North Norfolk PCT 315 94 — —
Chelmsford PCT 51 — — —
Castle Point and Rochford PCT 82 — — —
Ipswich PCT 48 — — —
SuVolk Coastal PCT 87 — — —
Central SuVolk PCT 116 — — —
Waveney PCT 148 — — —
SuVolk West PCT 171 — — —
Bury PCT 195 208 — —
Rochdale PCT
South Somerset PCT 118 118 — —
Taunton Deane PCT 122 25 — —
Swindon PCT 292 — — —
Kennet and North Wiltshire PCT 844 — — —
Brent PCT 180 46 10,201 22,726
Harrow PCT 111 111 — —
Camden PCT 156 — — —
Islington PCT 69 — — —
Croydon PCT 211 82 — —
Derwentside PCT 22 5 — —
Durham and Chester-le-Street PCT 149 56 6 6
Easington PCT 24
Sedgefield PCT 120 60 — —
Gateshead PCT 113 113 — —
South Tyneside PCT 206 116 — —
Hambleton and Richmondshire PCT 245 193 — —
Craven Harrogate and Rural District PCT 886 456 — —
Scarborough Whitby and Ryedale PCT 281 225 — —
Sunderland Teaching PCT 560 224 — —
Middlesbrough PCT 401 401 — —
Langbaurgh PCT 385 385 — —
East Elmbridge and Mid Surrey PCT — — — —
East Surrey PCT 60 40 — —
North and East Cornwall PCT 372 372 — —
Central Cornwall PCT 284 209 — —
Poole PCT 96 50 — —
Cheltenham and Tewkesbury PCT 170
West Gloucestershire PCT 310 62 — —
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Cotswold and Vale PCT 535 352 — —
Southampton City PCT 757 757 — —
Maidstone Weald PCT 259 67 — —
Medway PCT 426 310 — —
Swale PCT 419 285 — —
Guildford and Waverley PCT 753
North Surrey PCT 878 306 — —
Surrey Heath and Woking PCT 427 193 — —
Adur Arun and Worthing PCT 368 149 — —
Western Sussex PCT 384 121 — —
Kensington and Chelsea PCT 126 36 9,180 —
Westminster PCT 86 12 2,562 9,712
Lambeth PCT 144 57 — —
Southwark PCT 200 54 — —
Lewisham PCT 276 133 — —
Wandsworth PCT 604 309 — —
Tameside and Glossop PCT 486 486 — —
Huddersfield Central PCT 96 — — —
South Huddersfield PCT 114 — — —
Ashford PCT 184
Canterbury and Coastal PCT 227
East Kent Coastal PCT 367
Shepway PCT 72
Eastbourne Downs PCT 189 — — —
Sussex Downs and Weald PCT 408 257 — —
Northamptonshire Heartlands PCT 527 257 — —
Northampton PCT 177 5 — —
Fareham and Gosport PCT 559
Eastleigh and Test Valley South PCT 55 44 — —
South Birmingham PCT 677
Shropshire County PCT 649 166 — —
Walsall PCT 1,103 293 — —
South Sefton PCT 241 103 — —
Richmond and Twickenham PCT 104 51 — —
Sutton and Merton PCT 798 262 — —
North Somerset PCT 94 92 — —
Rugby PCT 26 26 — —
Crawley PCT
Horsham and CHanctonbury PCT 288 — — —
Coventry PCT
North Stoke PCT 836 46 5,259 22,610
South Stoke PCT 446
Oldbury and Smethwick PCT 157 165 — —
Rowley Regis and Tipton PCT 144 144 — —
Wednesbury and West Bromwich PCt
Telford and Wrekin PCT — 0 0 —
East StaVordshire PCT 68 — — —
Cannock Chase PCT 117 — — —
South Western StaVordshire PCT 223 12 — —
North Warwickshire PCT 1,051 1,042 — —
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South Warwickshire PCT 532
Redditch and Bromsgrove PCT 376 206 1,233 44,931
South Worcestershire PCT 570 338 — 16,929
Wolverhampton City PCT 666 370 — —
North Birmingham PCT 121 — — —
Heart of Birmingham Teaching PCT 447 — — —
Eastern Birmingham PCT 448 — — —
Redbridge PCT 200
Waltham Forest PCT 276 109 — —
Royal Surrey County Hospital NHS Trust 1,162 451
Weston Area Health NHS Trust 868 334 — 272,529
East Somerset NHS Trust 518 183 12,500 103,893
United Bristol Healthcare NHS Trust 1,030 252 137,214 284,256
South Devon Health Care NHS Trust 1,650 350 80,555 337,764
Bradford Teaching Hospitals NHS Foundation
Trust 540 696,000 861,000
Southend Hospital NHS Trust 1,072 231 — 548,369
Royal Free Hampstead NHS Trust 394 148 116,370 267,506
The Royal National Orthopaedic Hospital NHS
Trust 589 528 22,200 —
North Middlesex University Hospital NHS Trust
The Hillingdon Hospital NHS Trust 1,877 374 — 444,383
North East London Mental Health NHS Trust 739
Kingston Hospital nHS Trust 797
Avon Ambulance Service NHS Trust 291 — — —
Essex Ambulance Service NHS Trust 5 — —
Gloucestershire Ambulance Services NHS Trust 196 15 — —
Mersey Regional Ambulance Service NHS Trust 228 225 — —
StaVordshire Ambulance Service NHS Trust 89 2 — —
South Yorkshire Ambulance Service NHS Trust 245 30 — —
Taunton and Somerset NHS Trust 1,263 387 210,407 350,093
Royal National Hospital for Rheumatic Diseases
NHS Foundation Trust 22 — — —
West Dorset General Hospitals NHS Trust 848
NuYeld Orthopaedic NHS Trust 443 90 16,952 133,286
Walsall Hospitals NHS Trust 1,355 250 48,000 380,000
Wirral Hospital NHS Trust 2,358 1,104 — —
St Helens and Knowsley Hospitals NHS Trust 1,699 797 — 281,214
The Cardiothoracic Centre Liverpool NHS Trust 155
Royal Liverpool Childrens NHS Trust 1,025 819 — —
The Mid Cheshire Hospitals NHS Trust 1,733
Christie Hospital NHS Trust 653 245 54,464 138,567
Lincolnshire Ambulance and Health Transport
Service NHS Trust 331
Northern Devon Healthcare NHS Trust 1,000 309 72,578 238,858
Bedford Hospitals NHS Trust 1,113 836 24,444 152,431
Ealing Hospital NHS Trust 628 164 — 189,957
Luton and Dunstable Hospital NHS Trust 1,053 406 — 914,352
York Health Services NHS Trust 1,119 437 76,516 380,026
Scarborough and North East Yorkshire Health
Care NHS Trust 1,012 869 — 195,000
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Harrogate and District NHS Foundation Trust 331 120,499 302,101
Airedale NHS Trust 1,403 590 — —
Nottingham City Hospital NHS Trust 2,000 800 192,369 748,004
SheYeld Children’s NHS Trust 215
Queen Elizabeth Hospital Kings Lynn NHS Trust 1,082 621 93,330 372,119
Royal United Hospital Bath NHS Trust 1,145 437 114,090 599,288
Poole Hospitals NHS Trust 1,462 267 232,790 390,499
Heatherwood and Wexham Park Hospitals NHS
Trust 1,944 585 — 475,000
Milton Keynes General Hospital NHS Trust 1,274 465 74,403 337,733
Basildon and Thurrock University Hospitals NHS
Foundation Trust 1,368 — 1,039,481
Essex Rivers Healthcare NHS Trust 1,475
South DOWNS Health NHS Trust 730 — — —
Frimley Park Hospital NHS Foundation Trust 1,298 340 101,828 683,271
Dorset Health Care NHS Trust 634 12 — —
Royal Bournemouth and ChrisTchurch Hospitals
NHS Foundation Trust 1,905 598 — 476,708
Cumbria Ambulance Service NHS Trust 192 — — —
South Tyneside NHS Foundation Trust 49 79,246 290,005
Royal Cornwall Hospitals NHS Trust 2,483 732 63,043 474,301
Aintree Hospitals NHS Trust 2,368 375 145,000 587,000
Clatterbridge Centre for Oncology NHS Trust 318 97 — —
Liverpool Womens NHS Foundation Trust
Walton Centre for Neurology and Neurosurgery
NHS Trust 298 74 30,096 84,952
Barking Havering and Redbridge Hospitals NHS
Trust 3,214 718 — 1,013,029
Barnsley Hospital NHS Foundation Trust 368 47,000 313,000
Queen’s Medical Centre Nottingham University
Hospital NHS Trust 2,415 794 352,751 636,804
The Rotherham NHS Foundation Trust 1,076 1,076 — 234,922
Chesterfield Royal Hospital NHS Foundation
Trust 272 40,203 352,249
Bedfordshire and Hertfordshire Ambulance and
Paramedic Service NHS Trust 352 — — —
West Middlesex University NHS Trust 810
Queen Elizabeth Hospital NHS Trust 640 351 115,087 413,377
Bromley Hospitals NHS Trust 971 453 — 356,866
Whipps Cross University Hospital NHS Trust 1,071 326 — 350,000
Leeds Mental Health Teaching NHS Trust 863 393 — —
West Yorkshire Metropolitan Ambulance Service
NHS Trust 601
Papworth Hospital NHS Foundation Trust 135 — —
Peterborough and Stamford Hospitals NHS
Foundation Trust
James Paget Healthcare NHS Trust 1,503 498 — 458,187
Ipswich Hospital NHS Trust 1,804 432
West SuVolk Hospitals NHS Trust 1,275 1,225 412,000 188,000
Cambridge University Hospitals NHS Foundation
Trust 997 276,152 1,151,556
Queen Mary’s Sidcup NHS Trust 854 316 2,000 148,000
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Royal Berkshire Ambulance Service NHS Trust 281 197 — —
Somerset Partnership NHS and Social Care Trust 536 — — —
Royal Devon and Exeter NHS Foundation Trust
Nottinghamshire Healthcare NHS Trust 2,391 543 — —
Southampton University Hospitals NHS Trust 3,194 1,178 368,705 1,405,556
Dorset Ambulance NHS Trust 96 50 — —
SheYeld Teaching Hospitals NHS Foundation
Trust
Wiltshire Ambulance Service NHS Trust — — — —
Portsmouth Hospitals NHS Trust 2,367 1,096 — 1,119,602
Royal Berkshire and Battle Hospitals NHS Trust 1,774 432 98,300 689,000
Oxfordshire Learning Disability NHS Trust 155 84 — —
Two Shires Ambulance NHS Trust 280 — — —
Guy’s and St Thomas’ NHS Foundation Trust 252 418,152 641,272
The Lewisham Hospital NHS Trust 278 40 20,004 253,563
St Mary’s NHS Trust 219 — 54,000 —
Mayday Healthcare NHS Trust
St George’s Healthcare NHS Trust 1,159 516 181,199 605,276
Cornwall Partnership NHS Trust 449 418 — —
West Country Ambulance Services NHS Trust 515 21 — —
South Warwickshire General Hospitals NHS Trust 1,051 362 — 487,574
Mid StaVordshire General Hospitals NHS Trust 1,315 508 63,168 451,639
University Hospital of North StaVordshire NHS
Trust 3,329 1,062 114,998 521,998
Burton Hospitals NHS Trust 997 412 — 403,876
Good Hope Hospital NHS Trust 965 235 89,057 528,000
Northern Lincolnshire and Goole Hospitals NHS
Trust 2,423 925 — —
East Cheshire NHS Trust 1,287
Countess of Chester NHS Foundation Trust 504 14,198 370,378
Calderstones NHS Trust 493 129 — —
King’s College Hospital NHS Trust 703 — — —
Sherwood Forest Hospitals NHS Trust 1,647
Plymouth Hospitals NHS Trust 2,143 676 146,000 700,000
West Midlands Ambulance Service NHS Trust 500
University Hospitals Coventry and Warwickshire
NHS Trust 2,492 1,599 — 267,019
Hampshire Ambulance Service NHS Trust 324 — — —
The Whittington Hospital NHS Trust 115 105 32,114 15,634
West London Mental Health NHS Trust 1,502 878 — 37,459
Robert Jones and Agnes Hunt Orthopaedic and
District Hospital NHS Trust 620 620 — 29,970
The Royal Wolverhampton Hospitals NHS Trust 1,797 411 — 637,513
Hereford and Worcester Ambulance Service NHS
Trust — — — —
Coventry and Warwickshire Ambulance NHS
Trust — — — —
City Hospital Sunderland NHS Foundation
Trust 1,200 135,455 238,387
Hereford Hospitals NHS Trust 491 173 — —
George Eliot Hospital NHS Trust 1,241 312 92,000 227,000
Birmingham Women’s Health Care NHS Trust 547 40 23,457 53,073
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North StaVordshire Combined Healthcare NHS
Trust 849
Norfolk and Norwich University Hospital NHS
Trust 2,876 914 470,000 518
South ManchesterUniversity HospitalsNHS Trust 2,399 573 380,000 700,000
Salford Royal Hospitals NHS Trust 2,087 417 415,716 641,978
TraVord Healthcare NHS Trust 744
Northgate and Prudhoe NHS Trust 541 525 — —
Greater Mancehster Ambulance Service NHS
Trust 457 — — —
Bolton Hospitals NHS Trust 1,742 401 17,273
Lancashire Ambulance Service NHS Trust 390 20 — —
Tameside and Glossop Acute Services NHS Trust 1,074 777 105,846 398,467
Norfolk and Waveney Mental Health Partnership
NHS Trust 981 981 — —
East Anglian Ambulance NHS Trust 472
Winchester and Eastleigh Healthcare NHS Trust 1,418 437 87,000 532,000
Swindon and Marlborough NHS Trust 1,381 453 138,000 674,000
North Hampshire Hospitals NHS Trust 1,301 336 — 217,854
Dartford and Gravesham NHS Trust 1,185 — — —
Dudley Group of Hospitals NHS Trust 2,132 — 186,671
Newham Healthcare NHS Trust 687 216 69,000 —
Barts and The London NHS Trust 446 32 61,097 —
Tavistock and Portman NHS Trust 103 6 35,000 —
North Cumbria Acute Hospitals NHS Trust 1,404 611 73,595 113,096
North Cumbria Mental Health and Learning
Disabilities NHS Trust 354 271 — —
Newcastle North Tyneside and NorthumberLand
Mental Health NHS Trust 193
Kettering General Hospital NHS Trust 1,142 600 — 214,979
Northampton General Hospital NHS Trust 1,780 660 33,417 434,131
Oxfordshire Mental Healthcare NHS Trust 700 220 8,154 38,350
Oxfordshire Ambulance NHS Trust 69 22 — —
Salisbury Health Care NHS Trust 1,887 490 31,116 304,084
Northamptonshire Healthcare NHS Trust 1,094 1,094 — —
Great Ormond Street Hospital for Children NHS
Trust — — — —
Doncaster and Bassetlaw Hospitals NHS
Foundation Trust 893 63,560 205,617
Moorfields Eye Hospital NHS Foundation Trust — — —
Lincolnshire Partnership NHS Trust 757 329 — —
Medway NHS Trust 1,692 488 182,000 804,000
Queen Victoria Hospital NHS Foundation Trust 122 — 46,240
Oxleas NHS Trust 1,462 1,084 — —
Kent Ambulance NHS Trust 285 — — —
Worthing and Southlands Hospitals NHS Trust 1,041 360 92,807 649,733
Surrey Ambulance Service NHS Trust — — —
Royal West Sussex NHS Trust 1,141 448 18,000 520,000
The Royal Marsden NHS Foundation Trust 195 50,000 180,000
Sussex Ambulance Service NHS Trust 53 1 — —
Birmingham Children’s Hospital NHS Trust 468 69 91,389 —
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Royal Liverpool and Broadgreen University
Hospitals NHS Trust 1,607 139 252,079 225,432
Mid Essex Hospital Services NHS Trust 2,126 715 64,282 624,063
Chelsea and Westminster Healthcare NHS Trust 360 160 78,893 267,517
Hammersmith Hospitals NHS Trust 1,043 166 498,751 277,875
Hinchingbrooke Health Care NHS Trust 943 301 76,607 288,332
The Princess Alexandra Hospital NHS Trust 558 212 39,995 318,164
Homerton University Hospital NHS Foundation
Trust
South West London and St George’s Mental
Health NHS Trust 1,278
Heart of England NHS Foundation Trust 2,758 574 285,360 997,519
Isle of Wight Healthcare NHS Trust 1,129 1,129 56,000 250,000
Gateshead Health NHS Foundation Trust 289 88,400 277,800
Leeds Teaching Hospitals NHS Trust 3,974 809 819,029 661,824
North Essex Mental Health Partnership NHS
Trust 790 760 — —
South StaVordshire Healthcare NHS Trust 988 — — —
Wrightington Wigan and Leigh NHS Trust 1,670 417 129,280 461,830
Royal Orthopaedic Hospital NHS Trust 344 293 — —
University Hospital Birmingham NHS Foundation
Trust 590 117,000 1,500,000
Barnet Enfield and Haringey Mental Health NHS
Trust 1,188 728 — —
London Ambulance Service NHS Trust 1,042 78 — —
University College London Hospitals NHS
Foundation Trust
Cambridgeshire and Peterborough Mental Health
Partnership NHS Trust 1,143 1,143 — —
Pennine Care NHS Trust 1,243 1,022 — —
Royal Brompton and Harefield NHS Trust 695 145 50,000 —
Leicestershire Partnership NHS Trust 901 901 — —
SuVolk Mental Health Partnership NHS Trust 260 175 — —
County Durham and Darlington Priority Services
NHS Trust 822 762 — —
The Newcastle upon Tyne Hospitals NHS Trust 3,840 1,258 426,098 1,039,136
Gloucestershire Hospitals NHS Foundation Trust
Northumbria Health Care NHS Trust 2,432 1,054 — 325,002
Derby Hospitals NHS Foundation Trust 23 — —
Oxford RadcliVe Hospital NHS Trust 3,697 1,049 132,664 1,261,758
Surrey Hampshire Borders NHS Trust 254
Ashford and St Peter’s Hospitals NHS Trust 1,790 565 — 642,590
East Kent NHS and Social Care Partnership Trust 506
Surrey Oaklands NHS Trust 250 250 — —
Surrey and Sussex Healthcare NHS Trust 1,267 293 — 527,378
Gloucestershire Partnership NHS Trust 618 221 6 6
South Tees Hospitals NHS Trust 2,574
5 Boroughs Partnership NHS Trust 615 655 — —
Morecambe Bay Hospitals NHS Trust 2,116 634 74,369 352,370
Tees East and North Yorkshire Ambulance Service
NHS Trust 80 72 — —
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Central and North West London Mental Health
NHS Trust 280
South London and Maudsley NHS Trust 1,059
East Midlands Ambulance Service NHS Trust 660 — — —
Bedfordshire and Luton Community NHS Trust 555
North West London Hospitals NHS Trust 2,604 819 247,155 1,154,337
Humber Mental Health Teaching NHS Trust 777 744 — 7,684
North Bristol NHS Trust 3,495 895 — 526,560
North East Ambulance Service NHS Trust 78 13 — —
Barnet and Chase Farm Hospitals NHS Trust 1,890 749 7,279 1,100,922
Avon and Wiltshire Mental Health Partnership
NHS Trust 2,136 1,211 — —
Epsom and St Helier NHS Trust 1,849 542 — 1,037,500
East Kent Hospitals NHS Trust 3,165 991 111,000 1,319,113
North Tees and Hartlepool NHS Trust 2,434 944 245,790 860,043
Tees and North East Yorkshire NHS Trust 1,700 1,333 — —
Southport and Ormskirk Hospital NHS Trust 1,470 566 206,000 656,200
Hampshire Partnership NHS Trust 1,090 1,021 — —
Central Manchester and Manchester Children’s
University Hospitals NHS Trust 3,676 686 701,161 385,249
Mersey Care NHS Trust 2,437 1,435 — —
Lancashire Care NHS Trust 715
Pennine Acute Hospitals NHS Trust 4,595 3,083 338,631 1,114,564
North West Surrey Mental Health NHS
Partnership Trust 87 318 — —
West Sussex Health and Social Care NHS Trust 564 4 191 5,342
South of Tyne and Wearside Mental Health NHS
Trust 494 457 — —
Hull and East Yorkshire Hospitals NHS Trust 3,094 3,094 8,500 753,601
United Lincolnshire Hospitals NHS Trust 3,699 1,302 — 1,104,542
University Hospitals of Leicester NHS Trust 4,049 1151 — —
Maidstone and Tunbridge Wells NHS Trust 2,439 1,243 — 315,000
West Hertfordshire Hospitals NHS Trust 730 845 — —
East and North Hertfordshire NHS Trust 2,142 734 148,818 483,840
Stockport NHS Foundation Trust 719 144,983 301,849
East London and The City Mental Health NHS
Trust 260 96 — —
South Essex Partnership NHS Trust 937 — — —
Worcestershire Acute Hospitals NHS Trust 2,544 876 —
Worcestershire Mental Health Partnership NHS
Trust 652 375 — —
Hertfordshire Partnership NHS Trust 1,167 — — —
Buckinghamshire Mental Health NHS Trust 353 381 — —
Devon Partnership NHS Trust 615 — — —
North Cheshire Hospitals NHS Trust 1,839 602 — 430,000
Berkshire Healthcare NHS Trust 277 240 38 —
Calderdale and Huddersfield NHS Trust 1,637 496 66,673 207,406
Cheshire and Wirral Partnership NHS Trust 1,090 524 — —
East Sussex Hospitals NHS Trust 2,079 550 — 648,000
East Sussex County Healthcare NHS Trust 683
Doncaster and South Humber Healthcare NHS
Trust 803 778 — —
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Mid Yorkshire Hospitals NHS Trust 2,974 887 30,000 125,000
South West Yorkshire Mental Health NHS Trust 1,192 540 1,896 9,588
Brighton and Sussex University Hospitals NHS
Trust 1,550 1,068 36,000 446,849
West Kent NHS and Social Care Trust 1,013 774 — —
Sandwell and West Birmingham Hospitals NHS
Trust 3,025 1,020 130,500 894,210
Blackpool Fylde and Wyre Hospitals NHS Trust 2,672 872 121,000 419,000
Derbyshire Mental Health Services NHS Trust 815 334 — —
Lancashire Teaching Hospitals NHS Foundation
Trust 2,760 917 225,276 744,610
County Durham and Darlington Acute Hospitals
NHS Trust 2,873 1,006 125,280 159,065
Buckinghamshire Hospitals NHS Trust 2,532 743 484,452 690,052
East Lancashire Hospitals NHS Trust 2,605 1661 90,730 120,270
Birmingham and Solihull Mental Health NHS
Trust 1,589
Bolton Salford and TraVord Mental Health NHS
Trust 865 10 — —
Shrewsbury and Telford Hospitals NHS Trust 1,750 1,328 — 654,000
Northumberland Care Trust 350 280 — —
Bradford District Care Trust 681 681 — —
Manchester Mental Health and Social Care Trust —
Camden and Islington Mental Health and Social
Care Trust 65 — — —
Witham Braintree and Halstead Care Trust 137 37 — —
SheYeld Care Trust 681 681 — —
Sandwell Mental Health NHS and Social Care
Trust 463 252 — —
Bexley Care Trust 108 108 — —
378,720 156,031 15,130,961 62,755,934
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Supplementary letter from Lord Warner, Minister of State, Department of Health (CP 01B)
At the fourth evidence session by the Health Committee into NHS charges attended by Rosie Winterton
MP and Jane Kennedy MP, you made enquiries about a new dermatology clinic being run by Harrogate and
District NHS Foundation Trust (NHSFT) and asked for Ministers’ views on the treatments being oVered.
I am sure you will appreciate that due to their independent status within the NHS and the diVerent
accountability framework within which they operate, Ministers are no longer in a position to assess, validate
and provide information relating to operational management in NHSFTs in the same way we would for
NHS Trusts. The most common approach is to refer questions relating to the day to day activities of
NHSFTS to the relevant Chair for answer. In this particular case, I have been informed by the Chair of
Harrogate and District NHSFT that its dermatology clinic has been set up to fill a gap in service provision
for its community. The clinic oVers a range of cosmetic dermatology treatments which are not ordinarily
available to NHS patients as a result of a loclly agreed cosmetic exclusion policy at PCT level eg removal
of benign moles, warts and skin blemishes, and injections to reduce excess sweating. While the Department
of Health does not call upon the NHS to operate a cosmetic exclusion policy, I am informed that such a
policy has been in place locally at Harrogate and District Trust since 2003.
NHSFTs do not have powers to impose charges for any NHS services, however, legislation permits
NHSFTs to impose charges for other services in certain limited circumstances and provided specific
conditions are met. As Jane Kennedy highlighted during the evidence session, NHSFTs are also specifically
prevented in law from expanding private patient clinical activity faster than their expansion of clinical
activity for NHS patients. Moreover, as public benefit corporations, any operating financial surpluses made
by NHSFTs need to be reinvested to promote their public benefit mandate. NHSFTs are also overseen by
Monitor, the Inepdnent Regulator of NHS Foundation Trusts, for compliance with their terms of
authorisation.
NHSFTs are at the forefront of our programme of change and we share their enthusiasm to promote
innovation and enterprise and are committed to their continuing development. While NHSFTs are free to
set up new ventures (including entering into joint ventures) without Ministerial consent, these initiatives
must be consistent with their public benefit purpose and terms of authorisation.
Further details about the clinic may be obtained by writing to the Chair of Harrogate and District
NHSFT.
I trust you find this helpful.
Lord Warner
Department of Health
4 April 2006
Supplementary memorandum submitted by the British Dental Association (CP 11A)
Further to the oral evidence Dr Lester Ellman of the British Dental Association presented to the Health
Select Committee on Thursday 9 February 2005, there were a number of points that came out of the session,
which may be helpful for the committee to be clarified.
Questions 333, 346 and 355
Children being seen on the NHS on condition of parents taking up a private dental plan
Ms Charlotte Atkins and Mr Mike Penning raised the issue of constituents, and for Mr Penning
personally, who have been told by their dentists that their children will continue to be seen on the NHS on
condition that they [the parents] take up a private dental plan.
Under the current General Dental Service (GDS) system there is nothing that prevents dentists from
making it a condition of treating children on the NHS for their parents to be signed up privately. It is also
important to put this issue in context. The BDA believes this practice of “condition” is a very recent
phenomenon—happening only in the last two to three years, and exists at very few dental practices across
the country. Nonetheless, the BDA does not encourage members to take this course of action.
Under the new GDS Regulations, coming into eVect on 1 April 2006, dentists can continue to hold their
current contract value and attached Units of Dental Activity (UDAs) for the number of NHS children they
have, but the policy of condition will not be allowed. However, there may be circumstances, where PCTs
have agreed that dentists have a children-only NHS list and so the dentists will see all adults on a private
basis.
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The BDA fully supports this specific aspect of the Department of Health’s (DH’s) wide ranging reforms
of NHS dentistry, as it allows dentists to prioritise child oral health, to foster a good oral health regime in
children and provide a key NHS dental service to children in areas that need it.
Question 379
The BDA’s collective view about the new GDS contract
Dr Richard Taylor voiced the issue of the BDA’s collective view about the new GDS contract. As Dr
Ellman highlighted in his evidence to the committee (answer to Question 353), the BDA did not negotiate
the contract with the DH: Due to the way the primary legislation—the Health and Social Care (Community
Health and Standards) Act 2003—was drafted, it was entirely a Government contract, which the profession
could input into at a later date, via discussions with the minister and oYcials.
The BDA has made it clear to members throughout the reforms process that each individual General
Dental Practitioner (GDP) needs to decide whether the new GDS contract is right for their patients, for them
and for their businesses. The BDA oVers advice and guidance to members on how best to plan for their
futures. Some will be happy with the proposals being oVered by their local PCTs, others will not be and will
take appropriate decisions.
However, throughout the process, the BDA has made its “collective” feelings clear on the contract—in
December 2004, the BDA suspended discussions with the DH on the arrangements for a new base contract,
arguing that key elements of the draft contract would not allow dentists to spend more time with their
patients, to adopt a more quality-driven and preventive approach to oral healthcare, and improve the
working lives of the dental team and the patient experience. Dr Ellman was quoted as saying, “we have been
proactive in our discussions with the Department of Health but the traYc has been almost entirely one way”.
We supported the DH’s decision in January 2005 to postpone the implementation of the contract from
October 2005 to April 2006, citing the National Audit OYce’s (NAO) report, Reforming NHS Dentistry:
Ensuring eVective management of risks. November 2004, which raised significant concerns about the state of
readiness among the PCT charged with delivering NHS dentistry.
The BDA continued infrequent discussions with the DH, and agreed on a few issues, such as the children-
only NHS list, but the overall well publicised BDA belief is that the new contract is untested and that the
new way of monitoring targets for dentists is causing confusion across the NHS which is unable to cope with
the new arrangements. In a BDA press release of 2 February 2006, “New dentistry contract will fail patients,
British Dental Association warns Minister”, we called on the Government to suspend the contractual
requirement that means dentists must achieve an allocated number of “units of dental activity” (UDA) as
part of the new monitoring system, as well as asking for greater clarity about funding for those practices
which want to expand or have expanded during or after the test year (October 2004 to September 2005). Dr
Ellman is as quoted as saying: “The situation is a shambles for both patients and the profession. Our fear
is that the new contract will do nothing to improve access to care for patients or improve the quality of care.
The Government claims to be committed to preventive care yet that does not seem to apply to dentistry.
We’re now faced with a contract that puts dentists on a new treadmill and means they can’t give the care
and time that they want to give to patients. This is bad for patients, bad for dentists and disastrous for NHS
dentistry.” These comments were supported by the BDA’s General Dental Practice Committee, following
the motion: “The British Dental Association believes that the Government’s aims of securing patient access,
improving oral health and raising the quality of patient care will not be achieved by the imposition of this
target driven NHS contract.”
Question 38
Changes to the dental contract in Wales
The newGDS contract in Wales is devolved to theWelsh Assembly. BDAWales/Cymru’s General Dental
Practice Committee has been in discussions with the Welsh Assembly Government (WAG) regarding the
precise details of the Welsh new GDS.
The WAG has cautiously followed the “English model” towards the proposed GDS contract, but has
made two significant improvements—changes to the output leeway and monitoring trigger. The DH claims
that to “get dentists oV the treadmill” they are going to set the individual practitioner contract values
according to the level of itemof service activity and earnings in the current year, minus 5% activity. In Wales,
the proposed level of activity for equal funding is going to be lower—10% less. This is a very welcome move
for dentists in Wales as, in theory, it gives them more time to spend with each patient, oVering preventive
care and advice and gives them a slight freedom from the treadmill.
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In reality we are concerned that as dentists are alreadyworking to address the needs of the people of Wales
who have poorer oral health than in England, there will be little opportunity to free up timewithout aVecting
the standard of service and waiting times for treatment.
The monitoring trigger, a device used by PCTs and LHBs to oversee activity outputs by individual
practitioners, and is one of the contract measures—in England a 4% drop in agreed activity triggers an
investigation by the PCT and has to be made up within 60 days.
In Wales the LHBs will not contact practices until the contract figure falls by 5% from the agreed contract
value and, if there is good reason there will be no need to make up the diVerence. This is particularly
pertinent in the transitional period where dentists andLHBs will have to get used to the new ways ofworking
very quickly. Again, this is advantageous to NHS dentists in Wales as it theoretically allows them flexibility
and time to deal with the additional demands of administering a practice which include more clinical
governance activity, the training requirements of staV, especially dental nurses and increasing health and
safety requirements related to recent legislation.
However, WAG has been slow to develop its strategy for the future of dental services, with their legislative
programme a considerable number of months behind Westminster, but with the same 1 April deadline. To
date, the GDS contract regulations are due to be debated in the Welsh Assembly on 1 March. This delay
has inevitably caused considerable anxiety for BDA members.
Question 401
Free oral health risk assessment programme
In 2003, the BDA produced a report, Oral Healthcare for Older People: 2020 Vision, which emphasised
that the reform of the NHS dental charging system needed to take account of the anticipated growth in the
number of older people in England. It came up with 21 recommendations, including:
— A free oral health risk assessment should be available to patients from age 60, with referral to a
dentist for a strategic long-term oral healthcare plan oVered to those identified as likely to need
complex restorative care.
— Planned reform of NHS dental charges should take account of the growth in the older persons
population and the fact that older people are more likely to require more complex treatment and
also tend to be among the least able to aVord to pay.
— Information about full and partial exemption from NHS dental charges should be simplified and
publicised to older people and carers.
— Free NHS examinations for patients aged 65 and over is likely to improve the oral health of the
nation’s older person’s population greatly.
Free dental examinations have already been introduced in Wales for people aged under 25 and those over
65 years. The Scottish Executive are currently implementing free dental checks for all, with over 60’s being
the first section of the population to receive it.
The BDA supports preventative-led dentistry and supports the principle behind this policy. In fact, the
BDA favours the development of a comprehensive oral health assessment as part of basic oral healthcare
provision. However, it needs to be fully funded and the BDA has serious reservations, on two grounds,
about the Scottish Executive’s free dental checks policy—funding and workforce. There is neither a
suYcient workforce nor money to provide and fund this initiative. We are concerned that patients’
expectations would be raised and it will be left to dentists to deal with the consequences. Also, during the
legislative scrutiny of primary legislation, which introduced this policy, the Smoking, Health and Social Care
(Scotland) Act 2005, the Scottish Parliament’s Finance Committee raised questions about the funding and
financing of this policy.8
However, given that the BDA would support “in principle” the ending of NHS dental charges, the action
points above, were charges to be abolished, should be encouraged as “good practice” in the provision and
delivery of oral healthcare for older people.
The expert reference group for the report included representatives from the BDA, dental schools, the
British Society for Gerodontology, Help the Aged and Age Concern.
The BDA also played a key role in the Gerodontology Society’s December 2005 report, Meeting the
Challenges of Oral health for Older People: A Strategic Review. This report was commissioned and funded
by the Department of Health. It recommended, among other issues:
— The Department ofHealth should consider ways of encouraging older people to use dental services
on a more regular basis.
8 “Your [the Scottish Executive Health Department] testimony this morning has convinced Parliament’s Finance Committee
that this financial memorandum does not fulfil the legislative purpose that is laid down for it constitutionally.” “The
Committee is inviting you to go back to consider whether the financial consider whether the financial memorandum fulfils its
constitutional purpose of itemising fully the financial resources that will be required to implement the provisions in the bill.”
(Scottish Parliament OYcial Report. Finance Committee. 1 March 2005. Columns 2433–4).
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— All older people moving to care homes should receive an oral health and oral health risk
assessment that considers both preventive and treatment needs.
— The Department of Health must continue to ensure the availability of free, comprehensive care for
low income older people.
Please find included with this supplementary memorandum copies of both reports—Oral Healthcare for
Older People: 2020 Vision and Meeting the Challenges of Oral health for Older People: A Strategic Review.
I hope this is helpful.
James Clark
Parliamentary OYcer, British Dental Association
24 February 2006
Supplementary memorandum from the Citizens Advice (CP 20A)
Further to our appearance on 2 February, there were certain additional points we would like to make the
Committee aware of. Much of the CAB advice work which takes place in over 1,000 healthcare settings
across England and Wales focuses on tackling problems of low income and debt, thus helping relieve the
stress and anxiety which often underscore patients’ clinical symptoms. Typically the CAB adviser will run
regular sessions in the GP surgery or other health setting to see patients referred by their health professional.
A fundamental part of the work will be to ensure patients have claimed all the benefits to which they are
entitled, and so helping with claims under the NHS Low Income Scheme would be central to this work. The
presence of CAB advisers in the health setting also means they are well placed to encourage the general
promotion of help with health costs through the display of publicity material and claim forms.
For example, one bureau working in a mental health venue noticed that patients were being asked to
attend psychotherapy sessions in the evening, at a time when there was no facility open to enable them to
get refunds of travel costs. Following intervention by the bureau, this has been rectified.
One of the fundamental purposes of DWP is the alleviation of poverty, so issues around the cost of health
charges and take up of the Low Income Scheme (LIS) must be of concern to them. In addition a key strand
of their current plans is to provide greater support to people with health conditions and disabilities seeking
to move into work. Ensuring that this group, many of whom are on incapacity benefit, are not prevented
by financial reasons from accessing the healthcare they need, should therefore be a key concern.
The MORI figures we quote in our report Unhealthy Charges suggested that some 750,000 people are
failing to get their prescriptions dispensed because they cannot aVord the charge. We understand that the
Department of Health believes that some 44,000 have benefited from the April 2004 easement on
entitlement. This suggests that significant further reforms are still needed. One option would be to extend
exemption from prescription charges to anyone receiving a means tested benefit (ie housing or council tax
benefit as well as IS/JSA). This would be a better way of ensuring people on Incapacity Benefit and on a low
income receive the help they need, than relying on them claiming under the LIS. It would also have the eVect
of extending help further up the income scale.
In addition, one way to promote take up of the Low Income Scheme (LIS) would be to develop greater
links between DH and DWP, in order to take advantage of DWP benefit delivery mechanisms. For example
Jobcentre Plus is moving to a “Standard Operating Model” in which applications for incapacity benefit,
income support and jobseeker’s allowance are taken in a single phone call which is intended to capture the
applicant’s circumstances and to establish entitlement to benefits. This would provide an excellent
opportunity to identify claimants entitled to help under LIS, as on the one hand much of the information
required for the HCI is common to that required for IS/JSA, and on the other hand a key group to target
is people claiming incapacity benefit but not entitled to IS/JSA.
Please do let me know if you would like any further information.
Liz Phelps
Citizens Advice
13 February 2006
Supplementary memorandum submitted by the Association of Optometrists, Association of British
Dispensing Opticians and the Federation of Ophthalmic and Dispensing Opticians (CP 26A)
We would like to thank the Committee for inviting us to give evidence as part of your inquiry into NHS
charges. We both enjoyed being part of such a lively discussion. There were a few issues that were raised
that we promised we would clarify.
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Under 16s
During the session you asked about the take up of sight tests for children. According to oYcial statistics
21.6% of NHS sight tests are carried out on children under 16. In the year to 31 March 2005 11.7 million
NHS sight tests were performed in total, therefore 2.53 million children had a free sight test. This equates
to approximately a quarter of the total population of children under 16 in England. According to oYcial
statistics the total population of children under 16 in England is 9.75 million (OYce of National Statistics).
26.5% of vouchers or approximately half a million vouchers went to children under 16. Given the
importance of eye health and also the early detection of visual impairment on the development andwellbeing
of children, we strongly recommend as a minimum that all children should have a sight test before the age
of eight years old. Ideally all pre-school children should have a sight test to ensure early detection and if
necessary, the early treatment of eye disease.
Domiciliary Care
Our major concern in relation to domiciliary sight tests is that over one million older people live at home
or in care, unable to visit a high street optician unaided, yet only 344,000 domiciliary sight tests were carried
out in the year ending 31 March 2005. As we mentioned during the session, research carried out by the
University of York found that over 189,000 people with visual impairments fall each year at an estimated
cost to the NHS of £269 million (York University study, 2003).
Complex Lenses
During the discussion about voucher values we pointed out that the voucher value does not cover the cost
of spectacles, although two thirds of practices do subsidize this and oVer a range of spectacles for that
voucher value. We did not have time to raise the point that the level of reimbursement for complex lenses,
ie those of a high prescription, is particularly low and does not reflect the cost of these lenses. Generally
speaking people who require very high prescriptions and who would qualify for a complex voucher would
want to have the best thinnest lenses that they could aVord in order to improve the cosmetic appearance of
their spectacles. The allowances, which are currently a supplement of £12.40 or £31.30 for single vision and
for bifocal lenses are insignificant against the actual retail cost of these expensive lenses and should be
increased.
For accuracy, we would also like to explain to the Committee that eligible patients do make payments
when using hospital services, when there is a clinical need for contact lenses. The charge is £48 per lens, and
therefore £96 for a pair. This charge is close to the actual cost of the lenses which therefore means that NHS
patients are eVectively paying for their lenses. This payment ismade whether the contact lenses are dispensed
at the hospital or elsewhere.
National Service Framework
We would like to stress again the importance of eye health for people of all ages. Increasing public and
parents awareness of the importance of having regular sight tests is crucial in reducing the incidences of eye
disease and preventing avoidable blindness. That is why the optical bodies have given their support to the
RNIB campaign, “Open Your Eyes”. We believe that the Government should include eye care in all relevant
National Service Frameworks and public health white papers. In particular, we would hope to see a question
about eye examinations in the first (self-assessment) part of the new NHS Life Check. We also hope to see
the inclusion of eye care and the availability of free domiciliary NHS sight tests for vulnerable people in the
forthcoming Next Steps publication under the Older People’s National Services Framework. These would
be steps in the right direction in the promotion of eye health to the public.
We enclose a copy of our policy document, “Primary Eye Care in England—A Vision for the Future”,
which sets out our proposals for a national services framework for improving optical health. We also enclose
a copy of a recent report by Professor Nick Bosanquet, “Developing a New Partnership Contract for
Community Eye Care in England”. We hope that the Committee will find these publications useful.
Should the committee have any further questions relating to eye care services please do not hesitate to
contact us and we will be happy to provide you with any further information you require.
David Cartwright
President
College of Optometrists
Lynn Hansford
Chairman
Association of Optometrists
15 February 2006
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Supplementary memorandum submitted by Mind (CP 19A)
Mind would like to thank the Committee for the opportunity to give evidence relating to NHS charges
and the eVect they have, particularly on those who experience mental distress.
During the evidence session on 2 February 2006, the Committee requested that Mind forward
information relating people who pay for treatment prescribed by their doctor, in particular those who had
paid for counselling and talking therapies. The Committee was also interested in the impact of not receiving
prescribed care.
These issues were explored in Mind’s Hidden Costs of Mental Health report, published in 2003, a copy of
which is attached.
The report found that of the 455 respondents (all of whom had a diagnosed mental health problems):
— 64% had paid for some form of care or treatment (prescribed or non-prescribed) for their
diagnosed mental health problem. The average monthly payment for this group was £68, and
included counselling and talking therapies, complementary therapies, drugs and medication,
exercise, and other forms of help.
— Of the total group, 34% had paid for drugs or medication which had been prescribed by their
doctor.
— 45% of respondents had paid out of their own pocket for any form of care or treatment prescribed
by their doctor. Of this group 21% had paid for prescribed counselling or talking therapies, and
25% had paid for recommended complementary therapies.
— Of those paying for treatment, only one fifth were paying the equivalent of a single prescription
or less (£6.20 in 2002–03).The average monthly spend for those paying for treatments which had
been prescribed by their doctor was £37.
— 58% of respondents stated that they had missed out on some form of care or treatments which they
felt would have been beneficial, most commonly because they could not aVord it. The most
common treatment which had not been received was counselling or other talking therapy.
— Of those who had paid for treatment or who didn’t get a treatment they felt would have been
beneficial, almost one half (47%) felt their recovery had been held back or their ability to cope had
been reduced as a result of not getting the treatment they wanted or having to pay for it.
From this it can clearly be seen that many people who experience mental distress pay a significant amount
out of their own pocket for care and treatment for their mental health problem. The amount paid, even for
prescribed care, can be significant and can result in people not being able to access the help they need, or
experiencing hardship through being required to pay for care they need.
It is of particular concern that so many are prescribed counselling or other talking therapies by their
doctor but cannot receive this due to the NHS being unable to provide this within a reasonable timescale.
The NICE guidelines for depression and anxiety indicate that talking therapies should be the first line
treatment for those experiencing mild to moderate depression and anxiety. Mind therefore feels that
inability to provide this constitutes a failure of the NHS in its duty to provide adequate care and treatment
to people experiencing mental health problems.
Mind would be happy to provide any further information if the Committee would find it helpful.
Moira Fraser
Policy OYcer, Mind
20 February 2006
Supplementary memorandum submitted by Simplyhealth (formerly HSA Group) (CP 27A)
By way of further submission from Simplyhealth HSA following our evidence to the Select Committee
on Health’s discussion on co-payments, we advise the committee as follows.
A Society is defined by its care for all citizens. To that end, in our view, the role of the state is to secure
the appropriate acceptable level of health care for all citizens through general taxation that should be
available to all citizens, all over the country, all the time.
This should be funded through a general taxation that is a specific percentage of GDP, for example 9.5%
of GDP. Political parties can argue over the exact percentage as they see fit, but health services will then be
funded directly by what we earn as a country and out choice about the quaity of service for everyone will
be absolutely clear.
It is important to understand that there are no markets or services of any kind in any area of our lives
where we can all have the very best of everything all the time, how and where we want it. This is not the case
with food or shelter or education. It is unreasonable therefore to expect it of healthcare, it is not possible.
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If, however, we are all clear about what is available from the state we can make informed choices about
what else we would then like for ourselves as individuals.
Not everyone takes responsibility for their health in the same way. A large part of the population spends
billions of pounds each year helping themselves through high quality foods, vitamins and supplements,
alternative therapy, exercise regimes, health insurance, screenings, and other health related behaviours and
activities. The NHS by no means represents the whole healthcare spectrum in the UK today as many people
do much to help themselves.
Equally, many do not. They are content to abuse their health in the belief that if they hit the wall of illness
the NHS is there to fix it all. Consequently (and there are great parallels with education), they will not invest
in any way to promote their own wellbeing.
It is unrealistic and wrong to determine the whole healthcare regime for the UK on the taxation only route
for healthcare as you will actively work against those who do something to help themselves and they should
be encouraged.
What the state needs are the institutions that define clearly for the public what level of treatment they can
expect to be provided through taxation. Bodies like NICE will define, for example, which drugs the state will
provide and their accountability is to do this within the budget that society through an elected government
mandated them to levy in direct taxation.
If this is clear, then the private sector will step in and provide access to alternative if that is what people
want to buy.
We need to be very careful not to prejudge what people will spend their disposable income on. Many, in
all income groups, will decide between a mobile phone or Sky TV on the one hand, and a healthcare product
of some sort on the other, and we do those people an injustice if we think this is necessarily an income related
decision. Insurance schemes for healthcare start from as little as £1 per week. Our evidence is that this is an
attitudinal decision and not an income one.
If clarity does not exist then people will not understand what the state considers the acceptable standard
of healthcare and will not be able to make informed choices about whether or not that is enough for them.
Being brutally honest, the 11% of the population who purchase PMI today, pay twice for healthcare
because they are not being oVered by the state something they find acceptable even when it is free!
Cashplan customers are people who take the initiative and prepare for healthcare issues, partly because
they cannot aVord the surprise that a crown brings with it at £300 and partly because they are placing
healthcare at the top of their agenda of things that matter to them.
By helping people to understand clearly that there is no appeal against NICE or other institutions that
define our acceptable level of healthcare, those people will then define what else matters to them.
The concern today about a two tier healthcare system is antiquated and ideological, something we believe
the public are tired of. There are many tiers in healthcare depending on what you can aVord, where you live,
who you know and how educated your are.
The state’s role is to protect us all with what we choose to aVord, to defind the inclusive regime behind
that is the true cornerstone of the NHS, but then leave the rest to the people to decide for themselves.
We believe this would be preferred by the vast majority of people, whilst remaining inclusive and
aVordable to the nation.
Des Benjamin
Chief Executive, Simplyhealth
14 February 2006
Memorandum submitted by Hammersmith Hospitals NHS Trust (CP 39)
Jentle Midwifery Scheme at Queen Charlotte’s and Chelsea Hospital
Queen Charlotte’s and Chelsea Hospital is part of Hammersmith Hospitals NHS Trust. Queen
Charlotte’s has been in existence since 1739, making it the oldest maternity hospital in the country. Over
time the hospital has moved several times, most recently from Goldhawk Road to the Hammersmith
Hospital site. It now occupies a purpose-built hospital which is only five years old, which is one of the most
modern in the UK and specially designed to provide the best possible accommodation for mothers and
babies. In addition, it has a Birthing Centre run exclusively by midwives, where women with uncomplicated
pregnancies can choose to give birth.
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It is one of the UK’s leadingmaternity hospitals providing a full range of services for pregnantwomen and
new born babies. It is a tertiary centre of excellence for high risk pregnancies and births. It has a pioneering
midwifery unit and a full complement of staV—there are no vacancies. In partnership with Imperial College
it is also one of the UK’s leading research centres into conception, pregnancy, birth and neonatology. The
hospital contains:
— Maternity and gynaecology outpatient areas.
— Early pregnancy assessment unit.
— Ultrasound suite.
— Centre for Fetal Care.
— Birth Centre.
— Large labour ward with individual birth rooms and operating theatres.
— 44 antenatal/postnatal beds.
— Eight private patient beds.
— 40 cot Neonatal Unit.
— 33 inpatient gynaecological beds, including day care area.
— Paediatric ambulatory care unit.
The Jentle Midwifery Scheme
The Jentle Midwifery scheme was established in 2004 at Queen Charlotte’s and Chelsea Hospital to
provide an additional service to women who request one-to-one midwife support, from the same named
midwife throughout their pregnancy.
The hospital already provides a free one-to-one midwifery service for mothers where there is a clinical
necessity—such as diYcult social-economic circumstances or those for whom there is an expectation of a
diYcult birth. The Jentle Scheme is unlike a typical private system; the scheme directly enhances what the
NHS at Queen Charlotte’s oVers—a highly professional and safe service.
Expectant mothers participating in the scheme receive exactly the same medical interventions as other
NHS mothers, including scans and other tests. The main diVerence that the scheme oVers mothers-to-be is
one-to-one care from a dedicated midwife, available 24 hours per day, throughout the pregnancy. There is
also more flexibility over where and when ante-natal support can be oVered.
Mothers not on the scheme have access to the same advice, scans, ante-natal information, birthing
experience, equipment, specialist back-up as mothers who have paid for the scheme, except that it is not with
the same midwife guaranteed at all times.
The scheme costs £4,000 and has generated over £160,000 of income which is reinvested in the trust’s NHS
maternity services. 74 women have so far participated in the scheme and 51 babies have been delivered. The
scheme is covered by the Clinical Negligence Scheme for Trusts for which the Trust has level 2.
Hammersmith Hospitals NHS Trust
February 2006
Memorandum submitted by the All Party Parliamentary Group on Primary Care and
Public Health (CP 40)
Introduction
The prescription charge was first introduced in 1952, and apart from it being abolished for three years in
1965 the charge has increased over the years. Several organisations and politicians have called for a review
of the prescription charge, especially the exemption criteria, but as far as the All Party Parliamentary Group
on Primary Care and Public Health is aware, there has been no systematic evaluation of the scheme.
In recent years the scheme has been criticised as being outdated with unacceptable inequities and
anomalies and the All Party Parliamentary Group feel it is time to explore these criticisms.
According to the NHS, the principles of the charges themselves are based on the fact that those who can
aVord to contribute should do so whilst those who are likely to have diYculty in paying should be protected.
The Group wanted to look more deeply into this principle in order to gauge whether this is indeed working
in practice and also if it can be sustained into the future.
The Group sought written and oral evidence from a number of organisations including pharmacy bodies,
PCTs, allied health professionals, think tanks as well as voluntary organisations and medical institutions.
Written and oral evidence was received through addressing specific questions regarding the current
prescription charge scheme:
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Q1 Background
From your perspective what are the rules and history of the scheme?
What are the criteria for exemption from the prescription charge?
Are you aware of a previous review and what the outcome of this was?
Q2 The Current Situation
From the experience of clinicians, patients and pharmacists of the scheme in practice—what works and what
does not work?
Do you have an assessment of the contribution the scheme makes to the NHS?
Do you know of the experience of other countries in Europe with regard prescription charges and co-payment
and the lessons that may have emerged from this experience?
Q3 The Future
Can you tell us your views on the possible alternatives to the scheme taking account of the Wanless “fully
engaged scenario” as described in the report to the Treasury, Securing our Future Health: Taking a Long-Term
View, produced in 2002?
Summary of Evidence
The written and oral evidence provided by organisations (please see appendix 1 for details of those
organisations who contributed)9 to the specific questions asked of this inquiry by the All Party
Parliamentary Group are noted:
Q1 Background
(a) From your perspective what are the rules and history of the scheme?
(b) What are the criteria for exemption from the prescription charge?
(c) Are you aware of a previous review and what the outcome of this was?
(a) Since the NHS was established in 1948 the principle has been to provide healthcare for all based on
need not on the ability to pay except where regulations prove otherwise. Initially the prescription charge was
introduced in 1952 based on a charge per form. In 1956 a charge per item was introduced. The charge was
abolished in 1965 and reintroduced in 1968 due to a higher demand in prescriptions dispensed.
A charge is payable for each prescribed item or quantity dispensed unless the patient is entitled to free
prescriptions. Patients who require a lot of items or regular medication may buy a prescription prepayment
certificate (PPC). The charge from 1 April 2005 is £6.50 per item, or a fee of £33.90 for a four month PPC
and £93 for a 12 month PPC for an unlimited number of items.
(b) In 1968 the Government introduced exemption criteria which have never been reviewed. Entitlement
to exemption is based on:
— the method of delivery, eg to an in-patient or supplied and administered by a GP;
— the type of medication, ie contraception or for the treatment of STI;
— the age of the patient;
— the patient’s condition; or
— the patient’s income.
The current arrangements mean that around 50% of the population are exempt from prescription charges
and in 2004 around 87% of prescription items dispensed in the community were free of charge. 8.4% were
charged at the point of dispensing with another 4.7% of items going to PPC holders with no further charge
paid at the point of dispensing.
(c) In 1998 the Comprehensive Spending Review (CSR) for 1999–2002 was published by HM Treasury.
An internal review of prescription charges was undertaken as part of the formulation of government policy
and this fed into the outcome of the CSR.
9 Not printed here.
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As far as prescription charges were concerned, the then Secretary of State concluded that the charging
arrangements should remain unchanged for the rest of the Parliament. No undertakings or commitments
have been made since, however the House of Commons Health Select Committee is currently conducting
an inquiry into “co-payments and charges in the NHS” with the last oral evidence session taking place on
16 February 2006.
Q2 The Current Situation
(a) From the experience of clinicians, patients and pharmacists of the scheme in practice—what works and what
does not work?
(b) Do you have an assessment of the contribution the scheme makes to the NHS?
(c) Do you know of the experience of other countries in Europe with regard prescription charges and co-
payment and the lessons that may have emerged from this experience?
(a) The prescription charge scheme (PSC) is seen by all respondents as unfair for the following reasons:
— it exempts some patient groups but not others; the list of medical conditions exempt from
prescription charges has not been updated since 1968 and excludes several chronic conditions that
have become prominent since then, such as cancer, multiple sclerosis, arthritis and HIV/AIDS;
patient groups such as diabetics are exempt, but those suVering from cystic fibrosis, chronic
asthma, hypertension and a variety of dermatological conditions are not;
— the blanket nature of some exemptions means that some people with high incomes are exempt
while some people with low incomes are not exempt; for example, the PCS exempts anyone aged
65 and over and all pregnant women; and
— it presents a financial barrier to access to prescribed drugs for people with low incomes,
particularly those whose earnings are just above the threshold for receipt of government benefits.
In evidence from 2001 the National Association of Citizens Advice Bureaux and MORI showed that 28%
of those who had paid prescription charges had failed to have all or part of the prescription dispensed
because of the cost (38% of single parent households and 37% of those with long term problems). MORI
estimated that around 750,000 people fail to get their prescriptions dispensed because of cost.
The report identified a “poverty trap” in which patients just above the level of income support, for
example those receiving incapacity benefit, get no help at all, and those with long term health problems were
more likely to find charges diYcult to aVord, despite the season ticket scheme.
Doctors, nurses and pharmacists have reported that patients ask if all the medicines prescribed are really
necessary as they are unable to pay for them all. There are also patients who want large amounts of drugs
dispensed to reduce the number of prescriptions. There are patients who are unable to pay for all the items
on the prescription at once who seek several prescriptions (one for now, one for later). These scenarios can
result in admission to secondary and acute services as well as an overall increase in morbidity.
The availability of prescriptions for medicines that are legally classified as pharmacy only (P) and which
are sold under the supervision of the pharmacist leads to a perverse situation in which those who are exempt
from prescription charges will go to the GP simply to get OTC medicines on “free” prescription.
Some people try to avoid having to pay prescription charges by going to an A & E department instead of
seeing their GP.
(b) At present 87% of prescriptions are obtained free of charge. The prescription fee of £6.40 appears to
represent good value for money since according to DH figures for 2004; the average net ingredient cost of
a non-exempt item was £14.32.
Income from prescriptions is estimated at £500 million per annum this is 40% of all income raised from
NHS charges. While it only represents 1% of the cost of the NHS, it is nevertheless an additional
contribution.
(c) In 2004 Lexchin and Grootendorst surveyed literature from a range of countries on “eVects of
prescription drugs users fees on drug and health service use and on health status of vulnerable populations.”
The literature concluded, “Virtually every article we reviewed supports the view that cost sharing through
the use of co-payments (charges) or deductibles decreases the use of prescription medicines by the poor and
the chronically ill.”
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France/USA
The medical care systems in France and the USA work to insurance-based systems, where patients
generally pay the full cost of their medicines and are reimbursed for a proportion of the cost by their insurer,
rather than paying a fixed prescription charge. An international review of studies found that, in the USA,
limiting the level of reimbursement reduced the use of essential as well as non-essential medicines. The eVect
on vulnerable groups, such as patients with major psychiatric illness, was particularly marked and
substantially increased costs in, for example, acute mental health services.
Czech Republic
The Czech Republic has a public insurance system which provides ´ of all patients with drugs for a very
small payment.
For people with chronic illness or for emergency outpatients all drugs are free if generic or on a specific
list which is updated by the government every six months.
For expensive drugs there is a system of co-payment between the government and the patient. Doctors
can prescribe from the list or in consultation with the patients, choose drugs more specific to their needs
which will then require co-payment. Every pharmacy has a budget for certain drugs and diVerent prices for
co-payment.
Ireland
Ireland has a General Medical Services (GMS) scheme, which provides drugs free to approximately 30%
of the population and a drug payment scheme for the rest of the population. If the total cost per month, per
family, exceeds ƒ85, all further drugs are free. The number of people who qualify for the GMS scheme has
decreased and one of the key challenges is to find a way to help those on modest incomes who cannot receive
free prescriptions, yet for whom the cost of the consultation and prescriptions threshold of ƒ85 is too high.
Under the GMS scheme, doctors are less concerned about the cost of the drugs prescribed; there is little
incentive to keep costs within the budget as no penalties are incurred if they are exceeded. Patients can also
discuss the choice of the cost of their prescription; for example, inhalers for asthma are available to patients
on a sliding scale of ƒ10 to ƒ30.
Poland
Prescription drugs in Poland are divided into three categories of price. The Ministry of Health has a
special agency with responsibility for their allocation.
(i) Basic drugs, mainly generics and simple remedies. Patients pay a low standard fee, which is
described precisely (ie number of tablets). If more expensive drugs are needed, then patients pay
the diVerence.
(ii) 50/50 government/patient payment, which also applies to the cheapest, generic drugs.
(iii) 30%/70% government/patient—which applies to any drugs.
Spain
Spain has a private system and a separate system for civil servants. Under the private system, the working
population pays 40% of the cost of drugs. When they retire at 65, drugs are free.
The civil servants pay 30% of the cost, but do not have free drugs after they retire at 60.
There are specific drugs identified for chronic illnesses, for which patients pay a small amount.
There are economic incentives for doctors to use a recommended list of drugs based on clinical
eVectiveness rather than opt for new, expensive drugs as a first choice.
Q3 The Future
Can you tell us your views on the possible alternatives to the scheme taking account of the Wanless “fully
engaged scenario” as described in the report to the Treasury, Securing our Future Health: Taking a Long-Term
View, produced in 2002?
Taking into account the Wanless “fully engaged scenario” there is likely to be an increased demand for
drugs as the population lives longer and has more time to develop chronic conditions, normally associated
with older age, and there are more older people. Experience from the recently introduced Quality and
Outcomes Framework in general practice shows that if you are going to manage conditions such as diabetes
and heart disease eVectively, there will be a need to use an increasing range of medicines. Although there is
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the possibility of improved lifestyles, including diet, smoking and exercise, lessening the incidence of chronic
conditions, this is unlikely to stem the demand for drugs because at best, it will delay the onset of these
conditions rather than prevent them.
Abolish the Prescription Charge Scheme
If the objective is to improve eYciency by promoting more appropriate and cost-eVective use of drugs and
to reduce expenditure on pharmaceuticals, there appears to be no logic in applying a demand-side measure
to a prescribed medicine. There is also no evidence to suggest that user charges are successful in controlling
overall levels of health care expenditure. It would be more eVective to introduce supply-side measures aimed
at influencing the behaviour of prescribers (GPs) and suppliers (pharmacists).
Abolishing the PCS would remove any financial barriers for those not currently exempt, thereby
enhancing equity and bringing drug coverage in line with other NHS services (that is, free at the point of
use). It was acknowledged that abolition may well drive more people into surgeries and increase GP
workload which counters the current move towards health policies including individual responsibility and
self-care.
Low level payment on all prescriptions
This would see the removal of all exemptions and the introduction of a low level payment, for example
a £1 payment that all patients would pay per prescription or item. This might mitigate against inappropriate
use of the exemption status (ie: for OTC medicines) but be low enough to ensure that those on low incomes
or on multiple medication could still aVord it.
Change the rules governing the Prescription Charge Scheme
Raising the income threshold for exemptions would enhance equity but result in revenue losses. It would
still leave those whose incomes fell just above the exemption cut-oV at a disadvantage.
Updating the list of exempt conditions to take into account developments in drug technology would
ensure that the system was more equitable for patients with diVerent conditions. Ensuring that patients with
chronic conditions have access to appropriate prescription drugs without financial barriers could have a
positive impact on eYciency by reducing inappropriate utilisation of health services due to poor drug
compliance. It would also result in a reduction in revenue.
Introduce a system of variable co-insurance based on cost-eVectiveness
Introducing a system of variable co-insurance based on cost-eVectiveness aims to increase micro-
eYciency. It may also contribute to controlling drug expenditure, as has happened in Italy and New
Zealand.
Unless combined with other measures such as an out-of-pocket maximum or exemptions for poorer
people, a variable co-insurance system would negatively aVect equity. Depending on how it is introduced,
there might be significant costs of obtaining cost-eVectiveness information and administrative costs.
The following suggestions closely follow proposals set out by Walley (Walley 1998):
— abolish the flat-rate charge and introduce variable co-insurance rates based on the cost-
eVectiveness of diVerent drugs (see Table 1 below);
— all drugs approved by the MHRA and available on the UK market would be assigned to one of
the four categories in the variable co-insurance system set out below; the lists would need to be
updated on a regular basis; most new drugs would be B or C initially, but a few might be A
immediately;
— in the short term patients currently exempt might be entitled to B list drugs free of charge to give
GPs time to adjust their prescribing behaviour and to allow time for evaluation of the reformed
scheme; a reduced co-insurance rate for B list drugs might be considered in order to preserve equity
for low-income households, although the use of means testing carries administrative costs and is
inconsistent with the principle of universality; and
— protect low-income households and people with chronic conditions from excessive out-of-pocket
costs by setting an annual out-of-pocket maximum; this would replace the pre-payment
certificates, which currently cap prescription drug expenditure at £91.80 per year or three
instalments of £33.40.
Co-insurance rates and cost-eVectiveness thresholds would need to be calculated on the basis of
information about the value and volume of drugs consumed in each category, the willingness to pay and
aVordability of diVerent co-insurance rates and the cost-eVectiveness thresholds and recommendations of
NICE.
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Table 1
EXAMPLES OF A VARIABLE CO-INSURANCE CHARGING SCHEME
Category Description Co-insurance rate
A — a selection of eVective medicines 0%
— suYciently comprehensive to allow treatment of all major
conditions
— free of charge to all
B — medicines either no more eVective than A list medicines or oVer 20%
minor benefits at a disproportionate cost?
— might require a low co-payment, perhaps related to the cost of
the prescription, to a pre-set maximum?
— a maximum cumulative annual co-payment per patient should
also be set?
— GPs might be allowed to endorse a prescription for exceptional
patients who would benefit more from the B list than the A list
drug, but would have to justify this
C — medicines for which eVective alternatives are already listed; for 50%
example, branded preparations where a generic equivalent is
available or which are largely directed at patient convenience,
such as many modified release preparations
— patients pay 50% of the cost of these medicines
D — medicines not funded by the NHS at all (negative list) 100%
Source: Walley 1998
Conclusions
After careful consideration of the evidence provided by organisations the Group feels that it would be
unrealistic to ask the Government to abolish prescription charges. However, with the current phasing out
of prescription charges in Wales and the intention to eventually abolish prescription charges the outcome
of which will be evaluated, the Group recommends that this is considered carefully by Government when
the time is right. The Group noted that Scotland has considered the abolition of the prescription charge
scheme and decided against it.
There is clearly a balance to be struck between equity, fairness and dependency in and on the NHS.
Supply-side restrictions cannot exist in isolation and demand-side controls need to be constructed more
around incentives than the creation of barriers.
At the very least the Group feels that the Government undertake an urgent review of the exemption
criteria with advice on changes from doctor, nurse and pharmacist representatives.
The Group also feel that the pre-payment certificate system should be reviewed since even the instalments
of £33.40 can be diYcult to pay for some people on lower income and yet it is just above the threshold for
full exemption. The Group advises that a monthly payment structure should be considered with appropriate
safeguards in place to avoid abuse of the system.
All Party Parliamentary Group Primary Care and Public Health
10 February 2006
Memorandum submitted by the International Glaucoma Association (CP 37)
Introduction
The question of co-payments and charges is best divided between health service provision and amenities,
although there may be some areas, such as car parking, where the two overlap.
Consideration should be given to: The potential health consequences of a financial disincentive to the take
up of the service. The quality of life of the patient and those issues related to health outcomes. In all cases,
the transparency of charges should be improved, so that people can make a properly informed choice when
making their decision.
In this submission I will be concentrating on optical services as this is our area of expertise. I have listed
our responses in the order of the terms and references, followed by a detailed review of optical provision.
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1. Equitable and Appropriate Charges
(a) Treatments
(i) Prescriptions
Not equitable across a range of long term conditions eg a Type II Diabetic patient may not require
medication for the control of their condition, but they are entitled to NHS funded prescriptions. A glaucoma
patient for whom eye drop medication is essential for the preservation of sight must pay unless entitled to
NHS funded prescriptions for another reason.
(ii) Dentistry
Generally equitable and appropriate where provision is available. However exemptions do not apply to
private treatment which is often the only treatment available in a given area. Dentistry is only a partial NHS
service with many citizens unable to take up the minimal NHS service provision for routine check up
appointments.
(iii) Optical Services
Generally equitable and appropriate, however the limitations of funding in terms of the examinations
available under NHS funding leave many conditions under-detected.
(b) Hospital Services
(i) Telephone and TV
Generally equitable, however, it is often the case that no extra provision is made for people of limited
means and the level of charging especially for incoming calls to patients is excessive.
(ii) Parking
Generally equitable, but too little provision is made for disabled or elderly patients and visitors.
2. Optimal Level of Charges
Charging in the NHS should be set at a level where it does not act as a disincentive to those who are
required to pay, to take up the service concerned. Both dentistry and optometry detection referable diseases
for which the symptoms are not immediately apparent, the treatment of the conditions is vital to the health
of the individual concerned. Prescription charging has a significant impact on the take up of prescribed
medications.
3. Is the System of Charging Sufficiently Transparent
No. A specific example being an NHS funded eye examination for a relative of a person with glaucoma.
Only one of the three necessary tests is funded by the NHS with the other two being chargeable additions
to a test that is supposedly NHS funded in order to detect glaucoma at the earliest possible stage.
4. Criteria to Determine Who Should Pay and Who Should be Exempt
Simple ability to pay is an insuYcient ground for this decision as it is important to include the disincentive
to seek treatment for asymptomatic conditions that a charge causes. Many conditions are better treated at
an asymptomatic stage and many cannot be reversed if they become symptomatic. Glaucoma and diabetic
retinopathy (the two leading causes of preventable blindness in the UK) are prime examples, but likewise
intracranial cancers, hypertension, ocular hypertension, diabetes, multiple sclerosis, etc (optical detection),
mouth cancers (dentistry) may be missed without routine examinations.
5. Making Patients Aware of the Exemptions
Exemption criteria are complicated, and in many cases diYcult to understand. It is probable that a person
actively seeking will make their initial descisions on the basis of a perceived cost, rather than fact.
This is of particular concern in people with.
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6. Whether Charges Should be Abolished
From a practical point of view it is probably impossible to abolish most of these charges. However, in
terms of prescription charges there is clear evidence of a disincentive to comply with prescribed treatment
regimes for chronic conditions (particularly those which are asymptomatic) which is seriously detrimental
to the long term outcomes in such cases. Access to primary care ophthalmic services may also be reduced
due to a perception that an appointment, (whether charged for or not), will result in the need for replacement
spectacles and a pressure to purchase these from the optometrist practice concerned (ie the mixture of
medical and commercial activities within the one facility).
Review of Optical Services
The purpose of the standard General Optic Council eye examination (the eye test) is generally considered
to have two parts:
1. to correctly identify and rectify, by means of spectacles or other optic aids, poor vision caused by
long or short sightedness, astigmatism or other deficiency.
2. to detect signs of ocular disease or abnormality that requires referral to an ophthalmologist within
the secondary care system.
A consequence of the standard test to examine the interior of the eye (ophthalmoscopy or slit lamp
microscopic examination) in the detection of high blood pressure, diabetes, some types of cancer, multiple
sclerosis and other systemic conditions can be detected in the eye, often before symptoms become apparent.
Technically an optometrist does not diagnose referable diseases such as glaucoma, diabetic retinopathy
or macular degeneration, this being the role of the ophthalmologist or hospital specialist.
In terms of glaucoma, the Government has recognised the importance of early diagnosis of this condition,
by means of the provision of NHS funded eye tests for first degree relatives of glaucoma suVerers over the
age of 40 ever since the introduction of eye test fees.
However, the Government has not recognised the importance of the two additional tests required for the
earliest possible detection of glaucoma in a primary setting by providing funding for these tests to be carried
out. In 1996 this Association carried out a large scale analysis of 275,000 eye tests by 189 diVerent
optometrists across England and Wales to establish the relative eVectiveness of the diVerent modes of
glaucoma screening10. This research showed that the one mandatory and funded tests (ophthalmoscopy)
would only detect about 25% of the detectable people with glaucoma who were presenting for an eye test.
The additional two tests; tonometry—a measurement of the pressure within the eye and perimetry; a check
of the field of vision gave a detection rate of about 75% and about 100% respectively (when applied in
addition to one another).
These two additional tests are available in most optometric practices today, but both may attract a charge
despite the possibility of the remainder of the test being NHS funded. From the patients’ point of view, these
charges seem suspect because their test is being funded as a result of their increased risk of developing
glaucoma, yet if the purpose of the NHS funded eye test is to find early cases of glaucoma in people at
increased risk of developing the condition and these tests are essential for that early diagnosis is to be
achieved.
Glaucoma is more common in the elderly population, the re-introduction of the NHS funded tests was
an important advance, however the failure to fund all three tests needed for about 100% detection rate, has
reduced their value preservating sight. The transparency of charging and also the NHS receiving value for
money by minimising sight loss will inevitably become more severe as the general population ages and as
newer diagnostic techniques such as the Heidelberg Retinal Tomograph become more readily available in
primary practice.
It is not unreasonable for people who are able to pay for an eye test, to be asked so to do. Where there
are known additional risk factors or disincentives for people to use the facilities provided by the optometric
community, there should be a significant and sustained eVort encouraging people to ensure their long term
vision by going for a test. It is important to note that some racial groups are at particular risk of certain
conditions and these groups often have a low usage of chargeable NHS services.
A prime example of this are people of African Caribbean origin who are more prone to developing
glaucoma than the Caucasian population and that such glaucomas tend to be more diYcult to control
eVectively, making early detection even more of a priority if vision is to be preserved for life.
Glaucoma remains the leading cause of preventable blindness in this country with approximately 50% of
those with the condition currently undetected and consequently without treatment. This is because the most
common forms of glaucoma do not give warning symptoms until a late stage when irreversible damage has
already been done to their vision.
10 Not printed here.
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As one eye tends to fill in for the other, glaucoma does not usually become symptomatic until between
40% and 50% of the visual field has been lost. A loss of this magnitude would generally be considered to
equate to a loss of between 80% and 90% of the nerve fibres within the optic nerve. These losses cannot be
recovered and are permanent. While treatments for glaucoma are now very eVective, the combination of the
natural loss of nerve fibres that occurs with age and the losses due to the glaucoma means that the remaining
10% or so of nerve fibres at the time of symptomatic presentation are extremely vulnerable and permanent
visual impairment is much more likely than for someone diagnosed at an earlier stage. Approximately 2%
of people over the age of 40 have glaucoma in the UK with less than half detected and under treatment. If
the precursor condition to glaucoma (ocular hypertension) is added to the equation, as many as 2.2 million
people are at increased risk of permanent visual impairment.
The second most common cause of preventable blindness in the UK, and the leading cause among the
working age population is diabetic retinopathy. Diabetic services are well developed in most parts of the
country, with eye tests being provided by the NHS without charge to the patient. However, the best way to
detect signs of diabetic change within the eye is through a special form of ophthalmoscopy, called
fundoscopy, which requires that the pupil be dilated for the examination. While as with glaucoma, many,
probably most optometrists do not make an additional charge for this test, when combined with the
additional liability to glaucoma of diabetic patients and their consequent best practice requirement for the
additional two glaucoma tests, this is another potential point of misunderstanding or missed diagnosis due
to a lack of understanding of the system.
To the patient NHS fundedmeans “free” and any additional charges are likely to be viewedwith suspicion
which means that some will opt not to have the necessary additional tests, and also that their confidence in
the eye care professional concerned may be damaged.
This concern also applies to dentistry where it is not the treatment of damaged teeth that is the most
significant element of the work, but rather then detection of other conditions such as cancer that can be
extremely significant in terms of the health of an individual and the population as a whole.
Summary
All charges levied for NHS treatment are by their nature undesirable, some areas such as optometry are
of particular concern because of the prevalence of serious sight or life threatening disease within the
population. The standard eye test does not provide a comprehensive examination in terms of the detection
of some of these conditions at the most appropriate stage and this undoubtedly results in unnecessary
blindness that is disproportionately biased towards the less educated and aZuent communities within
society. The costs of this blindness also fall disproportionately on both the people and the social services
within these communities.
More should be done to highlight the exemptions to charges that are already in place and much more
should be done to provide comprehensive examinations (to prevent false negative results from tests) and to
encourage take-up of the available services. Particularly in the area of optometric services, a more realistic
scale of payment to the optometrist should be considered taking into account the provision of tonometry
and perimetry and any other tests that may be necessary for the timely detection of ocular disease. The
introduction of shared care community based systems for the management of glaucoma is an ideal
opportunity to improve the provision of these essential detection systems.
International Glaucoma Association
January 2006
Memorandum submitted by Ms Anna Dixon and Ms Sarah Thomson (CP 44)
Anna Dixon is Lecturer in European Health Policy in the Department of Social Policy at the London
School of Economics andPolitical Science and currently aCommonwealth FundHarkness Fellow inHealth
Care Policy based at the University of Oregon, USA. Author of numerous articles on health care financing
including co-editor of Funding Health Care: options for Europe (Open University Press, 2002)
Sarah Thomson is Research OYcer in Health Policy at LSE Health and Social Care and a Research
OYcer at the European Observatory on Health Systems and Policies and author of numerous articles and
chapters on user charges and private health insurance
Summary
This evidence focuses on user charges that apply to prescription drugs within the English National Health
Service (NHS). We present evidence to suggest that the prescription charge scheme (PCS) as currently
designed results in inequities in access. User charges may be appropriate to achieve certain objectives such
as utilization of cost-eVective drugs but they are a weak instrument compared to incentives for providers on
the supply side (eg doctors, nurses and pharmacists). We present data on types of user charging schemes
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found in other countries and recommend that a system of variable coinsurance rates be considered for drugs
in the NHS. We would argue that rational use of cost-eVective health care can best be promoted through
ensuring that the behaviour of providers is controlled.
Are Charges Equitable and Appropriate?
1. User charges may be appropriate depending on their objectives and how they are implemented.
Economic theory underlies arguments put forward both in favour of and against user charges for health
care. There are a number of stated objectives that user charges may achieve:
— reducing unnecessary or excess utilisation;
— reducing overall expenditure (cost containment);
— raising additional revenue; and
— directing utilisation to more appropriate care/services.
2. Neo-classical economists claim that the use of health services exceeds socially beneficial levels when
health care costs are fully covered by insurance or free at the point of use. Because the price of using health
services is eVectively zero, individuals make use of more health care then they would if they had to pay for
it at the point of use (Arrow 1963; Pauly 1968). It is often argued that user charges (such as prescription
charges) will reduce “excess” utilisation and selectively discourage the use of health services that provide
little value to the individual.
3. A number of arguments are used to criticise the neo-classical economic model which would suggest
user charges are inappropriate:
— the diverse nature of health care “goods”;
— the existence of information asymmetries in the health care market;
— individuals may not be well-informed about their own need for health care;
— individuals may be unable to distinguish between eVective and ineVective or harmful treatment;
— health care providers are usually better informed than patients; and
— providers can influence both the type and quantity of health services used (Evans 1984).
4. The case for user charges as a means of reducing excess utilisation is weak, particularly when charges
are applied to health services that are used as a result of a provider’s recommendation, referral or
prescription (Chalkley and Robinson 1997).
5. The prescription charge scheme (PCS) in the NHS may be regarded as inequitable for the following
reasons:
— it exempts some patient groups but not others; the list of medical conditions exempt from
prescription charges has not been updated since 1968 and excludes several chronic conditions that
have become prominent since then, such as cancer, multiple sclerosis, arthritis and HIV/AIDS;
patient groups such as diabetics are exempt, but those suVering from cystic fibrosis, chronic
asthma, hypertension and a variety of dermatological conditions are not;
— the blanket nature of some exemptions means that some people with high incomes may be exempt
while some people with low incomes may not be exempt; for example, the PCS exempts anyone
aged 65 and over and all pregnant women (although the latter could be seen as a means of
protecting the health of the foetus); and
— it presents a financial barrier to access to prescribed drugs for people with low incomes,
particularly those whose earnings are just above the threshold for receipt of government benefits.
6. The PCS (along with other NHS charges) undermines a core principle of the NHS, which is to provide
services that are free at the point of use (Department of Health 2000).
What is the Optimal Level of Charges?
7. There is no optimal level atwhich user charges should be set. Such a decisionwill depend on the balance
between revenue raised (income), administrative costs (direct expenditure) and the ability to control
expenditure. We look at these issues in turn.
Revenue raising
8. The revenue-raising potential of user charges may be limited by the existence of protection
mechanisms, high transaction costs, fraud or providers’ reluctance to enforce charges (Brandt, Horisberger
et al. 1980; Evans and Barer 1995). However, increasing the financial burden on individuals lowers equity
in access to health care. Those with low incomes are most likely to be discouraged from using health services,
while those in poor health will suVer most from lower levels of use. Attempts to exempt these groups of
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people are not always successful (Brandt,Horisberger et al. 1980) and the claim that any extra revenue raised
can be directed towards people with low incomes or in poor health may be diYcult to substantiate in
practice.
Administrative costs
9. The costs of administering the PCS exemptions may be high relative to the amount of revenue
generated by non-exempt prescriptions. If the objectives of the PCS are to generate revenue while preserving
equity, then the use of prescription charges is a weak instrument.
Expenditure control
10. The PCS is unlikely to succeed in controlling expenditure in the long term for various reasons and
may encourage ineYcient patterns of health services utilisation.
11. Prescription drugs are provider-initiated care (that is, initiated by the prescribing doctor, usually the
general practitioner, and not the patient). Consequently, a demand-side incentive such as the PCS is unlikely
to have much impact on controlling drug expenditure. Supply-side controls such as prescribing budgets and
prescribing guidelines are more eVective in ensuring the rational use of drugs. Furthermore, total
expenditure on pharmaceuticals is generally rising due to increases in the cost per item rather than volume.
Therefore, pricing regulation is more likely to have an impact on overall spending than volume controls.
12. Prescription charges are a weak instrument for deterring frivolous or unnecessary consumption of
high-cost or low-eVectiveness pharmaceuticals. As a result of prescription charges a patient may choose not
to fill a prescription or not to take a full course of medication by not filling a repeat prescription, but this
behaviour might lead to worse health outcomes. Also, because charges apply to all prescription drugs,
regardless of whether they are high or low cost, branded or generic, high or low eYcacy, they do not
encourage cost-eVective patterns of drug utilisation or substitution of generic drugs by pharmacists.
13. User charges are unlikely to contain health care costs in the long term, as spending on health care is
primarily driven by supply-side factors (Evans and Barer 1995).
What Criteria should Determine who Should Pay and Who Should be Exempt?
14. Prescription charges in the United Kingdom (UK) are flat-rate payments; regardless of the cost of
the drug, the patient pays the same amount, with the remaining cost met by the NHS. Drugs received in
hospital or from a hospital pharmacy are not subject to co-payments. The current system of exemptions
from prescription charges is extensive, accounting for about 85% of all prescriptions dispensed.
15. Lowering the charge could reduce financial barriers for some non-exempt categories of patients.
16. The current system of means-tested exemptions means that those who fall just above the threshold
are disadvantaged. Raising the income threshold for exemptions would enhance equity but result in revenue
losses. It would still leave those whose incomes fell just above the exemption cut-oV at a disadvantage. As
will all means testing, there is a trade-oV between targeting benefits and the need to keep down
administrative costs.
17. The current system of charges results in inappropriate utilisation patterns. Drugs prescribed in
hospital are not subject to any charges, but in an attempt to shift costs to primary care, hospitals are
increasingly reducing the amount of drugs prescribed on discharge. This requires individuals to go to their
general practitioner for follow up prescriptions after discharge from hospital. The availability of
prescriptions for P category drugs leads to a perverse situation in which those who are exempt from
prescription charges will go to the general practitioner simply to getOTC drugs on “free” prescription. Some
people may try to avoid having to pay prescription charges by going to an A & E department instead of
seeing their general practitioner. Standardisation of charging across settings would reduce this problem.
18. Updating the list of exempt conditions to take into account developments in drug technology would
ensure that the system was more equitable for patients with diVerent conditions. Ensuring that patients with
chronic conditions have access to appropriate prescription drugs without financial barriers could have a
positive impact on eYciency by reducing inappropriate utilisation of health services due to poor drug
compliance. It would also result in a reduction in revenue.
Should Charges be Abolished?
19. If the objective is to improve eYciency by promoting more appropriate and cost-eVective use of drugs
and to reduce expenditure on pharmaceuticals, there appears to be no logic in applying a demand-side
measure to a prescribed substance. Furthermore, there is no evidence to suggest that user charges are
successful in controlling overall levels of health care expenditure. It would be more eVective to introduce
supply-side measures aimed at influencing the behaviour of prescribers (general practitioners) and suppliers
(pharmacists).
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20. Abolishing the PCS would remove any financial barriers for those not currently exempt, thereby
enhancing equity and bringing drug coverage in line with otherNHS services (that is, free at the point of use).
21. It would be useful to evaluate the phased abolition of prescription charges in Wales.
User charges in other countries
22. There are a variety of diVerent forms that user charges may take in diVerent health care systems.
These include:
— flat-rate payments: fixed fees per item prescribed or per prescription;
— co-insurance: the patient pays a fixed percentage of the total cost of a good or service;
— deductible: the patient pays the full costs of goods and services consumed directly out of pocket
up to a defined ceiling after which the services are free (costs being met by the insurer or the NHS);
deductibles can apply to specific cases or to a period of time (usually a year);
— extra billing: the patient pays the diVerence between the reimbursement value and the actual price
of the good or service (see reference pricing, below).
23. In the pharmaceutical sector extra billing is often used where a fixed or reference price is set for a
group of drugs with similar therapeutic eVects. This may be set at the average price of the drugs in the group,
the price of cheapest drug in the group or benchmarked to the price of similar drugs in other countries or
the price of the generic alternative. The reference price is the amount that the insurer or the NHS pays. If
the patient chooses a drug that is more expensive than the reference price, they must pay the diVerence
themselves.
24. Other features of user charge schemes exist in other countries:
— annual out-of-pocket maximum: in order to limit the total amount spent by an individual in the
course of a year, a maximum ceiling may be set on the total amount of out-of-pocket payments;
for example, a chronic disease patient who requires a lot of medication might have to pay for their
drugs, but if, after nine months, they had reached the out-of-pocket maximum they would not need
to pay for drugs consumed in the rest of the year;
— variable co-insurance: in some countries diVerent levels of co-insurance (for example, 20%, 50%,
100%) apply to diVerent groups of drugs depending on their eYcacy/cost-eVectiveness; for
example, a 20% co-insurance rate might apply to generic drugs, whereas “lifestyle” drugs with no
proven eYcacy might carry a 100% co-insurance rate.
25. Examples of specific charging policies in diVerent countries and their impacts are evaluated in more
detail in Thomson S and E Mossialos (2004), “Influencing demand for drugs through cost sharing” in
Mossialos E, M Mrazek and T Walley Regulating pharmaceuticals in Europe: striving for eYciency, equity
and quality, Open University Press, which is attached for your information.
Recommendations
26. User charges can be used to encourage more cost-eVective patterns of utilisation. This is achieved by
conveying price signals to users to opt for certain types of health care or follow a particular system of referral
or to providers responsible for prescribing treatment (via users) (Brandt, Horisberger et al 1980).
Introducing a system of variable co-insurance based on cost-eVectiveness aims to increase micro-eYciency.
It may also contribute to controlling drug expenditure, as has happened in Italy and New Zealand.
27. A variable co-insurance system would negatively aVect equity unless there was no charge for eVective
prescription drugs. Combining co-insurance with other measures such as an out-of-pocket maximum or
exemptions for poorer people would help to preserve equity. Depending on how it is introduced, there might
be significant costs of obtaining cost-eVectiveness information and administrative costs.
28. The following suggestions closely follow proposals set out by Walley (Walley 1998):
— abolish the flat-rate charge and introduce variable co-insurance rates based on the cost-
eVectiveness of diVerent drugs, with no charge for eVective prescription drugs (see Table 1 below);
— all drugs approved by the Medicines and Healthcare products Regulatory Authority and available
on the UK market would be assigned to one of the four categories in the variable co-insurance
system set out below; the lists would need to be updated on a regular basis; most new drugs would
be B or C initially, but a few might be A immediately;
— in the short term patients currently exempt might be entitled to B list drugs free of charge to give
general practitioners time to adjust their prescribing behaviour and to allow time for evaluation
of the reformed scheme; a reduced co-insurance rate for B list drugs might be considered in order
to preserve equity for low-income households, although the use of means testing carries
administrative costs and is inconsistent with the principle of universality;
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— protect low-income households and people with chronic conditions from excessive out-of-pocket
costs by setting an annual out-of-pocket maximum; this would replace the pre-payment
certificates, which currently cap prescription drug expenditure at £33.40 per quarter or £91.80
per year11.
29. Co-insurance rates and cost-eVectiveness thresholds would need to be calculated on the basis of
information about the value and volume of drugs consumed in each category, the willingness to pay and
aVordability of diVerent co-insurance rates and the cost-eVectiveness thresholds and recommendations of
NICE.
Table 1
EXAMPLES OF A VARIABLE CO-INSURANCE CHARGING SCHEME
Category Description Co-insurance rate
A — a selection of eVective medicines 0
— suYciently comprehensive to allow treatment of all major
conditions
— free of charge to all
B — medicines either no more eVective than A list medicines or oVer 20%
minor benefits at a disproportionate cost
— might require a low co-payment, perhaps related to the cost of
the prescription, to a pre-set maximum
— a maximum cumulative annual co-payment per patient should
also be set
— general practitioners might be allowed to endorse a
prescription for exceptional patients who would benefit more
from the B list than the A list drug, but would have to justify
this
C — medicines for which eVective alternatives are already listed; for 50%
example, branded preparations where a generic equivalent is
available or which are largely directed at patient convenience,
such as many modified release preparations
— patients pay 50% of the cost of these medicines
D — medicines not funded by the NHS at all (negative list) 100%
Source: Walley 1998.
These views are our personal views and do not represent the position of either the London School of
Economics or the European Observatory on Health Systems and Policies
Ms Anna Dixon and Ms Sarah Thomson
London School of Economics
28 February 2006
Memorandum submitted by David Magnus (CP 35)
Hospital Car Parks—East and North Hertfordshire NHS Trust
Table 1 below shows the increase in visitors car park charges that came into force on 3 October 2005. For
three, four and six to 10 hours the charges were doubled. Table 2 shows that the new charges are excessive
when compared to the corresponding charges at council-run short-stay car parks in five town centres in the
Trust Area.
In addition I would like to make the following points:
The Trust’s car parks are funded by cash payments from those members of the public who use them,
whereas the remainder of the Trust’s activities is funded mainly by central government and the general
taxpayer, and by National Insurance contributions. I believe it is therefore logical to expect the The Trust’s
accountants should treat the car park as a separate business enterprise operating within the Trust, with its
own capital assets, its own cash income, and its own relevant outgoings. Any fair and reasonable assessment
of car parking charges should match the case income against those outgoings that are not already paid for
by central government. Otherwise, if the charges are set too high, then:
(1) the car park operation will become a profit-making concern, subsidising the other loss-making
clinical and medical departments through the excess cash payments of car park users; and
11 These currently have to be purchased in advance and awareness of them is low.
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(2) because the car park users are also taxpayers, any excess cash payments they make will in eVect
be an unfair tax surcharge.
I suggest these consequences are unacceptable and represent a corruption of the fundamental principles
of the NHS.
I also believe that the new charges were deliberately pitched at an excessively high level in order to help
rescue the Trust from its overall financial deficit of £8.6 million in 2004–05. In that case it would appear that
visitors to the Trust’s hospitals have been unfairly targeted, just because it is easy to do so by manipulating
the pay machines in the car parks. This is blatant overcharging for non-medical ancillary services.
Table 1
INCREASE IN CHARGES
Time, hours 1 2 3 4 5 6–10
Old charge, £ 2.00 2.00 2.00 2.00 2.50 2.50
New charge, £ 2.00 2.00 4.00 4.00 4.00 5.00
% increase 0 0 100 100 60 100
Table 2
COMPARATIVE CHARGES, £
Time,hours 1 2 3 4
Stevenage 0.80 1.00 2.20 2.50
Hitchin 0.50 0.50 2.00 3.00
Letchworth GC 0.40 0.50 1.00 2.00
Hertford 0.50 1.10 1.70 2.20
Welwyn GC 1.00 1.00 2.00 3.00
Average 0.64 0.82 1.78 2.54
E & NH Trust 2.00 2.00 4.00 4.00
% excess 212 144 125 57
David Magnus
16 January 2006
Memorandum submitted by Dr GeoV Searle (CP 38)
I am a Consultant Psychiatrist in Bournemouth. I have recently taken on a role leading a Community
Crisis Response Team. I was unaware of your inquiry until I saw a news item in the BMA news two days
ago. I would like to raise two points.
1. The current charging rules have a serious impact on those with serious mental illness who require long
term treatment. Such patients are invariably on disability benefit and pay prescription charges. They never
have enough cash in hand to buy pre-payment certificates. For those on three or four medications long term
the prescription charges are a considerable burden and expense, and for those with doubts about the need
for medication the charges are a great excuse not to comply with needed treatment. At present on occasion
Health workers have to “mistakenly” fill in the prescription as if the patient is on income support.
2. I have taken over a crisis intervention team and we are trying to find flexible alternatives to in-patient
care. However as our patients are not in hospital they have to be charged for their medication—which is
very diYcult and complex for my team (especially if we are giving the patients their medication and
monitoring their compliance). The cost can also be considerable for any patient on three or four medications
when doses are changed frequently or prescriptions are kept short to guard the patient from a dangerous
overdose.
Overall the current NHS charging for medication rules are a significant obstruction to modern psychiatric
practice. I would be happy to give oral evidence. This is an individual submission.
Dr G F Searle
30 January 2006
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Memorandum submitted by Professor Peter C Smith (CP 36)
Introduction
Most health care is directed at individual patients, seeking to improve the duration and quality of life. It
is therefore perfectly feasible to charge patients a fee for their use of health care. Indeed it is worth recalling
that until recently doctors in all countries relied mainly on patient fees to provide their income, and that this
system is still dominant in much of the developing world. It was only in the latter half of the twentieth
century that socialised medical care has become widespread in developed countries.
User charges in health care have two broad roles: to raise finance for the health system, and to send signals
to patients who would otherwise face a zero price for access to health care. Developed countries do not
currently rely to any great extent on charges as a significant source of finance. However, there has been a
persistent concern with the dangers of “moral hazard” in health care.12 That is, in the absence of direct
prices, patients may use health care when it is not warranted. Moreover, given the power of doctors to
influence patient behaviour, moral hazard might be exacerbated by “supplier induced demand”, particularly
in systems where doctors’ incomes rely directly on attracting high levels of business.13
This note assesses the current role of user charges in developed health systems, and possible future options
for the English National Health Service.
User Charges in High Income Countries
Figure 1 shows that direct user charges (out of pocket payments) account for between 10% and 20% of
health system revenue in high income countries. Most of the “other” private expenditure relates to voluntary
private insurance. In particular, in countries such as France and Ireland, patients are in principle liable for
quite high user charges. However, many citizens take out voluntary private health insurance to secure
protection from out of pocket payments. Note that the OECD has not been able to report these data for
the UK since 1997.
Figure 1
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(Source: OECD Health Data 2004).
The especially low reliance on user charges in the United Kingdom reflects the founding principle of a
NHS “free at the point of access”. Eversley relates the fraught history of NHS charges, the imposition of
which in 1951 led to the resignation of Aneurin Bevan, hastening the demise of the Atlee government14 An
attempt to abandon prescription charges by the Labour government in 1965 was soon reversed in 1967, and
further increases were subsequently imposed in 1975 under pressure from the International Monetary Fund.
In 2004 prescription charges in England accounted for income of £446 million, with only 8.9% of
12 Zweifel, P and Manning, W (2000), “Moral hazard and consumer incentives in health care”, in J P Newhouse and A J Culyer
(ed), Handbook of health economics, Amsterdam: Elsevier.
13 McGuire, T (2000), “Physician agency”, in J P Newhouse and A J Culyer (ed), Handbook of health economics, Amsterdam:
Elsevier.
14 Eversley, J (2001), “The History of NHS Charges”, Contemporary British History, 15(2), 53–75.
3312493017 Page Type [E] 12-07-06 01:32:43 Pag Table: COENEW PPSysB Unit: PAG6
Ev 156 Health Committee: Evidence
prescriptions directly attracting the full charge of £6.20.15 The vastmajority of prescriptions are exempt from
charges on grounds of age (young and older people), sickness (certain chronic conditions), maternity, or low
income. The Welsh and Scottish government intend to abolish prescription charges.
Recent Developments in Europe
Western Europe countries have traditionally sought to model their health systems on the principle of
“solidarity”. This implies universal coverage, and contributions to the financing of health care according to
ability to pay, irrespective of age or level of sickness. User charges appear to contradict the principle of
solidarity. Yet, as expenditure on health care has grown inexorably, there has been growing interest in
imposing some modest charges.16
In general, these new charges do not raise a significant volume of finance for the health system—indeed
in some circumstances the sums involved are outweighed by the collection costs. Rather, the main purpose
of these experiments is to encourage patients to use the health system to better purpose, by discouraging
treatment when benefits are small and creating incentives for eYcient use of services when it is justified.
Examples of objectives underlying charging schemes include:
— moderating the number of physician and hospital visits;17
— encouraging use of cheaper generic drugs, through the use of “reference prices”;18
— directing patients through gatekeeper physicians;19
— encouraging the use of less costly or higher quality “preferred” providers; and
— encouraging early discharge of patients from hospital.
Most of these initiatives have been directed at cost containment, and many other experiments in a similar
vein could be envisaged, such as charging patients for outpatient visits, but oVering a full or partial rebate
if the appointment is honoured (in order to discourage “did not attends”). Moreover, user charges could in
principle be used to encourage healthier behaviour on the part of patients. For example, one could envisage
a scheme of exemption from charges if a patient complies with a course of treatment in its entirety. There
follows a brief sketch of a few recent European innovations.
Sweden was one of the first of the traditional public sector systems to experiment with quite small user
charges across a wide range of health services. Children and young people are generally exempt, and the
maximum annual liability for charges has traditionally been set at quite a low level (ƒ90 in 2001). Charging
on this modest scale appears to have been generally accepted as reasonable, but it has resulted in reduced
utilisation amongst low income patients, and a concern that equity of access may be compromised.20
Some countries in eastern Europe are experiencing especially severe problems with financing health care,
and are therefore experimenting with more radical approaches to charging, especially where a tradition of
“informal” payments to doctors and other professionals exists.21 A particularly ambitious scheme of
“diagnosis based reimbursement” is being introduced in the Slovak republic. A national tariV for
reimbursing providers is set for all interventions, according to diagnosis. Patients will then be reimbursed
for a proportion of the costs of treatment, depending on the diagnosis group. The proportion reimbursed
depends on the estimated benefits and costs of treatment, and there is full reimbursement for 33% of
diagnoses. This scheme is consistent with the prescriptions of the economic theory of “optima” commodity
taxation.22 However, as experience unfolds, it will be important to see whether it is in practice sustainable,
whether unintended behavioural responses on the part of doctors or patients emerge, and whether the lack
of exemptions leads to especially adverse outcomes for poor and sick people.
15 House of Commons (2005), Hansard 27 January 2005 : Column 561W, London: The Stationery OYce.
16 Robinson, R (2002), “User charges for health care”, in E Mossialos, A Dixon, J Figueras and J Kutzin (ed), Funding health
care: options for Europe, Buckingham: Open University Press.
17 Gericke, C, Wismar, M and Busse, R (2003), Cost-sharing in the German health care system. Discussion Paper, Berlin:
Department of Health Care Management, Technische Universita¨t Berlin. Grabka, M, Schreyo¨gg, J and Busse, R (2005),
Verhaltensa¨nderung durch Einfu¨hrung der Praxisgebu¨hr und Ursachenforschung—eine empirische Analyse. DIW Discussion
Paper 506, Berlin: Deutsches Institut fu¨r Wirtschaftsforschung.
18 Kanavos, P and Reinhardt, U (2003), “Reference Pricing For Drugs: Is It Compatible With US Health Care?” Health AVairs,
22(3), 16–30.
19 Bellanger, M and Mosse´, P (2005), “The search for the Holy Grail: combining decentralised planning and contracting
mechanisms in the French health care system”, Health Economics, forthcoming.
20 Andersen, R, Smedby, B and V‰gero¨c, D (2001), “Cost containment, solidarity and cautious experimentation: Swedish
dilemmas”, Social Science and Medicine, 52(8), 1195–1204.
21 Lewis, M (2002), “Informal health payments in central and eastern Europe and the former Soviet Union: issues, trends and
policy implications”, in E Mossialos, A Dixon, J Figueras and J Kutzin (ed), Funding health care: options for Europe,
Buckingham: Open University Press.
22 Smith, P (2005), “User charges and priority setting in health care: balancing equity and eYciency”, Journal of Health
Economics, 24, 1018–1029.
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Evaluating User Charge Experiments
There is in general a shortage of reliable evidence on the impact of user charges on the utilisation of health
care and the consequences for the health of patients. The major exception is the celebrated RAND
experiment, under which over 2,000 US patients were randomly assigned to one of four charging regimes
over an extended period.23 One group of patients enjoyed complete freedom from charges, while those at
the other extreme were charged 95% of fees for virtually all care, up to a maximum annual “catastrophic”
liability of about $6,000 at current prices.
The experiment resulted in consistent reductions in utilisation across all types of health care as the charges
became more severe. For example, physician consultations varied from 4.55 per annum amongst those
incurring no charges, to 2.73 amongst those in the highest charging scheme, a reduction of 40%. However,
with one major exception, evaluation of the experiment did not detect any material variations in health
outcome associated with charging. Researchers have therefore concluded that—for most of the
population—charges succeeded in encouraging less profligate use of health care without serious health
consequences.
The one important exception was the finding that charging had a seriously adverse eVect on those who
were both poor and suVering frompoor health. TheRANDevaluation estimated that for this disadvantaged
group therewere a wide range of serious consequences, in spite of some cost subsidy for low-income families.
For example, when charges were imposed, hypertension was less well controlled in this group, to the extent
that the annual likelihood of death rose approximately 10%.24
It has proved much more diYcult to evaluate the consequences of user charges where there is no
experimental design. However, when statistical analysis has been undertaken in other countries, it appears
to corroborate the RAND results. For example, results from Belgium suggest a distinct impact of charges
on demand for GP home visits and oYce visits, except amongst older or disabled patients.25
A Future Role for User Charges?
In the light of the above discussion, the question arises: what is the most appropriate role for user charges
in a modern health system? Experience in high income countries suggests a persistent tension between the
equity goal of assuring universal access to health care and the eYciency goal of assuring frugal use of health
services. In short, unless carefully designed, user charges designed to curb excessive demand amongst the
bulk of the population could have ruinous financial or health consequences for a relatively small number
of poor people with health problems. It is therefore important to view the design of user charges within the
broader objectives and institutions of the health system as a whole.
With the notable exception of the United States, there is a general consensus that public funding of tightly
regulated delivery should lie at the core of the modern health system. However, there is also a growing trend
in such systems towards the use of small but symbolically important user charges. Why this should be the
case may be a matter for psychologists, sociologists and political scientists to explain, as—from an economic
perspective—they appear insuYcient to aVect demand materially, except amongst the very poor, who are
often exempt. Rather, the intention of new charging initiatives seems to be to influence very specific aspects
of patient behaviour, and to act as a signal of preferred behaviour. In this respect, in conjunction with a
system of carefully crafted exemptions, they may oVer an important policy option for influencing demand.
Moreover, the may help reassure the taxpayer that patients are being encouraged to use the services they
pay for responsibly.
However, beyond the largely symbolic nature of these recent developments, I believe that in the more
medium term the accelerating pace of technological innovation and the inexorable rise in patient demands
may require a more fundamental rethink of the role of charges. At present, European countries are (just
about) able to ensure that most mainstream interventions are included in their statutory package, allowing
policy makers to claim that coverage is comprehensive. However, there is growing evidence that such a
policy may become financially unsustainable, and that policy may have to resort to increased use of explicit
rationing of health care.26
If it does, the central policy problem is to decide which health care technologies should be subsidised from
public funds. User charges policy then flows naturally from the choice of the subsidised treatments. Once
the “public” package of care is chosen, patients would still be free to purchase the remaining unsubsidised
interventions at market prices, or to purchase complementary private insurance to cover such interventions.
This is the essence of the Slovak experiment. I have shown elsewhere that, from an economic perspective,
the choice of interventions in the public package should be guided solely by the expected health benefits they
23 Newhouse, J (1993), Free for all? Lessons from the RAND health insurance experiment, Cambridge MA: Harvard
University Press.
24 Newhouse, J P (2004), “Consumer-Directed Health Plans And The RAND Health Insurance Experiment”, Health AVairs,
23(6), 107–113.
25 Van De Voorde, C, Van Doorslaer, E and Schokkaert, E (2001), “EVects of cost sharing on physician utilization under
favourable conditions for supplier-induced demand”, Health Economics, 10(5), 457–471.
26 Coulter, A and Ham, C (2000), The Global Challenge of Health Care Rationing, Maidenhead: Open University Press.
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bestow in relation to costs.27 Equity concerns should in my view be tackled not by the health care system,
but by the tax system used to finance the public package. However, if political considerations demand that
the package should be skewed in favour of diseases of the poor, then this does not aVect the general principle
of explicit definition of the package.
The scope of the statutory package will be determined by the public’s willingness to pay the necessary
taxes—in particular, the willingness of the healthy and the rich to subsidise the sick and the poor.28 It is
therefore essential that the package is of high quality, so that richer people do not choose to use private care
in preference to publicly subsidised care. If quality is poor, widespread resistance to paying the taxes
required to finance the public package may arise, making the public system unsustainable.
In England, the National Institute for Health and Clinical Excellence (NICE) is charged with evaluating
new technologies, and issuing associated clinical guidelines. Therefore, although a daunting technical
undertaking, NICE could in principle be given the expanded remit of recommending the entire scope of the
publicly subsidised package. Charges (partial or total) would then be paid by patients on interventions that
fell outside the chosen package. Indeed one could envisage that—if a technology fails its cost-eVectiveness
criterion—NICE could nevertheless determine the (lower) price at which the intervention or drug that could
be included in the public package. The patient would then be asked to fund the diVerence between the NICE
price and the provider’s price.
Whether charges are symbolic or substantive, the issue of exemptions has proved a problematic issue for
policy makers. For example, successive UK governments have introduced exemptions for prescription
charges on the grounds of age (young and old), health needs (an apparently arbitrary selection of conditions)
and income, resulting in a very low proportion of patients being liable for charges. Clearly exemptions can
often be arbitrary and pervert the intended economic signals. Yet equally, the evidence from RAND and
other experiments is that at least some disadvantaged patients will suVer catastrophic financial or health
eVects if some system of abatement of charges is not put in place.
The solution to exemptions adopted in many countries has been to set a maximum liability for health care
in any one year, perhaps as a proportion of total income. The intention is to ensure citizens experience some
of the incentive eVects of user charges, but are protected from ruinous health care expenditure.
In summary, therefore, I believe that the publicly funded health system of the future should look
something like the following:
— an explicit set of interventions is subsidised by public funds (the “health basket”), the choice of
which is guided by the criterion of cost-eVectiveness;
— the size of the health basket is determined by the willingness of the population to pay the
necessary taxes;
— there should be no compromise on the quality of publicly funded health care, the intention being
that all citizens should use the public sector for interventions within the health basket;
— charges (partial or total) are paid by patients on interventions that are not deemed cost-eVective;
— those able and willing may purchase voluntary (complementary) insurance to protect against such
“economic” charges;
— there may in addition be small “symbolic” charges even on fully subsidised interventions, as signals
of preferred behaviour—these cannot be insured in the private market, otherwise the incentive
eVect is lost; and
— there may need to be a carefully crafted system of exemptions from symbolic charges to protect
very poor or very sick citizens, perhaps in the form of a maximum percentage of annual income;
however exemptions will not apply to interventions that lie outside the statutory package.
This system may at first glance appear unattractive compared to the stated principle of a comprehensive
NHS, free at the point of access. Yet many commentators feel that it will be infeasible to adhere to that
principle indefinitely, as the scope of health care increases inexorably and the limits to popular willingness
to pay the necessary taxes are reached. If this is the case, the proposals set out here oVer policy makers a
framework for making the hard choices that follow in a systematic and fair fashion.
Adoption of such a system may also help convince the public that taxes are being spent wisely, in line with
both eYciency and fairness criteria, so maximising the chances of creating a high quality statutory package
of broad scope. It will take political courage to implement such explicit rationing, but the alternative may
be steadily to reduce the scope and quality of the NHS by stealth, and reduce the widespread support for
tax funding of the NHS, an outcome that cannot be to the general public good.
Professor Peter C Smith
January 2006
27 Smith, P (2005), The statutory health care package under private health insurance. Paper presented to World Bank conference
on Voluntary Health Insurance in Developing Countries, Wharton Business School, University of Pennsylvania
28 De Graeve, D and Van Ourti, T (2003), “The distributional impact of health financing in Europe: a review”, The World
Economy, 26(10), 1459–1479.
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ANALYSIS OF CAR PARKING (PROVISION, CHARGES AND INCOME) AT NHS TRUSTS
Summary
This analysis demonstrates that there are substantial variations between NHS trusts in the availability,
cost of and income generated by parking for patients and their visitors. It is possible to develop statistical
explanations of some of these variations but in others there does not appear to be a systematic pattern. In
summary there is:
— Variability in the availability of parking whether this is expressed in terms of ratio of parking
spaces to beds (a measure of hospital capacity) or to the ratio of parking spaces to patient numbers
(a measure of demand for parking spaces). Some, but by no means all, of this variation seems to
be related to site constraints.
— Variability in parking charges which does not appear to be systematically related to demand (the
ratio of patients to parking spaces), suggesting that other unobserved factors aVect the way prices
are set for car parking. There is some evidence that prices in London and the South East are higher
than elsewhere.
— Variations in the cost to the patient of car parking: on the figures provided by the department,
these range up to a maximum of £4.35 though in the majority of cases a figure of £1 per hour is
more usual. It is not possible to estimate the total cost per patient because we do not have data on
the number of times they attend hospital from this source, and nor do we have details about how
patients get to hospital.
— Great variability in the income generated by car parking. When this is related to the Trust
operating income, in the great majority of cases it accounts for under 0.25% of the budget but there
were 15 cases where it exceeded 0.5% of the budget and in two cases it exceeded 1%. If this reflects
the costs of establishing and running car parks, it is not easy to see why the cost of running car
parking should vary to this extent.
Introduction
1. The Department of Health supplied data to the Committee on a range of variables pertaining to the
provision and cost of car parking and to revenues derived from charges for parking at NHS acute hospital
trusts. The data were drawn from a number of statistical returns which Trusts make to the department. They
included information on: total numbers of inpatients, patients, and casualty attendances at each trust;
average number of beds available; total trust income; the proportion of the site which was occupied by
buildings; numbers of parking spaces, sometimes broken down to give the numbers available for staV,
visitors, and places reserved for disabled drivers; total income derived from parking for visitors and patients;
the hourly parking rate charged to visitors and patients. The data related to trusts, not to individual hospital
sites. Information was provided on 203 hospital trusts, containing nearly 150,000 beds.
2. The data do not include information on several variables which it would have been desirable to include
in the analysis, such as: the availability of parking in the vicinity of each Trust; accessibility by public
transport; and the modal split of journeys to hospital (ie the proportion of journeys made by various modes
of transport). In addition not all hospitals were able separately to identify the provision of parking
specifically for patients and their visitors (as opposed to staV) or the revenue generated by it.
3. Several additional variables were computed from the data, such as average income per parking space,
the ratio of parking income to the operating income of the trust, average income from parking per patient
treated, and indicators of patient throughput, such as the number of patients treated per bed. It was also
possible to identify which Strategic Health Authority each trust was located in, permitting some contrasts
between places to be assessed. The analysis largely consisted of tests for diVerences between means,
correlation and regression analysis; further details are available from the author.
4. Evidence from the Department of Health29 argued that car park charges will vary because the
situations of and constraints on trusts will vary, so the imposition of a central directive on Trusts was not
feasible, as it could not have dealt with the range of local circumstances. As they pointed out, some trusts
were in heavily-built-up areas while others were in rural locations with large amounts of land. Trusts also
incur costs in running car parks and the Committee was told that these should not be a charge against the
NHS budget, so charges had to be levied to cover them. NHS Trusts therefore had to make individual
decisions on the provision of and charges for car parking; there are no national instructions or guidelines,
and the matter is left to individual trusts. They are not obliged to provide car parking, nor to charge for it,
but if they wish to charge for it they are free to do so within income generation rules.
29 Ev 9 Volume II and Qq 77-88.
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5. Consequently it is not surprising that there are clear variations in the availability of parking, the cost
of it to patients and visitors, and the income generated by it. But are these variations justified by the
circumstances of individual Trusts? Here I examine the pattern of car parking charges and the variations
that exist, and I seek to identify any systematic underlying factors that might explain the pattern.
Availability
6. There is great variability in the availability of car parking, whether this is measured in terms of the
ratio of car parking spaces per bed or in terms of the ratio of patients to parking spaces. Of those hospitals
giving specific figures for patient and visitor parking, 45 trusts have at least one parking space per bed, 12
have at least two, and the maximum value is 3.3. As might be expected the ratio seems to be lowest in urban
general hospitals, and provision is significantly lower in London, with an average of 0.5 spaces per bed
compared to 0.79 at hospitals outside it.
7. Provision is, as the Department suggested, strongly associated with availability of land—one measure
of this was the extent to which the Trust site was built up (measured by the ratio of the area occupied by
buildings to the area of the site as a whole). This is strongly negatively correlated with the ratio of parking
spaces per bed, and it is a strong predictor of the availability of spaces—in other words, the more constricted
the hospital site the fewer parking spaces, and this will account for some of the diVerences between London
trusts and others. Provision of parking is not associated with throughput—there are no significant statistical
associations, suggesting that site constraints are more important. To some extent, therefore, this supports
the Department’s view.
8. There are also significant variations in the ratio of patients (inpatients and outpatients combined) to
parking spaces, which is a bettermeasure of demand for car parking than the total number of beds in aTrust.
There are a number of Trusts where there aremore than 10 patients per parking space per day, and in around
a quarter of all hospitals there are roughly five patients for every available parking space per day. We do
not know how many visitors should be added to this total, though many of these will visit in the evenings
when outpatients are generally not attending). Of course, many Trusts are in city centres where it can
reasonably be assumed that many patients and visitors will arrive by public transport.
9. Provision for disabled drivers can be assessed because figures were given for the numbers of disabled
parking spaces, although the dataset did not allow exploration of the availability of concessionary spaces
(eg the extent to which permits were made available to individuals to exempt them from charges in
unreserved parking places; evidence to the Committee suggested that some Trusts grant concessions to those
attending for regular outpatient appointments). There are variations in the availability of such spaces but
in the great majority of trusts they accounted for up to 25% of patient and visitor parking spaces, and the
ratio of spaces per bed does not seem to vary systematically with hospital size, location or patient
throughput. It is associated with site constraints, but not as strongly as is the case for the ratio of all parking
spaces to beds, suggesting that Trusts are giving some priority to the needs of disabled drivers.
Cost to patients
10. While nearly half of all hospitals charge less than £1 per hour (this is consistent with the Department’s
oral evidence that this is the median charge), 41 (or 27%) charged at least £1.50 per hour, the maximum being
£4.35. The hospitals in London appear to charge more than their counterparts elsewhere, since the average
hourly rate for car parking in London hospitals in the sample was £1.42 compared to an average outside
London of £1.08; this diVerence is statistically significant. Of course, there are numerous, central London
hospitals which do not provide car parking themselves. Patients and visitors travelling by car therefore must
rely on local car parks and the average cost of parking for those who do attend London hospitals by car,
including NHS and non-NHS car parks, would most likely be significantly higher than elsewhere. If parking
charges for the South East of England are compared with those elsewhere, the average charge is £1.41
compared to £0.97, which is a significant diVerence.
11. It could be argued that higher prices were a way of rationing parking space and if so we might expect
to be able to relate these charges to the availability of parking or to the ratio of patients per parking space.
However there appears to be no systematic relationship between the hourly charges for parking, the
availability of parking, and throughput; whatever it is that determines parking prices is not captured in these
statistics. It is possible that the pricing policies adopted by Trusts relate to the availability of parking and
the degree of congestion in the surrounding area.
12. Much concern was expressed by witnesses to the Committee about the costs incurred by individual
patients, but calculating the income from parking per patient is not possible because the data only give us
total numbers of attendances, which does not tell us how many times a particular patient went to hospital
as part of their course of treatment. There are some patients who, depending on the nature of the treatment,
will incur higher parking charges (this point was made repeatedly in evidence to the inquiry; several
organisations observed that there is quite a diVerence between attending for a very short outpatient checkup,
and having to spend most of the day in hospital on a regular basis, receiving chemotherapy). Nor do the
data include information on exemption policies of individual Trusts and we have no information on the
numbers who travel by public transport.
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Income
13. There have been suggestions that car parking is being used as an income generation measure for
Trusts so that the prices charged are higher than might be justified if the aim was solely to cover costs. One
way to explore this is to see whether there are variations in the income generated by car parking both in
absolute terms and as a proportion of a trust’s total operating income; the higher the figure the more
plausible would be a suggestion that Trusts were raising more money than was strictly justified.
14. There are variations in income per parking space which to a large degree are a combination of charges
and throughput of patients. However there is a substantial range—over £2,000 per parking space in several
provincial hospitals (Southend, Sutton Coldfield, Frimley Park and Epsom) to less than a quarter of this
even within the same region, such as East and North Hertfordshire, North Hampshire, and Queen Mary’s
Sidcup. Generally hospitals in London and the South East have a higher average score on this indicator than
is the case elsewhere in the country.
15. As for the proportion of income generated by car parking charges, in the majority of cases, this
proportion is very small—for over half of the Trusts reporting this information, it accounted for less than
0.25% of the hospital’s budget. However, in 15 cases, hospital parking revenue accounted for more than
0.5% of the Trust’s annual expenditure, and in two cases it exceeded 1% of the revenue expenditure of the
hospital trust. For comparison, figures provided by the Department suggested that the total income from
car parking at NHS Trusts was c £62 million, or around 0.1% of the NHS’s budget.
16. If, as the Department of Health implied, the primary aim of NHS Trusts is to cover the costs of
running car parks, it is not clear why there should be such large variations between apparently similar
institutions, particularly when the third-largest figure recorded was 0.7%. The proportion of a Trust’s
operating income derived from parking is statistically related to patient throughput, which we might
expect—the more rapid the turnover of patients, other things being equal, the greater the demand for
parking spaces. Interestingly, however, hospitals in London and the South East of England typically
generated a lower proportion of their revenue from car parking than was the case elsewhere in the country.
We would probably expect property and labour costs to be higher in these regions which would imply that
above-average costs would be incurred in running car parks.
17. What about NHS foundation trusts? Some data were supplied for NHS foundation trusts. There are
diVerences between these trusts and non-foundation trusts in respect of hourly charges and the income per
patient are not statistically significant. It does appear that for foundation trusts, car parking income, when
expressed as a proportion of the revenue budget, is significantly higher than is the case with non-foundation
trusts. However, since only 16 foundation trusts reported data to this analysis, this result should be treated
with some caution, and as the data relate to the first year of operation of Foundation Trusts, it probably
reflects the historic pattern of charges and is not necessarily a consequence of the change of status of
these Trusts.
Conclusions
18. There are clear variations in the availability and cost of parking at NHS hospital trusts. The question
is whether the variations are justified. If the Department of Health is correct these variations should reflect
site constraints and local circumstances such as demand for parking. To some extent this is true of provision,
which is associated with site constraints, but not of charges (though these are higher in London and the
South East) or the income raised from them. In particular variations in the proportion of income raised by
parking charges are not easily explicable in terms of site constraints or throughput of patients.
19. As lengths of stay continue to decline, and as the number of patients treated as day cases or as
outpatients continues to grow, the numbers of people competing for these spaces will rise, posing additional
problems of managing transport to and parking at hospitals.
20. Some of these demands might be mitigated if more people travelled to hospital by public transport,
or if more services were delivered locally, eg through GP surgeries. Otherwise the numbers of people
competing for these spaces are going to rise. Trusts could deal with these demands by increasing prices as
a rationing mechanism, which would impose additional costs on patients of the kind described by several
witnesses to this inquiry. Alternatively they could deal with them by providing more parking spaces, or by
developing travel plans which would facilitate access to hospital by public transport.
John Mohan
School of Social Sciences, University of Southampton
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